>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLibLcbsbRsbLobLhbLcbRsbLobLobLoRsbRjbRobRcbRcRibsbRobRsbLjLhbRcbLhbRj
RsmbRcbLiLcLsmbLibRsbLsLsmbRjbRobRgRsmbLobRsLsRsRsmbRsbRsLsbRsLsbRsLsL
sRjmbLsbsbRobReRsRsmmbRibLsbRibRgbsbRgbRsbRsRsRembRgbLcbLiRsRsmbLcRsbL
ibLcbLeLsLsmbLgbLjbLjbRsRsRembRgbRebRebLgbLhbLibRcbRebRobRcRsLsmbRsLcR
sbLiRgRiRsmbRebRsbLjbRcbRcbLiRsbRcbLcbLiLhbLjbRcbLebLcbLebLibRgRsRgRsR
smmmbLcbLsRsbLebLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRobRcbRibRiRsRsmmbRgbRibRcRsmbRebLobRsRibRibLcRsbLhbLobLobLobRgbRsRsR
smmbLobRsLibRjbRcRsRsmmbRhRibRibRiLsbRhbRgbRibRiLsLsmbRibRobLobLibLibL
ibRobLcRsRsmbLobRebReb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRcbRibLgbLobLsLcbLobLobLobLcbLobLobLobLobRcRsmbRcRsmbLjbLjRsbRibLibLs
bRjLsRsbRsRsRsmmbLsRsbLsRsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bLsbsbRsbsbsbsbsbsbRsbReLsLsRsmbRgbRcRsRsmmbLibLcLsLsLsmmmbLgLsbLsbLib
RibRiRsmbRoRsmbRgbRsbRsbLsRsbRsbsbLsRsbLsbRsLsbLsRsbsbRgbRgbRibRsbRgbR
sRsmbLgbRhbLobRebReRsmbLsbRibRsRsmbRsRsmbRsRsmbRsbLsbLsbLsbRsLsbRsbRsb
LgbLgbLsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bLebLobLjbLobRjbLcbLcbLobLhbLobLobLobLhbRobRobLsRcbRobRgbLjbLcbLibLsRs
bRsLcRibLjLsmbRebLibLibLibLibLibRsbLibRsbLibLhLsbRsbLcbLcLibLhbLobLhbL
hLsbLsLsLcRsRsmmbLsbLsLsmbLsRsbRsbsbsbLebsbLiLsLebLhLsbsbLgbLhbLsLsmbL
sLebRgbRibRibLcbLcLsmbRhbRibRhbLcbLcbLcbLcbLhbLcbLhbRibRhbRhbRcRsmbRsL
jbLhbLhbRgbRobRsbRiLsLsmbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bLobLhLsLsmbLobRobLcbRobRcbRhRsmbRobRsbRobRibRcbLsbRobRsbRcbRcbLcbLibL
obRjRsRsmmbRobRobRhbRobRcRsmbRiLsbRcRsRsRsmmmbRgRsRsmmbRgbRgbRsLsbRjLs
bRgRsRgRsmmbRgbRiLsbRibRgbRjbRibRgbRgbRgRsmbRsbRsRgbRgbRibRsRsmbRibRgb
RsRsmbRiRsmbRibRsbRgbRhbRsRsRsmmbRibRcbRibRibRibRibRsbRhRsmbRgRsmbRibR
sbsbRsRsmbsbRsRsRsRsRsRsmmmmmbRsbsbRsbRsbRsRsmbRsRsmbRiRsmbRgbRsRsRsRs
Rsmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bRibRhbLjbRcbRcbRibRiLsbRjbLjRsbLobLcbLcbLsLebLhbLobLjbLjbsbsbLobRsbRj
bRsbRsbLsbLsbRsbRsbLsbLsRsbRsbRjbRsbRsbRjbRsbLsbLjbRjbRsbLsbLsbLsbLsbR
sbLsLsmbRsbLsbRsbRsbLsbLsbLsbLsbRsbRsbLsbRsbRsRsmbLsbRsRsmbRsbRsbRsbLs
bRsbRsbLsbLsbRsbRsLobRsbRsbRsLsbLsbRsbLjbLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRhLsbRcbLcbLjbLobLobLcbRoLsbRjbRiRsmbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLsbLsbsbRhbRiRsmbLobLjbLhbLibLcbLobLcbLgLsRsbLgLcbLibLobRjbRcRsmbLibR
hbRcLsbRgbLibRobRhbLsbRobRebRhbLiLsbLibLibLibLcbLcbLobLcbRobLobLobRobR
ibRsRsRsmmbRoRhbRcbRibRgRsmbRcbRibRibRobRcbRobRcRcRgRsmbRcbRiRsmbRsRsR
imbLoLsmbLhRsRsmbLibLibRcbRcbLoLcbLobLhbLhbLobRcRsmbRiRsRsmmbRobRcbRhb
RibRcbRhRsmbRiRsRgLgmbLcLsmbRsbRsbLibLcbLcLsRsmbLcbRiRsmbLcLsmbLcLsmbL
ibLjbLoLsmbLgbLsbsbsbLibLsLebLebRebLsbRhRebReRsmbRgRsmbRiLsLsRsmbRoRsm
bLobRcbRcRsmbLcbRcbRobRcLsbRcRhLsbRcRsmbRcbRiRsmbLcbLibLibLcbLobLcbLob
RoRsmbRcbRhRibRiRsmbRcbLsLsmbRcRsRsmmbRibLcLsmbLhbLcbRcbRcbRobRsRgRgLs
bRcbRiLsLsmbRiRsmbLsRcLsbRobRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRobRibRibRgbRsbLibLobRgbLcbLiRsRsmbRjbRebLcLsmbRobRibRsbRoLsbLiLsbLob
RsbRsbLsRsbLebLibLcLgbRgbRsbLcRsbRgbLjbRjbRjRsmbRiRsmbRsRsmbLoLsmbLgbL
gbLiRsRsmbRgbLsbLibRjRgbLsbLgbLsbLcbLcbLgbReRsmbRhRsmbLgbLhbLsbLgbLibL
sbLhbLgbRsRsmbRgRsmbRgbRsbLsbRgbLsbRsRsmbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bLibRsbRobRcbRsbLcRsbRsbRsbRebLoRsbLgbLsRsbRiRsmbRoRsmbRobRobRcbLobLcb
LcbLcbLjLhbLsbRjbRobLgbRiRsRsmmbRsRsRsRsmmmbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bRsRsmbRhbRsbLsbLibLibLoLsLsmmbLoLsmbLsbLhbLsLsmbLgbLoRsbRgbRsbRoLsbRg
bRsbRcbRobRobRobLcbLobLobLhbLhbLcRsbLjLsmbLjLsmbLcbLhbLibsbRebLibLcbRg
RsmbRgbLcbLcbLsbsbsbsbsbRsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRobRibRobRibRibLcbLjbLcbLobLgbLibLsbLcbLcbLibLobLcbLcbLcbLcbLobLhbLcb
LsLsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLjbLibLgLsbRjbLsLoRsbLcbLibLobLhLsbLobRhbRoLsbLsbRobRhbRcLsbRcbLibReb
RhbRobRobRcbRcLsbRoRsmbRobRibLobLjbsbRobLjbLsbLcbLebsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLsLsmbRsbRoLsbLsbLiLsbLsbRjRibRcbLibRobRsbRobLsbLibReLsbRobLgLsbRoLsb
RebLobRiLsbLcbLoRsbLobLiLsbRhbLcbLsLsmbLhLsbLeLgbLobLjLsmbLobLibLhLsbL
cbLcbLobLebLcbLsLeLsbLeLgbLsRsbLibRobLsbLsLsLsLsmmmbLsLsmbLsLsmbLgbLcb
RsbLcLsLsmmbLebLeLibLgbLsbLgbLeLgbLcbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bLgbRobRiRsRsmmbLjbLjbRjRhbRobRsRsmbRibLgbLobRebRobRibRobRjbRcbRsbLjbL
obLcRsbLcbLibLjLsmbLobLoRsbRobRjbRobRjLsbRobRjbLobLcLcbLoRsbRcbLcbRjbL
cRsbLcLsLgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bLobLcbLibLobLjLsmbLhbLcbLhbLobLgRsbLebRobRcLsbRiLsbRoLsLsmbRjbRjbRjbR
iLsLsmbRjbRibRiRsmbRgbRjbRjbLsbRjbRsbRgbRgRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bLsbLcbRhbLeRsbLibLobRibLobLibLiRsbRibsbRgbLibRsbLcbRoRsmbLjbRhbRebRhb
RcbRobRjbRjbRobRcbLcbLcbLobLcRsbLgbLgRsbLgLsLsmbRsbLoLsmbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bRcbsbRjLsbLjbLcbLobReLsbRgbRcbLcLsmbLsbRcLsbReLsbRcbRcbRiLsbRcbRgLsbR
cb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bRsbRobRsbLibLjbLhLsbLhbLcbRcLsbRibRibRgLsbRgLsbRsbLiLsbLebLibRgbRgbRc
bLgLsbLebRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bLibLobLoLsmbLjbLsbRgbLobLibLebLobLibRcbRobRcbLcbLjbLiRsbLcLsmbLcbLgLs
RsbLibRebLsLsmbRsbLsbLsbLsbRsbsbRsbsbLjbLibRcbRsbRsbLhbLebLibLsRsbLcLs
mbRgLsbRcbRobRsbRoRsmbRhb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLsLsmbReLibRoLsbLibRobRobLcbLeLsbLjbRjbRobLsLsmbLsbRebLibLgbLobLibLob
LjbRcbRobLsLcbLobLjLsmbLibLsLsmbRsRsmbRsLsbLjLsmbLcLsmbReRsmbRcbRcLgRg
bRcRiRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bRcLsbLsRsbRgbRsLsbRhbRgbRgLsbLjbLgbsbLgbRsbLgLsbLgbLibRsLsbLcbRsbLgbL
eLsbLjRsbLcbLcbRgRsmbLobLibLcbLgbLcbLobLgbLibLibRiRsmbLobLiRsbLjbLiRsb
LhbLjRsbLhbLcLsmbRobRcbRcbRcbRcLsbRobRhbRibRhbRcbRibRcLsbRjbRsRsmbRhLs
bRgbLcbLsLebLsbsbLgbLsbLgbLcbLgbLhbLhbLiLsRsbLiLsbLeLsbRibRcbRsbLsbLsb
RgLsbRgRsmbRsbRibRibRsRgLsbRgbRiRsmbRgbRgbsbRhbLibRcRsmbRibLobLibLiLsL
smbRcbRobLebLibLcbLgbLibLhbLebLcbLhbLibLcbLcLsmbLibLibsbLcLsmbLibLibLc
bLibLcbLibLhRsbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bLgbRgbRgRsmbRibRobRjbLsRcLsbRhbRibLsbLsbLsRsbRgbRobRhbRibLgbRibRsRibR
gbLjLsmbRhbReRgbLgLsLsLhmbRcRsmbRibLgbRcbLobRhbLibLobLcbLobLjbLobLibLc
bRibRcbRcRsmbLsLgbLibRobLjRsbRjbRiLsbRoRsRsmmbLsLsLgLsmbLcbRibLjbRcbLs
RcRsLsmbRcLsRsbLgbLebLgbLgbLsLsmbLgbLsbLibLibLcbRsbLsbLcbRsbRobRcRgLsR
gbLjbRcLsbRibRobRcbRhbRcLsbLobLcbRcbLcbRcbLoLsRsmbLcbRibRcbRcbRibLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRibRibRgbRibRsRsmbRsRsmbRsRsRsmmbRgbRgbRgRsmbRsbRsRsmbRjbRgRsmbsbRsbL
sbLgbRsbRsLsLsmbRsbRgLsbLebLgbLsbLgbRsbRjbLsbRhbRibRgRsmbLgbRjbRobReLs
bRgRsRsmmbRiRsmbsbLgbRsbLgbRsbRsbRgRsRsmmbRsRsRsmmbRsbsbRgbRsbLjRsLcbL
ibRjbsbRiRsmbRiRsmbLsbRsbLjbLhbLgbRsbLsRsRgbLeRsLsbRsbRcbRsRibRibRsbLi
bRjRsmbRgbRibRjRibRibLsLsmbRcbRibRibRcbRibLgbLgbLoLgbLgbRcbRiRsLsmbRsb
RhbRcbRiRibLsbRgReRgbLsbRgRsmbRsbRhbRibRiRsLsRsRsmmbRebRsRgbRgbRgbRsbR
hbRibRibRebRibRibRcbRcbRcbRhLsbRcbRcLsbRhbRcLsRsbLgbRibLcbLiLhbLhbRcRi
bRcbLsbRibRibRcLsbRsRsmbRjbsbLgbRcbRjLsbLjbLjbLibLcbLibRcbRcbLjbRiLsbR
eLsbLibRibRebReRiLsRebRebRebRhbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLgbLgLsbLsbLobLsbRsbRgbRsbRjbLcbLibsbRobRgbRobLgbLsbLcbLobLcLsmbsbLsb
LgbRobLgbLiLsbRjbLhLsbLcbLcbLgbLibRcbRsbLjbLjLgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRoRsmbRiRsRsmmbLiRsbLobReRsRsmmbLiRsbLoRsRsmbRibRsRsmbLobLjbRobsbRsbR
gRsRsmmbRjbLibRcbRsbRgRsmbLgRsbRgRsmbRsbRgRsmbLsRsbRgRsmbsbRhbLgbLgRsb
LibLgbLgbLgbLjbLiRsbLiRsbRgRsmbRsRsmbRsbLsRsbRebRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLibLiRgbLibLgLsLgbLsLsmbLsbRsbRobRgLsbRoRsmbsbLsLsmbLsLsmbLiLsbLobLsb
LcbLcbLoLsmbLcLsmbLiLgLsbRcLsbLoLsmbLibLeLsbRiRsmbRsRsmbLobLcLgLsbRobs
bRsLsbsbRsLsbRsbLcbLcbRcbLibLsLsLsmmbLcLsmbLcLsmbRcbRhbLcbLiLsbLeLsLsm
b

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bRhbRcLsbLobLjbRhbRibRobRobRcbLoLsmbLsLsmbLcLsmbLcLsmbLcbRobRoRsmbRcbL
eLsLsmbLiLibRsRsmbLhLsbLhLsbRebLibRsRsmbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsbRjRsmbRibRibRsRsmbRibRiRsmbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bLibLgbLibLgLsLsmbLiLsbLgLsbLsLsmbLhLcbLcbLhbLgLsbLiRsbRobRobLobLibLcb
LibLgLsbLgRsbLsbLsbRobLjbRobRibLcRsbLibRibLhbRobRjLsbRcbRcbRobRobLjbRc
bRcbRcbRcbRjbRcbRcbRjbRjbRcbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bRobLjbsbRsLsRsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbLsbsbsbsbsbLsbsbsbsbRsbsb
Lsbsbsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRobRibRgbRsLsbRsbLcLsmbLhRebRoRiLsbRobLebLcbRcbLsbRibLobLhbRibRebRoRs
mbLsRsbLsbRobRjbLsbLobLgbLcbLcbLcbRobRebRhbRobRobRhbLcbLibLgbLibRcbLsb
RobRobRobLcbLjLgbLobRcbRobRobLcbLcbLcbRcbRcbRhbRcRgbRobRobLjbRcRsRsmmb
RjbRcRsmbRjRsmbRoRsmbRcbRcRsmbRcbRobRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bReRsmbRjbRhbLibRobRcbRgRsmbLibLibLibLebRhbRiRsmbLobLcbRsLsbLgbLiRsLsR
sRsmbRjbLsbLjbLiRsbLsLcRsbLcLsmbLiRsbRsbRsbRibRcbLcbLhbLcbLjbLgbLibLib
RcbLcbLcbLhbsbRsbRibsbRgbLcLsmbRcbRjRsmbRcLsLgbLgbLsbLsbRcbRcbLobLsbRo
bRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLobLibRibLobLibRobRibLobLibRobLcbLhbLibRsbLsRsbLsLibLsbLoLcbLebRibLgb
RobRibRibLjbLibLsbLsLsmbLebLgbLsLsRsmbRsbLgbLsLsmbLgbLsLsmbLsLsLsLsmmm
bLgbLgbRsbLgbLsbLsbLgbLgbLhbLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLhRsbRobRsbLibLgbLobLibRibRcbRibRebLsLgLsLgbRobRgbRobLibRobRgbRobRsbR
sbRhbRibLibLsbRcbRcbRoRsmbRgbRibRsbLiLsbLcbLibRibRcbRsRsLsmbRjbRibLcbL
cbRjRsmbLcbRcbRgbRjbLjbLibRcbRjbRsRsmbRsbLjbLibLibRjbRibRsRsmbLjbLibRj
bRsbRibRsbRiLsbRibRsbRhbRsbRjbRsRsmbLjRsbLgbRgbLcRsbRsRsmbLibLibLibLgb
LsbLgbLgLsLsLsLgmmbLsbLgbLsRsbLiRsbRsRsmbLsbRjbLsbLjbLibRgbLibLsbLibLi
bLsRsbLsbLsbLgbLibLsLsmbLgbRsLsbLibLsbLibRsbLiLsbLibLsbLibLgbLgbLgbLsR
sRsmbLibLibLhRsbLsbLibLgbLgbLjbRgbsbLsLsmbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bLgbLobLjbRcRsmbRgbRgbRgbRgbLhbRjbRiRsmbRgLsbRgbRgRsRsmmbRgbRobRibLhbL
cbLjLcbLoRsbLgLsLsmbLjRsbLobRebLobLobRibLcRsbLsbLsLcbRhbRobRhRsmbRobRo
bRobRjbLgbRjbLcbLiLgLsbRsbRgbRgRgbRgbRjbLjbRebLcbLcbsbRiRsRsmmbLhLsbLe
RgbRcbLiLsbRhbRibRhbLiRsRsmbLiLsbsbRoLsbLobLobsbRobLsbRoRgRsmbRiLobRcR
smbRcbRcLsLsmbRsbRiRsmbRhRsRsmmbRcLsLsmbRobRgbLcbLoRsbRjbRiLsbLhLsbRoL
gbLjLsmbLsbLgbLsRsbLobRobLhbRhbLiRsbLcbLhLsbsbLsbLjLsLsmmbRsLsbRsbLcbL
cbLebLibLjLsmbLiLsRsbLgLsbLhbLcRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLcbLibLcbLobLcbLoRgbLibRibRhbRibRcbLcbLhbRobLobLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bLiLsbLibLibLibLsbLsbRcbRhbRsbRsbRiLsbRgbRsbRsbRgbRgRsmbRsbRibRobRcbRc
RsmbRsbRobRibRhbRiLsbRsbLibLeRsbRoRsLsmbRgbRsbRsRsRsmmbLcbLiLsbLgbLgbL
gbLibLobLsbRcbRobRcbLibRsbRcbRcbLsbLcbLibLibLsbsbLjbRibLgRsbLsLsmbRebR
ebLcbLhbLhbLcbLcbLobRcbLcbLibRebRsRsmbRsbLiLebLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bRjbRobLhbLcbRcbRcbLhbLhbLsLcLsmbLhLsbLobLibLcbRcbRiLsbLjbRcbRobRcbRob
LcbLobRebRcbRcbLcbRcbRcRsmbRcbLhbRcbRcbRcbLjbRcbLibRcbLcbRcbLcbReRgbRc
bRcbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRoRsmbRobRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bRcRsmbRcbLebRgRsmbRcbRcbRjbRobRebRibLgbLcLsmbRcbRobLobLobRebRoRsmbLcb
LhbRsbLjLsmbLjbLiLsbLebLiLsLsLsLsmmmbRgbRcbLjbLgLsbLibLgLsbRjbLhbRsbLc
bLsbLebRhbLiLsbRsRsmbRsRsmbLgLsLsmbRsbLibLgbLiLsbRsLsbRsLsbRsLsLgRsbLs
LsLsLsLsLsLgmmmmmbRsbLgbLsRsLsLsmbLgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bLibRcbRobLsRobLsbLsbLsLsmbRsRgbLobLjbLobRsRibLgRsbRoRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bRgbRgbRibRcbRsbRsbRibRibRsLsbRibRjbRsbRhbLibLhbLibLcbLhbLgbLsbLebLcbL
cbLhLsbRsbsbRsbRsbRsbLsbLsbRsbLsbLsbRsLsbRsbRsbRsbLsbLsbRsRsmbRsbLsbsb
LsbLsbsbRsRsmbRsbsbRsbsbsbLsbRsLsLsmbsbsbsbsbsbsbLsbRsbLsbLsbLsbLsbLsb
RsbLsbLsbLsbLsbLsbLsbLsLsmbRsbLsLsmbLsRsbLsbLsRsbRsbLsbRsRsRsmmbRsRsRs
LsmmbRsLsLsRsLsmbRsLsRsRsmbLsbLsLsRsLsRsmbRsbLsRsRsLsRsLsmbLsLsmbLsRsR
smbLsbRsRsLsLsLsmmmbLsRsRsLsmbsbRsbLsLsRsRsmmbsbsbsbsbsbRsbsbsbsbsbsbs
bsbsbsbLsbsbRsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bRsbRcbRcRsmbLgbLibLiLsbRhbLebLcbLcbLibLcbLobLsbLhbRjLsbRcbRoRsmbRsbLi
bLhbLcbLsLsRsmbLhLsbLobRcbRcbLcbLcbLibLcbLgbRcbRsRhRsmbRobRoRsmbLcbLcb
LjLsmbRcRsmbRiRsmbLhbRhRsmbRiRsmbRcRsmbRjRsRsRsRsRsRsRsRemmmmmmmbRcbRs
RsmbRsbsbLhbLoLgLsbRiRsmbRcLsbRjRjRsRsmmbRcbRiLsbRebRhbRcbRjRsRsmmbRiR
jbLsLsmbReRsmbRiRsmbRoLsbLhbLcbLibLsbRcRsRsmmbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bLcbRebLcbLcbLhbLobRjbRibLobLibLoLsmbRhbLobLobRhbLobLcbLobLobLgbRjbReb
RibRoLsbLjRsbLoRsbRibRobRgbRebRobRoLsbRcbRiLsbRoLsbLoLsmbLcLsmbLcbLobL
cbRobLcbLobRsRsmbLoLsmbLjLsLgmbRjbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLoRsbLgbLoLsmbRcRsRsmmbRobReRiRgRsmbRiRibRsbRgbLcbLhbsbRhbsbsbsbRsbLo
LsmbLsbRibLsbLibLcbLobLibRcbLgbRibRoLsbRcbRhLsbLobLhbLobLobLobLcbLobRc
LsbRhbRiRsRsmmbRgRsRgRsmmbRebRsRsmbRgRjbRgLgLsbRibRhbRsRcbLibLcbLcbLib
LcRsbLobLobLoLsmbLcbLhbLhbLhbRsLibRjbRsLjbLibRobLjLsmbLibLibRjbRibLibR
sLsbRjbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153315; End: 153815;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bRsbRjLsbLgbsbsbLsRsbRsbReRsmbRgbLsRsbLibLcbLcbRebRibRcbLobLcbRhbLhbLc
bLcbLibLobLcbLsRsbRsRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLsLjbRibLsbLgLeLebLcbLebLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRobLebLcbLebLobLibRsbRsbRsbsbRsbsbRsLcbLobRobLhLsbLcRsbLcbRhbLcbRhbLi
bLsLobLobRsRsmbRcbLgbLobRoRsmbRhLsbRgRcbLhbReRsmbRebLsLsmbLibLiRsbLibL
cRsbLibLibLobLiRsbLiRsbRcbRcRsmbRcRsmbRjbRcbRoRsmbLcbLibLibLcbRjbRcRsm
bRcRsmbRibRobRibRibRoRsmbLgbLcLsmbLobLgbLobLibLsbsbLcbRcRsmbLebLoLsLsm
mbLjLsmbRcRsmbLcbRgbLjbRgbLibLibLcbRobLhbLiRsbLibLoRsbRiLsbRobRibLobLe
RsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRsRgRsmbRsRsRsmmbRsRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRsbLibRsRsmbsbsbsbsbsbLsRsRsmbsbsbRsRsRsRsmmmbRsLsRsLsbRsRibRsbRgbLjb
LobLsbRhbLcbLgbLgbLsbLsbLsbLsLsLsmmbLgLsLsmbLgbLsbRjbsbLoRsbLibLibLobR
gRsmbRcRsmbRgbsbRiRsmbRgbRgRsmbRgbRgbLoLsmbLsbLsbLgbLsbRjLsLsmbLeRsbLi
bRsbRobRgbLsRsbLcbLjbLcbLcbLsbRibLhbLobLobLoRsbLcbLibLobLsRsbLobLiLsbL
obLibLobLobLobLhLsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bLjRsbLgRsLsbRibRibLsbRibLsbLcLsmbLeLsbLsLsmbLiLsLibLiLsbsbsbsbsbsbsbL
sbsbRsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRgbRsRsmbRsRsmbRsLsbRsRsRsmmbRsRsmbsbRgbRsbRgRgbRgbRgLsLsmbLsbRiLsbRg
bRiLsRsLsbRsRsRsmmbRsRsmbRgbRsbRgRsmbRoRsmbRobLsbRobRiRgbRsbRsbRsRcbRe
bRiRgbRebRgRsRembRibRibRgbRebRsRsmbRibRibRcbRgbRiRsRsmmbReRsRimbRsbReR
smbRibRgRsRsmmbRgbRgbRgRsmbRgbRibRgbRgbRgbRgRebRhbRebRgRebRgbRibRebReb
RebRhbRsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLjbLcRsbLhbLeLsLsmbLiLsLgbLibLoRsbRcbRiRsmbLobLgbLebLebLebLsbLiLsLsmb
LcbLcbLeLsLsLgmbRjbLebLcLsmbLcLsmbLcbRjbRcRsLsmbRiLsbRiRsmbRibRsbRobLg
LsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRcbLcbLgbLcbLhbLibLsbLcbLcbLgbLgbLgbLgLsbLibLiLsbRsRsLsmbLcbLobLibLcb
LhbLgbRsbLcLsmbRobRibRiRsRsmmbRgLsbRsbLjbLibLcbRebLcbLhbLgLgLsbLsbLibL
cbLcbLcbLsLsmbRcRcbRobRsLsLsmbLgbLcLgbLibLebLgLsbLgLsLgLsLsLsmmbLibLgb
LiLsbLiLsLsmbLiLsbLiLgLsbLiLhbLgLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLcbLcbLcLsLsmmbLhbRcbRcbRhLsbRcbRcbRcbRoRsmbRcLsbRcbRhbRcbRsRsRsmmbRi
bRsRsmbRiLsbRjbLhbRjbRhbRibRcLsbRhbRjbRibRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRsbLgbRgbRsRgRebLgLgbRsLsbLjbLibRiLgbLibLsbLsLiLgbLsLsmbRibRgRebRsbRg
bLsbRjbsbRebRebRebRgRsmbLibRebRsbLhbLibLgLsbLgbRsbLebLsLgLgbLgbLsbRibR
sbRgbLsbLhbRjRsmbLibLgbLsbRiRsmbLgbRgbRgbRsbRgRsRgRsmmbRebLeLsbLgbLsLs
mbLgbLibLgRsbRgbLibLgRsbLibLebLsbLsbRjRgbRebLibRhbRsbRgbRibRiLsbRhRsRs
mmbRsbLsbRgbRibRgbLeLsbLgbLgbRjbLjbRebRgbRsReRsmbRgbRhbRhbRgbRhbRibReb
RgRsmbRibLibRiRsRiRsRsRhRimmmbLsRsbRgRsmbLgbRibRsRsmbRcbRgbLibLsbLgbLi
bLgbLgbLebRsbLgLsbLgbLhbLgLsLgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRcbLcLsLsmmbLgLgRsbLobRiRgRgRsRsRsRsmmmmbRgbRcbLobRiRsRsmmbRebLebLjbL
cbLibLcbRgbLhbLcbLgbRiRebRibRgbLiLgbRjbRhbRcbLgbLeLsbLiLsLsmbLobLiLsbL
ibRobRcbLsRibRebLibLcbLibLibLobRiLsbRibRgbRjbRgbLjbRsbRgbRiRsRgRgmbRhb
LhbLsLsLsmmbLsLgbLsLsLgLsmbLgbLebLcbRebRibRhbRibRgbRsbLibReRiRsRsmmbRe
bRibRgbRebRhRsmbRiRsmbRibLgbRgRebRebRiRgRsRsmmbLcLsmbLebRhbRebRgbRibRe
bLhbLebLibLgbLgbLiLsbLsLsmbRsLsbLhbLebLebRgbRibRsbRebLobLgLcbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bsbRsbsbsbsbsbsbRgLsbRsLibRgbLgbRjbRsbRiRsmbLsRsbLsLsmbLibLsLsmbsbLsLg
LsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLjbRjbLhRsRsmbLcLsLsmmbRhLsLsmbRobReRsmbRgRsmbRgbRgLsbRibLsbRiLiLibLg
LsLsmbLiRsbLiLibLibLcbLcbLibLcLsmbLibRsLsbLcbLiLgbLhLsbLgbLiLsLsLsLsmm
mbLgbLsLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRjbRhRgRsmbRhRsRsmmbRsbRoLsbsbRhbLcLgbLcbLsLsLsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bRsLgbLgLgbLebLebLgLsLsmbLeLsbLebLeLsbLsLsmbRsbRgbLsbLiLsbRsbLsLsLsLsm
mmbLiLsbLcbRibLcbLcbLiLsLsmbLiLgbRcbRgbRhRsRsmmbRsLsbRcbRibRcbRcbRsbLi
LsLsmbLhbLibLibLebLeLgbLebLhbReRebRibLjLibLcbLibLebRsLsLsmbLgbLsLsLsmm
bLgLsbLibRibLjLsmbLibLsLsLsmmbLiLsbLgbLiLebLsLgbLhLsbLiLgLibLibRiRgbRg
bRgbRibRebRgbRgRsmbRhbRhbLjLsLgLsmbLebLiLsbLibRsbRsbRsLsbLsbsbLsLsRsmb
sbLsbLibLgbLgbLgLsLhbLebLibLsbLsbLsLsLsLsmmmbLcLsmbRgbLcLsmbLgLsLsmbLh
bLibLcbLgLsbLgLsbLcbLhbLhLsbLcbRibRcRsRsRsmmmbRhbRiRsmbRiRsmbRgbLcbLeb
LibLiLgbLiLgbLebLebLebLibRsbLibLsbLgbRebRgbRgbLsbLjbLgLebLgbLebLgbLhbL
sb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRcbRcbRcRsmbRjbRcRsmbRhbRcbRcRsmbRcRsmbLcRsbLobLcRsbLiRsbLobLcLsmbLcR
sbLcbLgbRoRsmbRhbRiRsmbRcRsRsmmbRcbRcbRsbRcRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bLsbLgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bLibLsLgbRjLsbRgRsmbRjRsmbRsLsbRgbRoLsbLgbRcbRibReLsbRsRhbRcbRsbRcbRib
RjLsbRcbReRsmbLoLsmbRcbRebRgbRoLsbRibReRsmbRibLjbLcbLebLebLebLebLibRjb
RcbRcbRibRsbRiRibRhRsmbRgbLcLsLsLeLsmmbLgbLgbLgLsbLibLsbLgbRibLsbRcbRh
bReLsbReRsmbRcbsbsbsbRsbRebRhRsRsmmbReRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bsbLcbLhbLsbRjbReRsmbRsRsmbRsRcLsbLhLsbLibRebLcbRsbLhRsbLibLibLsbLcRsb
RsbRhRsmbLsLsRsmbLebLebRebLsRsbRebRhRsLsmbRibRibRcbRibRjRsmbRjbLsbRgbL
jbLcLsmbRcbLjbRcbLgbLcRsbLibRsRsmbLgbLoRsbLcbRgbRobRebRiRsmbRgbRhbLgbL
obLibLibLgbLcRsbRsbLobLhLgbLiLsbLcRsbLgbLhRsbLibLsbLibRcbRibRgLsLsmbRi
LsbRhbRhRsmbRgRibRebRgbRibRgRsmbRgbLiLsbRcRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bRhLsbRcbRcbRgbRibRiLsbRcbReLsbRobRibRiLsbLsLhLsbLibReRgbRgbRiLsLsmbRc
bRgbRcbLoRsbLebLcbLobRjbLcbLcbLgbLhbLiLsbLsLeLgbLibLibLebLeLsbLcLsmbRc
bRgbLhbLcbRgbRebRibLgbLibRgbLgbsbLgLsbRjbLsbLibLgbLcbRgbRsbRcLsbLiLsbL
cLiLsbLsbRebRsbRebRsLsbRcbRgbRibRsLsbLjbLibRebRibRiRgbRsbRsbsbLsbsbRiL
sRsbRibLhbLiLsbRibRcRcbLoRsRsmbRgbRsbsbsbsbsbsbsbsbsbLsbRsbsbRsbLsRsbs
bsbsbsbLsbLsbLsbsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bLsRsLsbLcbLcbLgbLibLsbRsLsLsmbLsbLhRsbLhbLibLebLebLhbLsbRsbsbRjbRobLc
LgRsbLhLsbLibLiRsbLibLjbLibLibLhbLcbLhbRjbRcbRsbLsbsbLsLsmbRsbRjbRsLsb
LibRjbRcbRcbLcRsbRsLsbLsbLjRsLsbRcbRcbLjbRhbRhLsRsbLibRsbRiRsmbLjbRjRs
RimbRhbRcbLsbLibRjbRibRcbRhRsmbRhbRcbRhRsmbRjbRcbLibLebLcLsmbLebLgLsbL
iLsbLgbLibLibLebLgbLjLsmbLsbLiLsLsmbLcbLcbLibLiRsLsbLebLcLsLsmmbLibLib
RibRsbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bLcLsLsmmbLcbLcbLjLgbLiLsbLhbLcbLcLsmbLebRjRibLcbLcbLobLobLibLebLsbLib
LgRsLiLsbLiLsbLibLsbsbRsbRsbLibRsbRibRcbLjLcbLiLsbLjRsbLgbLcLsmbLiRsbL
iLsLsmbLhbLibLeLiLebRgbLebLjbRgbLebLgbLoLsLsmmbLiLobLebLebLsbLgbLhbLjL
sLsmmbLhbLhLsbLhLsbRibRibRiRsmbRjbRebRibRhbRhbRsbRhLsbRhbReRcbRgbRiLsb
RgbRsRsmbRebLsbRibRibRibRiRsmbRhLsbRibRgbLgbRibRcbRibRibRhbLjbLhbRsbRo
bRiLsLsmbRsbRcbRgbRiLsLsLsmmbLhbLibLjbLjRsbLcbLsRsbRsRsLsmbsbRibLjbLjb
sbsbLgbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRsbRhLsbRiRjRsmbRibRiLsRibRgbRebRibRibRebRebRhbLsbsbsbLsbLsbRcRsmbLib
LgbLgbLjbLjRsbRsRibRiRcbRcbRiRgbRibLsRsLsbRsbsbRsbsbsbsbRsbsbsbsbsbRsb
sbsbsbsbLsbLsbsbsbsbsbsbLsbRhbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLsbLsbLsRsbLsbLsbLsbLsbLjbRgbRsRsRsRsmmmbRsRsmbLsbsbRsbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bsbRgbLsbRsLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLiLsbLcbLebLjRsbLhbLhbLebLcLsmbLgbLcLsLsmmbLgbLgRebRibRhbRgbLcbLcbRib
LcLsmbRsRsmbLebLjbLebLgLsbRcbRgbLjLgbRsbLsbLoLsmbRsbLoLsmbLiLsbLsbRjbR
hbLcbLhLgbLibRobRiLsbRsRibRebLgbLgbLgRsbLhLsbRgbLibLcbLgbLiLgLgbLibLib
RjRsmbRhbRgbRibRibLibLgbLeLibLgRsRsmbRjbRcRsmbRibLjbRjbRgbLcbLhLsbRsLs
bRoLsbRibLcbLiLjbLsbRcRsmbRebLgbLhbLibRcbRibRebRibLjbLgbLcbLsbRebRjbRc
bRobRiLsbRgbLcbLjLgLsbLeLsbLiLsbLcbLibLgbLgbLgbLgbLebLiLsbLibRibRgbRcb
RgbLibRgLgLgbLgLgLsLgLsLsLgLsLembLgLiLsLebLebRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRsLibRgbRebLhbRcRgbRcbRcRsmbRsRgbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bReRsRsRimmbReReReRebReRsRsRsmmmbRiRsRgmbLhbLiRsbRgbRgRsmbLsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbRsbLsLsLsRsmmbsbsbLsbsbRsbRsRcRgbRebRibRgbRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bLjLsmbLjLsLsmmbLgLsbLjLsmbRjRsLsLsmmbLibLibLsLgbLsbRjbRjbLibLjLsmbRcR
sRsRsmmmbLjbLiLsLsLsmmbLiLsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRsbLsbsbRsbRsbLsbsbLsbLsbLsbRobLoRsbRebRobLobLobRebRsbLcbRsbRhbLebRsb
RobRobRsbRsbLobLebLsbRebRobRgbRobLebRobLobLsbLebLebLobRsbLsbLcbRsbRsbL
obRgbLgbLobRsbRsbRobLebRcbLibRobRsbLcbLobRebLebRebLgbRebLjbRcbRobRcbLi
bLsbRobLgbRsbRobLcbLsbRobRobLobLsbLcbRibLjbLobLebRsbLobRobRcbLebLobRcb
LobRobLjbLgRobRobLsbRobRobLgbRjbLcbLcbRcbLobLobRsbRhbLgbLobRebRjbLebRc
bRebLsbLcbLobLobLobRsbLcbRibRobRcbLsbRgbRjbLebRobLibRsbLobRobRhbLebRib
RibRobLsbRobLobRsbLobLebLobRobRebLcbRobRsbLjbLobRsbRobLsbRcbRobLsbRsbR
jbLebRjbLibRgbLebLobLebLebLibLebRcbLebRobRsbRebLsbLsbLjbLobLebRobLjbRe
bLsbLsbRjbLsbLcbRobRobLsbRebRobLhbLjbLcbRgbLebLjbLsbRobRsbRsbLebLsbLgb
RobRobRebRobRebRobRebRobLsbRebRobRebLobRobLhbLsbLsbLsbRcbRsbRebRcbLobL
sbLebRobLjbLjbLsbLebLsbRobLsRgbRsbRebRcbLsbRobRebRobLgbRobLobRobLsbRsb
RsbRobRsbRobLgbRsbLobRobRcbRsbRsbLsbRsbLebRobRebLobLsbRebLsbLcbRhbLebL
obRobRebRobRsbLsbLjbLsRsbRsbRebLebRobLsbRjbLobLsbLebRibRebLcbRobRsbLeb
RgbLsbRobRoLjbLebLobRibLcbLsbLcbRobLebRgbLsbRcbRgbLebLsbLjbRobLgbLebLe
bLebLsbRobRebLobRebLhbLcbRebRobRobLobLibRobLobLobLebRjbLcbRjbLsbLebLob
LsbLsbLgbRebLebRebRcbLobLebLibLjbRebLobRcbRsRcbRobLobRibLjbLebLgbRobLe
bLobLobLobRjbLobLebLibLsbRsbRcbRsbRebRsbLebRjbLjbRcbRsbLobLebLobLobLob
RsbLebLcbRjbRobLebLebRsbLebLibLsbRjbRhbRobRebRobRobLobRgbRobLobLebLobL
sbLjbRcbLsbLebRsbRebRobRsbRebLsbRobLsbLebRobRobRebLsbLjbRebRcbLobLobRj
bRobLobLobRobRobRebLebLebRcbRgbLobRebRcbLobLobLgbLsbLcbLobLibLobRjbReb
LebLgbRobLsbRgbLebLcbLsbRobRcbRobLsbLjbRsbRobRebRibRsbLebRibRobLebLebL
obLsbRebRebRobRebLobRebLobRsbRobLsbRebRebRobRebLsbRobLibLgbRobLobRsbLe
bRobLobLobRsbRibRebRsbRsbRsbRsbRobRsbLgbRebLjbRsbLjRjbLjbLobRobRsLsbRs
bRebLcbRsbLsbRobRsbLsbLsbRsbRibRjbRcRebRebLobRebRobLobRebRsbRsbRebLcbL
cbLgbRsbLebRsbRebRsbRsbRobRsbLebLobRsRcbLobLobRobLebRobRobLgbLobLcbRob
RhbRebRebLibLcbRcbRsbRebRebRobRsbLebLobLsbLobLeRjbLebRobLsbRgbRobRobLc
bRibRgbLcbLobRgbLobLobRobRobRobLibRobRobRobLebRebRobRobLibLobLcbLobRcb
RobRsbRebRcbRebLebLgbLobLobLgbRcbLebLobLsbRobLsbLobRsbLobRobLcbRebRobR
obLsbRcbRsbRibLebRobLobRobLibLebRobRcbLobRobLobRcbLcbLsbLsbRobLsbLcbRo
bLebRsbLobLobRobLobRgbLobRobLebRobLebLobLgbLebLibRobLobLobRgbRobRebLeb
RobLhbLobRebLcbRobLobRobLebLhbRebLsbRobRibLibLebRebLobLsbRobLobRcbLcbL
obRobRibLgbLebLgbRobLebRobRcbRjbLebLebLsbRebLebLobLobRcbRcbRcbRsbLgbLg
bLobLjbLobRjbRebLcbLobLobLobLebLibLobLobRcbRobLebLjbLebRobLobLebRebLib
LobRobLobRobLjbLobRobLjbRobRgbLebLobLebLjbLebRjbLobLebRsbLobLgbLobRcbR
obRobRibRsbRobLebLobLebRebLcbRobRobLsbLobLebLhbLsbRobLcbRcbRibRcbRibLo
bRsbRgbLebRhbRjbLcbRebLebLobLjbLebLebRcbLjbRibRsbLcbLsbLobRcbRibLobLib
LobLebRobRebLebRcbLibRebRobLcbLebLobLebRjbLobLobLebLgbRebRobLjbRjbLibL
ebLobRebLobRsbLibLobLobLebLobLobLjbRobLjbLcbLcbRebLobRebRhbLobLobRibLo
bRcbLobRobRobRobLobLobLobLobLobRebRgbRebRibRjbRebRobRibRobLobRobLcbLjb
LcbLebLjbLobRcbLjbRobRobLcbLibRibRebRobLebRebLobLobRgbRobRjbRobLibRebR
ibLibRcbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLibRcbLibRobRebRhbRhbRgbRiRsmbRcLsbLebLgLsLsmbRsLsbRebRgRsLsmbLcbLiLs
bLjLsmbRsbLiLsbLibLgbRebLcbLibLibLiRsbRsbLcbLebRsbRjbRebLobLhLsbLibLsb
RibRibRgLsbRibRibLsbLcbLebLgbLgbLibLibLgbLgbRgRsmbRhbRibRgbRibRiRsmbRh
RsmbRcbLjbLibLeRsbLiLsbLibRhbRcbLsbLibRebRibRgbRiRsmbRgbLsbRebRsbLjbLi
bLibLgRsbLibLsbLibLibLibRhbLjbRcbRibRgbRsbRibRsbRjLsbRibLsRsbLjbLeLsbL
ibLgbLiLsbLgbLeLsbLcbLibLhLsbLgbLgbLsbRsbLebLibLgLsbLibRibRcbRgbLsbRiR
smbRibRgRsmbRgbRibRgRsRsmmbRibRsRgbRgbLgbLebLgbLsbLgbLibLiLsLsmbLgbLsL
sRsmbLsLgbLgRsbLsbLsLsmbLsbLgbLsLsmbLgbLgbRebRsbLibLsLsmbLjLhbLsLsmbLg
bLibRsLsbLgbRsbLgbLsbLsbLgbLgbRsbLhbLgLsbLibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLibLiLsLsmbLcLsLgLiRsmbRsLgLibLebLebLcbLibLebLebLeLsbRsbRsbsbRgbLcLsL
hLjLimbLgbLsbLsbsbRgbLibRsbsbRsbLgbLsRsLsbLsbLibLsbLoLsLsmmbRebRhbRibR
ibRibRcbRibRcLsbRjRgbRgbRiRgRibRhRgbRgbRiRsmbRiRsmbRibRiRsRsmmbRibRsbL
jbLebLibLibLebLjRsbLgbLjbLibRjbRibRibRgbLgbRsbRgbRsRsmbRibRgRsmbRjbRgb
RhbRjbLiLgbLgbLgbLgbLgbLgbRgbRhbLibRibRgbLjbLibLiRsbLibLibLgbLsRsbLibL
gLiLsbLebLgbsbLhbLgLebLgbLiLsbLibRibLcbRhbLhbRjbRobRibRibRgbRgRsmbRsRi
RsmbLjbLcLsmbLibLiLsbLgbLgLsLsLsmmbLsbLgbRhbRcbRibRibRibRiLsbRgbRiRsmb
RgbRgbRgbRiRsRimbRgbRcRgLsRsbLjbLgbLgbLgLsbLgbLgRsbRgbRjbRibRibRiRsmbR
ibRgbRsLsLsmbsbRobRiRgLgbRiRsRsRsRgRgRsRiRimmmmbRgbRibRsbRgRsmbRiRgbRi
bsbRcLsbLibLiLsbLgLsbRsbsbsbsbRsbsbLgbLibLhRsLibLgbRjRibRiRgbRgRsmbRib
RibRibRgbRgbRibRgRsmbRiRsmbRiRsmbRcbRsbLibLcbLgbLgbLgbLsbLjbLsbLibLjRs
bRhbRgbLhbLsbLcbLibLgbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bLcbLjLsmbLhRsLsbLobLiLsbLibLhRsbLcLsmbLjLsLsmmbLiRsbRsbLsbLiRsbLgbLgb
LsRsbLjRsbLsLsmbLiRsRsmbRsbLgbLsLsmbLsbLsLhbLsRsbLgbLgbLgbLgbLsLsRsmbL
sbLsLsLsmmbLsLsmbLgbsbLsLsmbLsLsmbLgbRgbLiLsbLiRsbLibLgbLibsbLsbLsLsmb
RsRsmbRsbLibLgbLgRsbRsLsbLsbLsLsmbLsLsLsLsmmmbRsLsLsLhmbRjRsLsmbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bRobRcbLsbRobLobRcRsmbRgbRhbRcbRobRibLobLibLiLgbLgbLgbLibLsbRjbReRgRgR
gbRibRiRsRsRgRgRgReRsRsmmmmbLcbLibLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bLeLsbLebLeLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLibLcbLiLsbRcRcbRhbRgbRibLjbLibLiLsbLsbRebRcbRibLsRibRibRsbRgbLhbLhLs
bRcbRcbLjbLhbLebRcRsmbRcbRcbRgbRibRiRsRimbRcbLibLibLibLiLsbLsbLcbRjbRi
bRgRsmbReLsbLibLibRgbRebLoLgbLibLgbLhbLibLiLsbLgbLibLhbLiLsbLhbLibLibR
ibRsbRcbRibRhbRgbRebRcbLeLsbLibRebRcLsbLjbLgLsbLeLsbRsLgbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRobRcRsmbLiLsbLibLjLsmbRgbRsRibRibRobRgbRobRoRsmbRobRibRobRiRibRsRhLe
bRebLsbLsbRsbRgbRgLsbRsbRobRsbLibLcLsmbRgbRcbRibLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bLsLgLsbLsLsLsLgLgmmbRgbLgbRsLsLgbLsLsLsLsmmmbLgbLgbLgbLhbLhbLibLgbRiL
sbsbsbRsbsbLsbsbLibRjbReLsLsmbLibLibLibsbsbLsbLsbRcbRsRsmbRcbLgbLsLsmb
LsbLgLsbLsLsLsmmbLgbRjbRcbLsbRibRibRsbRgbRhbRcRgbLibLibLhLgbRsLsbLsLsL
smmbLsLsLsLsmmmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bsbLgbRjbRobLobLjbRobLoLsmbLjLsmbLibRsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bsbsbRsbsbRsbLsbRsbLsbsbRsRsmbsbsbRsbsbsbsbLsbLsbRsbsbsbLsbsbsbsbsbsbs
b

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bLobRjbLjLsRsmbRiLsbLhbRjRsmbLhbLcbRsLsbLcbLibRiRsmbLobLcbLibLcbLobLcL
smbLcbLgbLibLhbRsbRiRsmbRiRsmbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bsbLsbLsRsLsRsRsmbLsLsRsmbLsbRsbRsbsbRsbLsbLsbRsRsmbRsLsbLsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bRibRcbRibRgRsRsmmbRgRsRsRsRsRsmmmmmbRibRiRsmbRgbRgRsmbRcbRibRsRsRsRsm
mmbRgRsmbRibRiRsRsmmbRhbRebLjbRcbRibRiRsLsmbRibRcRsmbReRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 153817; End: 154317;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bLjbRgLsLsmbLibLobLsLjbLcbLcbLcbLsLcLsmbLibLhRsbLcbLgbLcbLibLgbLgbLgbR
gRsmbRgRsRsmmbRgbRcRsmbRhbRgRsmbRgbRoRsmbLcbLibRiRsRsmmbRgRsRsRsmmmbRi
RsmbRgbRebLjRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLjRsbRibLgLsLsmbRibRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLcbLhRsRsmbLibLiRsbLhRsbLgbLobLcbRebRiRsmbRsRsmbLobLcbLsbRcbRobRcRsmb
RcbReRsmbLsbLiLsbLibLiLibLhbLibLiLsRsLsbLsRsbRsLiRsbRjbLsbRibLcbLiRsbR
sbLibLibRsbLibLcRsbLibLeLgbLibLibLcLsmbLibLgbLgbLiRsbRsLibLibLibLiLsbL
ibLibLibLebLjbRgbRjbRhbRebLhbLgbLibLgbLgbRebRgbLjbLiRsbRebRcbRibRebRib
RobLibLebRibLcbLiLsbRebRcRsmbRsbRgRgbRsRsRgRsRsmmmbLiRsbLobRjbRebRibLj
bLsbLibLcbRgbLjbLiLsbLibLgbsbsbRsbRobRhbLgbLeLibLibRjbLcbLgLsLsmbLgLsb
RsbRjbLibLsbRjLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRsRsRsmmbRsRgbRsbRsRgRsRsmmbRibLsRsbRibRibRsRsRsRsRgRsmmmmbRgRsmbRsRs
mbRibRsRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRebRebRebRgLsbRsRsmbRhbRgbLeLsLgbLibRcLsbRibRgbRiRsmbLhbRjRcbRibRsbLe
bRibLgbLsbRcRsmbRcbRibRgbLcbLgbRjbRebRgbLobRcbRsbRgbRobRjbRgbRobRcbRob
RgbRhRjbRiRsmbRibRgbLsbRibLeLeRcbsbLsbLibLgbLibLcbLobRgbRgRsmbRebLcbLh
bLibLhbLhbLibLjbRsbRsbLcbRobRgbRcbLsbsbLhbLibRgRsmbLobLibLobRgLsbLjbLi
bLgRsLsbLgbRjbRjRsmbRibRsbRhbLcbLibLsbLcbLjbRgbLgbRsbRhbRsRibLobLibRhb
LjbLgbLgbLibLsRsbRobRgbRgbRgbRsbRgbRsLsRsRsRsRsRsRsmmmmmbRsbRibRgbRgbR
gRsmbRsRsmbRsLsbRgRsmbRgbLsbRgbRgbLsbRgbRgRsmbRgRsRsmmbLcbLgbLibRcbRob
RgbRsRgbRgbRibsbLgbLcbLsbRiLsbRsbRsRsRsRgmmbRsRsRsmmbsbRsRsRsmmbRgbRgR
sRsRsRsRsRsRsmmmmmmmbLsbLsRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bsbRsRsmbLcbLsLjbRcbRgRsmbRiRsmbRibRgbRibRibRhLsbRsLsbRcbRhbRobRibRgLs
bRibRiRsmbRiRsmbRjRsmbRibRgLsbRiRsmbRgbRiRsmbRgbRgLsbRibRcRsmbRibReReR
ebRgbRsbLjbRebLcRsbLibLhbLcbLcLsLhLembLeRsbLsbRcLcbRhbLcLsmbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRjLgbLsbRibRgLsbLibRcLsbRgbRibRebRebRibRiLsRebRebRgbLjbRjbRcbRiLsbLgb
LhbLiLsLiLsbLiLsbLhLsbLeLsbLcLsLembRsbLsbLebLibLsLsmbLgLsbLcbRhbRsbRcb
RiLsbRgbRhbRibRibRobRoRsmbRibRgbRhbRgbRibRsbRiRsmbRgbRibRibRjRsRsRsRsL
smmmmbRgbRiRsRsRsRsmmmmbRibRsbRibRebRibLsRobLibRsbLhLiLgbLebLebLibRsbR
ebRibRebRsbRebRoLgbRebRebRebRgbRhRgbRibRebLjbRsbRgbRiRsRsmmbRibLcbLcbR
ibRibRcbRgbRgbRebRibRibRibRcbRebRiLsbLobLhRsbLhbLibLobLgbRsbRobRibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bRcRsmbRiRsmbLsbLoLsLimbLebLgbRcRsmbRgbRibRiLsbRgbLcbRcbRibRgbsbLsbsbL
sbLsRibLcbRjbRebLhLibLgbLgRsbLibLibRhbRgbRgbLibLiLsbLiLsbLiLsLsmbLgbLc
bLhbLobLsbRgbRcbRiRsmbRhRgLsbRibRsRsLsmbRhbRebRcbLsbLeLsLsmbLhbRcRsmbL
gbRibRgRsRsLsmmbRiRsmbRsRsmbRiRsRsRsmmmbsbRgbRhbRibRibRhRsRembRiLsbRib
LjbLhLsLsmbLhbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bLcLsmbLeLsbLsLsmbLsLsmbLsbLcLsmbLeLsLsLsmmbRibRcLsbRibLiLibLsbLibLcbL
cLsLsmmbRhbRjRsmbRcLsbLjbLcbLhbLhbLibLsLsLsmmbLgbLgLsbLcLsmbLsLsmbLiLs
bLgLsLsLsmmbLibLgLsLsmbLebLgLsbLgbLgbLiLsbLgbLibLgLsLsLsLsmmmbLgLsbLhb
RibRebRiLsbLcbLiLsbLiLsbLhLgbLiLsLgbLiLsbLgLsbLcbLeLsbLgLebLibLeLsLibL
ebLhbRebRibRjbRoLsbLeLsbLibLcLsmbLcbLebLgbLcLsLhmbRibRcbRobRgbRcbRibRg
bRibLsbLsbRhbRibRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRgbLiLsLsmbRiRsmbRsLsbRibLhLobRebLsLsLombLibLibLgLiLhbLhLibLibLhbLgLs
bLhLgLsbsbsbLoLsmbRiRsRsmmbRibRjRsmbRhRsmbRhRsmbRjRsmbRcRsmbRcbRibRcbR
cbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bLiLsbLsbLiLsbLgbLhbLsbLgbLgLsLsLsmmbLsLsmbLsLsmbLgbLgRsbRsbLibLgbLiLg
LsbLgLsbLiLsbLsbLgbLgbLsbLsbLgLsbRjbLhbLibLsLsmbRsRsmbRgbLgLgbLebLsLib
LgbRsLgbLsLeRsbLgRsbLibRsbLsbLsLsmbLgLsbLsbLgLsbLsbLjbLgbLgbRjbRgbRebL
gbLibRgbRebRgbRsbLsbRgbRgRsmbLsbRibRgbRgbLsRsbRgbRibRgbRibRgRsmbLsbRsb
LsbRgRsRsmmbRsRsRsLgmmbRsbRgbLsbRsbLsbRgbRsbLsbLsbLibLebLebRcRsmbRhbRg
RsmbLsbRibRgRsmbRsLsbRsbRgRsLsmbRsbRgRsmbLgbRgbRiRgbRsbRebRgbLgbRgbRsR
smbRgbRibLgbRgRsmbRebRgRsmbLgbRgbRgRsmbRgRsmbLsbRsbRgRsRgmbRsRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bLsLebRcRsmbLobLgLibLgbLebLgLsbLibLgbRgbRebLibRcbRcbLhbLeLsLsmbLobRsbL
cLsmbLibLhLsbLgbLiLsRsbLgbLebLgLsLsmbLsLibLeRsbLsbLibLibLiLsbLhbLsLsmb
LiLgbLiLsbLgbLibLhbLsLebRibRsbRebRebLsbRsLsLsLsmmbLgRsbLgLibLsLsmbLsLs
mbLgbLibLebLgLsbLibLiLsbLgbLgbLobLeLebLgRgRsmbRcRsmbRebRgRsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLsbLgbLcLsmbLgbLsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRebRcbLcbLiLsbLcRsbLcLsmbLiLsbLcRsbLoRsbLsbLcbLcbLoLibLgbLgbLiLsLibRs
RgbRcbRsLsbRcbRibLgbLcbLhbLiLsbRcbRibRibRsRsmbLcbLeLsLsLimbLgbLgLsLgLs
LsLsLsLsmmmmbLgbLhLsbLhbLhLhbLcbLiLiLsLibLiLsbLgbLiLsbLsbLiLsLsLsmmbLs
RsbLsbRsbsbsbsbRsLsbRsLibRhbLhbLjbLcLgbLibRiLsbRiRsRsRsmmmbRcbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLobLobRsbRcbRcbRibReRsmbLoRsbRsRsmbLobLiLsLsmbLibLcLsmbLiRsbRcbRibLhL
sbLjRsLibLiLsbLoLsmbLibLoLsLsmmbLhbRjRibRibRibRgbRgLsbsbRsbLobLsLsRsmb
LsLsmbLsbLibRcbRcbRgbRsRsmbsbRhbRgbLiLebLebLebLebLebLgbLebLsLebLebLebL
gbLjRsRsLsmbLjbLjbRibReRsLsmbRcbRhbLibLjbLcLsLsmmbRhbRobLibLcLsmbRcbRc
RsmbRcbRhbRhbRcRgRgbRsbLgbLibLgLsbLiLcbLcbLcLsmbLiLiLebLgbLiLgRsLsbLgb
LgLgbRhbRibRibLhbLiLsbLibLebLgbLiLsbLgbLsLsmbLsbLhbRcbRcbRhLsbRibRsRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLsbLsbLgbLeLsbLibRsRsmbRcbRiRgbRibRibRgRsmbRibLebLiLsbLgbLiLebLebLgbL
gbLcLsmbLhbLiLsbRobRhbRibRibRibRhRsmbRhbRiRsmbRebRgRsmbRsbLjbsbLgLsbLg
LsLibLiLsbLgLsLsmbLiLsLsmbLibsbLsbLsLsmbLgbLibLsLsLsmmbRsLsbLgLsbLgLsL
sRsLsmbLgbLsbLsLsmbRsbLgbLgbLgbLsbLgLsbLsbLsbLsbLsbLsbLsbLsLsmbsbLibLi
LsbLgLgbLgLsLsmbLsbLsbLsbLgLsbLgbLgLsbLiLsbLiLsbLgbLhbLgLiLsbLiRsbLiLg
bLiLgbLiLsbLcbRibRiRsmbRibRiRsRsmmbRibRebRcbRiRgRibRiRsRsRsLsmmmbRibRi
bRgLsbRhRsmbRibsbLjbRsbsbRsbsbLibLibsbRsbsbsbsbsbLgbLsbRsRsmbLsbLeLsbL
cbLebRibRebRsRgbRebRhbRebLsbLeLsRsbLiLsLgbLgLsLsLsmmbLsbLsRsbLibLgbLeb
LcbLiLeLsRebRebLiLsbLgbRsLsLsLsmmbLibLibLgbRjbRebRiRsmbRiLsbRhbRebRsbR
sbRsRsRsRsmmmbLsbLgLsbLgLsbLgLsbLsLsLsLsmmmbLgLsLsmbLsbLsLsLsLsmmmbRsL
sLsLimbLebLgbLiLsRsbLibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRibRcRsmbLobLcbRcbRgbRobReRsmbReRsRsmmbRebRcbRibRiRsmbRibRiRsmbRebReR
smbRcRsmbRobReRsRgmbRcRibRcRiRsmbRiRsmbRjbRibRcRsmbRcRsmbRgReRibRibRiR
smbLjbRhbRcRsmbRcRsmbRiRsmbRibRebLsRsbRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bsbsbRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bRebRhbRjRsLsmbRcRsRsmmbRjRgLsbReRsmbRebLobRhbRcbRiRgbReLsbRibRhbRhbRi
bRiRsmbRibRcLsbRebRebRcbRhbRebLsbRiRsmbLjbRcLgbLhbLibLsbRcLsbRsbRebLsR
ebRebRsbRobRcbRoRsRgmbRiLsLsmbRcLsbRgbLjbLcbLsLsmbLgRsbLgLsbLgLgbLgbLg
LsbLibLgbLgLsbLoLsmbLibLiLsbLibLebLsRhbLiLsbLhLhbRsbRcbRcbRsRiLsbRgRsm
bRibRibRcbRcRsRsmmbRsbLsRgRsRgmbRsLsbRsbRiLsbRcLsbRibReLsbRgbRibRibReb
RiRgbRiRsmbRobRobRhbReRsmbRoLsbRobRgRsLsmbRebRgbRsRcbRibRebRsbRiLsbRcb
RcbRibRebRhbRgbRcbReRsmbRgRebRebRsLsbRibRibLibLcLsmbLgbLsLsmbLsLsLsmmb
LeLsLsLsmmbLeLsbLibLsLsLsLsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bRsbRcbLcbRobRgbRgbRgLsbRebRcbRiLsbLoLsmbLibLgbRiRsmbsbRgbLjbLibRgbReb
RobRcbLgbLgbLebLjbRcLsLsmbLjbLibRsbRibRiLsbRiRsRgRgmbRgRsRsmmbRiRgbRcb
RgbRgbRgLsbRibRibReRsmbRcbRibLibLcbLiLsbRgbRebRsbLgbLjbRgbRgbRsbRsbRsb
RgLsRsbRiRgRsmbRgbRibRibReRsmbRibRibRibRebRsbRibRsLsbRebRgbRebRiLsbLib
LibLobLibRibLibRcbLhbLebLsbLgbLcbRibRiRgbRgbRcbRibRcbLobRjbLiLsbLgbLjb
LgLiLsLsmbLgbRsbRjbRhbRhbLsbRcbRebRebRgbRcbRiRsmbRsbLsbRsbRcbRcRsmbLeb
LibRgbLsLibsbsbRoRsmbRgbsbRsbsbRsbRsbRsLsbLiLsbLgRsbLsbLsLsmbLiLsbLibR
gbLeLsbLibLibLcLsmbLiLsbLoLsmbRsLsbRcRsmbRebRcbRcbLiLsbLcLsmbLgLsbLobL
ibRobRsbRobLhLibRhbRgbLibLsLsmbLgbLsbRhLsbRiRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bRibRiLsbRsbRgbLgLsbRsLsbRhRsmbRibRhbRsbRiRsmbRiLsbRsLsbRsRibRhbRsbRib
RsRsmbRgLsLsmbRsbRsLsbRiRgbRsbRcbRiRsmbLhbLibLibLibLsbLibLgbRjbLhLgLsb
LibLgLsRsLsbLgbLgbLcbLsbLsbLiLsbRsbLgLsbLgLeLgRsbLcbRiRsmbRjbRhRsmbRcb
RhRsmbRjRsmbLjbLcbLjbLgLsLsmbLibLgLsbLgLgLgbLibLjLsLsLsmmmbRgbLjLsmbLi
LsbLgbLsLsmbLgbLgRsbRsbsbRsbLsbLsLsmbLsbRjbRjbRibRjRsmbRjRsmbRsbRibRsb
LhbLcbLcRsLsbLcLsmbLhLgbLsbLibLgbLjRgbLcLsLsmmbLhbLibLeLsbsbsbLibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bRebRebsbRsbRibLgLsLhbLsRsbRsbsbsbsbsbsbsbsbsbRhbRgbRgbLgbLcbLibLcbLjL
smbRhLsbRcbRgbRibRibRhbRgbLcbRjbsbsbLjbLhbLgLsbLjbLgbLiLsbLjbLibLiLsbL
cbRsbLgbLebLibRebLsbLcbLjbLibLhbLibLjbLibRjbLiLsbLobRgbRibRebRsbRgbRjb
RebLiLsbLibsbLgbLobLsbLebLgRsbRjbRebRoRsmbRsRsmbRsbLsbLibLgbRgbRebRgbR
ibRibRjbLsbRgbRebRgRsmbRibRhbRibRibRgbRgbRibRibRibLsbRiRsmbRibRibLcLsR
smbLsbLcbLibLiLsLibLsbLeLsbLgbLobLsbLjbLjbsbRsLsRsbLgbRgbRcRsmbRibLcbL
iRsbReRibRibRibLgLsLsmbRgbRibRiRgbLgbLsbLcbLcLibLeRsbLibLebLibLsbRjbRj
bRobLcbLcLsLsmmbLcbsbLiLsbLgbLgbLibLibRobRibRsbRsRsmbRsbRibRsRsmbRgbLj
bLhbRjbRibRibLjbRjbRibRgbLjbLcbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bLjbLjbLibLsLsmbLjRsbLcbReReRebRebRibRibRcbRcbRsbRiRiRhRsRsmmbRibRhbRc
RibLiLsRibRiRsmbRsbRsLsRsbRiLsbRibRhbLsRcbRibRhbRsbRsbRsbRjbLcbLiLgbRg
bRcbRgbRibRibRibRgbRibRhbRsbRibRsbRcRsmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bRgbRsbLjbRiRsRsmmbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bRsLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsRsmbLsbLsbLsbLsbLsbLsbRsbRsbsbsbRsRsmbLsbRsbLsbLsbRsbLsbLsbRsbLsbLs
bRsbLsbRsbRsbRsRsmbLsbLsbRsbLsbLsbLsbLsbLsbsbRsbRsbRsbLsbRsRsmbLsbRsbL
sRsbRsbLsbLsbLsbRsbRsbRjbRobLebLsbLsbLjbRjbLsbRsbRjbLsbLsbLsbRsbLsbRsb
RsbLsbLsbRobRobRsbRsbLsbLjbLsbRsbRobLsbRebRsbRobLobLsbRobRjbLobLebLsbL
obLsbRobRsbRsbLsbRjbRjbLjbLebLobRsbRsbRsbRobLsbRjbLobRebLobRsbLsbLsbRc
bRobRcbLobLobRobLjbLsbRsbRsbLsbLsbRobRsbLobRsbRsbLobLobRebLobLebLsbRsb
RsbRobRobRjbLsbLobRsbLoRjbLsbRobRsbLsbRsbLsbLjbRsbRsbLjbRsbLsbRobRsbRj
bLsbLsLsmbLebLsbRsbRcbRsbLsbLsbLobLebRobLobRobLjbLsbRebRsbRobRobLjbRsb
LobRobLcbRobRsbLobLsLebLgbLobRcbLobLebRobRobRjbRsbRebLebRebLcbRobLobLs
bLobLebLhbRebRcbRobRobLobLcbLcbLjbRobLobLobRebRcbLcbRobLobLebRobRobRsb
RcbLgbRobLcbRebRcbLobRcbLebLgbLjbRebRobRobRebRgbLcbRobRcbLobRobLebLobL
ibRebLobLcbLobLcbLobLobLebLsbRibLibLebLebLobRcbRobRobRibLobRobRobRobRe
bLobLobRobRobRcbRebLobRobRobLibLobLebRebLobRebRhbRcbLobRebLobRsbRobLcb
RebLebRobRobLibLobRebRobLibLhbLgbRebRobRobLgbLobLcbRobLgbRibRobRobLcbR
cbLebLcbLobRobLebLobLebRobRobLsbRobRebLebRcbRcbRibLebLsbRhbRebLsbRcbLc
bRibLobRebRcbLcbRobLcbRebLebLobLebRcbRjbLobLebRgbRebLobLibLobLgbRobLib
LobLobRibRibLcbRibLobLobRcbLibRobLcbRobLebLobRobLobLobLjbRsbRebRebRibR
cbLebLsbLobRobLebRcbLobLobLgbLibRgbRobLobRebLobLcbLobRobLcbRobRebRgbLe
bRgbLobRebRobLobLobRibRobLobLsbRobRobLcbRobLebLgbRibLgbRobRobRobRobLob
LcbLobRgbRobRobRobLgbLebRibRcbRebLobLibLsbRobLcbLebRebLobLebRibRibLcbR
obRobRsbLebRobLobLcbRebLebRcbRobRsbRobLebRobLsbLebRobRgbRcbRobRebLebRo
bRebLobLobLebLebLebLsbRobLibRsbRobLobLobLobRgbLobLobLebLibLebLcbLebLob
LcbLobLcbLebLibLebLsbRobLobRebRcbLebRcbRsbRobLobLobLobRsbLobRobRobLebR
ebRobRgbRobLobRibRebLobRcbLibLobLebLobLgbLebRebLebRgbRobRobRebRobRebLg
bLsbLobLcbRcbLcbLobLcbLobRcbRgbRobLebRibLcbRobLobRobLobLebRsbLobRcbRcb
RobRobLebRebRcbLobRobRsbLsbRobLcbLobRcbRgbRsbRobRcbRebLobRhbLibLobRgbL
obRgbLcbRobRobLsbRsbRobLebRobRibRobLibLebRobLobLibLcbLcbLhbLebRcbLebRi
bLobRebRobRobRobRsbRibLobRobRobRsbRobRgbLgbLobRobRobRibLebRebRibRibRcb
LobRgbLebLobLcbRobRibLobLebRobLibRobRcbRebRebLcbRebLebRobLgbRobRcbLebL
obRcbLobRobLebLcbLobRebLgbRobRobRobLobRcbLgbRebRcbLhbRebRcbLsbRobRebLo
bLobRsbRebRcbLobLebLcbRobRcbLebRobRcbLibLebLcbRobLgbRobLjbLebLebLobLeb
RobLobRobRcbLgbRibLebLsbLobLcbRobLcbRobLcbLcbLobLebRobRebRebLcbRgbLebR
obLebLobLcbLebLobRcbRibLobRobRobRhbLobLebRobRobLobLobLgbRebLcbLsbLebLe
bRobRebLcbLebRsbRobRibLobLgbLobRgbLcbRebRobLgbRcbLcbRcbRsbRobRobLobRib
RibLcbRebLgbRobRobLebRobLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bsbsbRgbLcbLcbLgbLhbLcbLcbLcbLsbLsLsmbLibLebLgbLgLsbLiRsbLsLibRsbLibRc
bRibsbReRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bLiLsbRjbRjbLiLsbRgRsRsmmbLebRcbRoLsbLcLsmbLhbLcbLhLsbLeLsbLcbLebLebLe
bLgLebLgRsbLsbRcRsmbRcbRjbRjbRjRsmbRjbLibRjbLjbRibLiLsbRcbRhbRobLiLsbL
ibLgbLsLgbRgbRoLsbRsRsmbsbsbLsbLsRsRsRsmmbRcbLcbLcbLoLsmbRebRiLgbRhbRi
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLsbLibLsLsmbLibLibLsbLgbLebLgbLsLeLsbLiLsbLibLgLsbLiLsbLgbLibLgbLibLs
bLhbLiLsbLgLsbLiLsbLgbLgbLgLsRsbLgLsbLgbLgbLsLgLsbLsbLgbLgbRsLsbLgLeLs
bLibLgbRsbLcLibLgbLgbLgbLibLsbLiLsbLebLibLebLibLsLsLgmbRibRsbRgbRgbLsR
gbRsbRgRsRsRemmbLsbRgbRsbRhbRgbLhbLgLgRgbRobRibRibRiRsmbLsbLgbLibLibLg
bLibRgbRebLibLeLsbLgbLgbLibRjbRibRhbRgbRibRgbRgbRibRebRgbRhbRhbRebLibL
iLsbLgbLgbRebLsbLgLiLsLgbRjbRsbLibRcbRibLjbLibLiLsLsmbLhbRsbLiLsbLibLg
bLgbLiLgbLgbRsbLcbRsbRiRsmbRcbRgbRgbLjbLiLsbLgbLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLibLgbLjLsmbLsbLibLibLibLibLebLsbLiLibLhLgbLiLgLgbRibRibRgbRiRsmbRiRg
RgRsmbRebRjbRgbRsbRgbRsbRgbRgbRsbRiRsmbRgRsmbRhbRsRsmbRsbRgbRhbRiRgRiR
smbRgbRgbRjbRgbRjbRsbRibRibRhbRibRgbRibLgbLsRibRgbRsbRcbRibRebRgbRiRsm
bRgbRgRsmbReRsmbRgRiRsmbRebRgbRgbRsbRsRsmbRgRsmbRgLsRsRsmbLjbLcLsmbLib
LgbRgbRjbLsbLsRsbLibLibLiRsbLibLgbLibLibLibLgbLsbLibLgbLiLgbLhbLsbLgbL
ibLiLgbLgbLsbLiLeLsLibLibRjRsmbRibRiRsRsmmbRgRgbRiLsbsbRgRgRsRsRgmmbsb
RgRsmbRsRgbsbRibRsbLsbRgRsmbRgRsRsmmbRibRsbLsbLsRsbsbRibLjbLhRsbLgbLiL
sbLoLgbLeLgLsLsmbLiLsbLibLiLgLiLsLibRjbRiRsmbReRsmbRgbRebsbRsRsmbRgbRg
LsbRsbRiRsReRsLsmmbRhRsRsRhRsRemmmbRgLsbRcbLibLgbLjbLibLsbLibLiRsbLiLg
bLiLsRsbLibLgLsbLibLobRhbRibRcbRgbLsbReRsmbRsbLhLibLebLebLebLiLibLgbLg
LgRsbLiLsbLibLiLiLgbLgbLjbLgLsbRsLsbRjbRcbRjRsmbRibRgLsbRgbRibRibRsbRh
bRgbRebRibRiRsRsmmbRgbRibRgbRibsbRsbLcbLibLibLibLiLiLsLsmbLiLsbLgLsbLi
LsbLibLsRsbLsbLsbsbLibLibLgbLiRsbLcbLsbsbRjbRgbRhbRibRiRgRsmbRgRsRsRsR
smmmmbRsRsmbRgbRgbRibRsRsmbRsbRsbRsbRiRsmbLhbLibLgLsbLgbLgLsbLiLsLsmbL
hLsbLgbLiLsbLiLgbLhbLibLeLiLebLgLsLsmbLibLibLgLsLgLebLgLebLibLibLibRib
RiLsbRibRibLjLibLiLgbLibLibLgbLibLeLgbLgbLgbLeLsLebLgLibLibLgbLeLsbLiL
gbLsbLsLsmbLgLebLsbLgbRsbLgbLgRsbLsLsLsmmbRebRibRgbRcbRibLhbLjLsLsmmbR
hbRibRgRsmbRibRsbRgbRgbRiRsmbRgbRsbRgRsmbRgbReRsmbRebRibRibRgbRsRsRsRs
mmmbRsRsmbRgbRgbRsbRsRsRgRsmmbRgbRgbRibLhbLcbLgbLhLsbLgbLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bRjRsmbLhbLoRsbLgbLgLsbLgLsLsmbLgbLibLcRsbLibLcLsmbLhbLebLgLeRsbLsbLsL
iLsbLgLiLgRsLgbRibRoRibRsbRsbLsLsmbRgbRebLebLcbLebLgbRebReRibRcLsbRcLs
bReRebRhbRobRibLcbRjbRibRjbRjbLcbLibRjLsRsbRsbRjRsmbRcRsmbLhLsbRiRsmbL
sLsmbRhRsmbLiLsbRsbLsbLsRhbLebLsLobLobLiLiLsLgbLhbLebRibRhbRebLhbLiRsb
LibLjbRobRiRjbLsRsbLcbLobLgbRcbRgbRibsbsbsbLsbsbRgbRsbsbRibRgbRiRibLiR
sbRibRgbRiRgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLibLhbLcbLhbLibLibLgbLibLibLibLcbLgbLibLibLhbLgLsbRebRebRebRebRebRebR
sbRhbLcbLcbRebRcRsmbLjLsmbLcbLiLsbLcbLiLsbLsLsmbLibRcbRgbRibLcLsmbLhbL
sLcbRibRgbLobLibLibLgbLebLibLcbLiLsbLsbRgbLcbLsbLsbLibLgbLibLgbLhbLgbL
gbLcbLgbLibLiLsLsmbLgLsbLibRsbLcbRsbLobLgbLebLiLsbLgbLibLobLibLebLgLsb
LcbRcRsmbRibRhRgbRgRsmbRgbLcLsmbLgbRoRsmbRgRsRgRiRsRemmbLebLibLgbLibLg
bLibLgbsbLgbRjbsbRjLsbRgbRebLcbRcbRgbRibRgRsRsmmbLebLhbLgLsbLgRsbRjbLc
LsmbLibReRsmbRibLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bRjbRebLjbLsbRobRobRebLobLgbRsbRebRebLebLobRcbRebLcbRsbRcbRsbLebRibLcb
RobRsbLobRjbLcbLobRibLebRebRcbRebLebRcbLsbLobLobRobRobLebLebRcbLcbRebR
obRcbRebRobRibLgbLobRjbLebLjbRobLebLobRobLebLsbRgbLibLobLgbLebLobLcbRe
bRobLcbRebRobLcbLebLobLebRsRjbRobRobRobRgbLobLobRobRobRobRobLebRcbRobR
gbRebLebLebRobRebLebLobRebLgbRgbLobLcbLcbLobRobLsbLebRsbRebRobRobRobLc
bLebLobRobLcbLebRgbRobLgbLcbLobRhbRobLobLcbRebRsbRobRcbLobLebRobLobLob
RcbRgbLebLobLcbRobRebRobLebLobRobLcbRebLobLcbRobLcbLebRibRobRobRobRobL
sbLobRsbRgbLgbRcbLcbRebRebLibRobLgbLobRebLebRcbRobLobRebRibRobLebLibLo
bRsbLebRsbLsbLsbLobLsRsbRebRgbRobLobLebLhbLibLgbRobRobLebRebRcbRhbRhbR
ebLobRebLgbRobLhbRsbLobRobRebRibRobLebLebRebRebLobRebLebRobLebLebRobRo
bLobRebLobLebRcbRgbRsbRsbLhbRcbLobRebLobRsbRibLibRobRhbLobRobLhbLcbRob
LobLebLobLcbLcbRobLgbLibRcbLobRhbLobLhbLobRibLebLobRcbLcbLebRcbLobRobL
obLobRebRjbLobLobLebLobRebRebRebRobLobRobLibLcbLobLebLebLobRebRibLebLo
bRibLobRhbLgbRebLobRhbLibLebLibLibRobLibLebRobRobLebLibLobLibRebRobRib
RobRgbLgbLcbRebRobRibRobRebLobLobRsbLobLebLobLobLibRcbLobRibLobRebRobL
cbLebLcbLcbRobLibRcbLebLobRobLobLebRcbLobRobRobRobRobLobLibLgbRibRcbLo
bLobRobLcbLobRsbRebLcbLcbRobLibLobLgbRibRobRebRobRobRebRebLobLebLobRcb
RebLsbRobLcbRebLibRcbRcbLibRobRobRobLobRcbRobLobLebRgbLsbRhbLsbRobRebL
ibLcbRsbRebLebLebRebRebRebRobRibLobRibRebLibRobRcbRgbLobRobRsbRobRobRi
bLgbLobRobLgbRebLebRebLobLgbRobLobLobRibLobRebLcbRobLibLobRcbLibRebRgb
RebRcbRgbLibRhbRibLibLobLgbRobRebRibRobLebRobLcbLobRebRebLsbLebLhbLobL
obRobLibRobRcbRebLobRobRcbLobLibLebRobRebLobLobRobLebRsbLsbLebRebLobRg
bRebLgbLobRcbRobLobRcbRgbRebLobRhbLebRcbRebLhbLobLgbLgbLobRebRobRobRcb
RobRebLebRobLobRgbRobLobRebLebRcbLobRcbLhbRebRcbLobLobLobLebRibLcbRebR
ebLgbLgbRhbRcbLobRobLobLibLgbRebRobRcbLgbRebLebLobLcbRcbLobLebLcbRsbLc
bRobRgbLobRjbLcbRebRobRcbRobRcbRcbRsbLobRebLobRobRebLcbLhbLcbRebLibRob
RibRgbLobLobRibLebLobRobLcbRobLobLobRebRobLobRobLcbLobRcbLibRobLcbRgbL
gbRobLobLobRhbRsbLibRcbRcbLibLgbRobLebRcbLebRobRobLibLobLibRobRsbLebLi
bLobRobLobRobRibLobLibLebRibRobLebRcbRebLgbLgbLobRebRcbRcbRebRibLebLgb
RibRobRcbLobRobRobRibRcbLobLobRebLcbRebRcbRebLcbLibLobRhbLobRibLobRobR
sbLcbRobLgbRobLobLobRobLobLebLobRobRobRcbLcbLcbRebLobRobLhbLcbRebLobRe
bRibRobRcbRibLebRibRcbRgbRgbRobRobLebLhbRobLebRebLobLsbRobLobRgbRobRcb
RgbLcbLcbLibRobRobLebLobLobRebLgbRhbLobRhbLgbLsbLcbRgbRebLobRobRibLebL
ebRebRobLobLobLobRcbLebRebLobLsbLgbLebRebRebRobLhbLibRobRobLibLgbRobLs
bRsbLebRobLgbRobLobLcbRebLobLebLobLobRobRebLobLebRebRebLibRebLobLobLgb
RobRobRibLhbRcbLobLebRebRobLebLcbLobLcbLobLcbLhbLibRgbLebRobLibRibLcbR
obRobRcbRobRcbRibRibRsbLibLebRebRobRobRcbLobLobRcbLobRgbRobRobLibLobLe
bLobRibLobLgbLgbLebRgbLebRobRobRebLcbLcbRcbLobLcbLobLibRgbRgbLgbLobReb
LobLsbRcbRobRgbRjbRebLobLobLsbRobRgbLobRobRsbLebRebLcbRhbLobLgbRobLsbL
obLobLobRobRobRobLobRibRebRibRobLobRobLobRcbLobRobRebRobLobLebRibRebLe
bLobRebLsbLebRsbLibRebLebLsbRebRebLcbRebLgbLibLobRibLobRobRobRgbLebLcb
LibRgbLebLcbLcbRobLebLebRibLgbLobLebLcbRcbRobLebLsbRsbRibRibLebLcbLobR
ibRebLobLobRcbRebLgbLobLibRibLibLobLebLebLgbLebRebLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRobLibRibLcbLebLgbLibLeLsbLgbRsbLcbLiLsLhbLibLebLsbLibLgbRjbRcbRibRhL
sbLsbRibRibRcLsbLibLgbLgbLcLsmbLibLibLgbRsbLibLebRgbRibRiRhRebRgbRgLsb
RgbRgbRcRibRobRjbRcbLjbLibLjLsmbLibLsbLcbRsbLhbLiLgLibLsLgLsLibLgbLgbL
gbLcLsmbLsbRibRibRsbLcbLgbLobRiRibRgbRibRgbRibRgbRgbLobLhbLsbRobRgLsRs
bRgRsmbRjLsLsmbRibRibRgbRgbRibRcbRgLsbRjRibRibRgbRsRsmbRibLcbLiRsLsbLs
LibLeLhbLgbLcLsmbLgLgbLgbLibLebLibRgLsbRsLsbRgbRsbRibLcbLiLsbRgLsbRjbL
sbLcRsbLjLsLsmmbLgbLgbLibLgbLsbLsLsLimbLebLgLsbLgbReRibLcLsmbLjLsLsLsm
mmbLsbLgbLibLiLsLsmbLsbLhLsLsmbLgbLiLgbLibLgbRobRibRgbRgLsbRsLcbLcbRsb
RjLsbLcbLsLsLsmmbLgbLsbLsLsmbRsRibRsbRgbRiLsbRgbRebLhbRcbRiRsRsmmbRgRs
mbRibRiRsmbRgLsbRibRgRsmbRgbRgbRgbRsbRgLsbRgbLebRcbRhbRibRsbReRsmbRsbR
ibRoLsLsmbLgbLibRsRhbLsbRobLsRsbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bLsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bLsLsmbLgLsLsmbLibLsbLebsbLobLgbLcbLjLsmbLsLgLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bLobRjbLsbRebLsbLjbLibRebLjbLjbLsbLsbRjbRsbRjbLsbRsbRebLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLcbLibRgRsmbRibRcRsmbRhRsmbRiLsLsLsmmbLcbLgbLgbLgbLeLsbRhbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154318; End: 154818;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bLiLsLsmbLcbLobLcLsmbLiLgLsLsmbLhRsbLobLiLsbLibRsLcbLibLiLgbLobLhbLcbL
eLibLibLibLibRsbRoRsmbRgbRiRsRsmmbRibRgbRibRibRibRgbRgRgRsmbRiRgbRiRgR
sRsRsmmmbRibLcLsmbLebLibRgbLiRsbLhbLibLibLibLiLibLiRsbRibRcbRgbRibRebR
cbRgbRebRibRiRsRsmmbRgbRhbRibRhbRgbRebRibReRgbLoLsLsmmbLgLgLibLeRsbLhb
LiLsbLsRsbLjLsLsmmbLhbLgRsbRjbRgbRhbLebLibLhbLgbRibRhbRgbRsRsmbLebRcbR
sRibRgRsmbRgRsmbRgRsmbRgbRsRgRsRimbLibLhbLgbLcbLibLgbRjbLebLiLsLsLsLiL
gLsmmbLiLsLsLsmmbLoRsbLeLsbLiRsRsmbLgbLcbRibRibRibRhRhbLoRsbRgRsmbRhRs
mbRgbLeLsbLhLgLibLiLibLiLsbLibLcbLcbLiRsbLcbRibRibRgRiRsmbRiRsRsmmbRgR
smbRgbRibRibRiRsmbRiRsmbRiRgbRgbLcbLcbLgbRcbRcbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRsbsbsbLsbLsbRsRsmbLsbsbsbLiRsRsmbRoRiLsbsbLsbLsbLsbsbsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbRgbRhbLibRgbRibRibLsbLsbLgbLsbLsLjbLsbLiLsbLo
RsbLsLsmbLsLsLsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLcbLsbRcLsRsbRhRsmbRiRsmbRiRsRsmmbRiRsmbLgbLhbLcLsLgmbLsbLgLsbLsLsmbR
sRgbLiRsbRsRsmbLiRsbLiRsbLsRsRsLsmbLibLgLsRsRsmbLibLibLobLibLiLsbLgbLs
LsLsLsmmmbLsLsmbLsbRobRiRsmbLgbLsbLhRsbLibLiLibLibLiLsbLebLsbLcbLcRsbR
sbLebRgRsmbLsRcLsbRebRobRebsbLsLsmbLgRgbLiRsbLsLsmbLgbRsRjbLcbRsbLcbRs
bRsbLibLcbLibLgbLobRibRhbRebRcbRebLsLsmbLobLibLoRsbRhbRcRibRsbLsLsmbRc
bRcbRcbRcbRhbRibRiLsbRgbRibLgbLhbLiLsbLhLsbLjRsLsLgbLgbLibLibLgbLibLiL
sbLiLsLgbLibRjbReRsmbLcbLjbLhbLibLibLcbRcbRiRsmbRgbRiLsbLibLgbRcbRibLc
bLhbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bsbRsRsRsRsRsRsmmmmmbRsRsRsmmbRgRsmbRsbRgRsmbRsRsRsmmbRsRsLombRcRgbRoR
eRsmbRebReRsRsmmbRgbLcbLeRsbLsRsLgbLjRsbLsbLhbLgbRjbRibLsRsbRibRiRsmbR
ibRgbLebRjbRjRsmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRsRsRsRsRsmmmmbRcbRsbLsbLobLgbLiLsbLibLsLsLsmmbLibLsLsLsLsLsRsmmmmbsb
LgbRsLsbLibRcbLsbLgRsbRgbRsbRibLobLhLsbLgLsbLsLsLsmmbLiLsbLsLsmbRgRsmb
RebRsRsmbRobRjbRgbLcLsmbLgbLibLibLsbLcbRsbRobLsRibRibRibRibLsbLoLsmbLh
bLibRgbRsRsmbRsRsmbRgbRiRsmbRebLsbRobRsbLjbLgbLibRsLsbLhLsRsbRsbRgbRib
RgbRsRsRsLsRsmmbRsRsRsRsmmmbRsRsRsmmbRsbRgbsbRhbLsbLgbLsbLsLsmbLgbLjLi
bLibRsbLsbRgRsmbRsbRsbRgLsbRsbRsRsmbsbRsRsRsRsRgRsmmmmbRsbRsRgbLsbRsbR
sRsRsmmbLsRsRgbLsLsmbsbRsRgbLsbRibLgbLsLebLcbLhbLcRsbLgbLibLcbRiLsRsbR
ibRcbRsbRebRobRgbRsRsmbRibLebLebLgRsbRjbRhRsmbLgbLsbLjbLsbRibRibRgRsmb
RgbRsbLhbRjbLsbLeLibRcbLebLcbLsbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bLcbLcLsLsmmbLebRjRsmbLobLcbLcbLcLsmbLsLsLgLsmbRiLsbLoLsLiLsmbLcbLoLsm
bLobRhRiRsmbRgbRiLgbRibRoLsLsLimbLeLsbLoLsmbLsbRcbRcbRiLsbRgbLsbRibLob
LibLiLgLsLiLsbLhbLiLsbLiRsbLobLcbLcLsmbLjbRobRibRiRsRembRiRiRsmbRobRgb
RcRsRcmbReRgbRhLsbRcbLhLsbRcbRibLobLibRoLsbLsRcRsRsmmbLhbLobLsLoLsmbLc
bLcbLobRcRsmbRobLoLsmbLcbRjbRhbRgRsRsmmbRgbRebRebLoLgbLgLsbLcbLgbRobRc
LsbRcbRiRsmbRhRsmbRiLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRibLsbRcbRsbRiRsmbRibLibLibLibLcbRobRebLibLgbLgbLibLibLgbRcbRibLgbRcb
LcbLibLsbLibLgbLibLibRjbRibRgbRgbRibRibRgbLcbLiLsbLgbLibLsbLsLiLsbLgbL
gbLibLgbLgbLobLgbRibRgRsmbRhbRcbRgbLhLsbLgbLgbLoLsmbLgbLibLibLibLgbLob
RsbRebRgbRgbRhLsbRgbRsbLebRibRibRibRgbRgbLsLsLsmmbLsbsbRsbLsLsmbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bRcRsmbLoRsbLiLsLsmbReLsbRgbRibRibLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bLcLsmbLiLsbLhLsbRsLsbLhbLhbLgbLgbLgbLiLsbLgbsbLibLiLsbsbsbsbLjLsLsmmb
RobRiLsbRiLsbRgLsbRcbLoLsmbLcbLgbLgLsbLibLcbLsbRcLsbRhbRiRsRgRiLsmbRgb
RsbRjbRsbRibsbRgRsmbLgbLebRoRsmbRhbRhbRcbRgbRobRiRsRgRsLsmmbRebRsLsbRi
bLcLsmbLiLsbLibLiLgbLcbRcRibRgbRiLsbRiRsRsmmbRiRsmbRiLsbRhRsmbLcLsmbLg
bLcbLiLsbLiLsbLebLgLsbLjLsmbLibLsbLcLsmbLsbRibRobRibRibRibRebReLsRsRib
RebReRsmbRibRebLsbRsLibLjbLsLiLsbRibLcLsmbLibLgbLsbRjbLgbRebRobRgRjbRi
bRiRsRsmmbRibRibRobRgbReRsmbRgbRebRibRibRibRgbRgbLibLibLsLgbLjbRsLsbLg
LsbLcbLjbLgbLcLsmbLiLgRsLsLebLcbLsbLibLiLgbRjRsmbLsbLeLsLsLembLebLsbLg
bLiLsbLiLsbLgbRibRcbRgbLgbRhbRibLjbLgbLsbLebLibLibLibLibLgbLgbLebLgbLe
LebLgbRhbRibRcbRhbRgbRsbLsLsmbLgbLibLgbLebLeLsLsmbLgbRiLsbRgbRobLiLgbs
bRjLsbRcLsbRiLsLsmbRgbRgbRibRjRgLsbLebLcbLjbLiLsbLcbLebLgLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRibRhRsmbRcbLcbLobLhLibLcRsLsLiLebLsbLiLiLsbLiLiLsbLebLibLiRsRibRjbRc
LsbRibRcbRcRsmbRcbReRebRcbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRsbReRsRsRgmmbRgbRgbRgbRsbRgbLgbRgRsRsLsmmbRibLsbRgbRsRsmbRgbRibRsRgb
LsbRibRgbRsbRgbRgRsRsmmbRibRgbRgbLsRsbRsbRsbRsbRsbRsbRgbRibRsbRgRibRgb
LgbRiRebRgRsmbRsbLsbRibRsbRsbRsbRibRgRsmbRsbRsRsRsRsRsRsRsRsmmmmmmmbRs
RsmbRsbLsbRgRsRgRsmmbRgbRgRsmbRsbRgRsmbLsbLgbRebRgbRsbRibRgbRsRsmbLsbR
sbRibRsRsRsmmbRsRsRsRsRsRsmmmmmbRsRgbLhbRebRsbRsbRsbLsbRhbLsRsbLebLebL
eRsbLhbLibLibLgRsbLsbRjbRibRebLsbRibRgbLsbRibLjbRiRsmbRgRsmbRiRsmbRsbR
ibLsbRgbRsRsmbRgRsmbRebRebRsbRgbRgbLibLgbRsbLgbLgbLibLsbLibLibLgbLiLsb
LibLgbLsbRsbRibRebRgbLsbRcbRgbLgbRebLobRiRsmbLsbRgbRgbRebReRibRsReRgbL
gbRgRsRsmmbRibRsRgRsmbRhRsmbLibLgRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRgRsRsRgRsRsRsmmmmmbRcRsRsRsRgRgmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLcbLebLeLibLebLebLsbLsbRgbsbRsRsmbsbsbLsRsLsRsRsmbLsRsbRsRsmbLsLsmbRs
LsRsbLsbsbLsRsbLcLsRsmbLgbLebLebRebLibLibLoLsmbLcLsmbsbLsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRjbRsbLcbLcRsbLcLibLibLcLsmbLgbLiRsbLiLgLsbLiLsbLcLsLsLimmbLeLsLhbLhb
LiLsbLibRibRcbLcbLsbLsbLcbRgRsmbRibRiRibRgRsmbLcbLiLsLeLsLibLsLsLsmmbL
eLsLebLsbLsbLibLobLcbLgRsbsbLjLsmbLgbLhbLcbLibLibLgbRcRgLsbLcbLcbLiLsb
LiRgbRibLsbRgbReRsmbRsLcbLibLgLsRsbsbLsLsmbLoLsmbLibLiLgLibLiLsLsLsmmb
LsLsmbLsLsLsLsmmmbLebLebLjLsmbRsbRjbRibRsRsmbRiRsmbRgRsmbRjRsRsmmbRhRs
mbRgbRcRsLsmbRibLcLcLsmbLebLsbLsbLiRsbLibLibLcbLiLeLgbLibLgbLgLsLibLhL
ebLiLsLsmbLsLsLgmbLgLsbLsLsLsLsLsLsmmmmmbLibLcbLiLhLhLsLibLsbLeLebLsLh
LsbLebRebLcbLhbLcbLiRgbLjRsbLibRgLsbLiLcLsmbLcbLiLiLsbLiLiLgLsbLgLeRsb
LiLsLeRsbLibRsbLebLgLsbLcbLcbRebsbsbsbsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRiLsbLcbLibLcbLjbRebLgbLobRcbRcbLibLcLsmbRobRsLjbLsLhLsbLiRsbLgLsbLcL
sLsmmbRobRcbRgbRgbLgbRibLcbRcbLoLsmbLcbsbRsbRsbRsbRsbLsbLsbRsRebRhbRhb
RobRcbLjbsbLgbLsLibLgRsbRsLsLsmbLsbLiLsbLcRsbLcbLeLsLsmbRobRibRsbRsRsm
bsbRgbLsbRgbLjbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLgLsbLcLsmbLsbRcRibRiRsmbRiLsbRiRgbRebRhbRhLsbRibRiRsRsRsmmmbRibRibLc
bLeLsRsbLcbLeRsLsbLhLsbLebLhbLsbLiLsbLibLebRsLebLibLgLsLsmbLsbLgbLeLeb
LgLsbLiLsbLgbLebLcLsmbLhLeLsbLibLiLsLsmbLebLhbLiLsbLcbLcbLiLsLsmbLgbLo
LsmbRcRiRsLsmbRibRhbRsbRibRibRsRgbRebRiRgbRgbRcbRgRsmbRibRgbRcbRibRibR
iRsmbRiRgbRhRsmbRcRcbRebRiRsmbRibLsbRsRsmbRoLsLsmbLsbLebLgLsLsmbLgbLgL
gbLiLsbLibLiLebLhbLhLsLgLsLsLsLsmmmbLebLibLiLsbLcLsmbLgLsbLibLhLsbLibL
cbLibLiLsbLiLsRsbLsbRcbsbsbRsRgbLsbRsbLsbsbLsbLsbsbsbRsRsRsRsRsRgRiRsR
gLsmmmmmbRiRgbRgbLcbLcbLebLeLebLibLebLhLsLsmbLsbLhbLhbRibLobLebLibLhbL
hbLeLsbLjbRibRibRhbRgbRibRiRsmbRebRebRcbRhbLebLiLsbLcLgLsbLibLiLsbRcbR
ibRsbRgbRiLsbLhbRcRgbRhbLsRsbRsRebRibRhbRibLiLsLsLsmmbLibLiLsLsmbLebLi
bLgLsbLgLsbLiLsbLgLsbLobLcbLgbRcbRjbRibRgbRgbLsRsbLjbRobRgRsmbRgRgRsRg
mbRebRgReRsmbRgbRgRsmbRgLsbRgRsRgmbLsbRgRsmbLeLebLiLgRsLgLeLsRsbLeLsbL
iLsbLcbLibLgLsbLsbLsRsbLsbLsbLiLsbLsLsLgRsmbLsLsLsmmbLsLebLiLsbLgLsLgL
sbLhLsbLcLsLsmmbLsbLibLibLeRsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRcRsmbRcbRcRsmbRcRsmbRcRibRcbReRsmbRsReRsRembRgbRebLoReRsmbLebRsLgLsb
LhRsbLcbLiRsbReRebRsRebRebRhRgRiRsmbRebRebRiRsmbRibRgbRebRibRcRiRsmbRe
bRebLgbLgbLgLgbLebRcbRcRsmbRiRsmbRcRibRcbRiLsbLcbRcbRibRebRebRebRebReb
RcbRgbsbRebLibLsbLsLcbLebLjbRobRgRsmbLcbLebRjbRjbReLsbRgbRjbLsbLcbRsbR
gRebRcbLcbRcRsmbRibRebRgRsmbRhRiRgbRjRebRgbRsRsRembRibRsbRebRcbRcbRcRs
mbLhbRcbRcRsmbLebRgbRcbRebRebRiRsmbRgbRebRgLsbRjbRhbRibRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRsbLsbRsbRsbLsLsRsRsmmbRsbLsbLsRsbLsbRsRsmbRobRsbRsbLsbLsbRsbLobLobLs
bRjbLsRsRsmbRsbReRsmbLsLsmbRsbRsbLobRobRoRsmbLsbRsbRsLsLsmbLebRebLsbLo
bRsRebLeRsbRobRebRebLsbLsbLsLebLobLsbLsbRsbLebRsbRobLebLebLsbLsbLsbRob
RebLsbLcbLobLobLsbRcbLobLsbRsbRsbLobRsbRebRsbRobLebRobLebLobLobLobLobL
sbLsbLsRgbLebLsbRsRsmbLcbLobRsbLobRsbRobRobReRsmbReLsbReLsbRebRsRsmbLc
bLsRsbRsbLsbLsbLsbLobLsbReRsmbRsbLsLsmbLsbRebRobRebLsRebLsRsLsbRobRsLe
LsLsRsLsLsmmbRobRebLsLoLsmbRoRsmbRsLsbLsbLsRsbRobLsbLobRsbRsbLsbRsbLsb
RsbRsbRgbRebRobLsbRsbReLsbLsRobRsbLsLsRsmbRsRsReRsLsRsLsRsLsmmbRsbLsRs
LeRsRsmbRsLoRsRsRsmmbRoLsbRsLsRsLsRsLsRsLsbRsbRsbLsbsbLsbLsbLsRsRsLsLs
RsmmbLsRsLsRsRsLsRsRsLsRsmmbLsLsLoRsLsLsRsRsmmmbLebRsRsRsLsRsLsLsRsRsL
sRsLsLsLsmmmmmmbRsbRsRsmbRsbLsRsRsLsRsLsRsLsmbRsRsmbLsLobRsRsmbRsbRsbR
sbRsbLsbLsbRsbRsbLsbLsLoLsLsRsmmbLsbRsLsLsRsLsmbLsRsLsLsLsmmbLsbLsbRsb
RsbRsbRsbRobLsbLsLsRsmbLsbLsbRsbRsRsmbRsbRsLsbRsbRsbRsbLsRsbRjbLsbRsRs
mbLsRsbLsLsmbRsbLsbRsbLsbLsbLsLsLsRsLsmmbLebLsRsbLsbLsLobRsRsRsLsRsLoL
smmmbLsbRsLsbRsLsbLsLsRsLsRsLsRsLsLoRsmbLsbLsbRsLeLsRsRsRsLsLsLsRsmmmm
bLsLsRsmbRsLsRsLsbRsLsLsLsLommbLsRsbRsLsLsRsRsmmbLsbRsLsRsRebRsbRsbLsb
LsLsmbRsbRsbLsbRsRsmbRsbLsbRsRsmbsbLsRsLsRsbRsbsbLsLsmbLsReRsmbRsbRsbR
sRsmbLsbsbRsReLsRsLsRsbRebRsbLsbRsbLsLsmbLsRsLsbRsbLsbRsRsmbRsLsbLsbRs
bRsbLsbRsbRsLsbLsLsRsmbRsLsRsRsmbLsbLsRsbRsbRsbRsRsmbLsLsRsRsLsmmbRsbR
sLsbRsbLsRsbRsbRsLsLsRsLsRsRsLsLemmbLsbRsbRsLsRsbRsbsbRsbLsbLsbLsRsbLs
LsRsLsLsLsmmmbLsRsbRsbRsbLsbLsLsLsmmbRsbLsbRsbRsLsLsmbRsRsmbLsbRsLsbLs
bRsbsbLsbLsbRsRsmbRoRsmbLsbRsRsRsmmbLsbRsRsmbRsRsRsmmbRsbRsLsLsLsmmbRs
bRsbLsRsRsmbsbRsbRsbRsRsmbLsbLsbRsbLsLsRsmbLsbRsLsbRsLsLsRsRsRsLsLsmmm
mbRobLsLsmbRsbRsbRsRsLsRsLsRsRsmmbRsLsRsLsbRsbRsbsbRsbLsLsRsmbLsbRsRsm
bRsRsLsmbRsbRsbLsbRsbLsbsbRsRsmbLsRsbRsLsRsbLsRsbRsLsbLsLsmbLsRsLsbRsb
RsRsmbLsbsbRsbRsLsLsRsLsmbRsbRsbRsbRsbLsLsmbLsbRsRsmbLsRsbLobLsRsbLsbR
sbLsRsRsLsmbRsbRsRsRsmmbLsbsbRsLsLsRsmbRsbRsRsLsmbLsbRsbLsbRsLsbRsRsmb
RsbLsRsLsbLsbLsbRsbRsbLsbLsRsRsRsRsmmmbLsbRsLsRsLsRsbLsbRsbLsbRsbLsbLs
LsLsLsmmmbLsbRsLsbRsRsmbRsRsmbsbLsbsbRsbLsRsbLsLsRsmbLsLsmbRsbLsRsbLsb
LsbRsbLsLsRsLsRsmbRsLsbRsbLsRsLsbLsbLsbLsbLsLsmbLsRsRsmbRsbRsbRsLsbLsb
RsbsbsbRsLsbLsbLsbLsbRsbLsbsbLsbLsbLsbLsbLsRsbRsLsbRsbLsbLsRsbRsbRsbRs
bLsRsbRsbLsbLsLsmbRsbRsbRsLsbsbLsbsbLsbLsbLsbRsRsmbsbLsbLsbRsbLsbsbRsb
RsbLsbLsbLsRsbsbLsbLsbsbRsbRsLsbsbRsbRsbLsbRsbLsbLsbLsRsbLsbLsbLsbRsbR
sbLsbRsbRsbLsbLsLsRsmbLsbLsRsbLsbLsRsbRsbRsRsmbRsLsbRsbLsRsbLsLsmbLsbL
sbRsRsRsmmbLsLsRsLsmbRsbRsbRsbLsLsmbRsLsbLsbLsbRsbLsbRsRsmbRsbLsRsLsRs
LsbRsLsRsbsbRsbLsbRsbLsRsbLsbLsbLsbLsbRsbLsbLsbLsbLsbLsRsbRsbLsRsbRsRs
mbRsLsLsmbLsLsmbLsbRsRsmbRsbLsbRsbRsbLsLsmbRsbRsbLsbLsbRsbRsbRsbRsbsbR
sbRsbRsbRsbLsbRsLsbRsbLsLsmbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bLcbLgLsLsLsLsmmmbLgbLibLobLgbLgbRcbReRsRiRsmmbRcbRobLibRcbRibRobRcbRh
bRebLgLgLsLibReLsLsmbLgbLebLsRjbRcbRgbRcbRcbRebRsbLcbLhLsLibLgbLsbsbsb
LgLsbRebLsLsmbLsLsLsmmbLsbLsLsmbRcbRcbRobRcbLgLsbRobRgbLibsbRibRebRebR
sbRobRgbRjbLibLebLibRibRsLsLsmbLgLsbRjRjbRgbLgbLsbLsbLsbLsLgbLebLgbsbL
gbLgLsRsbLibLsbLibLsbLibRobLgbLobRhbRcbRibRhbRcRsmbRcbRobRsbLoLsmbLgbL
gbLibLgbLsbLibLobRsbLhbLibLiLsbLibLibLiLsbLiLsbLgbLgbLsbRcbRibRhbLiLsb
LsLsmbLgRsLsbLgbRcRsmbRiRsmbRgbLsbRgbLibRsLebLibLibLgbLgLibLibRsbLibLi
LsbLiLsbRgbLhbLiLsbLibRcRsmbRibLsLsmbRsbRiRsmbRsRsRsRsmmmbRibLgbLjLibL
ibLgbRebRhbRiRsmbRgRsmbRibRsLsbRsRsmbsbLjbLiLsbLibRsRsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bLeLsbLcLsLsmmbLibRcbReRgbRibRibRibRcbRibRhbRibRgRsmbRiRsmbRsRhLsbRsRh
bRgbRibRsbLjRsLsbLsLiLsbLsLsLsmmbLgbLgbLiLgbLiLsbLgbRcLsbRhbRgbRcLsRsb
RgbRcLsbRibRcbRgbRcbRiLsbRhbLsLsLsmmbLjbLebLebLibLibLebLsbLsRsbRiLsbLj
LjLsmbLcbLobLsbRsLsbLibLibLgbLgbLsbLcbLgbLibRibRcbRgRibRgbRcbRcbRhbRib
RibRiRsmbRjRcbRebRgbRebRiRsmbRhRsmbRcbRjbRcLsbRgRiLsbRiLsbRiRhLsbRiRgb
RebReLsbRhbRibRcLsbRibLjbRebRebRebLsLjbLoLsmbLgLhbLiLsRsLiLhLoLsmbLsbR
ebRsRgbRgbRsbRjbRgRsLsmbRsLsbLjbRsbsbRsbsbRibLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bRsLsbRsRsRiLsRsmbReRgLsbRcbLsRiLsbRibRebRgbRibLcLsmbLibLgbLobLhLsbLsR
sbLgLsbLiLsLebLiLsbLgbLhbLsbLcbLhLgbLgbLcbLibRjbLhbLhLsbLibRsbRgbRibRg
bRgbLcbRcbRcbReRsmbRgbRiRsmbRsRebRiRgbRiRsmbRsbRsbRsRsmbsbsbRsbRsbsbLs
LsmbLsbRsbRsbLsRsbLsbLeLsbLgLsbRsbLiLsbLibLsbLgbRsbRhbRibRhbRsbRibRibR
gbRiLsbLebLjbLgbRibRsbRgbRobRgbRebRebLebLgbLsRsbLgLsbRjbLjbLcbLgbRsbLs
bLgbLgbLsLsmbLgbLibLeLebLgbRhbReRgRsmbRobLibLhbLhbRibRibRgRsmbLjbLhLsb
LsbLhbLibLibLgbRebRgLsbRgLsbRgbRgbRsbRgLsbRibRsbsbRsbRgbRibRsbRebsbRgb
RebRebRsLsbRgbLhbLsbLsbLibRjbRibRibLebRebRobLibLibLiLsbLgbLibLgbLebRcb
RsbRibRcbRgRsmbRibRsbRsbRgbRgbRsbRgbRgbRibRsbRjLsbRgbRebRgLsbReRsmbLgb
RibLhbLhbLibLiLsbRgbLsRgLsbRgbRgbRsbRiRebRsbRsbRsRsmbRsbRsRsmbRsRsRsmm
bRibRsbsbsbsbsbsbLsRsbRsbRebRibRebRebRebRgbRgbRsbRgbReRsmbRebRebReRibR
ebRhbRsRgbRibsbRgbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bLiLgbRhRsmbRibRebRibRhbRibLcbLsLsmbRiLsbLsbsbLibRibRebRcbRsbRsLsbRgbR
sbRgLsbRsbRgbRgLsbRgbLsLsmbRsbRobRsLsbsbRoRgbRgbRsbRibLebLibLibLgbLsbR
sbLiLsbLhbLiRsbLcbLgbLiLsbLhLsbLiRsbLhbLjLsmbLhbLhLsbLiLsbLhbLgbLgbLhb
LibLgbLhbsbLgbLibRobRgLsbRgbLebLibLibLibLjLsmbLhbLsbLibLibLeLsbLiRsLib
LibLiLsLgLsbLeLsLsmbLgbRgbLsbsbRibRsbLgbRsbLjbLsbRsbLibRsbRgbRcbRiLsbL
jLgbRcbRgbLsbLjbLjLsmbLgLgbLibLgLsbLibLcbLiLsbLibLebLebLcbLgbRhbLsRsbR
eRsmbRjbRiLsbRibRjRsmbRhbRibRjRsmbRcbRiRsmbRgbRibRibRibRibRjRsmbRibRhb
RcRsmbRgRsmbRsbRibLhbLcbLiLibLibLcbLibLgbLibRjbRcRsmbRibRibRgbRjRgRsmb
RiRsmbRjbRhbRiLsbRibLjbLsbLibsbsbLibRiRsmbRsRibLcbLibLibLcLsmbLgLsbLiL
sbLibLiLiLcbLibLibLsbLsbLgbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRsbRsRsmbLebRjbLhbRjbLcbRgbRebLjLibLibLgLsLsmbLgLgLgLsLsmbLeRsbLibLib
LebRsbRobRibRgbRibRgLsbRcbRiRcLsbRcbRgRibRibRobRsbLsLsmbLsbRsbLgbLibLg
bRsbLgbRsbLhbLjLcbRgbRiRsmbRibRebRibRgbRcbRcbLjbLibLibLobRsbLiLgbLsbLi
bLibRebRsbLcbLgbLgbRhbLgbLobLjbLebLgbLsbLsbLgbLibLibLeRsbLibRibRcbLsRg
bsbLibLgLgLgbLgbRibRcLsbRcbLebLhbLcLgbLebRebRsbRibRgbRgRsmbLjLjbRsbRsb
RsbRsbRsRsmbRsRsmbRgbRgbRibLibLjbLhbLebRgbLjbLsbLcbLibLgLsbLiLsbRjRhbL
cbLgbLibRsbLhbLcbLebLiLsbLgbLgbLgbRcbRcbRgbRgbLcbRibRcbRsbRgbRibLjbLib
LiLsbLiLgbLobLjbLjbsbsbRjbRsLsbsbRiLsbsbRsbLjbLhbRebRiRsmbRgbRgbRgRsmb
RgbRgLsbRgbRibRibLsbLibLibLibLibLibLhLsbLsbLeLibLsbLobLebLibLibLhbLebL
ibLebRgbRgbLsbRibRebLebLobLebLgLsRsbLgbLobLibLobLgbLsLcbRobRibRgbRsbRi
bRhbLjbRgbsbLsbsbLsLsmbRsRsRsmmbsbLibRibRgbReRhbRgbRobLgbLhbLcLsmbLibL
gLhbLhbLibLibLibLsbLsLiRsbLebLgbLoRsbLsbLibLebLiLsbLibRgbLcbLsbLoRsbRe
LsbRibRgbRibRibRgbRibRgbLgbLjbLibLsbLjLsLsmmbLsbLiLsLgbRgbLhbRibRhbRib
RibRibRiRsmbLsbRibRiRgbRibRgbRibRgbRgbRhRsmbRgbRiLsbRiRsmbRibRgbRibRgb
RibLsbRsRsmbRibRgbRgbRgbRgbLjbRibRgbLcbLgbLibLsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRhbRsRsmbRiRsmbRebLoRsbLibRhRsmbRgbRgbRsbRibRsbRibRiLsbRgbRgRsmbRsbRi
RsmbRibRgbRibRiRibRibRsbRgbRsbRsbRgLobRoLgLgLsbRjbRcbRibRgRsmbRgRsmbRi
RsmbRgbRibRiRsmbRiRhRgbRibRsbRsbRiLsRsbRsRjbRgRsRsmmbRsbRgbLsRsbRsbsbR
gbRsRsmbRibRgLjbLjRsbLjLgLgLsbLiLsbLgLsRsbLjLsmbLsRsLsbLjbLibLjbLibLjb
LibLjbLcbLgbLhbLjbLgbRsbRcRcRhRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bReRsRsmmbRsRsmbRsbRsRsRsRsmmmbRsbRsRsmbRsRsmbLsbRsbLsRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRsRsRsRsRsmmmmbLebRibLoRsLsbRgbLobRsbLcbLobLcRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bRcbLcLsmbRobRoLsbLoLsLcmbLcbLhLsbLiLsLsmbLsLsmbLhLsbLgbLobRcRsmbLcbLc
LgLsbLibLcLsLsmmbLgLcbLiLsbLsLeLsbLsRibRgbLcLsLsmmbLibLiLsbLiLsbLgLsbL
ebLgLsbLsbLjbLebLgLsbLiLsLsLsmmbLsLsmbLcLsmbRjRsRhmbRjRiRgbRibLhbLgbLs
LsLembLebLebLebLibLebRjbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bRsbsbsbsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsbLgbReRsRsmmbRsLsbRgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bRobRebRobLobRibLgbLcbLobRobLebRibRcbLebRibRobRobLobRobLobRebRobRcbLcb
LebRobRobLobLobRobRgbRsbLibLobLibLobRcbRebRcbLebRgbRobLebLobRgbRcbRebR
obRobLobRebLobRgbLobRobLcbLjbRebRebLebRobRcbRcbRobLobRobLibLobRebRebRo
bLebRobRobRebLobRcbRebRebLhbLebLobLobLobLibRobRobLsbRibLobRebLebLobLob
LebLibRhbLobRcbRgbRebLobRobRebLobRebLibRgbRebRsbRgbRebLcbRobLobRobRebR
obRsbRebLobLebLobRebLobLobLsbRsbLgbRcbLobLcbRgbLobRobLibRebRobRgbRcbRe
bLsbRsbRibLobRgbLebRobLobLobLebLcbLcbRcbLobRcbRobRebLobRobLebLobLgbLob
LobLobRobLebRobLobRebRhbLibRobRcbLebRibLobLebRebRibLcbRhbLobLobLgbRobR
obRobLsbRobLobRebRobLobRcbLebLobLobLobLobRcbLebRgbRcbRobLobRcbRobLobLe
bLibRebLobRcbLebRobLobRibLobRebLobRcbLjbRebRebRebLcbRobLebRibRibRebRib
RebRibLebLebLgbLcbLobLebRebLcbRsbRebRobLobLcbRebRobLobLobLebLcbRebRibR
obLebRobLibRcbLobLebLobLebLobLobRobRobLcbRcbRhbRobLobRsbLebRobLobLebRo
bRobLobRobRcbLobLobRobLobLebRsbLobRobLcbLobRobRobLgbLcbRibRgbLebRcbLeb
LcbRgbRobLibLcbLebLobRgbLibLebRobLebRobLjbLcbRobLcbLebLebRsbLobLobRhbL
cbLsbRcbLcbRobRobLobRobRebRobLobLhbRebRcbRgbRebRobLcbRebLcbLobLcbLibLg
bRebRibRebLibLsbRobLebLobLobLebLobRcbRebLobLobLobLcbLebRebLebRebRobLcb
LcbRibLgbRgbLebRcbLgbLebRcbLsbLobRcbLebRgbLobLcbRobLobRobLobLobRobRsbR
obRcbLobLebRobLibLcbLgbRcbRobRcbLcbRobLhbLcbRsbLobLobLebLobLobLhbLcbLo
bLobLobLibRobLgbLcbLobRebRobRcbLobLebLobRobRobRebLebLobRgbLebLebLibLcb
LebLobLobRobRobLibRobLobRibLebRebLjbLebLsbLibRebRcbRobRebLobLobLsbRobL
ibLobRibLhbLebRibLebRcbRgbRobRebRhbLsbLibLebLobRobLobLobRobLobRcbRgbLe
bLebLobLobRobLobRebLgbLobLobLebRcbRsbLobLobLobLibRobRobLebLcbRebRibLcb
RobRebRebLobLobRobRsbRobLobRibLobLobLibRobRebLcbLobRobRebRobLobLobLibL
obRobRebLobRsbRobRgbLobRobRobRobRebLobRebLhbRobRibLobLobRobRebLobRobLi
bLibLobLobRebLsbLebLobRcbLobRobLobLobRobLibLgbLobLebRcbRobRobRobLhbRcb
LebRgbLcbLobRobLobRobLobLebLgbRcbRobRobLobLobRobLibRgbRcbRobLebRobLibR
ibLebRobLobRcbLcbLibLebRgbRobLebRebLobLcbLobLcbLobRobLobRobLgbLibLcbRe
bLobLibLobRobLcbRebLebRcbLibRobRebLsbLobRobRcbRjbRebLobRobRebLobLcbRgb
RobRobRobRobRobLobRobLibRebRcbLobLebRobLobLobLcbRgbLsbLsbRgbRobLobRobL
ebRcbLobRobLcbRobRobRhbLobLibLibRobRobLobRcbLebRobRebRobRebRebLcbRcbLe
bRgbRcbLebRobLobLgbRjbRcbRobRobRcbRobLgbLcbLobRgbLcbLobRibLibLibRibRob
LsbLebRobLcbLcbRobRebLobLcbRibLobRgbRibLsbLobLgbRobRobLobLcbLsbLobRcbR
obLobRcbLibLobRsbRobRibLobLobRebRebRhbRobRgbLgbLibLobRcbRsbLgbLobLibLc
bLebRcbLcbLobLcbRebRobLobRobRebLebLobRobLobRobLhbRobLsbLcbLebLobLobLib
LobRgbLebLobRibLjbRobLcbRibRobLobLebRobRebLhbLobRebRobRcbLobLcbLhbRobL
obLebLebLcbRobRsbRcbRcbLobLobRobLebLsbLobLcbLobRobRobLobRobLibRibRibRo
bLcbLebRcbRobLebRsbRsbLobLobRgbRobLobRobLobLobRcbRobLobLobRebLobRebLob
RobRcbLobRobRgbLcbRobRsbRcbLcbRebRebLobRobRcbLcbRcbLebRcbRobLebRgbRebL
obRobRobRebLebLobRobRobLebLebLebRobLgbLobLcbLobRcbLobRebRgbLgbRobLcbLc
bRibLgbLebRgbLobLsbRcbLjbRobLgbRebRgbRobLobLebRgbLhbRebLgbRcbRobRgbLeb
RcbRcbRibLobRobRebRobRebLobLobRobLobRobLibRebRobRcbLobLobRebLcbRcbRgbR
obRebLobRobLobRobLobLobRobRobRobLob

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRjRsLsmbRjbRibRjbRjbRjbRjbRhRsmbRhbRibLcbLiLsbRjbLcbLcbLhbLcbLebLibLg
LibRgLsbLgbLgLsbLibLjRsLsLsmbRsLsbLibLibLhbLcLiLsbLsLsRsLsmbRjbLsRebRi
bRibLgLsLebLsRsRsmbLgbLcbLcbLibLibLeLsbLiLsbLgbLiLsbRebRcbReRsmbRgLsbR
ebLsRgRgRgRsRsRgLgmmbRjbRcbRcLsbRibRjbRjbRiLsbRjbLcbRhLsbRibRjbRcbLeLs
bRcbRobRobRcbLcLsmbLhLsbLiLsbLiLsbLiRsbRjbRibRibRibLjbRsRsmbRibRiRsmbs
bRsRsRsmmbRhbRhbRiLsbLjLjbLibRgbRhbRjRsmbRiRgReRsmbRiRsLsmbLgbLgbRsRib
RibRibLsLsmbRsbRsRibLibLjLhbLiLsbsbLsLsRsmbRjbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRsbRgRsmbRgRsRsmmbRibLoLcbLcbLhLgLsbRjLebLeLsbLebLcbRcbLibRcRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLibRsLsLsmbLebRjbRcbLiLsbLebRgbRebRgbRibRgbLsLsmbLcbLibLibLgbLgLgLsLg
LsbLiRsbLgbLibLcbLibLibLsbLgRsbLeLsbLgbLgbRcbRibRibRsRsmbLsbLiRsbRebRg
bRhRsmbLsRsbRibRebRgbRebRjbLhbLibLiLsLsmbLibLcbLebLgbLgbLgbLcbLgLsLsLs
LsRsmmmbLibLiLsLsLsmmbLgbRgRsmbLsLsmbLebLgbLebLgbLsLsmbLhbLibLhLibLiLe
bLgLsLsLgmbLgLsbLhbLgLsLsRsmbLgLsLsLsLsmmmbLgLsLsLsLsLsmmmmbLsbLgLsLsL
sLemmbLgbLibLibLgbLsLsLsmmbLiLsLsLsLiLsmmbLiLsbLibLcbLibLiLsbLcbRgbLsL
sLsLsmmmbLgLsLsLsLgmmbLebLsRsbLibLhLsbLgRsLsLgbLibLgLsbLgbRibLebLgLsbL
gbLgLsbLsLsLsmmbLgLsLsLsmmbLiLsbLibLebLcbRcbRibRibRibRiLsbRgbLhbLibLgb
LhbLgbLcbReLsbRibRjRsmbLsbLgbLibLgLsLsmbLgbLgLsLsLsLgmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLibRcbRibRcbRgbRcbLibLibLibLiLsbLibLsbsbLgbLibLgbLiLsLsmbLgbLiLsbLgbR
sbLgbLgbLibLgbsbsbsbLgbRjRsmbRjbRibRibReRsmbRcRsmbRibRiRgRsRimbRiRsmbR
gRsRsmmbRsbRiRsmbRibRiRsmbRibRibRsbRibLiLibLhLsbLiLgbLsbLsbLsbLibLiLeL
iLibLgbLsbLibLhbLibLibLiLgLsbLsbLiLsLeLibLgbLibLibLiLiLsLsmbLsLibLsLgL
iLsbLgbLgbLgbLiLeLsLebLiLeLsLiLsbLeLsbLsbLgbLsLsLembLeLsbLgLsbLebLebLe
LsbRjbRjbLibRgbRcbLjRsbLjbRgbRjbRibRgbLjbLibLgbLgbLgLjbLsLsmbLibLgbLeL
hLibLjbLibLiLsLhLsLebLibLebLgbLibLeLeLgbRjbRcbRibRcbRgRsmbLjLsmbLebLgL
sbRsLsbLgLgbRsbRhbRibRibLsbLsbRiRsmbRiRsmbRgbRgbRgRsRsmmbRsbRsbRsbRsbL
jRsbRcbRiLsRsbRsbRgRsmbRgbLjbLgbLebLibLibLibLibLibLgbLgbLibLgRsbLgbRjb
RebRebsbRibReRsmbReRsmbRiRsmbReRsRsmmbRgRsRimbRebRibRibLjbLhLsRsbLhRsb
LibLibLeLibLebLgbLiRsbLibRibRhbRiRsmbRibRgbRgbRsbRebRiRgbRibRgRebRebRg
bRibRebRgbRiRsmbLjbLjbLibLgbLgLsLgLsbLgbLibLibLgbLibLgLiLsbLgbLibLgbLg
RsbLsbLgbLibLgbLgbLibLiLsbLcLsmbLgLsbLgbLgLibLiLeLeLgbRjbsbLsbLsbLjbLs
bsbsbsbLjbRsbLgbRsRsmbLsLsmbLgLsbLsLsLsmmbLgbLgbLsbLibLibLsbLcRsbLgbLi
bLibRcbRiRsmbRsbLjRsbLibLiLsbLjRsbLsLsRsmbLsLsLsmmbLsLsmbRsbLibLsbLgLs
LsmbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bLhbRgbRcbRgRiRsmbLgRsbRibRiRsmbRiRsRiLsRsmbLjbRsbRibLsbRsbRibLsbsbRib
LgbRgRgbLeLsbLibLgLibLibLgbLibLsLsmbLgbLiLibRibLgbLebLhbLhLebRgbLiLsbR
hbRibRsbRgbRiRsmbLgbRibRhRsRgmbRjbLibLibLebLebLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLsbLsbLhRsbRebRiRsmbRgRsmbLcbLsLibLebLcbRebLobLibLeLsbLiLsbLibLebLgRs
bLobRebRoRsmbRcRsmbLcbRcRsmbRebRgbRgRsmbLjbLibLcLsmbLsbLibLibRsbRsLsRs
bsbLsbLcbLhbLiLsLsmbLibLgbLhbLgbLibLibLiLsbLiLsLsmbLeLsbLgbLgbLiLsLsmb
LsLsmbLebLebLhLsLhbLibLiLsbLiLgLsLsLsmmbLibRgbLebLibLibLgbLsbLgRsbLgbL
iRhRsRembRiRsRembLjbLoLsLsmmbsbLsRsbLsLsRsmbLsRsLsbsbLsLsRsmbRsbsbsbRs
bsbsbsbsbLgbLsbLjLibLibLsLsmbLiLsLsmbLgbLiLsbLiLsLsmbLcbLgLsLsmbLobLcb
LebLhbLgbLibLsLsRsmbLebLiLsbLibLibRjbLgbLibRhbRjRcRsmbRiRsmbLcbLsLhLsb
LgbLibLgbRjbRgbReRgRsLsmbRiRsmbRsRsRsRsRsRsmmmmmbRsRsmbRgbRsRsRsmmbRgb
RebRibRgbRsbLebLgbLiLsRsbLebRsbsbRgbLsbLgbLgRgbLibRcbLcbLibLcbLibLcbLi
RsbLgLsLibLiLsLsmbLibLgLsLsmbLhbLiLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLcbLcbRcbLibLcbLebLgbRcbRobRibRebRgbRebRebLebLhbLsbLhbLebLgbRibRcbLob
RgbLhbLobRgbLjbRcbLcbLsbRobLsbLsbRsRobLsbRebRsbRobLobLhbLebRebRibRcbLo
bLhbLobLjbLebLcbLebLobLobRibLebRgbRebRobRcbRebLcbRibRebRgbRhbRebRsbRhb
LebRobLibLobRobLcbLgbLobLibLibRobRsbRibLgbLebRgbRgbLobRebLebLebLebRcbR
ebLcbRebLebLgbLsbRobRobRebRobLhbRobLobRhbLobRibLobLobLebLebLibRobLobRo
bLgbRobRcbLcbRebLobRcbLebRhbLebLgbRebLibLgbRgbLobRsbLobLcbRibLebLebRcb
LgbLsbLobLobRcbLobRobRobLobRcbRebLcbLibLobRibLobLgbLobLebLgbLobRebLobR
gbLgbLgbLsbRcbLcbRibRobLibRobRobRobLobRibLobRobRobRobLebLebLobRobRobRc
bLebLobRebLobLobRebLebLobRobRobLcbLobRgbRibRobRcbRebLibLobLebRebLgbLcb
RcbRobRobLebLebLsbRcbLebRobLebRebLobRebRobRebRibRebRobLobLebRebLobRcbR
ebLobRcbLebLhbRcbRsbRebRobRibLebRebLebLebLobRobLobLobRobLobRcbRcbLebRc
bLibRcbRhbLgbRebRgbRebLgbRgbLobRebLobRibLibRibRcbRobRebLgbRibLebLcbLjb
LobLebLcbLcbLebRobRobLobRobRibRsbLobRcbLhbRobLobLobRibLhbRebLobLobRobR
ebRobRcbRebRobLobLgbRgbLobLgbRebLcbLibLebRobLjbRebLebRcbRebLibRobRobRc
bLebRobRsbRcbRobRibRsbRobLcbLobRcbRebRsbRobLhbRcbRobRebLobLobLobLebRob
LobLobLgbRebLobLobRcbLebRgbLebRobRcbLebRgbLebRibRgbRhbLebLibRobLobLebL
obRobLcbLobLsbLobRcbRibLobRebRcbLibRcbLsbLcbRgbLobLebRgbRobRobRcbRibLo
bLobRobLobLobLcbRgbLcbRobLobRebLibLebRebLebRebRgbLsbRebRcbLobLebLobRob
LebRcbLobRebLgbLcbRebRobRobLebRcbRsbLcbLobLgbRibLobRhbLobLobLobRebRgbR
obRobRobLcbLibLebRobLhbRgbLebLobLobLebRebRibLobRebLcbRobRebLobRobRhbRe
bRhbLobRobRibLebLgbRcbRobRebRsbLsbLjbRobRobLobLobLcbRibLobRebRebLibLob
LgbRcbRcbLobRobLsbRobRobLgbRobLgbRobLibRcbRcbLobLobRobRcbRobRcbLcbRcbR
ebRcbLebRebRibRsbLgbLobLcbLibLgbLgbRobRobLobRcbLebLobRobRcbRibRobLobLe
bRobLibRobLobLcbLebLobLcbRgbRhbLcbRebRgbRebLebRcbLobLibLgbLobLcbLobLob
RcbLebRsbLhbRebLobRibRobRobLcbLobLgbLobRebRebLebLsbLibRobLobRgbLcbLebR
ebLobLobRsbRcbRsbLebLebRcbRibRibRobRhbLcbRobRcbRobLcbRebLibLgbRebLcbLo
bRobRcbRcbRebRjbRobLibLcbLobRibLgbLobRebLcbLobLobRobLobRobRebRcbLobLib
LobRcbRebRobRebRhbLobRobLobLebLsbRobLgbRcbLgbRcbLebLobLgbRibLcbLobLcbR
gbRobLobRobLobRobRobLcbRobLobRcbRobLobRibRcbRobRcbRobLobLobLobLcbLebLo
bRobLebLebRobLcbLgbRebLcbLcbLebRibRsbRobRebLibRobRibRobLobLobRebLobLob
RobRebRobRobRhbRebRcbRgbRobLobRcbRebLsbRobRebLobLobLjbRobLobRobLobRgbR
obRcbLjbLebLcbLobRjbRcbLjbRjbLebLobRcbLobRobLcbLobRobRobRebRjbLebLjbRo
bLcbRhbRebRebLobRobLcbRcbRobRebRebRebRobLebRebRgbRobRjbRobRebLobRgbReb
RebLobRobRcbLjbLobLcbRebLjbLobLobRobLobLobLcbRebRcbRobRjbRobLjbLjbLebL
obRobRobRjbRebRobLcbRebRebLjbRobRcbRobLjbLobLobLobLsbLebLebRsbRebLebLj
bLobRsbRjbRcbRcbRebRebLebRebLobRobRobRobRcbRobRobRobLebRobLobRsbLsbLeb
RjbLobRjbRobLjbLjbRsbRobRobLebLjbRsbLobLebLjbLcbLsbRebRjbRobLobRcbRobL
obRjbLjbLebLobLebLobLobRebLcbRobLebLsbLebLobRobLcbRcbLebLobLobRebLobRs
bLcbLsbRebLcbRcbLjbLcbRobLobLobLobLsbRebLobLobRobLebRjbLcbRebLebRebReb
LebRobLobLobLsbLcbLcbRobRebLjbRebRobLobRobLebLcbRebRebRcbRobRjbRebLobR
obRobRcbRjbRebLcbLjbRcbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bLgbRsLiLsbLcbLgLibLebRibRsbRibRgbLsRgLsbRgbRibRgbRhbRgbRgbRibRibRibRo
bRiLsbRebRiRsmbRgbRgLsbRiLsbRgbLeLcLsmbLiLsbLgbLibLgbLiLsbLibLcLsLsmmb
RobRobRibRibRibRobLebLgLgbLgbLgLsLsmbLgbRibLcbLeRsbLgLcLgbRjRcbLcLsmbL
gbLgbLsbRsRjRsmbRiLsLsmbRgbRgbReRsmbLibRcLsbLjbLeLsbLebRcRhbLcLsmbLgbL
gLsbLeLsbLiLgbLiRsbRgRsmbLibLsbLgbLgbRoLsbRobRoRsmbRgbLobLebLibLibLgbL
gLsbsbRcbRiLsbRsRcbRgbRebRgbRgbLjbLibLsbLgLsbLiLibLsbLsLsmbLibLsbRcbRi
bRibLcbLcbRcbRgbReRgRibLgbLeLsbRjbLcbLibLgbRgRsmbLsbLobLhbRjRcLsbLjbLi
bLgLsbLsbLgbLgLsLsmbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bRcbRjLsbRcRsmbRcLsbRgbLebLiLsLsLsmmbLobsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bLcbLcbRjbRibReRiRsmbRibRjRiRsmbRsRsmbRjLsbLjLgRsbRiRsmbLjLsLsLsmmmbLj
bRcRsmbRsRsmbLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bsbsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 154820; End: 155320;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bLiRsbRsbRsbRgbLcbLcbRibLcRsbLibLhLsLsmbLgRsbRcbRgRsmbRiRsRsmmbRibRiRs
mbRgRgbRcbRgbRgbRhbRiRsmbRsbRcbRsbLcbLcLcLiLebLebLebLeLibLibLcbLsbRcRi
bRibRgbLcbLibLgbRcbRgRsRsmmbRcRsmbRcRsmbRcbRobRobLoLsmbLcLgbLiLibLgLsL
sLgLsLsLsLsLsLsLgmmmmmmbLibRgbRibRiRsmbRcbRibRhbRibRhbLsbLhbLibLibLcbL
gRsbRobRibRobLgbLibLebRibRcbRibLcbLobLsbRhbRiRsmbRibRgbRhbLibLibLcRsbR
cRsmbLcLsLsRsmmbLibLeRsbLsbLcbLhLsbLhbRgbRsLsbLhbLcbLcbLhLsbLgLsbLibLo
bLgbRsRsmbRhbRhbRiRsRsRsmmmbRibRiRsmbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRgbRibLibRsbLeLsLsmbLsLsmbLibLgRsbRsbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRsbLibLcbRgbReRsmbRgLsbRhbRibRgbRcbRcbRiRhbRobRibRhbRcbRobRhbRhbLibRc
bRibLsbLibLgbRebRibRgbLgbRsbLiLgRsbLibRsRsLsLimbLibLsLgbLgRsbLsRcbLiLs
bLibLibRcRiRibLsRsbRcRsmbRhRsRsmmbRiRsmbReRsRsmmbLcbLibLgbLoLgbLibLibL
hRsbLgbLiLibLgLiLsbLgbRjbRsRsmbRgbLsbLiRsbLhLebLcbLibLsbLobLsLhbLgRjbL
hbLibLhRsbLsRsbRobRjRsmbRibRiRsLsmbRiLsbRgbLhbRhbRoLsbRibRsbRebRgbRcRg
RibLsbRibRebLjbRjLsbRsRsRsRsRsRsmmmmmbRgLsbRcbLjbLibLgRsbLgLsbLibLgbLi
LsbLibLgLsLsmbLibLibLibLsLsLsmmbLgbRjbLibLiLsbLibLiLgbRhRcbRgbRgRibLsb
LjbLibRibRcbRcbRcbRibRibRhRsmbRgbRcbRgbRcRsmbRcbRibRibLebLibLibsbRebRs
RgRsmbRsRsmbRsRsRimbLiRsbLcbLibLibLibsbRsbsbLsLsmbRsLsRgLsbRcRgRsmbRjb
RsbRibRgRsRsmmbRcRsmbRebRobRsbRibLcbLsbLhbLiLsbLgbLcbLiLebLibLiLsbLibL
gbRobRibRjbRcRsmbRebRhbRibLibLjbLibLgbLibLgbLibRsRsLsmbLjbLebLibLjbRib
RcbRibLsbRibRibRebLcbLibLibLgRsbLsbLsRsbLsbsbsbRcRgbRcbRebLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRiRsmbLjbLsbsbRoRsRsmmbLgLsLsmbRibLgbRhRsmbRiRsmbRcbRebRsLsbRsLsRsbRi
RiRgRsmbRsbRsRiRgbRjbRhLsbRcbRsbRgbRsReLcbLebLebLibRsbLibLgRsbLiRsbLgb
LgbLiRsLsbLsbLibLgbLibLiLiLeLebLgbLgbLsbLebLeRsbLgRsbRibLgbLibRobRebRe
bRebRgRebRsRebRjbRgbLgbRhRgbRiRsmbRgbRibLhbLhbLiRsbLgbsbsbsbsbsbsbsbRj
bRhbRgRsRgmbRsbLsLsRsmbLgRsbLjbLjbReRsRgmbsbLjbLsRsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bLibLiLgLibRebLibRsRebRebRgbRgRsmbRibRsRibLgbLebRsbLiRsbLcbRgRsmbRgbRg
bRgbLobLebLgRsbLgLsbsbLsLsLsmmbLsLsmbRjbLcRsbLebLebRjbLoLsmbLjbLibLsLg
bLgLsbLsLsmbLsLsmbLsLgLsbLsLsmbLsbLsbLiRsbLgLsbLsLsLsLsmmmbLsLsLsmmbRs
bLeLgLsLgbLebRsbLsLhLsbRsLsRsbRgRgbRiRsRsRsmmmbRsbRgbRsbRsbRsRsmbRsRsm
bRgRsLsmbRsRsmbRgRsmbRgRsRsRsmmmbRsRsmbRsbRsRsmbRgRsmbRgRsmbRsRgbRsRsR
smmbRsbRsRgRsmbRsbRgbRgRsRsRsmmmbRsRsmbRsRsmbRsRsmbRsbRsbLsRsbRsRsRsRs
mmmbRgRsmbRsRsmbRsRsRsmmbRsbRsbRgRsRsmmbRgbRgbRgRsmbRsRsRsmmbRibRgRsRs
RsmmmbRsbRsRsRsmmbRsbsbRsRsRsmmbRsRsmbRsRsRsRiRsmmmbRgRsmbRgRgRsmbRsbL
sbLgbLcLsLgLsmbLsbLgLeLebRsLsbLebLibLgbLgLibLebLsbLsbRsbRgbRgRsmbRgRsm
bLsRsbLcbLsLgbLsLsmbRobLsbRsbRiRsmbRgbRgbRsRsRsmmbLgbRgRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bsbRibRiRsReLoLiLsLgmbLiLsLsmbLgbLibRoRibRgbLjbLcLsmbRobRhbRhbLobRcbRo
bRebRoRsmbLibRobRobReRiRsRsmmbRiRhbRhbLgbRobRibLsRsbRibRsReRgRsmbRsRsm
bReRsRsmmbRhbRoLsLsmbRoLsbRobRcRsRsRsmmmbRcbRhbRgLsbRibRibRiRsmbRgbRcR
smbRgbRibRiRsmbRhRsmbRibRgbRhbRgbRhbRcbLgbRobRgbRgbRhbLcLsmbRcbRsLhbRo
bLsbRoLsbRobRhRsmbRibRsRsmbRsRgLsLsmbLoRsbRjbLobRoLsbRobLebLobsbsbsbRs
bRsbLsbRsbsbRhLsbRobRcbRebRcbRgRsmbLsbsbsbLcbLoLsLsmmbLcbLgbLcbLgbLibL
hbLibLibsbLcbLsbLeLsLsmbLgbLeLsbLcbLhbLgbLhbLibLcLsLsmmbLebsbsbsbsbRsL
sbsbsbsbLsbLjbLcbLsRcLsbRobRiRiRhb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bLgbRobRoLsbRhbRcbRibRgbRcLsbRobRobReLsbRobLjbLoLebLebLgRsbLgbLgLeLsLi
bLibLgbLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLobLoLsmbLibRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRcbRcbRhRgLsLsmbRsbLgbRsRjbLibLgbLsbsbsbLeLjbLiLsbLiLsbLibLcLsmbLibLe
LsLebLebRobLsRsbRsbLsLsmbRhbRsbLjbLcbLebLsbLobLgbLgLsLibRgbLcbLgLsLebL
sbLsLjbLeLsbLgbLgbsbLsbRsLsLsmbsbsbsbsbsbsbRobRobRgbRgRjbRsbRsbLsRgbRs
bRgbRibRjbLibLgbLibRsbRobRibRsbRsbsbsbLibRsbRebLsbLcLsmbLjbRgbRgbRgRib
RgLsbRjbRgRiLsbRgbRsRsmbRjbLiLsbLebLebLebLebLobLcLsmbLebLgbLsbLsbLgbRg
bLcLsmbLibLibLibLsbLgLhLgbLiLsbLgLsbLcbRgbLsbLjbLibLgbLibLgbLsbLgLgbLs
bLgbRcbRjbRibRgLsbRiRsmbRibRiLsbRsLsbRjbRsbRibRebRibLgbLgbRoLsbRibRgbR
hbRgLsbLgbLiLsbLjbRjbLiLsbLsbRcLsbLhbRcbLobRgRgLsbLibRhbRoLsLsmbLibRsb
LibRsRsmbRhLsbRgbRgRgbLjbLsLsLiLembLgbRoLsbRcbRcbRjRgbLcbLgLsbLgbRibRo
bRgRgbRobRjbLibLsLhbLgbLhLgbLiLsLsmbRjLsRgbLjbLcbRjLsbRibLgbRgbRiLsbRo
bLgbRgbRhLsbRiLsbLjbRibRjRhbRibRjbRhbRjLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRsbsbRibLjbRhbLsRobRcLsbLcRsbLcLsmbLcLsLgmbRsbRsbLeRsbLiLsbLibLoLsmbR
ibRcbRoRsRsmmbRcbRibLsRsLsbLsLsmbLsbLsbLsbLsbRsbLsbLsbsbsbLsbRibRebRhR
sRsmmbRcRsRsmmbRcRsmbRcRsRsmmbRsRiRsmbRgbRhLsLsLsmmbRibRibRibLcbLcRsbR
cbRiLsbRgRsmbRibRhRsmbRiRsmbRiRsRsmmbRcRsmbRcbRebRibRgbRcbRiRsmbRsRsmb
RhLgLsbLibRjbRcbRhRsmbReLsRsLsbRcRsmbRcbRiLsbRebRibRhRsLsRgmbRiRsmbRhL
sb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRiRsmbRsRsRsRsmmmbRsbRgbLgbRiRsmbLsbLsbRsbRgRsmbRgbRsRsmbRgbRgbLgbRsR
sRsRiRimmbRgbLjbRhbRgRsRgmbRgRsmbRsbRibLgbLgbLiLgbLibLebRsbLebRoRsmbLc
bRobLsbLgLsbLobRiRsmbRcbLebLoLsmbLsbRsbRsbRsRgbRgbRgRsmbRgbRgRibLgbRgR
smbRsbRsRsRsmmbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRhbRebRiReRsRsmmbRobReRsRsRsRsRemmmmbRhbLoRebRhRgRiRhRsRsmmbRgRsmbRsb
RiRsRsRgRsRgRsmmmmbRgRgbRibRiRgRsmbRiRgLsbRjbLeLhbLibRgbRsbLcRsRsmbRjb
LiLsRsbLibRcLsbLhbLsbLgLsbLjbLebLsbRibLcbLebRcbLebLeLibRebLsLhLsLibLsL
eLsbLibLgLsLeRsbLgbRoRgRsmbRebRhbRebRgRiRsmbRiRsRsmmbRibRjbLgbLobLsbRi
bLebLiLgbLsLsLsLsLsmmmmbLebLhbLibLhLsLeRsbRgbLebLhbLgLebRgbRgRsmbLsbRs
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLsbLsLsmbLgbLsLsmbLgLsbLsbLobLebLjbLgbRibRcbRjbLsbRhbLjbRibLobLcbLsbR
ibRcbRibRibRhRibRiRsmbRibRibRoLsRsReRsmbLobRibRhLsbRiRcRcRebRibRibLoLs
mbLcbLsLsmbLsbLiLsbLgbLgbRcLsbRiLsbRcbLoLsmbLhbRcbRgbRhbLobRobLibRcLsb
RjbRobLhbLcbLibLibLiLsbLcbLibLcbRobLibLiLsbLiLsbLjbRsbRcbRibRibRgbLeLs
bLiLsbLebLhbLhLsbLibRsLsbLsbsbLgbLsbLsLsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLsLhbRcbRibRcbRcRsRimbLjbLhLsbLiLsbLcbLoLhLsLsmbLsbRsRsmbLsbRsbRsbLsR
sbLcbLiLsbLibRsRiRhbRoRsRsmmbLsbRebLsLsmbRcbLcbLebRebRebRibLiLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLcLsmbLhbLcbsbLebsbsbLsbsbsbRsRsLsRsmbLsLsmbLsbsbLsbRsbLsbLiLsbRjbRhR
gRsmbLjbRibLjbRibLcbLgbRsbsbLsbLsRsbRsbsbLsbsbRsbRsbsbsbsbLsbRsbsbLsbs
bLsbsbRsbLiLsLsmbRsbLgRsbLsbsbLgRsbRsbsbsbRsbsbsbsbsbLsLiLsLsmbLiRsbLg
bLibLibLgbLsbRsLsbLgLsbRcLsbLibLhbsbRsbsbsbsbsbsbLsRsbRsbsbsbsbsbLibLi
bLcbLibLiLgLsbLgbLiRsbLsbLibLiLsbLgbLibLibLsbLgbLiLsbLsLsmbLgbLiLsbLib
LgbLsRsbLgLsbsbLiLsbLhLsbLibLsbLcLsmbLibLibLhLsbLgbLsbLibLebLgbRjbLebL
cbLebLcbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bRiRsmbRiLsbRibReRsmbRibRgbRgbLhLsLsLgmbLiRsRsmbLgLsRsbLibRsbLiLsLsmbL
jbLsbLsbLsbLsLsLsLhLsLsLsLemmmmbLiLsbRebRgRgbRibRgbRiRgRsRsmmbRibRibRs
RibRiRsmbRgRsmbRiRsmbRibLebLcbLcbLcbLiLsLsLsmmbLgbLibLgLsbLgLhbRjbRhRs
mbRgRsmbRiRsmbRgRsmbRgbRibRgbRgRsRsRsRimmmbLcbLiLsLsmbLiLsbLibLgbRjbRi
bRsbRgbRgRsmbRsbRibRgbLsRsbLsbRsbRgRsmbRiRgbRibLeLhbLiLgbLeLsLsmbLsLsL
smmbLsLgbLibLeLibLebLiLsbLiLsbLhbRoRsmbRsRibRgRsLsmbRgbRibRibRiRgbRgbR
ibRgbRiRsmbRibReRgbRibRgbRgbRgbRibLjbLgLsbLeLsbLhbLebLiLsbLibLebRsRgbL
ibRgbRgbRgbRgbRibLhbLibLsbLsLsmbLsbRsLsLsmbLsLsmbLsbLsRsbLsbLsbLsLsLsL
sLsLsLemmmmmbLsbLsLgbLeLeLsbLebLibLsLiLebLibLiLsbLibLeLiLgbLcbRcbRgbRs
bRebRgbRgbRgbRgbsbLjLgbLiLsbRgbRgbRibRebRsbRhRsmbReRgbRsbRiRsmbRgbsbRi
bRgbLsbRgbLsLsmbRjbLoLsmbLebLgbLsbLsbLebLebLibLsLhbRsbLsbLsbLsLsmbsbLs
LgLsLgLsbLgLibLebLgbLeLsLsmbLebLsbRcbRiRsmbRcbRibRebRgRsmbRiRgbRhbsbsb
RgLsbLjbLhbRsbLhbLebLhLibLeLsbLebLeLsbLcbLgLsbLoLsmbLebLsLibLgLsbLebsb
RsbLsbLsLiLsLsmbLiRsbLiLsLsmbLebLcbLgbLcLebLgbLeRsRsmbRiRsReRsRcRsmmmb
RibRiLsbRoLgLsbLeLsbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bLhRsLhRsbRcbRcbRibRhbRcbRgRsmbRhLsbRiLsbsbRhRsmbLibLibLcbLjbRibLcbLgb
LibLhbLibLibRsbRcbRibRibRiRsmbRibRcbRgbLcRsLsbRsbLibRjbRcRsmbRibRibReb
LebLhbLcbLobLebLgbLiRsbRjbRcRiRsRsmmbRibRibRgbLhbLgbRibRsRcbRibRibRcbR
iRsmbRcbRgbRjbLjbRcbRhRsmbLibLcbLeLsbRhRsmbLjbLcbLcbLhLsbLgLsbLibLgbRc
bLcbRobLobLcbRibReRsRgmbLsbLsbRgbLgRsbLoRsbRebRebRiRsRsmmbsbLsbRiRsRsm
mbRebLobRcbRebRgbRgRsRsRsmmmbRhbRjbRebRebLoRsbRebRibRcbRsbRoRsmbRiRsmb
RebRcbRgbRhbRcRsmbReRsmbRhbRgbRebRgRsmbRibLcbLgbRcbLjbRsRhRsmbLjbLcbLg
bLsbLgbLgLibLiLsbLcRsbLhbLcbLsRcbRcbRibRiRsmbRsRjbRsbRsbRebRibsbRcbRib
RcbRcbRgbRibRgRsmbRgRsLsmbRibLhbLcbRhRsRsmmbRiRsmbRgbRibRibRgbLsReRsmb
RcbLobLcRsbLgbRcbRcbRibRiRsmbRibRgbRsbRibLcRsbRhbRcbRcbRebRcbReLsbRiRs
mbRiRsRsmmbRibRhbRhRibRhbRcbLjRsbLcbLhRsbRcbRcRsmbRgRsmbRgbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRjbLebRsbRobLebRcbRobLebRebLjbLobLobLjbRebLebLsbRebLjbLjbLsbRjbLebRjb
RsbRobLebLobLjbLebRobRobLebLjbRjbLjbLebRjbRobRjbRjbLsbLebRsbRsbRebRjbL
obLobRobLjbLebRjbLjbRobRebRjbLobRobRebRobLjbRobLebRobRobRebLobRebRobRc
bLebRobLjbLobRobRobRobRobLobLjbLobLjbRjbLebRcbLjbRjbRobLsbRcbLebRebRsb
LobLebRjbLobRebLebLobRobRobLcbRcbLcbLobLcbRobRebRcbRjbRobRobLsbLobRebL
cbLobLobRobLobLjbRcbLsbLobRobRjbRobLsbRebLobRebRobLobRjbRobLcbRobRsbLo
bLebRebLebLobRcbRebLobLobRobRsbLebLebRjbLsbLobRsbRjbLjbRjbRobRobRebLeb
RcbLsbLobLobLebLebRobRobRebLobLebRebRsbLsbLjbRebLobLjbLsbLsbLgbRobRsbR
ebRjbRebRcbLsbLobRjbLebRobRcbRobRjbRobLebLjbLobLobRjbRsbLebRobRgbRobRo
bRobLobRjbRebLebRjbLobRsbLebLobRobLobLebLjbLebLebLobLjbLjbRjbLjbLjbRjb
LobRsbRjbRsbLebLjbLobLebRobLobRobLobLebLebRjbRobRjbLebLjbRobRebRgbRcbR
cbLebLjbLebLebRobLobRcbRobRebLebRcbRsbRobRsbRjbRobLobRjbLsbRsbLebRjbLe
bRsbRebRobRebRebLebLobLsbRcbLgbRobRobLobRsbLgbRobRobRobRcbLobRobRcbLeb
RobRobRobLobRebRsbLobRebLebRobLobRjbRobLjbLebLobLsbRjbLcbLcbLebRcbRobR
sbLebRebRgbRobRjbRsbRebLebLebRebRebLobLebLebLsbLjbRibRcbLebRobRcbRsbLs
bLcbRebRcbLgbRibRebLobLebRgbLgbRebLobLobRobRibRebRibLobLhbLebRcbLobRob
RebLobRibLebLebLebLebRobLobRobLgbLobLebRebLebLobRobRobRobRcbRcbLcbRcbR
ebLsbRobLcbLobLebLcbRobLebLcbRibLobLebLobRobRebRsbRgbLebRobRsbLgbRebLg
bRsbLgbLebRebRebRobRobRebLsbLebLcbLcbRebRcbRobLcbLibRibRibLobRgbLcbRsb
LobLebLibRobRobLcbRobLcbRobLsbLobLebLebLobLobLibLobLobLebRcbRcbLobLobL
ebLebLobLibRebLobRcbRcbRebRebLobRibRibRhbLsbLcbLobRebLobLobRobLobRibLo
bLibRobRcbLhbLhbRcbRsbLebLobLcbLebRobLobRebLsbRibRobLobLsbLsbRibLgbRob
LobRobRobRhbLsbRsbRobLobLcbRgbRebRgbLcbLibLibLebRobRebLhbLobLebLobRibL
obLobLibLebRebRcbLobRobRcbLobRobRobRebLobRobRgbRcbLcbRebLibRobRibLibLi
bLobLebLobRobLebRcbLibLibLjbLobLobRcbLgbLobRobLobRebLebRgbLobLebLobRib
RebRobLcbRcbRobLsbRebRobLsbLibRobLobLebLgbLcbRhbLobRobRebRobLibLcbRebR
ebLobRobLebRcbLebRobLebLcbLhbRobRibLebLjbLebLebRsbRcbLebRobRebRobLsbLo
bRsbLobLebLibRcbRcbRebLcbRsbLsbRebLcbLsbRebRebRibRsbLibLibRobRebRibRob
RobRobLcbRibRebRgbLhbRgbLobRhbRhbRgbLebLsbLebLobRcbLobRobLobLobLhbLobR
obRebRhbRobRobLsbRgbRobRobLibRebLobLebRsbLebRcbLebRobRcbRobLebRebRebLo
bRobRjbRebLjbRebRgbRjbRobLobRebRobRebLebRgbLobRsbLebRhbLcbRebLobLobRjb
LobRobRebLebLcbLebRebRobLobRobRjbLebRjbRcbRobLjbRebRebLobLobRebRebLsbL
cbLjbLebLobLobRjbLcbRcbRobLcbRebRcbLobLjbLjbRcbRcbRcbLobRebRjbLobLhbLo
bRebLebRebRjbRibLjbRobLobLobRjbRcbRcbRobLjbLobLobLebRcbRobLebRjbRebReb
RebRjbRebRsbLobLebRcbLobLobLebLcbLobRobLobRjbLobLobRobRobLebLobRjbLobR
sbLebLsbLjbRobRobLjbRebLjbRcbLobRobLcbRcbLebLobLjbLcbRobLebRobLjbRobLc
bRgbRebLobRjbRobLobLjbRobLcbLjbLjbLebLjbLcbRcbLcbLjbLobRcbLebRebLebRob
LebLibRebLibRebLjbLjbRsbRobLobLsbRsbRsbRcbLjbLebLcbLsbRobLobRobRebLcbR
cbRobLebLobRobLibLobLebRibRebLebLebRobRebLobRjbLcbRebRjbLcbRjbLobRgbLo
bRebRobRebRobLgbLobLobRcbLjbRsbLobRebLebRebRcbRcbLobLsbRcbRobRobLcbLcb
RobLebLobLebLebRobLcbRebLobLebRjbRcbLebLobLcbLobLebRobRcbLjbRobLcbRebR
sbLobLcbLobRjbRobRobLobLobLcbRjbLjbRibLjbLebRobRsbRobLobRobLebRjbLobRo
bRobRobRsbRobLebLobRebRobLobRjbLobRcbRobLcbRcbRebLsbLobLobRsbLobRobLcb
LobLsbLobLsbLebLjbRobLebLobRjbLobLcbRjbLobLobRsbRobRobRobRcbRjbRebRcbL
cbRebRobLcbRsbLebLobLcbLjbLobLibRcbLebLebRobLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bRcbRibRhRsmbRibRiRsmbReRsmbRibRiRsmbRsRsmbLcbLgbLhLsbRebRcbLgbRgbLgbL
sbLsLsmbLsLsLsLsmmmbRsRsRsRsLsmmmbLsbLsLsmbLsLsmbRsRsmbLsbsbRcRsRsRsRg
mmmbLgbRebLgbRebRsRsmbLsLsmbRcbRibRgbLibRebRiRsmbRgbsbRsbRibLhRsRsmbLg
bLgLsLhbRobLsbRhbLebLsLoLsmbLsbLsbLiLsbLsbLibLsbLgLsLsmbLcbLgbLgLsbRcb
RibRibRibRcbRiLsbRiLsbRgLsbRibRgRsmbRhbRcbRgRsmbRgRsRsmmbRsbRsRsRsmmbR
iRsmbRsbRsbRibRgbReRsmbRebRhbRiRsmbRobLsbRcRsmbRiRsRsmmbRgLsbRiRgRsLsm
bRhbRgbRhbRgRsmbLsbReRsmbRgbRcbRebRiRsmbRgbRsRsmbRhRsmbRiLsbRgbRhbRebR
sRibRgRsmbRgRsRsRsRsmmmmbRibRgbRgbRgbRsRsRsmmbRgRsmbLhbLibLsbLibLebLeb
LobRebRgbLcLibLgbLsbLibRgbRgbLibRebRgRsmbRgbRebRgRsmbsbsbRsRsRsRsRsmmm
mbRsRsRsmmbLsbLhbLiLsLsmbLibLiLsbLibLsbLsbLsLsmbRsRsmbLgRsbRhbRobRibRi
bRibRhRsRhmbRiRsRsmmbRcbRgbRcRsmbLjbRhbLhLsbLibLibLgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bLsLsLsmmbLeLsbRobRebLsbRcLsbRebLebLsbLgbLeLsbLcLsmbLgLsbRgbRcbRibRebR
ebRsRgRgbRcbRcbLsRsbRgbRebRgbLhLsbLibRsbLibRcbRhbLibRgbRcbReRsmbRcbReb
RgLsbRebRcbReLsbReRsmbRebLsbRibLibLobsbLibLhbLcbLobRebRiLsbRibRgbLgbLc
bsbLsLsmbLsLsLsLsmmmbLebLibReRebRobLsbRjbRsbsbRsbRgbRsRsmbRgRsRsRgmmbs
bLsbRsbRsRsmbRsbRgbRcbLsbRebRibRebRjbRcbReLsbRibRjbRibRibRibLcbLcbLobL
ibLjbRhRgbRsbRibRsbRjbLsbLobLsbLebLhLsLsmbLiLsbLebLhLsLsmbRsLsLsmbLiLs
bLgLsbLiLsbLebRgbLebLebRsbRgLsbRcbLcbLibLgbRgbLjbLibLsLsmbLgbLgbLibLeL
ebLgLsbLsbLgRjbRibRsRcRsmbRjbRiLsbLsbLeLsLsmbRgbRcbRgRsmbRiRsmbLsbRcLs
bRgRibReLsbRiLsbRhRsmbRsbRcLsLsmbRgbRcRsmbRibRibRebRibRebRibReRiRgbRiR
smbRibRebLsbRibRiLsbLsbRcbRhLsbLjbLgbLhLsbLgLjbLsbLibRsbLhbLibRsbLhbRs
bsbLsLsLsLimmbLsbLsbLsbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bLeLsbLibRibRebRebRebRibRsbRibLsLjbRibLhbLgbRobLeLsbLsbLibLibLhbLiRsbR
obRgbReLsbReLsbReRsmbRibRobRobRsbRhbLcbLgbLiRsLsbLgbLsLsmbLiLsbLhLsbLi
bLgbLiLsbLsbRhbLgbLhbLgbLsbRcbRibRcbLsLsmbRiRsRsRimmbRibLibLiLsbRsbRsb
RjRgbRsLsbRibReRsmbRebRcbRibLsLsmbLsbLibLhLsbLibLgbLgbLgbLgLsbLgbLcbRc
bRgbRibReRsmbRgRsmbRebRsbRiRsmbRsbRebLiRsbRsbRiRsmbRhRsmbRebRgLsbRgbRh
bLobLsLsmbLgLsbLibRgbRcbLgbRibRgbRgbLsbRgbRsbRsbRsbRsRsRsLsmmbLsbLsbRs
bRibRgbRgLsRsbRsbRebRibRsbRibRcbRebsbLsbRsbRsLsbRsbLsbRiLsbReRgRsmbRib
RibLsRsRsmbRhRhbLsbLjbLgLsbRebLgbLibLgbRjbRsbRebRhLsbLgbLsLsmbLibLibLi
bLsbRjbRebRebRhbRibRibLjbLibRjbRebRebRgRsmbRgbRsRsmbRibReRsmbRgbRiRsmb
RgbLjLsLsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bLibRhbRiLsbRcRsRsmmbRibRgbRhbRibRibRjRsmbRgLsRsbRjLsbRjbRhbRibRgbRhbR
jRsmbRoRsmbRsbLjbRsRsLgmbLiLsbLiLsbLcLsmbLiLsbRcRsmbRibRibRgbRcRsmbRgb
RgbRgbRgbRsbRjbRsbRsbLibLjbRjbRjRsmbRjRsmbRiRsmbRiRgRsmbLgbLhLsbLibLgb
RgRgRsmbLsbReRsmbRibRgbRgbRhbRgLsbLcLsmbLibLibRgbRsbRsbLibLsbRgbRebRib
RgbRsRsmbLibLjbLibLeLsbLibLcbRsbLibRsbLibsbRebRsbRhRgbRjbLibLgbLgbRsbR
ebLgbLibLgbLgLsbsbRsbLibLjbLgbLibLibLjbLibLsLibLgbLjbLibLjLsmbLebsbLjb
RgLsLsmbLiLsbLgbLgLsbLgbLeLeLsLsLgmbLgbRcbRibRobRiRsLsmbRgRsmbRibRhbRi
bRibRiRibRsbsbsbRgbLgbLjbLiLsbLibLgbLibsbsbLsLsmbLsLsmbLgbLibLgbLibLeL
eLsLebRgbRhRsmbRgbRebRsRgbRjbLgbLsRsLsbRsLsbLcbLibLibLibLgbLgbRsbRjbRj
bRiLsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bRsLsbLgLsLgLebLgbRebLhbRebLjbLgbLibRjbRiRsmbRhbRhbRibRibRiLsbRcbLsbRg
bRibRgRsRimbRgbRiRcbsbRibRjbReLsRsbRgbLgbRgbLhbLibLibLibLebLgbLgbLobRs
bLjbRjbRibRhbRibLiLsbLhbLgbLibLibLgbLibLjbLcbLgRsbRobRibRibRgbRibRgbRh
bRiLsRsbRjbRgLsbRcbRibRjbLgbLgLsbLgbLgbLgbLgbLibLhbLiLsbRsbLgbLgLsbLgb
LsbLsLsRsmbLgLsbLibRsbRcbRebLibRibLiLsbRcLsbRcbRiRsLsmbLibRcbRibLgLsbL
jbLgbRsbLjRsbRsbRjbLjbLsLsmbLsbLibLgbLhbRhLsbLgLsLsmbLhbLiRsbsbRibLebR
sRsRsmmbLibLsbLsLgbLsbLgbLsbLiLsbLsLsmbLibLibLcbRjbLibLgbRsbLibLibLjLs
LsmmbLgLsbLgbLjLsLsmmbLibLibLhLsbLibLibLhbLcLsmbLgbLibLgLsbLibLibRsbRh
bLsLcbRcLsbRcbLjbRcbRjbRibRibRgbLcbLibLgLsbLgLsbLgbLcbLiLsbRibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRibLibLjLsmbRiRsmbLjLcbRcbLsRcRsRimbRgbRibRhbRhbLibRcbRgbLgRebRhbLobR
cLsRsLsRgbRhbLhbRcRsmbLhbLobLibLcbLhRgbRjbLcbLibLibLgbLcLibLsRsLsLsmbR
gbLgbLhRsRsLsmbRcbRiRsRsRiRiRsRgmmmbRsbRibRgRsmbRgRsRiRimbRhbLgbRsRsmb
RsbLgbLgbRsbRsbRibRsbRibRhRsRsRsmmmbRgRhRsRsmmbRgbRjLsbRgbRsbRhbLsbLgb
LcLiLibLgRsLsbRsbRsbRsbLiLhLsbLgLgbLsbLsbLebLgbLiLgbLebLsbLjbRjLsbRibR
gRsmbRsbRsLsbRjbRsbRsbRgbRsbRgRsmbLsRsbLcbLjbLgbLgbsbLibRsLsbLjRsbLgbL
ibLgbLgLgbLibLgLhLiLsbLibLgLibRgbLgbLgbLibLiLsbLibLibLebRibLebRsbRebRe
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLsLsmbLgLsbsbLgbRsRgRsmbLhLsbLgLsbLcbLebRoRsmbLibLebLcbLsRsbLebLebLeb
LeLsbLibLibLgbRcRsmbRsbRgRsmbRcbRoRsmbRcRsRimbRiRibRoRsmbLgbLcbLcLsmbL
sbLsbRebRiRsLsmbLiLsLgLsbLibLgbLcLsmbRsbRsLsbLsLsmbRjbRiRsmbRhbRebRibL
hLsLiLsbLgbLgLgLeLsbLibLibLgbRhbLcbLcbRjRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRiRsRsRsmmmbLjLsmbLobLobLoRsbLcLsmbLoRsbRebRsRsRsRsmmmbRgbRcRsmbRsbsb
Lgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bRsRobLsRsbRsbLsLsmbRsbRsbsbLsbsbLsLsmbLsLsmbRjbLebLebLsLobRcbRebLsbRe
bRgbRjbLiLsbLcbLcbLsLsLcmbRoLsbRoLsbRgbRibRsbRiRsmbRgRgLsbRhbLgLsbReRi
LsLsmbLibLcbLiLsLsmbLcbLcbLcbRhbRcLsLsmbLcLsLsmmbLgbLgbLsLsmbLgLsbRjLs
bRhbRoLsLsmbLcbLoLsLcmbLebLibLgLsbLcLsLiLsmbLoLsmbLibLcbLhLibLsRsbLgbL
ibLgLsbLgLsLsmbLgLsbLcbLgbRibRibRgbLsbLibLibLsbRsbRsbLgbLobLoLsmbLebLe
bLebLebsbRsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bLcbLobRibRcbRobRebRgbRobRcbLcbLobRobLobLgbRibRobRebLcbLhbRibLobRobRob
LebRcbRobLebLcbRebRobLsbLgbLebLcbLobLcbLobLgbLobLsbLobRcbRcbRobLobLobR
gbRgbLibLobRebLobRobLobRobRobRobLebRsbLcbRobLebRobRibRebRebRobRgbLobLc
bRobLcbLhbLobLebLhbLobRobLobRhbLobLobLcbLebRobLobRobRgbLcbRobRobRobLcb
LcbLcbLgbRobRcbLgbLobLibLcbLebLobRebRobRibLcbLebLebLebRcbRibLhbRobLsbL
cbLebLebLobLebRebLibRebRcbLobRobRgbLibLobLebLgbRcbLobLobLobRcbLobRsbLc
bRcbRsbRobRibRobLobRobLobRcbRcbRsbRcbLcbLobRebLobRcbRhbRebRcbLobRibRob
RebLobLobRibRebLebRibLebLgbLcbLobRebRebRgbLobLobLobLcbRobLobRebRgbLebL
obLhbLebLobRobLobLobLebLcbLobRibLobRhbRobLsbLebRobRcbLebLebLobRibRcbRo
bLibRebRobRobRebRsbRebRcbLobLebRobRobRobRgbRcbLobLcbRobRsbLobLgbRibLob
LcbLhbLsbRobRebLobRobRsbRibRobRebLhbLobRebRobLobRhbLcbLibLobRobRobRcbL
cbRobRobLobRibRsbRobRobLobLobLibRhbRebLcbLibLobRobRibLebRebRobLibRobLe
bLcbLgbRcbRhbRgbRibLcbRgbRgbRgbLebLcbRobRobRcbRobRgbRcbRcbRsbLebLebRob
LgbRgbLgbLobLobRobLgbRebRibLobLibLobLcbLcbRcbRcbRobLebRcbRcbLobLcbLobR
obLgbLibLebLibLcbRebRobRcbLebLobRobLobRebRobLcbLcbRobLobLibLibLobLobRe
bRobRibRobRobRgbLobRibRobRcbRobRebRobRebRcbRcbRibRgbRgbRcbLsbRebRobRcb
LcbLobLibRibRgbRobLobLebRobLibLsbRebLcbRebLebLibLobLcbLobRebRobLobLobR
gbLobRebRebLcbRebRebLebLobRcbRcbLgbRobRgbRebRsbRibRebRobLobLhbRobLgbLo
bRobRobLobRsbRgbRobRobLobLobLgbLobLcbRcbRobRobLibLibLsbRebLobRhbRebLob
RobRcbRcbLobRcbLebRebLsbLgbLebRebRebRobRobRobLcbRebRobRebRcbRebLobLcbL
ebLobRobLcbRobLebLobLebLebLcbLebRobRsbLobRjbRsbRobLcbRebRcbRibRobRebLg
bLebRobRcbRobLobRebLsbLobLibLobRebLobLobRebLgbRcbRobRcbLcbRobLcbLobReb
RobLcbRobRebRobRcbRjbLsbLcbRebLebRibRhbRobRibLibLcbLobRobRgbRebLcbLibR
cbRcbRhbLibLobRcbLebRebRobRobRebRebLobLebRobLsbLobRebLebLebLobLobRsbRc
bRhbLebRcbLobLobRcbRgbRebLobLgbRebRcbRebLcbLobLibRhbRobLcbRobRgbLobRob
LcbRibLebRcbLebLsbLobRobRobLebRebRobLcbLobLgbLgbLobLebLgbRobLibLobLobL
ibLobRibLibRgbRobRobLebLobLebLobRgbLcbLobRobRibRcbLebRobLcbLgbLgbLgbRo
bRibLebLibRcbRobRsbLcbLjbLcbRobLobRcbLobRcbRobRgbRebLcbLobLobLobLgbRsb
RcbLsbRgbLhbLcbRcbLibLhbRcbRibLebRebLibLebRobRobRjbRcbLsbRcbRsbLcbRobR
obRobRobLebRobLibRobLcbLibLobRobRobLgbLobLcbRibRibRobLobLebLobLebRobRg
bLobRobLobLibLebLebRobLgbLcbLcbRobLcbRobRebRebLcbLibLgbRibLibRebRebLob
LobRibRobRjbLebLsbLebLobRobLcbLobRobLobRibRibRobLibRobRebRcbLobLsbRobR
obLobLibLobLobLebRibRobLobRebLebLebRobRebRsbLobLcbRebLgbLebLebLebRobRo
bRibLcbRobLobRobLebLcbLobLebRgbLebRcbRgbRebRobRobRebLobLgbRgbLobLobLcb
RebLgbRebLibRhbLcbRobRobLcbRobRobLobLebRobLcbLhbRobLebRebLsbLobLobRcbR
obRibRgbRebLobLsbRobLebLebLobLobLebLobLebRobRobLgbRobLobRobRcbRobRgbRc
bRcbLcbRgbLobRebRobRebLsbLobLobRcbLebLebRibRebLibLcbLobRobLobRobRebReb
LobRebRobRebLcbRebLgbRcbLobRibRebRobRobRobLcbLibRobLebRobLebLebRebLobL
obLcbRebLibRcbLhbRcbLobLebRcbLebRsbLcbRsbLobLobLebRobRobLobRebRhbRibLe
bRibLobRobRobRobLebRobRebLgbLobRcbLcbRobLobRobRcbRobLobRcbLebLjbRibLeb
RebRcbRgbRibRebRebLobRsbLcbRobLgbLobRobRobLobRebRebLsbLobRobLgbRobRobR
cbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRhbRcbRcRsmbReRsRembRsRgLsbRhbRcRsmbRoRsmbLhbRjRsmbLcbRjbRcRsmbLjbRhb
LjbLiLsLsLsLsmmmbLhbLjLsLsmmbLcLsmbLeLsbLibLcLsmbLiLsbLhbLiLgbLgbLgbsb
LgLsbRjbLiLgLsLsmbLibLibLjLibLibLcLsLsmmbLsbRgbRsbRiRsmbLcbLebLcbLsLib
LgbLgLsLsmbRsLsbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRibRhbRcbRcbRobRcRibsbRsRsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLgbLgLsbLiLsbLibLgLgbRebRgbRiRsmbLsbLibLgLsbLsLgbLeLsLsmbRsRsmbLebLeb
LgLsLsLsmmbLgLsbLsLgbLsbRgbLgLsbLiLsbLgbLibLeLsLsmbRsLsbLcbLiLsbRebRib
LgLsbLsLsLsLsLimmmbLgLsLgbLsbLgbLsLgLsLebLgbLibLibLibLgbLeLsbLiLsbLgLe
LsbLibLcbLgLsbLibLeLsbLgbRjRsmbRgbLjbLgLsbRjbRhbRiRsRsmmbLibRhRsmbRebL
jbLibLsbLibLibLibLgbLgbLibLgbLibLiLsbLibRoRsRsLsmmbRebRgbRobLibLgbLiLs
bLiLgbLgLsLsLsLsmmmbLsbLsLibLgbLgbLibLibLibLcbLibRibRiRsmbRcbRibLibLib
LibLhLsbLgLsRsbLgLgLgbLhbLgLebRoRsmbRsbLjbLsLcbLgbLibLgLsbLibLeRsbRgbR
ibRgRsmbReRsmbRgRsmbRgbRsRgbRsbRibRebRebRgRsmbRgbRebRgbLgbLibLiLsbLgbL
gbLgbLibLgbLsbRibLibLibLibLgbLgbRgbRebRhRsmbRibRibLgbLibLebLgbRsbLibLg
bRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bsbsbLsbLsLsmbRhRsmbLgbRsbRcRsmbRsRsmbLibLibLibRjbLgbsbsbsbsbsbsbsbLiR
sbRjbLsbRcRsRsmmbLjbRebRebRsRsmbRsRsmbRgRsRsRsRsRgRsRgmmmmmbRebRebLcRs
bLiLsbRsLoRsbLibLibLsLgLsbLsbLobLjbLhbLibLobLiLsbLiLgLsbLebLiRsbRcRsmb
LibRsbLibRjRsmbLibLsbRcbRibRibRgRsmbRgRsmbRibRgbLebRibLcbLibLgbLibLgbL
ibLgbRgbLjbLibLiLsLsmbLgbLgbLgbLgbLgbLebsbLgbLsbRjbReRsmbRgbRiRsmbRgRs
mbRibRgRsRsmmbRsbRiRsmbRiRgbRgbRibRhRsLsmbRibRiRsmbRibRgbLjbLhbLgbLibL
hbLiRsRsRsmmbLibLgbLibLibRgLgbLibLgbLibLjLsmbLibLiLsbLibLiLsbLibRjbRhb
RebRibRgbRsbLebLgbLgbLsLsmbLiLsbLsLsLsmmbRhRsmbLcLsmbRsLsRsbLsbRcRsmbR
iRsmbRiRsmbRgbRgRsRimbRsRgbRibRibRgbLibLhbLibLgbLgbRsbLibLcbLebLiLsbLg
bLibLgbLgbLgbLiLgbLibLiLsRsbLgbLibLsLsmbLiRsbLibLjLibLebLeLsbLsbLhbLsL
hbRsbRebRibRgLsbLsLsmbRcbRhLsbLjRsbRjRgbLjbLjLsLsmmbRjbRibLgbRjRsmbRhb
RibLsbRcbLsbRhRsmbRsbRgbRhbRgbLsbLjLibLibLsbLibLgbRibLgbLjLsmbLjRsbLgb
RibRjbRjLsbRsbRibLgRgRsmbLjbRhbRibRibRgbLgbRjbLsbLgbLgLgbRibLcbLgbLibL
gbLgbRgbLibLhRsbLibLgbRibLgbLgLibLibLgbRebRiRsmbRgbRibLibLibLcRgbRgbLs
bLsbLgRsbLgbLgbRjbRibRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bRsbLobsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLgbLeLsRsbLibLeLsbLibLibLgLsbLibLgRsbRebRiLsbRcbRibRibRibRhRsmbRibLsb
LjbLiLgbLibLgbLibLibRcbRjbRibLcbLibLsLibLgbLsbLibLibLibLgbLiRsbLiLsbLi
bLsbRgbRcbRiRsmbRibRhbRsbRhRebRsLsbRgRhLeLibLgbLgbLsbLebRgbLgbLgbLjbRj
bRiRgbRgbRsRsmbRibRibRgbRhRsmbLjbLiLsRsbLibLgbRsLsbLgLibLgbLjLgbLgbLsb
LebLjRsbLibLsbLibLibLibLibLhLsbLibLsLsmbRjbLibLsbLgLsLsmbLgLsbLhbLgbLi
bLhbLgbLsbLgbLgbLibRsLsbLiLsbRsbLgbLsLsmbLgbLibRjbRcbLsbRiRsmbRcbRibRg
bRgbLiRsbLibLhLsbLibLibLgbLibRcbLibRhbLgbLgLsbLcbLebRgRsRsmmbRibLhbLiL
sbLibLgbLibLsLsmbRjbRhbLebLiLsbRsbLhbLiLsbLsLsLsmmbLhbRsbRebLcbLibLsLs
mbLebLgLgbLhbLsbLibRsRsmbRcbRiRsmbRibRibRgRsRsRsRsRsRsmmmmmmbLcbLcbLgL
sbsbRjbLhbLgLsbLibLjbLhLsbLiLsbLgbLgbRjbLsbRsRsRsmmbRsRsmbReRsmbRibRcR
sRsmmbLcbRgbRebRhbRsRsmbLebLiLsbLiLsbLcbRgbRhbRsLhbLiLsbRsLsbLibLhbLsb
LebRgbLhbRsbLjbLibLibLgbLebLiRsLsbRhbLgLhLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLebLhbLobLcbRhbRebLebLhbLobRobLebLsbRebLcbLibLobRobRobLobLobRcbLebLob
LebLebRobLgbRsbRobRibLobRcbLobLgbRebLebRobRebRebLgbLjbRobLebRcbRobLobR
cbRsbRgbRebLibLcbLobLibRobRebRobLobRobLobLobRgbRobLcbLobRcbLobRobLobLe
bLobLobRcbRobLobRobLobLebLsbRgbRobLobLobLcbLobRgbLobLebLebRebLcbLobLob
RibRgbRobLobLebLebRebRgbLebLibLobLibLebLibLobRobLebLebRobRebLcbRebRobL
ebLobLobLobLhbRebLebRobLcbLobRcbRobRebLcbRhbLsbRgbLibLobLobRobRcbRobLe
bLebLebLibLebLgbRobRjbRebLebLhbLebLebRobRcbRobRcbLobRebRobRebRibRsbRcb
RgbLobRobRebRcbLcbRobRcbLcbLebRobLgbRcbLcbRebLibRcbRibRobLobRibRobRgbL
cbRebLobLgbLobRsbRobRobLebLsbRebLcbLhbRobRobRobLsbLobLsbLcbLcbRgbLebLe
bLcbRcbRcbLebLcbRebRebLebLibRcbLobRobRobLobRcbRcbLobLebRebRobLcbLjbRob
RebRsbRobLcbLcbLibLobLobRgbLibRibRhbRjbRhbLobRobRibRibRebRobRebLobLcbR
ebLebLobRgbLobLsbRsbLobRebRobRobRobRibRobRobRobLobRobRibRhbRebRobLsbRc
bRcbRcbLebLobLcbRobLobRebLebRebLobLebLobLcbLobRibLcbLobRcbLobRebLibLgb
RebRsbLobRobLebLobRcbRebLebLobRebLebLebLebLobRibLebRgbLhbRobLcbRebLebR
ibRobRebLobLobLebRobLgbRebLobRebLgbLgbLebLebLebLobRobRobLcbRsbRobRobRo
bRsbLhbLobRobRebLcbRobRcbLibRibRobLcbRobLebLobLcbRsbLgbLcbRebLebRcbLhb
RebLebRobLgbLcbRsbLibRebLebRebLebLobLgbLsbLebLibRobLobRobLebRobLcbRobR
sbLobRobLebRibLcbLebLhbLobRcbRcbRebLobRobRobRobLobRobRjbRsbLcbLobLibLh
bRibLebLebLobRebRebLobLhbRobLobRhbLcbLobRebLobLibRebRibRhbRobRobLgbReb
LebRcbRebLobLobRobLsbRobLobRibLebLobLobLibLobRcbLcbRebLebRebLcbLobRebR
ebLebRsbRcbLibRobLebLebRebRebRobRobLcbRobLebLobRsbLgbRcbRcbRobLebRobLe
bRcbLcbLobRobRhbRcbRcbRobRobRcbRcbLobRobLebLobRgbLcbLcbLobRjbRebLsbRcb
RobRebLobRibRobLgbRhbRobRgbLcbLobRebRcbLhbRsbLhbLcbRcbRibLobRebLcbLebL
ebRobRebRgbRcbRobLsbLcbRobLebRebRobLibRgbLsbLobRobRebRcbLobRgbRobRibRo
bLgbRcbRobLcbRcbRobRhbRcbLhbRcbRobRhbRcbLobLgbLobLebLobLsbRsbLibRobLeb
LgbRobRobLcbRibRhbLobLcbLebLibLsbLgbRsbLcbLcbLcbLebRibLobRebLebLebLobL
ebLobRibLobRcbLsbRobRsbLebRebRcbRobLebLcbRcbLsbLobLebLibRibRebLobLebRo
bLibLebRibRebRjbLjbLcbRobRcbRgbRibLibRebRebLcbLebRibRcbLebLgbLebRcbReb
RebRobRibLibRcbRgbLobRebLobLsbLcbRgbLebLebRobRebLobRcbRebLobRebRobRobL
cbRobLcbLhbLibLobLobLobLobRcbLebLobLcbLebLebLebLobLebRsbRobRibRibRebRc
bLcbLobLobRcbLebRobRobRobLebLcbRcbRebLebLobLebLobRobLibRobLobRgbRcbLeb
LobRgbLcbRobLobRobLobLobLobLcbLebRobRebRobLobLobLebRobLsbLcbRobRobLobR
cbLsbLsbLebLobRibRobLebRgbRobLgbLobRobLebLcbRebLgbRibLobRebLobLebLobRo
bRobRcbLobLcbLcbRobLhbRobLobLebLobRebRobRebLhbRjbRgbRebLobRjbLobLobRcb
RobRobLcbRebLobLcbRjbRobRobLobRobRhbLsbRobRobRobRebRobRebLobRibLobLhbL
gbRcbRibRobRjbRobLobRebRcbRobRobRobRebLobLobRobLobLobLobRebRobRobRcbRs
bLcbRhbLcbRcbRcbRobLobLebLobLobLebRgbLobRcbLebLcbLobRobLcbRgbLobRobRgb
RjbRebRebLobRebRsbRibRebLjbLebLcbRobRcbRgbRcbRibRobLhbRobLobLgbRcbRobR
gbRebRsbLhbLebRgbRgbLcbLobRibRobRhbLcbLcbLgbRebLobLobRgbRcbRebRobRobLe
bLgbRobRcbLobLebRcbLobRebLobLgbLcbRcbRobRjbRebRgbRgbRobLsbLobRebRobLob
RobRcbLsbLobRibRebLibRcbLibLcbLebLgbLobRibLobRcbLgbRebRobRobRsbRobRobL
ebRcbRobRebLcbLebLebLobLcbRebRebLibLobRobRobLebLobLgbLebLjbRcbLobLobRo
bLobLebLobLobLcbLhbRobLebLgbLcbRcbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRgbLebLeLsbRjbRsbRgLsRsbRsbLiLsLsmbRgRsmbRiRsmbLiRsbLjRsbLibRgbLgbLeL
sb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bsbsbLsbLsLsmbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbRsbRsRsm
bRsLsbRsLsRsbLsbLsLsmbRsLsbLsbLsRsLsRsLsRsLsbRsLsRsbRsbLsRsbsbRsLsbRsb
RsRsmbLsRsLsbLsbRsRsmbRsRsLsLsRsmmbsbsbsbRsbRsRsLsmbRsLsbLsbLsbRsbRsRs
mbLsbsbLsRsbsbLsbsbLsbRsLsbLsLsmbRsRsmbRsbLsbLsbRsbLsRsbRsRsLsLsmmbRsL
sbsbLsRsLsRsbLsLsmbRsbLsbRsbLsbLsbRsbLsRsbRsbLsbLsbLsLsLsmmbsbsbRsLsLs
mbsbRsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsb
sb

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bLgbsbRsbRsbRsbRsbRgbLsRsbRsbRsRgRsRsmmbRgbRgRsmbRgRsRsmmbRsRsRsRsRsRs
mmmmmbRgLsbLsLsLsLsmmmbRebRebRsRsmbRsRibRebRcRsmbRiRsRsmmbRibRcbsbRebR
ebRgbLebLebLibLeLsbLibReRgbRoRsmbRhbRcRsmbRobLgbLcbLiRsLsbRjbRobLiLsbL
ibRcRsmbLjbLcbRcbLhbLeLsLsmbLibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155322; End: 155822;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bRsbRsRsmbsbRhbLoLsLsmmbLoRsbRhRsmbRcbRhbRibRgbRcRsRsRsmmmbRobRobLhbLi
bLhLcbLiLsbLgbLiRsbLobReRsRiLsmbRsbRibRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRs
RsRsRsmmmmmmbLobLcbLibLeLsLsmbLcbLhbLobLobRibRobRobRgRsmbRiRsmbRgRsRem
bRcRsmbRgbRibRgbRgbRgbRibLsLgbLcbLcRsbLgbLcbLibLgbLcbLhbLibLgLsbLibLiR
sbLhRsbRgRsmbRiRsmbLjbRsRibRibRoLgbRobRibRsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLcRsbLiRsbLcbRcbRsbLibLcbRjbRiLsbReLsRsRsmbLgbLobLsLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRsRsRsRsRsRsRsmmmmmmbRsRsmbLibLiRsbLiRsRsmbRoRsmbLjbLsLiRsbLiRsbLibLc
LcLsmbLoLsmbRibLobRebRgRsRimbRiRsRsmmbRgbLjbRobLgLibLcbLgbLgbLibLibLib
RiLsbLhLsbLgbLobLsbLcLsmbLibLiLsbLgRsbLhbRhRsmbLsbLcbLcRsbLeRibRhbRibR
hRsLsRsmbRhbRcbRibRibRhbRoRsmbRibLcbLgbLibLibLibLgRsbLgLsLsmbLibLibLgL
sbLibLsbLibLgbLsRsbLibLiRsRsmbRsRgRsmbRhbRsRsmbLcbLiRsbLibRebLibLibLgb
LoRsbLibLiLibLgbLcbLiLsLgbLhbsbsbsbsbLsbReRgRsmbLjbLiLsbsbRjbLcLsmbLib
RobLsbLiLsLsLsmmbLgbLsRsLsLsLsLsLsLsLgmmmmmbLsbsbLiRsLsbLibRobLcLsmbLi
bLibLsbLsLsLsLsLsmmmmbLsLsmbLsbLcRsRsmbReRsRsRsmmmbRoRsRsmmbRsRsRsmmbR
cRcbLcbLibLibLsLsmbLsLobLebLibLhbLiLsbLgLsbLibLhbRsLgRsbLgbRibLobLhbLc
bLibLgRsLiLeLsbLibLibRjbRgbRhbRgbRiRsmbsbRsLsbRibRhRsRgmbRobRsbRobLsbL
ibLsLsmbLsLsmbRgbLcLsmbRsLsbRebLiLsLsRsmbLiLsbLhbLjbLibLsbRcRsmbRcRsmb
RcbReRebRobRibRhbRgRsmbRgRsmbRhRsmbLgbLobLiLsLgLsbLiLhLgbLjbLiRsbRhRsL
smbRhRsRsmmbLhbLjbLhbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRibLcbLoLsmbLgbRjbRsbRcbRcbLsbLobRhRsmbLsbLobLhbLhRsbLcLibLibLiRsbLoL
ebLiLiRsbLiLhLiLsLsmbLibLsbLibRsLobLgbLiRsbLgbLgLsbLibLgbLiRsbRsLibLib
ReRebReLsbRibLjbRebRhbRibLibLibLhbLibLibLebLhRhbRiLsbRgbRsbRobRibLgLsb
sbsbRjbLjbRgbLobRibLcbLiRsbLibLobLgLiLsbLgbLjbRjbRgbLjbRjbRjbRgbRsRsmb
RobLibLhbLiLsbLibRcbReRsmbRiRsmbLgRsRibRibLgbLibLibLiRsbLjRsLsbLiLsbLi
bLibLcbLibLsbLhRsbLgbLgbLsLsmbLgbLgLsbLgbLgbLgLsbLiLsbLibLjRsbLibLibLi
bLgbLibLjbRibLibLgbLgbLebLebLebLgbRjbRjbLcbRebLgbLsbLgLsLsmbRjbLibLibL
sbLjbRiRsmbsbRsLsbRsbRsRsmbRsbsbLsLsmbRsRsRsmmbLsbLsbRsbRsbRsbRsLsRsRs
LsmbRsbsbRsbRsRsmbRsbRsRsmbLsbRsbRsbsbRsRsLsLsRsRsLsRsRsRsRsmmmmmmbsbs
bLsbRsRsmbLsbsbsbLsbsbRsRsLsRsmbLsbLsRsbLsLsmbLsbsbRsLsRsbLsbLsbsbsbsb
sbLsbRsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbsbLsbsbsbsbsbsbLsbsbsbLsbRsbLsb
RsbLsbLjbLsbLsbsbRebLibLcbLobLibLsbLgLsbLhbLobLhLsbLeLsLsLjmbLsbLgbLsb
LibRcbRiRebRsRebRgLsLgbRiLsbRjbLcbLibRhbLjbRiRgbRibRebRebRebRsbRebRebR
jbRibLsLibRcbRjLsRsRebLsbRgbRcLsbLjbLibLibLibLibRibLobRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRgbRsbRsRsmbRsRsmbRsRsmbRsRsLsmbRgbRsRsRsmmbRsbRsRsmbRsRsRsmmbRgbLobL
iLsbLsbLsLsLgLsmbLgLsbLsbLebLebLcbLgbRcLgLgbLsLsmbLgLsbLibLebLeLsbLsbR
sbLsLsLsLsmmmbLebLibRgbRsbLibLgbLgLgLsbLsRsLsbRsRsRsmmbLgbLgbLsLsmbLsL
sLsmmbLebLgbLgbLhbLsLsmbLgbRsbLebLsLgbLgbLsLsLsRsmmbLsbLsbLgLsbLsbLsbL
gbLhbLsLsmbLsLsLsmmbLsbLebLsLsRsmbLsbLsbLsLsmbLeLsbLibRsbRsRsmbLgLhbLg
Rsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bRiRsRhmbRibRibRcbRibLsLsmbsbRibRcLsLsmbLcLsmbLebLiRsbRsbLobLsbRiRsmbR
hbRhbRgRhRsmbRsbRibRsbRiRsmbRebRgRhRhbRibRsRgbRgRsmbRibsbLsbRsbsbRsbRi
bLcbLcLsmbLibLcbLgbLcLsmbLgLsbLebRibRiLsbLibLibLibLebLebRhbRibRibRibRg
bLsbRhbRiRsmbRibRgbReLgbRsbLoLsRsmbLiRsRsmbRcLsbLcbLcLsmbLibRcbRibRgbR
cbRibLcLcLsLsmmbRjRgbRcbRibRsRibRhbRcRsmbRiRgRsmbRjRgbRgbLsbRsbLsLsmbL
sbLsbRgbLobRsLhbRibLcLsmbRhbRcbRoLsRsRsmbLcLsmbLebLibLhbsbLiLibLibRcRs
mbLcbLcLsmbRobRibLcLsmbRoRiRsRembRgbRiLsLsmbRgbRcRsmbLobLcLsmbLcLsmbRs
LcbReRsmbLobLgbLcbLiLsbRoRsmbRhbRibRiLsbsbRibRcbLoLsmbLcLsmbLjLgbLobLc
bLhbLiLibLcbRibRgRsmbRgbRjbLjbLibRiRsmbLcbLcbRoRsRsmmbRiRsmbRoLsLsmbLc
LsLsmmbLebLobLobLcLsLsmmbRjbRhRsmbRibRiRsmbRgbRjbRibRcbRgbRcRsmbRibReR
sRsReRsmmmbRcbRsRhbRgRsmbRibReRebRiLsbLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRobRhRsmbRoLsbLgbRjbRgbRsbRebRgbRobLgbLibLcbLgbRjbRcbRibRhbRebRgbRcbR
gbRhbLsbRoRsmbRiLsbRebRibRcbLibLcbLobLsLgbLobLhbLibLhbLhbLobLcLsLsmmbL
oRsbLgbLoLsmbLibLhLsbLobLsbLhbLcbLibLobLgbLgbLobLibLobLibLcLsLsmmbLibR
cbRiRsLsmbRgLsbRgRsmbLsRsbRibRebRobLjbLobLibLhbLibLibLibLcbLibLjbRibRi
LsbRgbRcbLsbLibLibLobLhbLcbLibLgLsbLobLibRhbLsbLobLcbRoLsbLjbLsbLibLib
LcbLsbLibLgLsbLgbLobLgbLhbLgbLibLjbLobLgbLobLibRsRibRibRibRibRiLsbRsbL
cbLgbLgbLgbLobLsbLgbLsbLibLgbRebRebLsbRibRgbRiLsbRhbRibLcbLsbRcbRebRcb
sbRjLsLsmbLgbRebRjbRgbRhbLsbLhbRjbRebLibRhbRhbRjbRgbRibRibRjbRibLjbLgb
RibRcbRcbRibLoLsLsmmbLcbRgbLgbRsbLiLsbLcbRsbLjbRsbRcRsmbRibRsbRgbRiLsb
LjbRcbRgbRjbRcbLsRsbRobLgbRjbRhbRebRgbRibRgbLjbRcbRibRcbRebRobRobRibRg
bLebLiLsLsmbLiLsbLibLibLcbLiLsbLiLgLsbLhbLhbLibLiLsbLiLgLsbLobLsLsmbRi
bRebLsLsmbRibRgbRgbRiLsbRebLsbRiLsbRibRgbLhbRcbRsbLhLibLgbLobLgbLcRsLs
bLibLgLsbLgbLgLoLsRsmbRhbRiRsLsmbRhbLeLsbLobLgbLibRhLsbRibRibRsbRibRib
LibLcLsmbLibLibLgbLobLibRiRsmbRgbRsRsmbRibLibLcbLiLsbLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLsbRibRoLsLsmbLebRibRibLebLobRgbLsbRibLcLsLsmmbRjbLsLsLsmmbLcbLhbLgRs
bLibLgbLcbLgbLoLsLsmmbLebRhbRhbRibRgbLsbRebReLsbRgLsbLebLiLgbLcLsLsLsm
mmbLcbRobRibLgLsbLhbRjbLiLsRsbLibLgbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRcbRcbLjLsmbRcLsbRjbRjbLjLsmbRjRiLsLebLiLiLgLsLsmbRjbRoRsmbRobRibRjbL
iLsLsLsLgmmbRiLsLeLsLsLsLsmmmbRjLibRobLcLsmbLiLsLsLeLsLgLsmbLgLsLsLemb
RjRcLsbLibLebLgbLeLsbLgLsbLiLsbLgLsLiLsLsLsLsmmmbLhLgbLhbLcbLgbLiLsbLe
LsLgbLgLgLsLsRsLsLsLgLsLsLsLgLemmmmbLebLsbLoLsmbLcbLhbLcLsmbRibRoLsbRs
bRgbRiLsbRiRsmbRiLsLsmbRibRgbLgLsbRhbLsLsmbLgbLhLsbRebRcLsbRibRsRibRob
RiLsLsmbLjLsmbRobRcbRiLsbRibRhLsbRcLsbLjLsmbRcLsbRiLsbRcbRcLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRhLsbLsbReRsmbReRsmbRhbRcbRcbRibRebRibRiLsRsRsmbLgLsbReRsmbRcRsmbRiRs
mbRebRiRsmbRgbsbRgbRcbRcbRcbRiRsRsmmbRiRsLsmbRibRcbsbLsbRibRsbsbsbRsRs
LsmbRsbRgbLibRhRsmbRebRcRgbRebRcRsmbRcLsbRhLsbRgbRiRsmbsbsbRsLsbRsbsbs
bLsbsbLsbLsbLsbLjbRcRsRsmmbRcbReRsRsmmbRhRsmbLsbRsbLsRsLsbsbLsbRsbRsbR
sbsbRsbLsbLsLsRsmbLsbLsbsbsbLsbRebRcRsmbRcRsmbRcRsmbReRiRsmbRsRgLsbRgb
RiRsmbRiRsmbRgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bsbLgbLsLsmbLgbLgbLsbLgLgbLgLgbLsbLibRgbRgLsRsbLsbLsbLsLibLibLgLsbLgLs
LiRsbLebLgbLebLgbRgbLgbLebLibLibLibLgLsLsLsLsLimmmbLsbLsLsLgmbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bLcRsbRebRcLgbLebRibRsbLcbLhbLobRgbRcRsmbRibLgbLgLgLgLsbLsLsmbRsRsmbRi
bLobLibLibLsbLgbLgbLiLsbLibLibLsbLeRsbLgLsbLhbLgbLibLgLgLjbLeLsbRobReL
sbRgbRgRsmbRgbRebRhRgbRibRhbRibRiRsRgmbRsRibRiRsmbRibRebLibLhLgLsLebRo
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLsLsmbLgbLsLiLsRsbRhbRcbLjbLiLsbRcbRiLsbLiLsbRjbRibRibRgbLsRebLebLebL
gLsbLgbLgbRsbLobRsbLjbsbLibLhbLibLsbLibLgbLjbsbRsLsbRhLsbRiLsLsmbRcbRs
bRibLibRgbRcRgbRiRsmbRibRiRebRgbLcLsmbRgbLjbLhLsbLsLgLsLsmbLgLsbLibLgL
sbLgbRobRobRibRgRibRibRibRibReRiRsmbLebLsbRhLsbRibRobLibLgbLgbLgbLibLg
LsbLsbRiRgbRiLsbRgbRibLgbLjbLhLsbLibLebLgLsLibLgbLjbLgbLibRcbRibRgbRgR
smbRgbRgbLsbRibLcbLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLsbRiLsbRcbLibLcbLgbLcbLiLsLeLsLsmbLsLsmbLsbLgbLeLgbRibRcRsmbRgRjbRhb
ReRsmbRsLsLsmbRhLiLsbLibRsbLibLcbLhbRibRiRibRebRebRibRebRsRsmbRibRibRi
RsRsmmbRcbRibLjbLcbLhbLibLjbRcbRebRhbRobRibLcLsmbRsbRsLsbLiRsbLibLibLi
bLiLsbLibLhbLcbLibLebLgbLsbRsRsLimbLobLibRgbRsRsmbLibRgbLibLsbLsLsmbRs
LsLsmbRsbRcRsmbRiRsmbLjLcbLiLsbLgbLibRjbRsbLhbLiRsbLgbLsbLcbLcbLiLgbLh
LsbLgbLiLgLiLsLiLiLsbLeLsLsmbLibLiLsbLsLhLsbLibLcRhbRebRebRgLsbRgbRibR
cbRibRoRiRibRgRsRsmmbRgbRhbRebReLsbRsbRobRiRsmbRcRsmbRibRibRgbRgbRebRi
RsmbRibLgbRcRsmbRcbLsLgbLibRiRsmbRgRsLsmbRibRobRgbLeLiLgLsbRsLcRsLhbLg
bRgLibLibLiRsbLcLsmbLcLsmbLibLebLiLgbLiLsLsLsmmbLcLsLimbLibRgbLjRsbLjR
sbLibRhbLhbRibRobLhbLjbLsbLcbLgLgLjbLibLjbLjbRsbRibLcbRgLsRsbLgLsbLgbL
ibLsbRhbRebLobLhbLgRsbLibLgbRjbRebLibLcbLcbLibRiRsRsmmbLjbRgbsbLsbLjbR
iRsmbRgbRsRsmbRsRsmbRsbLsbRebRebRgbLcbRjRsmbRhLsbLcbLhbRcbRibRibRiRsRs
mmbRibRibLjbRibRgRsLsmbLcbLiRsbLobLibRsbLcLsmbRobLsbsbRsbsbsbRsbLsbRsL
sbLsRsbsbsbLsbLibLjbRgbRjbRsRsRimbRibLebLibLiRsbRcbRiRibReRsmbRsbLebRo
bReRgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRjRsRsRsmmmbLibLhbLcbLhbLcbLebLjbLibRcbRgbRsRsmbRsbRgbRsbLjbRibRibRib
RiRsRimbRgbRebLgbRebRebRebLsbLjbRcbRgbRcbLibLibLcLiLgLgbLebLebLgbLgbLg
LsbLsbLhLsbLiLsLsmbLsLsmbLjbRgbLgbRsbsbLhbRjbRsRiRsmbLhbLhbLibLgbLebLe
bLobRjbRsLgbLibLsbRibRcbRgbLsbLjRsbsbLibLibRsbsbLhbLibLibLhbLeLhLsLsmb
LgRsLsbLgLsLsmbLsbLsbLgLsLgbLiLsbLgbLgbLiLebLebLeRsbRjbRgbsbLebRjbLcRs
bLibRobReRibRibRoRsmbRiRhbRiRebRebRsRsmbRibRcbRsbRebRsbRgbLsbRgbLhbLib
LcbLsbLibLgRsbLjLgLgbLibLjRsbLobLibLiLsbLibLsbLsLsLgmbRsbRsRsLgLgmbLiL
sbLibRcbRibLjbLibLgbLibLhRsRsmbLsbLgbLsbRsLsbRsbLgbLgbLibRsbRjbLjbLeLi
LsbLhbLibLgbLiLsbLhbLhbLebLjbLiLeLsbLibLiRsLsbLgbLsbLgbLgRsbLgRsLsbRsL
sbLibLgbLsbLibLibLgLsbLgLsbRjbRsbRgbLgbLgbLsbLgLsbLgbLebLgbLiRsbLjbLgL
sLeRsbLgbLgbRgbRsbLhbLjbLiLgLsLsLiLsmbLiLsbLgLsbLibLhbRcbRibRibRsbRsbL
jbsbsbsbLjbLiRsbLgbLgbLsLiLsbLibLgbLgbLcbLebLebLebLgLsbRgbRobLsbLsLsmb
LjbRsbLjRsbRsbLsbLsbLibLgbLgbLgbLcbRjbLgbLgLebLeLsbLgbLgbLgbLjbLgbLiLs
LsLsmmbLgbLcbLebLsbLibLiLsbLibLgbRebRibRgbLjLsmbRsbLibLgbLgbRibRgbsbRg
bRsRsmbRgbRsReRsmbRgRsmbRsbLsbRsbRsbRgbRgbRsbLjbLgLsbLibRsbLgbRjbLibLi
bRgbLcbLibLeLsLgbLiLsLsmbLibLcbLiLibLgbLebLsbLgbLcbLsbLcbLiRsbRsbsbRgR
jbRcbRsRsmbRgbRibRcbRgRibRsbRsLsbLjbLsbRjbLibLgbLsbLgRsbLsbLgLsbLjRgbL
iLsbLgLsbLiLgbLibLgLiLsbLgLsbLibLibLsbLgbLibLebLibLhLsbLiLeLsbLgbLebLi
bLiLsLsmbLiLgbLiLgbRsRsmbsbRsRjbLibLiRsbLiLsbsbLiLsbLhLsbLibLsLeLsbLgL
ebLibLiLsbLobRjbLjbLgbLhbLgbLibLobsbLgbLhbLhbRcbRibRgbRgLsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLibLeLsLsmbLsLsRsmbLiLsRsbLobRcRsmbRgRsLsmbLsbRgbRgLsbRgRsmbRibLsbRsb
RsbLgbLgbLsbLiRsbLcLsLsmmbLeLsbLgbLibRibLcbRjbRjbRebRgRgbLebLibLebLeLs
bLgbLibLebLeLgLsbLsLibLgLsRsbLsbLgLgbRsLsLsLsmmbLiLgLoLsRsmbLebLebLsLs
mbLsLsLsLsmmmbLgbLsLgLsLsLsmmbLgbRebRebRibRgbRgRsmbRgbLjbLhbLgbLgbLsbL
ibLgbLgbLibLgLsLsLsmmbLgLsbLgLsbLibLsLsmbLsLsLsmmbLgLsLgLsbLsbLsLsmbLs
LsLsLgLsmmbLsLsLsLsmmmbRsLsLsmbLgLsLsLsLsLgLsLsmmmmbLgLgbLibLiRsbRibRi
bRgbRibRsbRgRsmbRgbRsbRsbRgRsmbsbRgbRibRiRgRsRiRsRsmmmbRgbLsbLobLeLsbR
sLsLsmbLsLsLgmbLgLsbLiLiLibLibLeLebRgLsbLsbLibLgLsbLsbLgLsbLgLgbLgbRsL
gbLobRsbRsRebRibRibRgbRgRsmbLsbRsRsRsmmbRibRgRgRsmbRgbRgRsmbRsRsmbRibR
iRsmbRibRgbRgbLsbLjbLebLsLgLeLsbLibLgbLgbLiRsbRsRgbRiRsRembRgRsmbRsRsR
sRsmmmbReRsmbRibRgbRsRsmbRebLeLsbLsLsLsLsLsLsLgmmmmmbLsLgLsLsLgLsmbLgL
sbLsbLibLsLsRsmbRobRebRibRibRgbRebLsbReLsbRebRsbLjbLsLeLsLiLgLsbLebRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bLsbRhRsmbRibRsRsRsLsmmbRsLsbLgbLcbRcbRcRiRgbRoRsmbLeLsbRobRhRsRsmmbRe
bRsbRoRsmbLcbRcRsmbReRsmbRgRsmbLobLgbLobRsbLobLgbRcbRibRgRgRibRcbRibRc
RsmbRibRcbRhbRhbLcLsmbLhRsbLcRsbRsbLjbLhLsRsbLebLibLiLsRsbLiRsbLgbLcRs
bLsbLhbLibLibLibLgbLibLibLsbLibRibRibLhbLibLibRobRibLjbRcbRcRsmbRhbRiR
smbLcbRcRsmbLjbLhbRcbRcbRcbRgRsmbRiRsRsRsRsmmmmbRgbRebRhbRcbRiRsmbRcbL
hbRhbRcbRgRsmbRcbRiRsmbRibRobRibRibLgLibRobRibRgbRebLgbRcbRcbLibRebRhb
RibRcbRhbRhRsmbRgbLgbRcbRgRsmbRgLsRsRiRsRsmmbRgRsmbRjLsbRcbRcbRibRobRc
bRibRibRcRsmbLiRsbRcbRibLsRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRsRsLsRsLgmbLgLcbRebLsRiRsmbRiRiRsmbRsbReRibRgbLcbRebRebRebRebRebRsLs
bRsbLcbLcbLibLgRsbLoLsmbRebLcbLcbLeLeLsbLibLebLebLebLebReRgbLiLsbLiRsb
LebLebLsRsbLsbLgbLebLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRgbRobLebRgbLibRjbRcRsmbRcbLobLcLibLsLsmbRibRebRebRebRibRobLsbReRsRsm
mbLebLhLebLebLibsbLsbsbRsbsbRjbLcbLobLhRsbLobLobLebLhbLobLobLcbLhLsbLc
bLcbRjbLgbLgbRcbLcbLeLsbLebLiLsbRsbRsbLsbLsbLiRsbsbLsbLsbLibLjbLibLobR
sbLgbLcRsbLhbRibRsbRhbRebLgbsbRsbsbLsRsbsbsbsbRsbRcbRibRsbRibRcbReRsmb
LobLoLhbLhbLjRsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bLgbLibLgbLsRsbLgLgbLgbLjbLebLebRibRgbRsRsRsmmbRsbRsbRebRgbReRsmbRiRib
RsRsRsmmbRsRsRsmmbLsLsLgLsLgLgLgLiLsmbLsbLsLsmbLjbRobRgRsRsRsRsmmmmbLs
RsRsRsRsRsmmmmbsbLsbLeLsbLgLsLiLsLgbLibLgbLiLibLebLgbLebRcbRibRsbRibRi
bRebLsLibLebLhbLcbLsRsbLsRsRsRsmmbLsLsLsLsLgmmmbLsbLsLsmbRsLsLsLsLsLsL
sLgLsLsLeLsLsmmmmmmmbLgbLgbLsbLsLsmbLsLsLsmmbLsLsmbLiLsRsLsbLsRsbRgbLs
LeLgbLsbLsLsLsLsLsLsmmmmmbRsLsLsmbLsLsLsmmbLgLsbLsbLiLebLgLsLsLgmbRebL
gLsLibLgbRsLiLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bRsLsbRjRibLgLsbLgbsbsbLibLibLgbRcbRgbRgRsmbRibRibRgbRsbRiLsbRiLsbLjLg
bRhbRgRsLsRgRsmmbRgbRibRgbRibRibRibRgbLhbRjbRcLsbLhbLibRiRsmbRcbRibRib
RgbRibRgRsmbRgbRibRsbLjLsmbRibLjbLjLibLgLsbLibLsLsLsmmbRsbRebLhbLsLsLs
mmbLsLsLsmmbLgbLibLjbLsbLgLgbLgbLsLsLsLsLsmmmmbLgbLsLgLiLibsbLhbLibLgL
sLsmbLsLgLsLibRsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsmbLiLhLsbRoRsmbLhbLjLs
LsmmbLsLgbLsLgLeLsLhLsLsmbLgRsbRsbLiLeLsbLgLsLgbLsLsLsLsLsLeLsmmmmbLsb
LgbLgLgLsLibLgbRsLsbLsbLsbLsbLsLsmbLsLsRsmbLebLgLsbLgLsbLsLgLsLgLgLiLs
bLsbLgLgLsLsLsLgLsLsLgLgLemmmbLsLgLsbLiLsLsLsmmbLsLebLhLsLsmbLiLgLsbLs
LsLgLembLgbLiLsLsLembRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bRsLsbLoRsbLebLcbLibRhbsbRebRcbRiRsmbRebLgbLjLibLgLsbLsbLcbLsRiLsbLibR
ebRgRgbRsbRgbRebRibRgRsmbLcRsbLibLgRsbLibLjbLsbLibRsbRcbRibRgRgbLsbRgb
RjbRebRgRsRsmmbRibRgLsbRibRibRibLibLibLcLsmbLcbLcbLibLibLibLibLcRsLsbR
hLsbRibRgbRibRibLiRsbLobRobRhRgLsbRibRjbRgbRcbReRsmbRibRjLsbRiRsmbLebL
jbLgLsbLgRsLsbRobRgbRgbRgRsmbRiRibRgRibRcbRhbRgbRgbRcRsRsmmbRgbRjRgbRi
RsmbLiLsbRcRsmbRgbRibRgRsRgmbRoRsmbRsbLgbLibLibLiLebLiLsLsmbLibLgRsbRs
bRibRobRhbRjbRgbRgRgbRibLsLcbRsbRsRcbRibRibLjbLhbRsbLgbRgRsmbLgbRcbRgb
LibsbLgbRsbRsbRsbLsbLsbLsbRsbRsbsbRsbLsLsRsmbLebRobRebRgbRibLgbRcbReRe
bRibRjbLobLobLsbLjbLiLsbLgLsbLgRsbLhRsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bRgRsRimbRsbRebsbRgbRgbsbRebRibLgbRgRebRgbRsLsbRsLsbRgbRiRsmbRsRsRsRiR
smmmbRgbLjbLiLsbLgLsRsbRsLsRsLgbLsbLgLsbLsbLgbRsLsbLsLibRiRsmbRgLsLsLs
mmbRebRsRsRsRsmmmbRsRgbRgbLgLjbLhbLibLgbRsbRibRibRsRsmbRgRsmbRebRsbRgR
sLsmbRhbRsRsmbRsRsRsRsRsmmmmbRsRsRgmbRsRsRsRsRsmmmmbRsLsbRsRsmbReLsbLi
bLcLsmbLcbLiLsbLebRgLsbRibRsbRgbRhbRibRibRebLsRgbRiLsbRgbRsRsmbRsRsRsm
mbRebRgbLgLgbLsRibLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bRgbRgRsmbRcbRgbRsbsbRsbsbsbRsbRibRgbRiRsmbReRsRsmmbRibRcbRiRsmbRibsbR
gbRsRibRobLgbLibLcLsmbLibLibLgLsbLgbsbsbRsbRsLsbRsbLsbLsLsmbRebRsbRgbR
gRsmbRibRibRcbRiRebRebLsbRgbRgbLgRsbRhbRgRsRsmmbsbRibRsbLebLgbLhbLibLi
LsLsmbLibLcLiLsLsmbLiLsbLgLsbsbLsLsmbLgbRsLsbRebRgRsmbRsbRgbReRhbRgbLi
bRsbLgLsbRgbLgbLibLebLibLibLgbRsbRjbRcRsLsmbLgbLibLhbLeLsbLsbLsRsbLsLs
mbLjbLsbLiLibLibLibLsbRsLsbLjbRgbLibLibLgbRsbLebRgbLebLibRgbRibRcLsbRi
bRsRsmbLsRsbLgbLcbLibLibLgbLebLsbLjLsLeLsmbRcbRiRsmbRgRsmbLobLgbRgbLib
LgbLhbLiLhbRjbRibRcLsbRgRsmbRjbLsbLsbsbRsRsmbRibRsRsRsmmbRgbLcbLhbLibL
jbLgLsbRjbLeLsbRibsbRsbLgbLsbLgbRsbLcLcLsLimbLibLgbLibLcbLibLsbRibsbLi
bLsLsmbRhbLjbRcbRgRsmbLibLhbLjbLhbLgbRjbLgbLsLsmbLgLhbRsLsbRjbLjbRsbLj
bLgbRibRcbRgbLebsbRebRgbRsbLjLjbRibLsRgbRsbRjbRsbLsbRjbRjbRgRsmbRsbRcb
RhbRebRgbLsbLsRibRibRiLsbRhbRibRgbRgbRibRhbRibLhbLsLsmbLjbLsbLgbLibLgb
LibRcbLjbLibLgbLebRebLcbLcbLgbLebLgbRsRibRiRsmbRebRhbLjLsmbLibLjLsmbLj
LsmbLhLibLibRgbRsbRsbLgRsbRjbLsRcbRibRibRhbRgbRibRibRhbRsbLhbsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bLgbLibLgbLgbLhLsLsmbLgbLhLsLsmbLebLsbLobLgbLibLiLsbLgbLsbRsbLibLibLeb
LsLsmbRebsbRgbLgbRsbLobRgbRibRcRsmbRibRcRsmbRibRgbRiRcbLibLiLebLebLcbL
gbLsRiRhbLsbRibRgRsmbRibLgbRgbRsbRhRibRgbRibRibLebLgRsbLsbLcbRhbRgbRib
RibRibRgbLsLgbRibLsbRibLgbRjbRgbRibRibRgbRibRgbLhbLcbLgLibLibLebLgbLsb
LcbRsbLibLsbRgbRcbRibRgbRgbRibRibLsbLibLiRsbLgbLsbRhbRgbRibRgbRibRgbRg
bLsbRhbLsbLgbLgLsbRgLsRsbLjbLsLsmbLibLsbRsbsbRibLjbLhbLibLgbLsLiRsbLsb
LgbLhbLgbLgLsbLsRsbLibLibRsbRsbLgbRgbLsLsmbLebLibRcbLoLsmbLgbLcbLebRob
RibRibRobLsbRgbRgbRiRsRsmmbRgbLibLgbLebLjRsbLhbLgbLsbLsbsbsbRjbLebLibR
sbRgbLibLgbLibLcbLibLsbLsbLeLsbLibRebRibRibRgbRibRebLsbLcbLgbLibLjbRhb
RsbRobRgbRsbRibRcbRgbRsbRgbRgbRibRebRsbRcbRgbLibLsbRebRebRhbRcbLgbLcbL
gbLgLhRsbLcRsbLibLhbLibLibLcRsbLgbRebRjbRgbRibRebLgbLiLsbLgbLsbLeLsbLg
bLcLsRsmbLobRsRhbRobLgbLibLibRsLgbLsbRjbLsbsbLsLsRsmbRgbReRsmbLcbLcbLe
bLgbLsbLsbLgRsbLibLibRsbRoRsRsmmbRibRibRgbRibRsbRcbRibLjbRcbLgLsbRgbRs
Rsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRgbLcLsmbRcbRcLsRsbLjbLcbRibRcbRhRsmbLibLiLsbLiLsbLiRsbLhLiLjbLsbRsbs
bsbsbRjbLhLsbRhRsmbRcbRcbRibRhbRcbRibRiRsmbsbRgbLgRsbRgbRsbLjbRjLsbRcR
smbRcRsmbRcRgbRebRebRgbRebRibRibRebRgbLgbRsbRsbRgbRgbLsbRiLsbLgRsbRiRs
mbRgbsbRsbRsbRgbRiRsmbRgRsRiRiRimbRhbRgRibRsRgbsbRiRsmbLsbRibRcbLsbsbR
sRsmbLibLsbsbRgRhbsbRibRiRsmbLgRsbLgRsbRibRiRsmbRiRibRibLgbLcbLiLsbRgb
RsbsbLgbLgLsbLgbLgLsbLgLsbLgbLiLsLgbLiLsbLibLiRsbLsLsmbLsbLgLsbsbLsbRg
bRgbLgbLjLsmbLgbLsbRjbRibsbLgbsbLcRsbRjbLjRsbLiRsbRjbRhbLebLhbLibRcReR
gbLsbRiRgbRibRgRsmbRiRsmbRibRsbRhRsRiRsmmbRiRibRibRhbRhbRibLgbRibRebRs
LsRgbsbRiRsmbRiRsRimbRgbRsbRgRhbRibReRsRsRsmmmbRgLsLsmbLjbRgbRibRebReb
RibRcbRsbRebRebRgRsmbRsbRebRsbLjbRjbLcbRiRsRsmmbLjbRjbLcbRhbRibRibRjbL
cbLiRsbLibLgbRsRgbRsbRiRjbRebRebRgbRgbRibRiLsbRibRcbLhbLeLgbLgLgbLgbLs
RjbRjRsmbRibLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bRcRsmbRhbRibRgRgRsReRiRhRsReRimmbReReLsbRhbRibRobLsbRjbLjbRjbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLsbsbLsbsbsbsbsbsbsbLsbsbRsbLsbRsRsLsmbRsRsRsLsmmbsbRsbRgbRsLibsbRoLg
bLobRobLoLsmbLhLsbLcbLobsbRsRobLcLsmbLgLsbLgLgbLhbLibLoLhbLebLebRhbLgb
LcLsmbLebLiLsLsmbLcbLcbLcLsmbLgLibLgbLgbLgbLgbLcLsLsmmbLcLsmbLiLsbLcbL
sbLgbLgLsbLibLibLgLsbLoLsmbLibLebLiLiLebLebLebLgbLebLsLsLimbLiLibLgbLg
bLibLoLsmbLeLibLiLsbLsLhbLiLsbReRibRsRcLsbRibRibsbLsbRsRsmbRgRsRsRgmmb
RibRibLhbLgLsbRibRibRgbLsbRibRcbRsLsbLjLsLsLsmmmbLcbLibLcLgbLiLsbLgbLg
bLgbLgbLjbLgLsbLjbLgbLsbLgbLiRsbLjbLeLsLsLsLjmmbRjRsmbRibRibLjbRcRgbLi
LsbLgLgbLiLsbRobRibLsbLsbLibLebLgLgLsLiLsbLcbLgbLiLsbRhbRibRcbRgbRibRg
LsbRgRsmbRsbRgbsbsbRsbsbsbLsbRsbLsLsmbRsbRibRobLibLcLsmbLcbLiLgbLhbLhb
LcLsmbLibLobLcbLebLgLjbLsbLgLgbLgbLgbLhbLibLhbLcbLiLiLsLebLebLebLebLeb
LebRjbRoLsLsmbLcbLjbLibLibLsLjbLgLgbLjRsbLgbRjRgbRcbLjLjbLjbLjLgLsbRib
RobLjbRhbLjbLgLsbLgbLjLsmbsbLsLsmbLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsbsbLsbLsbsbLsbRsRsLsmbRsRsmbRsLsbRsbLsbLsRsbLsLsmbLsRsRsmbLsLsmbRsb
RsLsRsLsbLsbRsbRsbLsLsLsRsRsmmmbLsRsLsbLsLsRsLsLsmmbsbRsbRsbsbLsbRsbLs
bLsbLsbsbLsRsbsbsbsbsbsbsbsbsbsbsbsbsbLsLsmbRibRjRhbLsbRsbLsbsbsbRsbsb
RsLsbsbRgbRibRibLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bLeLgbRjbLebLgLgbRcbRiRgbRgbRgbRgbRsbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bLibLhLgbLeLsbLhbLcbLiLgbLibLibRgbLibLcbLcbLhLsbLgbLebRibRgbsbRsbsbLsb
sbRjRjbRcRsmbRebRibRcbRcbRcbRjRsmbRibRcbRibLjbLcbLsRsbLiLsbLsRsbRjbLcL
smbLcLsmbLhRsbLibLibLeLhbLibLgbLibLeLsLsmbLibLgbReLsbRhLsbRhbRcbRhbRgb
RjbRsbLjbLibLsbLiLsRsbLibRhbRibRebRsbRcbRiRsmbLsbRgbLcbLibLcbLgbLibLgb
LsbRjRsmbRibRiRsmbRhRsmbRibLjbRibLhLsbLiLsbRjRsmbLhLgLsLsmbLibLiLsbLeb
LebLibLibLiLsLebLibLgbLiLsbLgLsLsmbLsbRjbReRsmbRibRcbRgLsbLgLcLgbLgLsb
LgbLgbLgLsbLebsbLgbLibRsbLcbLibLgbLeLiLsbLgbLgbLsbLgLsbLgRiRsmbRibRibR
hbRhbRcbRsRibRcbRcbRibRiRsmbRibRcLsLsmbRibRhbRiRebLiLsbLiLsLsLsLgmmbRs
bLibLibLiLsbLebLibLiLsbLibRjbLjbLjLsLsmmbLgLsbLgLsbRibRhbRcbRibRibRhbR
hbRsbRhLsbLiLsbRjbRiRsRsmmbLhLsLsmbRibRcbRebRcbRebRcbRhbRgbRhbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRsbRsbLsRsbRsbRebLcbLeLsbLiLsbRcRgRsmbRibRcbLsbRcbRhbRcbLcbLcbLeLsbLo
bRhLsbRhbRibRiRsmbRcbRiLcbLobRibRibsbLsbRcbRcbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bRgbRgbRibRibLgbLibLibLibLsbLibLibLgbLgbRcbRhbRgRsmbRiRsRsRsRsmmmmbRib
RgbRiRsmbRgRsmbRibRibLsbRsRsmbRcbRebRiRsmbRgbLsRsbRgbLsbLcbLgbLibLgLib
LebLibLgbLgbRjbRhbRjbRsRgbLsbRiRsmbRsLsbRsRsmbsbLsbLgLsbsbLgbLsbLsbRjb
LibLgbLhbLgbLibLgbLgbLsbLsLebLibLsbLiLsLibLgLsbLgLsbLgLsbLebLhRsbLsLgR
gbLebLiLsbLsbLgbLgbLsbLcbsbLibLhbLgbLgRsbLgbLcLsmbLibLibLibLgbRibLsbRi
RsmbRgbLebLhbLgLsbLsLsmbLgbLgbRjbRjbLhbLebLhLgbLebLsbLgLsbLibLgbLgbLib
LgbLgbLebLcbRgbRsbLiLsLsLgmbLgLsLsmbLgbLgLgbLebLgbLhbLibLgbLgLsbRhbLgb
LjbLiLsLsmbLgLsbLebLebLsbLebLsbLgLsbLiLsbLebLiLsbLsLsLsmmbLibLgbLibLgb
LgbLgLsbLgbLgbLgbRsbLiLsbLgbRhbRsbLjbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLcbRoRsmbRgRsmbRcbRsRibRcbRibRgbLsLsmbLjbLhbLibLibLibLibLibLsbLibLibR
sRsmbLhbLsbLhbLgbLjRsbLibLsbLebLibLibLgbLibLibLgbLibLibRjbRibRibRgRsmb
LgbLibLibLgbLebRcbRibRgbRibRgbRgRsmbRiRgRsRsmmbRobReRsmbReRsmbRhRsmbRi
bRgbRiRsmbLjbLiLsbLibLgbRsbLgLibLibLcbLebLgbLgbLibRgbLibRebRhbRgbLjbLi
bLibRsLsbLgLsbLcbLibLgbLgbLgLsbLiLsRsbLsLgLiLsLsmbLiLsbLgbLgLsbLsbLgbL
sbLibLjRsbLgbRgbRgbRcbRgbLgbRibLgbLgbRibRibRibRgbRgbRgbRgbRebRebLobLeb
LcbRjRsmbRiLsbLjbRjbRjLsbLgbLibLcbLibLgbLhbLibLsbLjbLgbLjRsbLgbLebLjbR
gbRgbRjbLibRibLsLjbRibRgbLjbRjbRgbRibRibRgRiRsmbRjbLgbRibRsRsmbRgRsmbR
gRsmbRcbLibRibRgbRgbRibRiRsmbRgRsmbRebLjbRsbRibLsbRsbLjbsbRcbRibLjbRjR
smbLibRcRsmbRgRsRsRsmmmbRgbRgRsmbRcbRhbRiRsRsmmbRibRibRibRiRsmbRgbRibR
gbRgRsmbRebRsRsmbsbsbRsRsmbLsbLjbRhbRebRgRsmbRgbLsRsbRibRsbRhbRgRebReb
RebRobLcbRibLibLibRsbLibLibLgLgbLcbRibRgbRsbLibLibLibLhbLjRsbLibLhbRjb
LgbRibLibLjbLhRsbRgbLhLibRsbLibLcbLgbRjbLjRsbLhbLhbRibLibRcRsmbRgbRjRi
bLsbLgbLgbRjRsmbRiRsmbRsLsbLjbLiRsRsmbRsRsmbLjbRgbLibLsbLgRsbRjbRibRib
RsLsRgbLgLsRsbLcbLgbRjbLibLibRibLibLgbRjbRibRibRgbRgbLcbLibLgbLibLgbLg
RsbLgbLebLsbLjbLcRsbRibLsbLhbLgbLibLsbLhRsbLjbRgRgbRsbLibLibRcbRibRsbL
jbLjbRjbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLsLgbLgbLsLsLsmmbLgbLibLcLsmbLgLsbLgLsbLcbLhbRsbLiLsbLgbLcLsmbLjLsmbL
gbLebLobLiLsLsLsLgLsmmbLibLhLeLibLibRgbLhLsbLhbLsbLgbRcbRibRhbRibRgbRh
bRgbRgbRiRsmbRibRibRcbRgbLibLgbLgbLibRjRibLibLgbLcLgbLgbLibLibLibReRsm
bLcbLgbLsLsLsmmbLebLebLebLeLiLsbLebLobRcbRibRibRibRsRgbRcbLcbLgbLgLsLs
mbLgbLsLibLgbLibLgbLgbRcbRhbRgRsmbRgbLibLibLibLgbLsLsmbLgbLibLgbLgRsbL
ibRibRibLcbLgLsbRjbLhbLibRsbReRsRsRgRsmmmbRgRsRsmmbLjbRhRsRsRsmmmbLjbL
ibLibRsbLibLgLsbLsLsLsmmbLibLsLsLembLsLsmbLobLcbLibLibLibLibLiLsbRgbLg
LsLsmbLsbLibRgbLcbRibLibRgbLibLibLibRhRsmbRcLsbRjbLcbLcbRibLhLsbLgbLsb
LibLebLebLgbLibRcbRebRcbRgbRibRsbLibLgbRcbRibRgbLhLsbLgbLibLibLiLsbLsL
sLsmmbLsbLgRsbLsbsbLgRsLibLiLsbLsLeLebLhbRhRsmbLibRcbLcLsmbLsLsmbRsLjR
sbLiRsbLsLsRsRsmmbRgbLiLsLgLsLsLsmmbLsbLiLsbLgLsLiLebLcLsRsmbRcbRiRsmb
RsRsRsmmbLjbLibLibRsbLgbLgbLibLgbLsbLgbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLgbRhLsbLcbLibLjLiLsbLhLsLibLgbLibLcbRcRsmbRibRiRhbRgbReRsmbsbsbLebLg
bLgbLiLsbLhbLjbLebLebRcRgbRhbLibRcbRgbRcLsbLibLiLsbLcbRcbRibsbRobLhbLc
LsmbLcbLibLibLcbLsLsmbLeLibLiLsRibLebLibLebLhbLcbLibLibRcbRobRgbLsLsmb
LebLiLsbLibLoLsmbRcbRjbRhRsmbRcbRebRcbRjbLcbLcbLcbRhRibRgRgbRgbLobLibL
ibLhbLgbLcbLgbLibLibLcLsmbLeLsbLhbLobRgRsRembRibRsbRcbRgbRcbRcbRhbRibR
gRsmbRebLiLsbLsLsmbRcbLsLcLsmbsbRsLjbRsLsbRobLobLeLsbLibRgbRibRibLcbLc
bLibLhLsLsmbLjLibRcbRibRhbRibRiLsbRibRibLjbLibsbLsbsbLibLsbLibLiLsbLhb
LibLjbLhbLgbRcbRebRebRhLsLsLsmmbLjLiLsbLcbLcbLeLsLeLsLhLsLsmbLhbLibLib
LcbRibRhbRibsbLjLsmbLiLsbLgbLibLgbLcbLhbRsLcbLiLsbLibLsLsLsmmbLebLsbRg
bLsbLobLebLebLiLsbLsbLiLsbLibLibRsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bLjLsmbLcbRsbRhRsmbRibLibLgLsbLcbLgbRcRsmbRoLsbLsbRoRgbRibRgRsmbRoLsLs
mbLsbLiLsbLcbRhbRhRsmbLcbLcRsLsbLibLgLsbLgbLgbLibLoRsbRibRibLcbLhbRibR
jbLjbLcbLgbRiLsbRebRgbLcbLibLobRgbRgbRsRsmbRgbRebRjbRsLsbLjbLiLsbRebRi
bRhbRoLsbRjbRcbRgbRhLsbLibLjbLjbLjbLgbLebRsLsbLcbLebLebRibRobRibRibLiL
sbRgbLsbLcbLgbRsRibRibRgbLcbLgbLibLgbLsbLibLcbRhbRebRgbRsLobLobRsbRgbL
jbRibRibRgbLibLjbRebRgbRebLibLiLsbLsbLibLjbLsLsmbRebRibLsLsmbRjbRebLgb
RibRgbRsbsbRcbRibLgbRibLibLjbLgbRiRjbRgbRhbLjLjbLgLsbLgbLgbLgbRibRcbRi
bRgbRibRgRsmbRgbLjLiLsLsmbLibRhRsmbLjLsmbRjbLjbLibRobLgbRcRsRsmmbRgRsR
smmbRibRibRibRebRhbLgbRibRibRiLsLsmbLgbRiRiRsRsRgRgmmbRsbRgbRibLibRcbR
gLsbRiLsRsbRibRiLsbRgbRibRsRsRgRsRsmmmbRibRgRsmbRhRsRiRsmmbRgbRibRiLsb
RgRsLsmbRgbLeLsbLebLibLiLsbLsLsmbLibLibLibLgbLiLsbLgLsbRobRibRobRgLsbL
gbLibLibRjbLibRhbRiLsLsmbRsbLebLibRgbRjbRiRsmbRiRsmbRibRoLsbLsbRgbRcRs
mbLcbRjRsmbRsRsRsRsRsRsmmmmmbRsbRhRsRsmmbRgbLcLsmbRibRibLibLibLjLgLsbL
gLsLsmbRsbLiRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bRsbLsRsRsmbRsLsLsLsmmbLsbLsRsRsmbLsRsbRsLsRsbsbRsRsmbLsRsbsbLsbLsRsLs
RsbLsRsLsRsLsLsmbsbRsRsmbLsLsLsmmbLsbsbsbLsbsbRsbsbRsbsbRsbsbsbsbsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsbsbLsRsLsbLsbRsbLsbLsbRsRsmbLsbRsRsmbLsLsmbsbR
sRsmbRsbRsbsbLsLsmbsbsbsbsbsbsbsbsbLsLsmbsbsbsbsbsbsbsbsbsbsbsbsbsbsbR
sbsbsbsbsbLsbsbsbLsbRsbRsbsbsbRsbsbsbsbsbRsbRsbLsbsbLsbLsbLsbsbsbsbsbs
bRsbRsbRsbsbLsLsmbRsbRsbLsRsbsbRsbRsbsbRsbLsRsbsbsbLsRsbRsbLsLsmbsbLsL
smbLsRsbLsbRsLsLsmbRsRsmbLsRsLsLsmbRsRsmbLsbRsRsRsmmbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bReRsmbRcbRibLhLsbRjRsmbRiRsRsmmbLjLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bLiLjbLeLsbLiLsbLibLsbRsbLsLcLsmbLcbRibRiLsbRiLsbLjbsbLsLsmbLeLhbRsbLg
LsLsmbRibLsRhLsbRiRsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bLibRhbRcbRcRsRsmmbRebRebRibRhRhRiRsmbRibRibRiRsmbLebLibLibLebLgbLibLh
RsRsmbLeLsLibLibLibLibLibLibLcbLiLhLibLibLgLsbLibLsbRjbRsRcRhbRebRibRc
bRiRcbRhRibRgbRgRgbLoLsmbLgbLebRjRgRibRiRsmbRibRsbRibLjLjbLcbLiLsbRjbL
sbLsRcbRiRsmbLiRsbLibLibLgbLebLeLibLiLiRsbLgbLjRsbLiLsbLgLsRsbLgbLgLsb
RoRcRiRsmbLsLgRsRsmbLibsbLiLsbLibLiRsRsmbLebReRgReRsmbReRsmbRgbRhbRebR
iRsRiRsmmbRgRsmbLcbLcbLibLgbLgbLgbLibLibLibLiLsbLibLhbLibLhbLsLsmbRjbR
jbRcRsmbRibLjbLcLsmbLgbLibLibLiLibLcLibLibLibLeLebLibLgbLgbLgLsbLibLgL
sLsmbLibLgLsbLibLibLibLgLiLsLsmbLeLsLsmbLebRebRebRsbRcbRebRobRebLjLhbL
hbRhbRcbLgbLhLsLsmbLibRjRsmbRcbsbLsbLebRsbLsbLgLsbLiLsbLibLiLsbLebRgbL
sbLsbLsbsbsbLsRsbLobsbLebRcbRsbRibRibsbRsbsbLsRsRjbRgRsmbRiRsmbRhbRibR
ibRiRsRsRgmmbLobLhbLhbLgbLgbLgbLiLsbLibLjbLsbLibLgRsLsbLgbLgLsRsbLsLsm
bLgbLibLibLjbLgRsbLibLgLsbLibsbLgbRjbLibRcbLjbRebRebRhRsmbRibRcRhbRiRs
mbRibRgbRgbLjbLjbLebLgbLibLebLibRcbsbRgReLsbRsRgbRoRsRsLsmmbLgbLibLibL
hLiLebLsbLeLeLsbLiRgbLebRcbRsRsmbLjbRsbLjLsmbLgLsRsbRhb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bRsbLsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 155823; End: 160323;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bRibLcbLcbLhLgbLiLsLsmbLibLiRsRsmbRibLeLsbLiRsbLsLhbLiLgbLeLhbLgbLcbLi
RsbLibRjbLebLiLsbRcbRiRgRsRgRsRsmmmbRcRsRsmmbLoLgbLcbRobLibLcbLoRsbRgL
sbLcbLhLsRsbLibLibRgLsbLsLsLsLsmmmbLsLsLsLgLsLsLsLsmmmmmbLiLiLsbLibLgL
sbLsLsLsLgmmbLsLsLgLsLgmbLgRgbLobRcbRobRsRcbLhbLibRsLgLsLsmbLibLcRsbLo
bRibRgRsRsmmbRiRsmbRgLsbRibRiRsmbRgbRhbRibRgLsbLjbLcbLhbLibLibRjbRiLsb
RibRiRsmbRgRgRsmbRibRgbLcLibLibLibLgLsLsLsRsLsmmbLsLibLcRsRsRsRsRsRgmm
mmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRsbRsbRsbRjbRiLsbRhbRhLsbLcbRcRsmbRcRsRcRsmmbRibRgbRsbLsLsmbRsRsmbRsR
smbRsbRibRobRcbRiRsRsRsmmmbRgbRgbLebsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbR
sbsbLsbLsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRcRsRsmmbsbsbLhRsbRoRsmbRcbLibLcLsmbLhbLibLibLsbLgbLsbLsbLsLsmbRsbRsR
smbsbLgLsRsbRsbRsbLsbLsbsbLiRsbRjRsmbLoLsmbLiLsbLibLibLeLsLgbLebReRsmb
RgRsmbRgRsRsmmbRsbsbRsRsRsRsmmmbRobRibReRsmbLcLsLsLsmmmbLsLgbRsbRiRsmb
RhbRibLsbLibLibLhbLgRsbLgbLsLhbLhLsbLcbLcbLiRsbLibLiLsbLibLibLiLebLgbL
gbLiLsLibLcbLibRcbRhbRebRibRhbRgbRibRibLgRsbLobLcLeLgbLgbLibsbRjbLibRh
RsmbLjbRcbRcRsmbRibRhbRhbRebRcRebRobRibRcbRibRcbRibRgbLgbLcbLibLgbLgLg
bLgbRebRsRjRsRgRsmmbLgLsLsmbLibLhRsbRcbRjRsmbLjbLhRsbLiRsbLibRebRcbLhb
LiLsLsmbLsLsmbLsRsLsLgbLsbLiLsLsLsLsmmmbRsbRcRsRsmmbRcbLgbLhbLcbLiLsRs
bLibLhbRsbLiRsbLiLsLsmbRhRsmbLjbLhbLiLsbLibRsRsRsmmbRsLsbLgLsbLiLsLsmb
LcRsbRsbLgbRsbLibLcLsmbRgbLsbLsLsmbRsbRsLsLsmbsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bLjLsRgmbRebRibRgbLcbRibLgLsbLgbLibRsbLcbRsbRgbRjbRibsbsbsbLsbLsbsbLjb
RebLsbRjbLgbRsbRcLsbRiLsbLgbRebRcbRiRsRsmmbRibLgbLsbRjbRiRebRgbLjRsLsb
RiLsbRsbRsbLjbsbLsbLcbLcbLjbLgbLcbLgLsbLibRjbLibLsbLcbLsbLgbLibLhLsbRi
bLjbRibRsbLcbRibLjbRcbLjLsmbLibLibLgbRebLjbRobLcbLgLsbLsLgbRsRsLsmbsbL
sbRsRsmbLsbRsbRgbRhbRibRsbLjbRibLjLsmbLsbRhbRgRsmbLsLsmbLgLsbLhbLjbLib
LibLiLsbLgbLibLiLsLsLsmmbLgbRgbLsbLcbLcbLiLsbLgbLiLsbLgbLibLgbLiLsbLgb
LiLsbLgRsbLgLsbRsRsmbLsLsRsmbRsbsbLsRsRsmbLsbLsbLsbRsbRsbRsbRsLsbsbRsb
RsLsbLsbsbRcRsRsmmbRgRsRsmmbLsRsbRibRgbRibLgLsbLcbLibLibLibLibLsLsmbLc
bLeLsLsLgLsRsmbLsbLgbLgbLsLsmbLcbLibLgLsbLibLiLsLsmbLgbLgbLibLgLsbLhbL
iLsbLgbLcbLibLgRsbLhLhLsbLsLsLsLsLsLsmmmmmbLiRsbLibLgbLibLiLsbLsbLiLsb
LgbLgbRiRsmbRoLsRsbLgbRibRibRiLsbRhbLgbLibRsbLiLsRsbLibLibRsbLcbLcbLeL
sLsmbLgbLibLsLsmbLiLsbLhbLgLgbLhLsbLibLsbRcbLsRsbRsRsmbRibRgRsmbRsbRgL
sbRsRsmbRsRsRiRsmmbRiLsbLsLsmbLhbLhbLgbLhbLibLsLgbLibLibRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRobRsbLsbLibLibLgbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsRsLsbLsbLsbLgLsbLsbLgL
eRsbLsLsLsLsmmmbLsbLiLsLsmbLibLibLebLsRobLsbRgbsbRsbRgbRsRsmbRsbRsRsmb
RsRsRsRsmmmbLsRsbRsbLsRsbLsRgRsmbRsbRsRsRsLsmmbRsbRsRsmbRsLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bRhbRcbRhRsmbLcbRcbRoRsmbLcLsLsmmbLcbRhbRcbRibLcLsmbLcLsmbLibRcbRcbReR
smbLobRcbRcbRibRiRsRsmmbReRsmbReRsmbRibRiRsmbRiRsmbRiRsmbRiRsmbRibRibR
ibRibRcRsmbRobRgRsmbLcLsmbLhbLcbLcLsmbLobLiLsLsmbLibLcbLebRcbLcLsmbLib
LiLsbRcbRiRsmbLcbsbRcbLhLgLsbRcRsmbLcbLiLsbRobLhbLobRcRsmbLcLsLsmmbLgL
sbRobLcLsLsmmbLcLsmbLcLgLsLsLiLsLsmmbLobLjbLibRjbRsbRibLcbLcLsmbLobRhb
RcRibRiRsmbRcbRgRebRsLeLsLsmbLgbLebLgRsbLiRsbLobLoLsLsmmbLcLgbRoRsmbLc
bLcbLebLobRhbRibRiLsbLsRibLcLcbLibRcbRiRibLhbLsLcLiLsLsmbLjLsLsmmbLcbL
cLsmbLcLsmbReRsmbLobLeLsbRibRobLcbLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRgbRcRsmbLcLsmbRebRgbRibRibLibRjRhbLgbRcRsRsRsRsmmmmbRgbLsbRibLjbReRs
mbRobRiRsmbRibRibLobLibRobRcbRibRsRsmbLcbLcLsLimbLibLgLsRsbLcbLebRebLs
LsmbRibRiRsmbRsbRebLibLibLobLiLsbLjbRgbRsbRebRoLsbRebLgbRebRiRebLgLsbL
gbRebRcbLibLibRibRjbRibRcRsRsmmbLibLcbRgRsmbRgbRibRgLsbLobLsLgbLsbRebR
cbRebRgbRibRibRjbLsbLibLobsbLebLgbRsbLoLsLsmmbRgbRhbRgRsmbLgbRibRgbLob
LsbRgbLsbLsLsLsmmbRcbRsRiRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRjRjbRcbRjbRoLhLsbRjbLgbReRsmbRcLsLsLimbRoLsbsbLibRsLsbLoLsmbLhLgLgbR
jbRsRibLoLsmbLibLgbLhbLgLgLsbRoLsbRibLhLsLsmbRhLgbLibRobRebRebRsbRebRg
RsmbLsRebRobRcLsbReRsmbRebLgLsbRibRobRiRgRsmbRebReRebLiLsLgLsbRibLcbLg
bLibLgbLibLsbLcbLgbLcbLgbRsbRsbRibRhbRiRsmbRibRiLsbRgLsbLsbRoLsbRsbRib
RgbRgRsmbReRsRsmmbRsRsReLsmbRibRsbRgbRgbRibRibRgbLcbRebRsbRibRjRsmbLgb
LcLsmbLibLgbLgLsbLeLgLebLgLsbRebLsbRoLsbRibRsbRibRoLsbRcLsbRgbRgbLsLiL
sbRobRibRsbRgbLcbLgLsLsmbRjbLcbLibLsbLgLsbLsbRjbRcLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRiRsRsmmbRcRcbRhRsLsmbRhRsmbRgRsmbRibRcLsbRibRcbRibRgbRcbRcbReReRhRsm
bRsRsmbRebRebRebLcbLcLsmbLcbLeLiLsLsmbLgLebLgLsbRjbRcbLcbRhbRcbReRgbRh
bRsRsRsmmbLsbRibRiRsmbRcRgbRcbRjbLcbsbRiLsbRcbsbsbsbsbsbRibLobLcbLcbLo
bLcbLiRsbLibLibLibLibLhLsbLobLcbLibLgLsbLeLsLsmbRsbLibLiLsbLibLsLsmbRg
bRcbRhbRjRsRsmmbRhRsmbRcbRebRibRcbRiRsRcLsmbRebRiRsmbRhbRcbRiRgRsmbRiL
sbRibRgbRibRibRhbRgRsRsRsmmmbLibLiLsbLgbLibLgRsbLgbLiLsbLgbLsRsbLibLib
LcbLcbLibLiLsbLibLhbLhbReRsRsLsRiRsmmmbRgbRoRibRibRiRsmbRgLsbRibRsbRgb
sbRiLsbRibRsLsRsbRibRcRsmbRobRcRsmbRebRiRsmbRgbRsbRsRsmbRibRsbRiRsmbRg
LsbRiRsRsmmbRiRibRjRgbRsRsLsmbLjbLcbRebRhRsmbRebReRibRsRhbRgRsRsRimmbs
bRiRsRsRimmbLjLhbLobLibLcLiLsbLibLsbLebLsbRebLgbLebLobLcbLcLsmbLgbLibs
bLsbLsbLibRcbRibLcbLsLsmbLiLebLebLgLsbLiLsbLsbLibLibsbRsbRsbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bLebLebLebRgbRcRcbRgbRibRgbRibRgbRsbLeLebLgbRgbRibLsbRsbLsbRibRsbRgbRs
bRsbRsbLgbRibRsbRgbRsbRsbRsbLsbRsbRiRsRsmmbRgbLsbRsbRgbRgbRsbRsbRsbLsb
RibLgRsRsmbRibLsbRiRgbRsbRsbRsLsbLsbRgbRsbRsbRsbRsRsmbRsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRsbRibLcbRgbRhbRibRebRgbLobRebLcbRcbRsbReRsmbRgbRgbRsRsmbRgRgRibRsbRg
RsRsRsRgmmmbRhbRgRsRembRsbRgbLsbRgbRsbLgbRebRsbRiRsmbLjbRsRsmbRgbRsRhb
RibLcbRjbRcbRjbRgbRhbLsbLcbRobRsbRibRgLgbLibLiLgLgLgbLgbRibRsbRgbLebLc
LsmbRobRgbLiRsbLobLobRsbRgRiRsmbRiRgbRsbRebLeLsbLiLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bRgLsbLjLiLsLsmbLgLsbLiLsbLsLgbLgbLhbLgbsbLgbLiLsbLibLhbLgLsbLgbLibsbL
sRsbRsRsmbsbLgLsbLgLsLsmbLgLsbLgbLsbLsRsbLsLsLsmmbLsLsLsmmbLiLsbLgLsbL
ibLsLsmbLsLsmbLsbLsLsLsmmbLgLsbLibLgbLgLsbsbRsbLsLsmbRobLebLgbRobRebRg
RsRsmmbRjbLsbRcbRibRgbRibRebLebLibLobLhbLibRsRsmbLiRsbLobLjbsbRgbRibRg
bRjbLsbRibRobRebRibRgbLcLsmbRibRoLgbRjbRibRgbLiRjbRsbRiRebRcbRibRoLsbR
gbLjbReRsmbRsLibLibRsRsmbLjLsmbLhLsbLibLgbLiLsbLgLsbLibLibLibLibLsbLib
LhbRgbRcbRiLsRsbRgbLcLsmbLgLsbLgbLgbLsbLibLsLsmbLhbLsbLgbLgbLibLibLgbL
hbRhbRcbRgbRsbRibRgbRibRgbRcRsmbRhRsRgLsmbRibRgbRebsbsbRibLsbRobRjRsmb
LgbLgLsLsmbLebLsbRiRsmbLebLsLgbLibLgbLsbLibLgLsbRjbRcbRibRjbLgbLgRsLsb
RebsbRjRsLsmbLjbLjbRjbLsLhLsbLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLhbLibLhbLibLiRsbLcbLibRcbRcbRgbRibLjbLcLsmbLiLsLsLsmmbLgbLgRsbLgbLhb
LibLhbLibLiLibLibLiLebLgbLgRsLjbLsLsLsLsLgLiLemmmbLeLsLsmbLsbLsRsbLibL
ibRsRhLsbLhbRibReRsmbRhRsmbRcbRcbLgbRhbRobLibLgbLiLsbLiLsLoLsLsmmbLiLi
LgbLhLibLiLgLsbLibLhbLcbLiLhbLgbLsbLsRsbLiRsbRsLsLsLsmmbLjLsRimbLibLcL
sRsmbLgbLcLsmbLibLiLsbLiLiLsLebLiLsbRoLsLsmbLsRibRiRsmbRcbRiLsbRibLsbR
hbRsbLgbRsReRsmbRhbLibRibRibRgRsmbRoRsLsmbRibLiLsbLcLsmbLiLiLhLiRsbLiL
ibRsRsmbRsbsbRjLcbRiLsbLjLsmbLcbLobRhbRcbRhbLcbLibLeLsbLobRsLiRsbLgRsR
smbLiLsbLibLiLhbLcRsbLjbLibLibLcbLibLgbLsbsbsbLsbsbLsbLgbLgbLjbLcbLsbR
cbRgbRhbRhbRibLebReRsmbLibRcbRjLsbLjbLibLgbLobLgbRcbRgbRobRhbLhbRibRcb
LcLsmbRcbLibRcbLjbRcbRjbLjbRcbLhbRjbLjRsbRibLibRjbLjbRhLsLsmbLjRsbRcbL
cbRjbRhbLhbRibRcbRiLsbRhbRcRsmbRcRsLsmbRcbRcRgRsRgRsmmbRjbRsRsLsmbRcbR
jbReRgbRsbRsbLcbLcbRjbLcbsbLjbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRjbLjbLiLsLsmbLgLsbLgbRgbLsLsmbLsbLsLgbLsbLsbLgLsLsmbRsbsbLhbLgbLibLc
LsmbLiLsRsbLsRsbLiLsbLhbsbsbLsbsbLiLsLgLsbLeLibLebLebLebLibLsLhLsbLibL
hbLsbLsLsmbLgbLsLsmbLgbLibLgLsbLibRsbLgLsRsbLibLibLgRsbLibsbLgLsbLibsb
RsbRjbRcbRibRhbRgbRiRsmbRgRsmbRiLsbLgLsbLobLsbsbLibLhbRsLibLcbLibLibLi
LsbLsbLsLsmbLsLsLsmmbLsbLgbLgLsbLsbLsRsbLgbRsLsbLgbLeLsbLsbLgbLgbLsbRg
bLsbLgLibLgLsLsmbLibLgbLiLsbLibLsbLhLibLiLsLibLiLsbLibLcLsmbLebLibRgLs
bLsbRibRgLsbRiLsbLcbLhRsbLiLsbLsLsmbsbLsbLiLsLgbLsbLjRsbLgLsbRjRgbRjbL
iLsbLgRsbLibLsLsmbRjbRhLsbRgRsRsmmbRcbLgbRsbLgbLgbRibRiRsmbRgLsLsmbRgb
RgbRsbLsbRibRgbRgbRibRibLcbLiLibLcbLcLsmbLsLsLsmmbLiLsbLgLgLsbLgRsbLiL
sbRcbRhRsRsmmbRsRiLsbRgbRibRgbRibRibRibRsRibRgbRhbRgRhbRcbRsbRgbRibRiR
smbRgbRcRgLsbRsRsLsmbRiRsmbRgRsmbLsRsRsLsLsmmbRsRsmbsbRgbLgbRgbRiRgLsb
RibRgbRsbRsbRgRgRsLsmbRsRgbRgbLjbRgbLjbLebLibLgbRsbLcbLibLiLebLgbLsbLi
bLiLsbLsLsmbLiLsbLiLsbLjbLgbLebLiLsbLibLgbLibLhLsbLhLebLeLiLeRsbRgRjbL
ebLgbLibRhbRcbRibRibRibRgbRgbLebLgbLgbRjbRcbRibRgRsmbRgLsbRsbLjbLjRsRj
bLjRsbLiRsbRjbLsbLiLsLsmbLjRsbLgbLibLibLibLhLibLgRsbLsbLiLsbLsLgbLeLgL
ebLgLsbLsLsmbLibLcbLhLebLebLibLsbLiRsbLgLsbRcRiRsLsmbRibRiRsmbRibRibRi
bRgbRibRgbRgbRgbLjbLeLsbLibLsbLsbLgbLgLgbRsLsLsmbRsbLsbLgbLgLsbLiLsLsm
bLgLsLsmbLibLibLibLiLiRsLibLgbLiLsbLhbLiLsbLhbLsbLsLibLgbLibLgLsbLsLsm
bRsRjbRibRgbRhbRgbRgbLjbRjbLiLgLsbLibLibRjbRcbRibRgbLjbRibRibRibRgbRsb
RibRibLgRsbRgbRiRsmbRgbRiRsmbRgbRgbLjbLjbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLcLsmbRgbRibRiRsmbRgRsRgRsmmbLsRgbLjbLeLebRebRsbRsbLibLgLsbLsRsLgLibL
iLhbLgLsbLgbLeLibLgLebLibLebLgbLiLsbLebRsbRiLsbLibLhbLhbLhLsbLibRobRib
LeLsbLgRsLsbLebLgbLibLhbLgbLsbLiLsbLibLsLsLsLemmbLebLiLsbLiLsbLebLebLg
bLeLsbLibLsLhbRsLobLsbLeLsLgLsbLebRsbLeLsbLgbRobLcRsbRsbRgbRgbRgLsbRsb
LebLcbLebRsbRcbLhbLebLsbRgbLiLgbLsLsLgLsmbLiLeLhbRsbLgbLiLsLsLsmmbLebL
ebLgbLcbLibRjbLgbRgLsRsbRgRgbLeLebLgbLibLcbLibLgbLhLgbLebRgbLeLsbLgLsb
LgbsbLibLebLsbLgbLhbLgLsbLgLjbRsbLsbRgbRsbRgbLgbLebLibLebRgbRgbLeLsbLe
bRibLjLiLsLsmbLibLhLsRsbLibLsLebRgbRgRiRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRsbRhbRcRsmbRobLcRsbRcbLjbRcbLhbRcbRibRiRsmbRibRhRsmbRcRsmbLjLsmbLsRs
RsRsRsRsRsRiRgmmmmmbLsbRgbRhRsRsmmbRebRcRsRsmmbRibLhbRcbLobRcRsRsRsRsR
smmmmmbRcbRcRsmbRsbRcbRsRsRsRsmmmbRsRgRsmbRsLgRsRsRsRsmmmbRsRsmbRiRsmb
RsRsRsRsmmmbRhRsRsmmbsbRsRgbRgRsmbRebRcRsRsRsRsmmmmbLsLhbRobRcRsRsRsmm
mbRsRsmbRsRsRsRiRgmmbRgbRsRsmbRsRsRsRsRgRsmmmmbRgRsRsmmbRsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRibRjbRjRsmbRhRsmbRhbRhbRiRsmbRgbRibLiLsLsmbRjRsmbRjRsmbRjbLsbRcbRobL
cbLsLibLibLcbLcbLcbLhLsLjbLebLeLsRsbRgLsbLsbLobRcbRibRhbRibRibRibRibsb
RsbRsbLiLsbLgbLiLgbLgLsbLcLibLsLebLcbLgLsbLhbLgbLhbLibLgbLiLsbLibLobLe
LebLibLhbLobLobLcbLgbRibRibRgbRgbLgbRhbRebRgRsmbRgbLebRgbRsbRibRebRgbL
ibLebLibLiLsLsmbLgbLsbLcbRsbLcbLcbLobLcbLeLsbLsbLiLebLebLgbRobRebLhbRs
bRhbRibRobRjbRibLcbRibRibRgbRebRsbRjbRibLebLebLhbLcbLeLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRsLsLsLsLsmmmbsbsbsbLsbRoLsbRoRsmbLcbLeRsbRoRsmbRsRsmbRiRsRsRsRimmmbR
ibRibLobLhbLjbRsLsbRiLsbLobLebLcbRcRsmbLcbLcbsbRibLjbLjbRebsbRsbRjbRsb
RibRibRgRsRsRsmmmbRebRsbRgRsmbsbLebLiRsbLebLebLebLgbLsLhbRsbLibLsLcRsb
LcbLiLebLebLgbLsLsmbLgbsbsbsbsbsbsbsbsbsbsbRebLebLgbLobLibLibLsbLgbReb
LcbRhRsmbRcbRcbRcbLjbLjbLgbLcbLebLoLsmbRibRsbRobRcRebRsbRgbsbRsbRsbReb
RgbLcbLcbRhbRgbLibLsbLsbLgbLebLibLsLobLsbRgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsLsLsLsLsLsLemmmmmbLeLsLsmbLsbLsRsLsLsRsmbLsLsLsLsmmmbRsbLsLsLsLg
mmbLebLsLsLsLgLimmbLsbLsLsmbLsLsmbsbLsLsmbLsbRsLsLgLgbLsRsbLsLsLsLsLsL
smmmmmbLgLsLgLebLsLsLsmmbLsLsLsLsmmmbLsbLsLsLsmmbLsbLgLebLsLsLsLsLsLiL
smmmmbLiLsbLgbLsLsLsmmbLsLsmbLgLebLeLsLsmbLsbLsLsLsLgLemmbLebLgbRcRsRs
LsmmbLsLgLebsbLsbLebLebLibLgbsbRsLsLsLimbsbLsbRsbLgbRsRsmbLebLebLhbLeb
LiLiLsbLhbLsLsLeLsmbLsLsLsLsLimmmbLsLebsbLsLsmbLsLsmbRsLsLsmbLsLsmbLsL
ibLebLgLsbLeLsLgbLsLsLsLsLgmmmbLgLsLsLiLeLsLsmmbLsLsLiLemb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bLobLgbLgbLgbLiLsbLeLsLsLgLsmbLsRsbLcbLcLsmbLgLsLsmbLgLgLsLsmbLsLsLsmm
bLgLebLebLsLgLsLgLibLsLgLsLsmbLibLibLibLibLhbLibLibLeLsbLiLsLeLsLsmbLg
LgbLgbLeLsbLgLsLgLsLgbLiLsLgbLgbRsbLsbsbLhbLibLsbLibRibRgbRibRiLsbRibR
gbRibRcbRibRgbRibLobLgbLsLsLsLsLsLgLgLsLsLsLemmmmmmbLebLebLebLsbLibLsb
RibRhLsbLgLsbRhbRgRgbLjLsmbRiRsmbRsRsRsmmbLsLsmbLsRsbLsLsLsRsmmbLsLsRs
LsRsmbLsbRsRsRsRsRsmmmmbRsbLsbLsLsmbRsRsLsmbRsbLsRsbRsLsRsbLsbsbRiRsRs
RsRgRsRgRsRsRsmmmmmmmbRsRsRsRsRsRgRsRsRsRgRgRgRemmmmmmmbRiRsmbRsRsRemb
LcbLeLsLsmbLgRsbLjLgLgLiLsbLiLsbLebLgLsbLebLiLsLsLsLiLgLsmmbLiLsLhbRjb
RcbLgLsLsLsLsLsLgLemmmmbRsLiLibLgbLgLeLsbLiLiLeLsbLgLeLgbLebLebRcbRibR
cbRcLsbRhRsLsmbLebLibLiLsbLgbLgbLebLibLgLsLsLsmmbLibReRsmbRsRsRgmbRcbR
ibRibRcbReRgbRcbRibLibLcbLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bLgbRcbRsbRgRsmbLjbRsbRcbLjbRebRibRgbRcbRgbRjRsmbRiRsRsmmbRgRsRsRiRgmm
bRsbRiRsLsmbLiRsbRiRsmbRsRgbRgbLgbRhbRiRsmbRsbLsRsbLsbLsbLsbRebRgbRgbR
gLsbRibRcbLsRgbRibRgbRgbRjbLjbRhbRgbRibRgbRjRsRsmmbRibRsLsbRcRsmbRiReb
LsbRgReRebLobRjbRhbRgbRhbRgRsmbRsbReRgRsLsmbLcbLgLsLsmbRjbRgbLjLsmbLib
LsLsmbLcbLcbLsbLcbLgLsLsRsmbLsbRcbLsLcRsbLgLsbRcbRsbRiRsmbRibLgbLcbRjb
LcbRjbRhRsmbRiRsmbRhbRibRcbLgbRcRsmbRebRibLibRgRoRsmbLjbLhbRcbLoLsmbLi
bLibLsbLsbRgRsmbRsLoLibLibLsbLibRjbLibLibLiRsLibLeRsbLsRsbLsbLiLsbRgRs
mbRgbLobLgbLobLibLgbRgbLcbLhbLgbLebLibLsRsLsLhLeLsLsLsmmbRoRsRsmmbRcbR
sbRsbLgbRcbRebRgbRibLsLcbRjbRhbRhRsmbLibLhbLiRsbLiLsbLgLsbLiLsLsmbLsbL
sLibLiLsLsmbLsRsbRsRsmbRjbLibLoRsbLebRcbRcbRcRsLsLsRsmmbLcbLibRjbRjRsm
bRgRsmbRgbRgbRiRsRsmmbRgRsRsLsmmbRgRsmbRgbRibRebRgbRsbRsbRiRsmbRebRgbR
gbRsRsmbLgbLcLsmbLebLebLsbRsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bLcLsmbLgbLibRcbRhbRgbRgRgbRhbRgbsbRsbRsbsbRsbRsbLsbLsbLsbRgbRebRgbRiR
sRsmmbRibRibRebRebRsbLjbRsLsbLhbLgbLhbLgbLgbRobRibRibLsLebRgbRsbRsRsmb
RebRebRebRiLsbRsRsmbRibRsbRsRebRgRsmbRsbRsbRebLsbRgbsbRgbRsbRebsbRsbLo
bLgbLobLgbLgbLjLsmbLgbLibLsbRgbRebRgbRgbRgbRsbRebRhbRsRgbRjbRobLibRgbR
ibLcbLhbLsLsLembLibLsbLgbLsbLsbLiLebLgbLibLebRsLsLsLembLebLeLsbLebLhbL
ebLebLebLsLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bLibLhLsLsmbLgbLibLibLebRibLhbLeLsLsmbLiLsbRsLgLsLgbLsbLgbLgbLibLiLsbL
hbLebRsbRsbLibLibLcRsbLgbLgLsbLsRsbLgbLsRsbRcbRibRgbLjbLcRsbLibLgbRjbR
hbRibLgbLibLcbLibLeLcbLgbLjbRibLcbRcbRiRsmbLjbLiLsbLsbLsbRgbLgbRgRsmbL
eLsbLiRsRsmbLibLjLsLsmmbLibLibLcbLgbsbsbRsbRebRgbLsLcbLiLsbLgRsbLibLiL
gbLhbsbLgbLgbLebLgbLgbLibLgbRjbRcbRibRibRgRsmbRibRhRsmbRsbRgbsbRgbRgbR
ibLibRcbRibRibRjbRsRgbLeLsbRsbLjbLhbLhbLsLhbLcbLgbLsbLsbsbLsbsbsbsbRsb
RibRgRsmbRobLiLsbLibLibLsbLgbLgRsbLibLibLebLgbRgbLsLsmbLcbLibLgbLgbLsL
hbLibLgbLibLibLcbLibLgbLiRsbLebLibLgbLibLhbLgLsbLgbLgbLgbLebLgbLibLibL
gbLibLhbLibLgbRibRcbRgbRgbRgbRgbRgbRiLsbRibRgbRibRibRgbRibRhbRgbLgbRgb
LhbLgbLibLebLgbLiLibLsbLgbLibLgbLibLgbLibRcbRgbRsbLsbRgbLebLgbLsLsLsmm
bLgbLsbRsbRjRjRsmbLjbRgbRsRsRsmmbRibRebLgbLibRsRiRsmbLebLsbRebRgRsmbLj
bLjbLsbRobRiRsmbLcbRhbLjbLhLsbLiLsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bLibRjbLsLsmbLgLgLsLsmbLgbLgLsLsmbLgbLhbLgbLibRibRsRsmbRsRsRsRsRsRsRsR
sLsRsmmmmmmmbLebRoRsmbRobLgLsbLgbLibRsRsmbLiLsLsmbRhbLgLsbLsLsLsLsLsmm
mmbLgbLiLsbLibLjLsmbLcLsmbLcRsbLibLeLsbRiLsbRiRsmbRgbRibLebLgbLiLsbLsb
LgbLjbRcbRhbLgbLhbLsLsLgmbRsbLhbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRiLsbRjbLjLgbRjbRibLjbLibRcRsmbRibRiRsRembRsbRiRsmbRibRibRgbRoRgbRhbR
jLsbLjbLjbRhRsmbRibLibRibRsRcRibRiRcbRcRsmbRobRcbRhbRebRibLibRibRgbLjb
LibRibLibRjbLhbLgbReRsmbLcRsRsmbRjbRjbRhbLcbRhRsmbRiRsmbRhbLgbLcbRjLcL
iRgbRjbRibsbsbsbsbRgbLsbLgbRgbRsbRsbLsbRsRibRcbRebRiRsmbRcbRgbRoRsRimb
RcbRibRcbRsbRhRebRgbLjLjbLibLgbLgbRjLsbLgbRibRibRsbRiRsmbLjbLcbLgbLgbL
jbLsbRjbLibRjRibRiRsmbLjbRiRsmbLcbLcbLsbLgRsRsmbLibRcbLibLcbLsLiLsbLib
LgbLibLiLsbLibLibLgRsbLibRsbLgbLsLgbLiRsbLgbLcRgbRibRgRgbRgbRibRjbRsbR
gRsmbRibRibLiLsbLjbLiLibLjbRibRcbRibRgbRibLgbRjbLsbLibRibRibLibRgbRhRi
RibRgbLsLsRimbRsbRgbRiRsmbLobLgbLibRgRsLsmbsbsbLsLhbLgbLibLibLgRsLibLi
bLgLgbLebLhbLebLhbLgbRsLiLsLsmbLgbLgbLsbLgbRjbLgbLiRsbLibsbLgRsbLgbLgL
sbLibLibLibLgbRgbLibLibLibLgLsRsRsmbLsbRjLsbRsbLjbRcbRiRhbLibLcbLhbRsb
RjbLjbRcbLjbRjRgbRebRhbRibRibRibLibRibLhbRibLibRiRsmbRibLibRibRcbLjbRh
bRibRhRsLsmbRsbRibRibRsRsRsmmbRiRsmbRjRibLgRsbRcRsRhmbReRsmbRgRsRsmmbR
iRsLsmbLibRhbRibRcbRhbRibRibRibRcRibRcRsRsmmbRgbRgRsmbRcbRiRsmbRhbRgbL
jbLibReb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLjLsLsLsLsRgRsmmmmmbRsRibRiRsRsmmbRiRsmbRibRsRsmbRiLsbsbLsLsmbLsLsmbL
sRsRsLsRsmbRsbLsbRsLsRsLsRsLsbRsbLsbRsbRsLsbLcLsmbLibLhbLgbLibLgRsbLgb
LibLcbRibLgbLebLebLebLebLiLsbLgLsbLgbLibLiLibLibRcbRibRobRibRoRsRsLsmm
bRibRsbRsbRibLsbRiRsmbLsRiLsRsLsbRcbRsbRsbLgbLibLgbLgLsbLgbLsbLiLibLib
LiLeLsLiLsLebLebLebLibLcbReRsmbRgbRibRiRiRiRebRebRobLsbRcLsbLsbRhbLgbR
cbRibRebRgbRsbRiRsLsmbLsLsmbRcLsRsbLgLgbRsbRhbRibRobLsbLsbLsbRgbLsbLsR
sbLsRsLsLsmbRsbLsbLsLsmbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLgbRcbRgLsbLgLsbLibRsbRsbRsbLibLgLgLsLsLsmmbRjbRgbRcbsbsbsbsbLiRsRcbs
bsbLsbsbsbsbLsbRsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLsbRsLsRsRsmbRsb
RsRsmbRsbsbRsLsbRiLibRjbRcbRibLobLcbLeRsbLobLsbLoLsmbLcLsmbRobLobLgbLe
LgbLsbLebLebLebLgbLhLibRibLgbRjbLiLsbLiLsbRhbLsbLibLgLsRgbRgbRebLcLgbR
gbRsLhbLcbLsbLibLibRcbRjbLgbLcbLcbLcbRsbLeLiLsbLhbRobRcbRibLsRsbLibLgb
LiLsbLgbLcbLcbLibLibLhRsbLcLsmbLcbLibRjbRcbLcbLiLsbLibLgLsLsmbRcbRhbRh
LsbLhbRoLsbLcbLcbLjLsmbLobLeLsbLgbLcbLcLsmbLiLsbRobRcbLcbLhbLibLsLsLgL
sRcmbLsRibLcbLgbLgbLcLsmbLibLibReRsmbRoRsmbRiLsbLhLsbLiLsLsmbLgbRcbRhL
sLsmbRibLjLsmbLjLgbLjLsmbLjLiLsLsmbLcbLcbLcbRoLsbLsLgbLiLsbLhbRgbLebRj
bRoRsmbRibLcbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bsbsbRsbLsbsbLsbsbsbsbsbsbRsRsLsmbsbLsbsbLsbLsRsbRsLsbLsbRsbLsbLsbsbsb
sbsbLsbRsbsbsbsbsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bsbRgRsmbRibLsbsbsbLobRsbLjLsmbLsbLsbLgbRsbLhbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRgRsmbLebLgLsbLoRsbRsbLcbLcLsmbLcbLebLibLgbLebLebLiRsbLebLeLsLebRcbRc
bLsbRibLsbLcbLebLiLiLeLgbLibRoRsmbRibRgLsbLsbRsLsbRcbLcbLebLhbLsLsmbLi
LebRjbRibRiRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bRcRjbLsbRhRibRgRsRimbRgbRgbRibLsbRibLgbLjbLjbLgbLgLsLsLgmbLgLsbLgbLsb
RgbLibRjbRcbLsbRsbRgbRgbRgbRsbRhbLsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbRsb
sbRsbLsRsbLsRsbsbsbRsbsbsbsbsbsbsbsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRgRgbLsLsmbLcbRsRjbRcRsmbLoLsmbLibRjRsmbLibLgLsbRjbRjbLcLsmbRcbRcRsmb
RcbLcLsmbRibLcbLjLgLiLsbLgRsLsbLibRobRibRjRsmbRjRgbRhLsbRjRgRibRcbRgbL
cLsmbLjbLhbLhbLcbLiLsbLgbLiRsbRjbLibLoLsmbLgbLcbLsLgbLibLibLibLgbLsbRg
LsbLibLhLiLgbLcbLibLibLibLsbRsbLcLsmbRjbRjbRhbRcbRjbRsRsmbLjLsmbLhbLcb
LhbLgbLiLsRsbRjRsmbLsLcbLeLsbRcbRcbLjbRjbRjbRiRsmbLhLgbRjbLcLsmbRjbLhL
sbRibLjbRibLcLgbRsbRjbRjbLjLsmbRjbLhLsbLsLjLsmbRjRjbRjbRiLsbLiLsbRjbLj
LsmbRjbLiLsLsmbRcbLhbRhbLeLsbRcRsRsmmbRjbLjLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRibRobRcbRcbRoRsmbRcbRsbRcRsmbRcbRcbRcbRcRsmbLsbLgbRcRsmbRsbRhbRcRsRs
mmbRhbRcRgbRhbRgbLsLsLsmmbRgbRcbLoLsLsmmbLhLsbLgLsbLiRsLsbLgLsLcbLgbsb
LcbLiRsbRobRibRcbRcbLhbLobLibLibRjbRcbRiRsmbRgLsbRibRhbRobRebRibRiLsRg
RsRembRibReLhLsLeLsbLibLgLsbLobLcbLcbLhbRcbRibLsRsLsbLcbLiLsbLgbLhbLhb
RcbRcRibsbRebRobRgbRibRobRhbLoLsmbRjbRibRcbLobLcLsmbLebLobRcRsmbRhbRib
RiRebRebRgbRjbLgbLcLsmbLcbLebLebLiLsbRcLsRgbLcbRjbRjbRobRgbRcRsmbRiRgR
iRibRcbRibRsbRcRgbRiRhRgbRibRebRgRsLsmbRcRsRsmmbRiRgbRibLcbLcLibLebLib
LjbLcLgbRibLcRsbRibLjbRcRsmbRiLsbRiRiRgRibsbLibLsbRhbRsRsmbLsRsLsbRibR
jbLobLcbsbsbLoLsmbRibLobLcbLgbLeLsbLibRcbRcRibLgbLcbLebRobRsbLcLeLsbLg
bRhbRcbRsbLgbRsLsbLibLcLsmbLsLsmbLeLsLsmbLcbLibLgbLibRsRobRibLobLgLcbL
iLsLsmbLiLsbLgbLobRhRsRsmmbRcRsmbRibRcbRiRsmbRgbRhbLebLcbLgbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLsbLsLsLsLsLsLsLsmmmmmmbLgbLgbsbLgLsbLsbLgLsbLgLsbLiRsbRjbLibLebLsbLs
bLgLsbRsLsLsmbLgbLiLsbLhbLebLeLsbLiRsbLgbLgLsLgbLgLgLsbLgbLibLsbRhbRsR
smbRgbLobLgLsbLibLsLgLsbLcbLgbRiRsLsmbRibRebRgbRiRsmbLgbLgbLgbLsbLsLsL
smmbLiLsLsLsLsmmmbLeRsbLsbRhbRhbRibRiRsmbRiRsmbLeLsLsmbLibLebLiLsbLgbL
gbLgbLsLgRsbLgLsbLgLsRsbLsLsLsmmbLgbLiLsbLibLgLsbLebRjbLibLiLsbLibLgbL
sLsmbLsbLgLsbLhbLibLebLebLebLgbRjRebRibLjbLgbLgLsbLibLiRsbLibLebLebRsb
LebRsbLgbRgbRgbLeLgbLgbLgLsLsmbLsLsLsmmbLgLsLsmbLgLsbLgbLgbLgLsLsmbLgb
LsLsmbLibLgbLsLsLsmmbRsbLgbLgLsbLsLsLsLsLsLsLsLsLsLgLgmmmmmmmmbLeLsbLi
bLeLsbRgbLiLsLsLsLsLsmmmmbLibLibLgbLgLsLsLsLgLsmmbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLgRsbRhbLsbRhbLgbRibRgbLgbLsbRjbRsbLjbRiRsRsmmbLjbRjLsbLjLsLsmmbRhbLg
bRhbLsbLsbLhbRcbRcRsmbRebRjbLibLjbLibLiRsbLsbLgbsbLjbLiRsbLhbRsbRcbRib
RgbRgbRgbRibRibRgRsmbRgbRgbLsRsbRgbLhLsRsbRjbLibLjbLibLgbLjRsbLjbLibLg
bLjbLiRsbLsbLibLgLgbLsbLjRsbLgbLibLibLgbLsRsbLibLgRsRsmbLhbLiLsbLgbLgb
LibLgbRgbLcbLsbRibRjbRibRibRibLgbLhLsbLiLsbLgRsbLgbLebLgLsbLibLibLgbLg
bLsbRjRjbRibLsbRobRibRhbRgbLsRsbRhbLgbLjbLibLibRjbRjbLjbLcbRgbRcbRiLsb
RjLsbRgbRgbRgbRhbRiRsmbRibRgbRgbLsRsbLjbLibLibLibRsbRibLjbRjbRibLgbLcb
RebRibLjbRibRhbLjRsRsmbLjRsbLibLgbLibRgbLhbRhbLibRhbRcbLgbLibLobRgbRib
RibLjbLhbLiLsLsmbLiRsbLibRsbRhbRibRgbRgbRhbLibLcbRhbRibLsbLsLjbLibRjbR
gRsRsmmbRsRsRgmbLsbRiRebRibLobLobLcbLibLiLsbLcLibLibLiLsbLibLcbLiLgbLg
bRjbRcbLeRsbLoRsbLobLiLsbLgbLsRsbLgLsbLibRibRibReRsRsmmbRibRgbRgRsmbRh
bRsbLsbRjbRibLsLsmbRgbRgLsbRsbRsbRsbRibRibRgbRibRsRsmbRiRsmbRiRsmbRibL
oRsbRcbLhLsbLgbLibLcRsbRgbLcbLibLgbLgbLhbLiRsbLgbLgbRsRsmbLgbRjbRjbRgb
RibLjbLjLsmbLibLgbRgRsmbLjbLcbLibLgbLsbLibLjbRjLsRsbLjLgbLebLgLibLhbLj
bLibLibLgbLibLibLibLgbLgLsLgbLgbRgbLiLsbLibLgbLgbLibLjRsbLjbRibLgbLiRs
bRiRsmbLsLsmbRsbLibLjbRjbLgLibRjbLjbRjLsbLibLjbLjbRiRsmbLjRsbRsRsmbRiR
smbRsbsbRsbLsbLsbLsbLsbRsbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLgLsLgbLibLiLgbsbLiLsbLiLeLibLeLsLibRgLgbReLsRsbsbsbsbLjbRsbRebRoRsmb
RcbLhbLjbLhbLgbLjbRsLsbLibLibLibLjbRjRsmbRcbLgbLibLgbLsbLgbLiLgLsbLgbL
jbLeLsbLcbRibRgbRhbRjbLjbLibRcbLcbLibRsRsmbRjRsmbLebLhbLsbRgbRjbRebRib
ReRsRimbLobLhLsbLsbLibRibLibLsbLgbLsLsLsLsLsmmmmbLsLsmbLhLsbRcbRsRgRsR
smmbRebReRsmbReLsbLcbLcbRjbLcbLibLsbRebLcbLibLhbRcbLibLsLsLiLsLsmmbLsb
LgbLgbLiLsbLsLsLsLsmmmbLibRgbRcbRsRsRsRimmbRgbRsbLsLsLsLgLsLsmmmbLebLe
bRcbRgRsRsmmbRhbRsbRhRsmbLcbLibLsLsmbLebLibRcbLjbLiLsbLibLgbLsbLgbRsRs
mbLgbLibRsbLgbLgLsbLgRsbRsbLgRsbRibRcbLsbLibLgbLibRsbLibLsbLibLgbRsRsm
bLgbLjbLcbLsLgLsbLgLsbLsLsLgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bRsbRibLobLhbLhLsbLibLsLsmbRcLsbRsbLibLsbLgbLibRibLhLsbLiRsbLiLsbRjbLg
bLiLsbLgLgLsbLiLsbLsbLgLsbRebRiRcbRibRibLsRebRibRibRgbLeRsbLibLiLsbLsL
sLembLjbLebRibRebReRiRgbRebRebReRsmbLobLebLsbRhbRgLsbRebLsLebLjbRcbRgb
RsbRcRsmbLebRoLsbLebLibLgbLsbLcbLjbLcbRcbLcbLeLsbLcbLsbLsbLiLsbLsbRoRs
mbRcbRsbRibRhbRgLsLsmbRsLsbRhbLhbLcLsmbLcLsmbLgLhbLibLgbLsLsLsLhLemmbL
hbRcLsbLhLsLsmbLiLhLsLibLeLhLsbLibLibRsLsbRcbRiLsbRcbLgbRibLjbLcbLibRi
LsbRebRjLsbLcbRgbLhLsbLjbLibLiLsbLibRibRcbRjbLiLsbRsRsmbRcbRhRibLibLiL
sbRiLsbLcbLeLsbRebRiRsmbLgbRhLsRsbLsbLcbLiLsbLeLsLsmbLiLsbLiLsbLhbLebR
obRsbLjbLiLsbLiLsLsLsmmbLsLsLsLsmmmbRgbLsbLsbLsbLsbRcbReLsRsbRibLsLsLs
mmbRcbRibRhRsmbRiRsmbRhbRibRibLsRgLsbRgLsbLsbRibRobRibRibLgbLcbLcbLibL
cbLcbLgbLhLhbRibRebRcbLebLoLsLsmmbLgLsbRibLcbLhbLibRibRcRsmbRibsbRiLsb
RsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bLsbLibLibLiLiLibLgbRsbLsLsmbRiRsmbRgRsRsRsmmmbRgLsLsmbRibRjLsLsLsLsRs
RsmmmmbLeLsbRjbRhRsmbRiRsmbRiLsRsbRgRsRsRsRsmmmmbLjbRhRsRsmmbRsbRsbRib
LcLsLsmmbRebRgbRibLebRcbLjbLcLibRibLcbLjbLjbLiLsLgLsbLsLsLsmmbLgbRsLsL
sLsLsLsLsLsmmmmmmbLgLsbLibLibLgLebLoLsLimbLsbRhbRgRsmbRhRsRiRsmmbRsRsL
smbRgbRsbRcLsbLiLsbLsbLgLibLsbLibLhRibRjLsbLjbLsLsmbLgbLgLsLibLjbLoRsR
smbRjbRebRgLsbRcbRiLsbRibRgbRibLjbLgbLibRhRsRsmmbLiLsLsLsmmbRjbRsRsRsL
smmbRsRsmbRibRcbRcbRibRgbRebRgRsRsmmbRgRsmbRiRgbRjbRsbRibLjbRgbRiRsmbR
gbLjbRoRsmbRgbRsbRiLsbRsRsmbRibRsRgRsRsRimmbRobLebRobRgbLgbLebLhLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bsbsbsbsbLsbRsRsLsRsLsmbsbRsbRsRsmbLsRsRsmbLsbRsbsbLsRsbsbLsbRsLsbLsbs
bLsbLsbsbLsbsbsbsbsbsbsbRsbsbsbsbsbsbLsbRsbLsbsbLsbsbRsRsmbRsbsbRsbLsb
sbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bRjRsmbRibLiLsbRobRcLsbRcbLcbLibLiLibLsLsLgmbLgbLobRebRebRebRebRebLsLs
mbLjbLiLsbLibLjLsmbLobRhRsRsmmbRcbRcRsmbRobRcRgbRgbRibRobLiLsRsbLoLsmb
LibRcLsbsbLsbRiRsmbRsRsmbRsRsLsmbRsbRgbRiRsmbRcRibLiLsbRcbRsLsRsbRiLsb
RsbRobLgRsbLgbLiRsbLibLiLsbLoRsbLgbLiLsLsmbLiLsbLsbLjLeLsbLebRjbLeLsbL
ebRgbLjbLhbRcRsLsRgmbRibRcbLgbLebLhbLebLebLjbLobsbLiLhbLsLibLoRsbLcbLh
bLcbRcbRobRibRhRgbRibLsLobLsbsbRoLsbRiRsmbRjbRhbRjbRcRgbRgbRebLcReReb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bRjbRebRhbReRsmbsbRcbLebLiLsLsmbLoRsbRcbRobReRsmbRgbRhbLsRsRhRsmbRcRsm
bRibLhbLibLibLibLibLibLeRsbLibLiRsRsmbLiRsbLibLgbLibLibLibLgbLibRebRhR
smbRgbRgbLjbLcLsmbLgbLgbLgbLiRsbRjbLobLgLsbLiLsbLibLibLgbLgbRibRcbRcRs
mbRgRsRembLjRibRjbRibLcbLcbLibLgbLiLsLsmbLgbLgbLsbLsLsmbLibRjRibRcbRcR
smbRebRhbRibRcbLibRibLebRgbRhRsmbRcbLibRcbRibRebReRsmbRiRebRgbReRiLsbR
ebLcbLiLsbLibLiLsbLibLsbRcbLcbLeLsbLhbLibLibLjLgbRjbRsRcbRebRibRcRsmbR
cbLibLiLsbLibLibLibLsRibRiRsmbRcbRjbRiRsmbRibRiRsmbLebLiLsbLgbLgbRjReb
ReRsmbRgRgbRiRsmbRsbRgbRgbRjbRcbRcbLjbLibLiLgbLgbLgRsbLibRjRebReRsmbRi
RsmbRibRobRgbRgbRcbLjLsmbLjbLibLgbLhbRiRsRsmmbLibLibLgbLiLsbLsLgLsbLjL
sRsmbLibLibRcbRiRsmbRibRcbRiRebRiRsmbRibLjLibLhLsbRcbRibLhbLiLsbLiLsLs
mbLibLsLsmbLgLsbLibRjRsmbRcRgbRcbLcLibLjLebLhbRcbRibRiRsmbRgbRibLjbRcR
smbReRsmbLibLibLebLiLsbLgLsbLgbLibsbLgRsbLibLsbLiRsbRiRcbRcbRiRgbRibLj
bLcbLiLgbLiLsbLgbLebLibLibLsLibLibLibLgbLcbLibLebLgRsbLeLsbLgbLiLsbLib
LibLgbLibLibLibLjRsbLibLgbLibLiLsbLibRcbRsbLjbRjbReRsmbRgbLcLibLiLsbLi
bLgbLibRjbReRibRibLibLiLsLgLgLsbLgbLhLgbLibLibLgbLibLibLibLiLsLsmbLgRs
bLgRsbLsbLiLsLsmbLibLiLsLiLsbLiLsLebLiLebLgRsbLibLiLsLgLsLsmbLebLibLgL
sbLhbRsbLibLsbLsRsbRcbLjbLibsbRjbLhbRobRibRgbLcbRsRcbRibRsbRcRsmbRibRi
bReRsmbRibRgbLsbRjLsbLjbLcLsmbLibRjbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160325; End: 160825;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bRob

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRobRcRsRsRsRsmmmmbRgbRsbLebLcbLgbLjbRgbRsRsmbRjbLibLcbLobLgLiLebLebLi
bRibLebLebLebLeLsLsmbLibRebRgRgbLsRsbLgbLcbLsbLebLsbRhbLsLgbRjbReRsmbR
sbRgbRebRcbRgbRcRsmbRibRcbRgLgRebReRebRebLcbLjbLebRhRsmbRebRjbRhbRsbLe
LsbLgLiLsbLsLgRsbRjbRsRsmbRgbRsbLhbLcbRsLgbLebLebLsbRsLsbLgRsbLiLibLsb
LebLiLsbLgLsbLgbRsbRjbLjbsbLebLebRsbLgbLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLcbLcbRibLobLgbRcbRibRcRebRobLhbRsbRsbLjLgbRsbsbRsbLsRsbsbsbLibLebLsL
sLsLsLommmbLeLsbLgbLsLsRsLsmbLjLoLsmbLiLibLiLebLgbLebLsbLcbLgLsbLgbRcL
sbRiRsmbRiRiRsmbReReRsRhRembRibRobLoLsRsmbLebLibLibRsbLibRibRibRhbRibL
sLsmbRhbRhbRgbLibLibLibLiLsbLibLgbLiRsbLgbRcbRibLibLjbLibReRsmbRiLsbRi
bRhRsRsmmbLsbRsRsRsmmbRsbRsRsRsmmbLgbLiLsbRgRsmbLhLsbLiRsbLgbRgbLcbLhb
LsLsmbLsbLsRsbLeLsbLiRsbRobRsRsmbRsbLiRgbLibLibRcbRsRsRsmmbRsRsRsRgRsR
sLsmmmmbLoLsLsLsmmmbLsRsbRjbRcRsmbRsRsRsmmbsbRsbRsbsbsbsbRsbsbRsRsLsmb
LibLhLsRsbRsbLsbLobLcbLiLsbLhbLobLhLsbLhbLhbLebLebLjbRgbRsLsbLobRibRhb
RibRsRsLsmbRiRsLsmbRibRhbRcbRsRsmbRcbRibLsbLobLiLsbLibsbRcRsmbLiLsLsmb
LsbLsbLgbRjbRcbRsRsRsRsRgmmmbRsRiRsmbRibRiRgbRsLsRsRsLsRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bLiLsbLiLgbLiLsbRgRsLsmbRsbLjbLsbLiLsbLebLebLebLgLsbLgLsLsLgmbLibLibLe
LsbLhLibLgLsLsmbLibLebLibLgbRsLsbRiRsmbRsbLsbRibRibRsbLcbLcLsmbLgLsbLj
RsbRsRsmbRhbRhbRgRsRsRgRsmmmbRgbRebLsRsbRibLibRsbLibRcbRgRsmbRsbRiRsRs
mmbRsRsRsRsmmmbsbsbLsbLsbRsbRsbRsbRgLsRsRsRgRsmmbRebRgbRibRsRsRsmmbRib
LsbRoRsmbLsbRcbRgbRibRgRsRiRsmmbRgbRsbLjbLhLsbLiLsbLgLsbLgLsLsmbLgbLgb
LebLgLibRibRcbRiLsbRgbLgLsRsbRibRsRsmbRsbLsbRsbLsLjbLsbsbLhRsbLebRibRi
bReLgbLcbLibLgbRjbLcbRsRobRhbLjbLibRjbLobRcbRgbRibLsbRgRsmbLjbLibRgbLi
bLgbRhbRiRsRgRsRsmmmbRibRgRsmbRiLsbRgbRibLgbLibReRgbRibRibRibRgLsbRhbL
gbRebRgRiRsmbRgLsbRiRsmbRibLibLcbLgRsbLibLjbLiRsbLibLgLibRsbLiLsbLgLsb
LhbRsRsmbRsbLebReRsRsmmbRiRsmbRsRsmbRiRsRsRsRsRsmmmmmbRhbRgbRiRsmbRsbR
ibRobLibLgRsRsmbLjLsLsLsmmmbLsLsmbLibLibRgbRibRibRiRgRgbRgRsmbRibRgRsm
bRiRsmbRiRgbLibRcbRgbLcbRgbRjbLcbRhbRsbRiRsmbLsbRibLjbLcLgLgLgLgRsbLiL
gbRsbLcLsmbLibLgbLibLgbLibLgbLibRcRsmbRiRsRsRsmmmbRibLgbLibLiLsLsmbRcb
RiRsRsmmbLsRsRsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRgRsRsmmbLgbLebRsbRsbRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbRsRsmbRgbRsRsmbRsb
RsbRsbRsRsmbRsRsmbRsbRsbLobLgbRgRsLsmbRsbRebLeRsRsmbLibLgLsbRsbLobLebs
bLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bReRiRibRhRsRsmmbRgbLebRsbRcRsRsmmbRobLcbRcbRiRsmbRibsbLjbLeRsbLiLsLsm
bLcbLebLobLiLsbLobLcLgLsbLibRobRiRibLjbLcLsmbRjLsbLcbRcbLibLebRibRobRi
RibLgbLcLgbLebLoRsbLhLsbRhRhbRoRsmbLhLsbLebLcbRobRibRcLsbLhLsbLobLjLsL
hmbRjbLibLhbLibLibLobRhRsmbRcRsmbRgbRobRhbLcLsmbLobLeLsbLcbRcbLeLhbRob
RcbRgRibRibRgRsRiRembLobLobLibRoRsmbRsbRibRibLsLgLsbRgbLcbRobRobRibReb
LjbLibLcbRgbRcbRebRhbRgRgRebRcbRibRiRibRgbRibRgbRiRsmbRobRoRibRsLcbLiL
gRsbLgbLebLsLcRsbRibRgbRibLgbRebRebRebLobLoLsmbRebRcRsRsmmbLcLsmbRcRsR
iRsmmbRibLjLsmbLjbRcbLcLsLsmmbLcbRcbLobRebRcbRcbRhbLjLsmbRhRsRsRsmmmbL
jLsmbReRsRgmbRsbsbsbsbRsbsbLgbRhbRhRsmbRjRhbRiRibRgbLoLsmbLsLsmbLsbRhb
LjLsLsmmbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRsbRsRebRibRcbRcbLobRjbRgbRcbRebLebLebLebRgLgbLhbLobRobLibRsbLhLsbLob
LsbLoRsbLgbLibLibRgbRsbLcbLebLobRsbLgbLobLcbRsbLobLgbLibLcbLgbLibLgbRc
bRcbRebLsbRhbLhbLgbLibLibLsbLcbLibLebLobLebRsRjbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bsbRhbRibLcbLcLsmbLcLsmbLsbLobRiLsbRhbRsLsbRhLsbRibLcbLsLsmbLsLsmbLjbR
ibRibRhRibRebRebRebRsbLgbRcbsbLcbLhbLobRcbRiRsmbLsRibRgRsRsmmbLcbLgLgL
sbLiRsbsbRsbsbRsRsLsmbRsLsLsmbRsLsRsLsbRsbsbRobRcRsmbLhbLcLsLsmmbLgbLs
bRsbLsbRjbRhRsRsRsmmmbRsRsRsRgRsRsmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRobRjRsRsLsLsmmmbRoLhLsLsLgLsLsLsLsLiLsLsLgLsLiLsmmmmmbLiLsbRobRgbRsb
LcLsmbRibRjbRhbRiRsmbLcbLcbLiLsLsmbLcbLeLeLebLeLsbLibRhbRebLoLsmbLgbLi
LsLsmbLhLibRhbRibRibRiRiRsmbRgbRiRsRsLsmmbRibRibRibRgLsbLcbLgbLcbLgbLi
bLgbLgbLgbLiLsbLiLebRsbRoLsbRibRgbRibRgRgLsbRgbRsbLsbRcbLibLibLiLsbLiL
gbLibLsbRobRibLsbLgbRobsbRgRsRsRsmmmbRgbReRebLebRjbLobLibRobRcbRcbRsRi
bLgbRebRhbRibLjbLsLiLsbLsRjbsbRgRcbLgbRjRibLibLgbRobRibRgbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRgbRibRiRsmbRibLibRcbLibRgRsmbRibRcbRebRhbRibRhbRiRhbRibRiLsbRibRibRi
bLjbLcRsbLsbRjbRibRcbLcbLoLsmbLhbLcLsmbLhbLcbLgLsbLibLcLsmbLcbLibLcbLc
bLiLsLebLhLsLsmbLibLgbLiLsbLiLsLsmbLgbLiRsLsLsmbLibLsRsbLibLgbLibLcLsm
bRcbLjbRcbRhbRhbLiLsbLobLhbLhbLgbLgLsbLgbLibLgbLjRsbRjbRcbLhbLcbLcbLcb
LibRhbRcLsbLibLjbRibRibRcbRcbRebRiRsmbLibsbsbLibLgbRsbLgLsRsbRjbRjbLob
RcRsmbRhbLgbsbLjbRhRsmbRcRsmbRcRsmbRhbReRsLsmbRjbRcLsbRcRsmbRcRibRsRiR
smbRcbRcbRgRsmbReRhRsmbLjbRsbRsLsbRsbRjbLcbRcbRhbRhbRibRibRiRiLsbRhLsb
RibRsbRjbLcbRcbRcRsmbLcLsmbReRsmbRibLobLcbLiLsLsLgLsLsmmbLiLibLibLibLi
bLibLiLsbLgbLgLsLsmbLgLsbRgbLiLsbRcbRcRsmbRibRiRsmbRibRgbRiLsbRgLsRsbR
cbRcbRcbRibRiRsmbRobRcbRebRibRhLsbLsRcRsmbLibLoLcbLhLsLsmbLgbLgLsLsmbL
gLsbLibLiLsbLgbLibLgbLsbLibRibRhbRcRsmbRiRsmbRibRiLsbLibLcRsbLgRsbLiRs
bRsbsbLibLgbLibLgbRcLsbRhbLcLhbLibLibLibLiLsbLibLibRgRsmbReRsmbLjbLobL
cbLibLibLeLgLsLgLgLsbLgbLibLgbLiRsbRgbLobLiLsLsLcmbLiLibLibLibLibLgLsb
RgRoRiRibRibRgbRibRcbRgbLebLibLgLsLsLsmmbLibLiLsbLibLgLsbLhbLhbLiLcbLi
bLibLibLiLsbLgRsbLibLibLiLsLsmbLgbLgbLgLsbLhbReRiRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bLebLsLsmbLebLebLiLsbLebRibLibLgbLebRgbRibLsbLsbLibRsbLebRsbLgbRibRgbL
ebLgbRgbRcbRgbRibRgRgbRibLsbLsbRibRsbRsRsRsRsmmmbRgbRgbRsbRgbRsbLibLib
LgbsbLsLiLsbLgbRsbLgbLcbLjbLebLebLcbLcbLcbRgRsRsmmbRibLibLgbLsbRibRsbL
gbRgbRgbRgbRsbRsbLsbLsbLibLsLsLgLsmbLsbLebLgbLebRsbLibLcbRibRgbRibLibR
gbRgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRgRiLoLgLsbLsLgbLgLhbLebRsbLebLibLibLoRsbLeRsbLobLiLsbLeLibLebLgLsRsb
LibLsLsmbLeLgbRiRsmbLsbRiRsRgmbRsbRgbRsRiRsRsRsRgmmmbRgRgbRiRsmbLobLcb
LgbLebLobRibLobLiLsbLgbLgLsLsmbLiLsLsLsmmbLsLsLsLsLsmmmmbLsbLsbLgbLibR
sbLgLsbLgLsbLgbLgLgLsLsmbLsbLgbLsRsbRsLiLgbLgbLgLgLebLiLsbLobLibRsRsmb
LgbLibLsbLiLsbLsLsLsLiLgLgLiLgmmbLsLsRsmbLibLgLsLsLsLsmmmbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bsbRsRsRsRsmmmbRsRjRsmbRibLjLsmbLcbLeLsbLsLsmbLgLsLsmbLcbLsbLsLsRsRsmm
bLsbLgbsbsbsbsbLsRsbLsRsbLsbLsbsbLsLsLsmmbLsbRsbsbRsbLsbsbsbsbLsbsbLsR
sbsbsbLsLsRsLsLsRsLsmmbRsLsbsbsbsbsbsbsbsbRsbsbsbLsbRsbLcbRobRobRobRib
RibRiLsbRhbRibRgbLoRsbRibRgbRsbRibLhbReLsbLsbRoRsmbRsbLcbRibRgbRgbRebL
sbRebLgbLibLiLsLibLhbLibLiRsbLibLgLsbLsLsLimbLgLsbRiRsRsLsRgmmbLiLsbLg
bLgbRjbRcLsbLsbRobLjLsmbLibLsbLibLhbLibLcbLebRebLobRhbRgbRgbReRsRsRsRi
mmmbRgbRgbRgbRibLoLsLsmmbLgbLiLsbLibLsLsmbLhbLsbsbLsLsmbRsbLjLsmbLeLsL
smbLibLibLhLsLsmbLiLsbLsLgLsbLibLgbLsbLebLgbLhbRcRsRsmmbRoLsbRgbRgRsmb
RiLsbRibLsbLcLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRjbRiRsmbLcbLhLsbLjbLiLsLsLsmmbRsRiRsmbRcbLjbRcRsmbLjbLjbLjbLjRsbLibL
cbRibLjbRcbLhbRjbRjbRjbLjbLcbLsLibLiRsbRjbLjbLjbRobLhbRcbRibRoLsbRcRsm
bLjLobLjbLhbLibLibLiRsbLhbRcRsRsLsmmbRgbRiRsRsRsmmmbLcbRhbReRibRcbRcbR
ibRibRcbRcbRibLjbLcLsmbLgLsbLiLsLsLgLiLsmbLiLsbLibLibLebLiLsbLgbLibLoR
sbLjbReRsmbLcbRcbLcbLiLsbLibLeLibLiLsLhbLgLeLsbLibLgbLoRibRhRebRgbLibR
cbRcbRcRsLsmbRcbRgbRibLibLjbRcbLjRsbLibLibRiRsmbLgLsbRsRsmbLoRsbLhbLhb
LibLibLjbRibRjbRcbRjbLcLsmbRibLsLjbLjbRcbLobLiLsbRcbLibRjbRhbRiLsbLjLs
mbRcbRjbRgRsmbLjbLhbLgRsbRgRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLgbLsbRsRsmbLgRsbLjRsbLjRsbLhbLgbLibLibLibLgRsbLgbLibLibLibLiLsbLgbLg
bLgbLgbLibLibLgbLhbLgbLgLsRsbLebLebLiLsbLhbsbLjLsLsmmbLibLibLcbLibLibR
sbLiLsbLsRsbLjbLhbLibRcbRgbLcbLgLsbLcbLgRsbRcRsmbRibRibRibLiRsbRibRgbL
ibLhbRjbRhbRibRgbRiRsmbRiRsmbRgbRibLgbLjbLhbLebLibLgbLibRibRcRsmbLsLsm
bLhRsbLibLibLcbRcRsmbRgLsbRgbRibRgbRgbRgbRgbRibRibRgbRgbLgbRhbRiLsbRiR
smbRgbRibRibRiRsmbRgbRgbRgRsmbRgbRcbRgbLjLsmbLjbRibRsRsLsmbRsRsmbRiRsm
bRgRsmbRiRsRimbRibRibRibRgbRibRhbRgbRibRgbRibRhbRsRsmbLjLibLiLsLsmbRsb
LibLiLsbLibLiLsbLgbLibLibLgbLgLsLsmbLgLsLsmbLiLsbLibLgLsbRsRjbRibRibRg
LsbRgLsbLgbLebLibLgbLjRsbLibLgbLgbLiRsbLgbRjbLibLiLsbLgbLgbLiLsbLiLsbL
gbLgbLgbLibLibLgLsbLgLsbRibRhbLgbRgbLjbRgbRgbLsbLsLsmbRgbLgbLsRsbLsbLe
bLeLsLsmbLoRgRsRsmmbLcbLeLebLiLsbRgbLgbLhbRjRsmbRgbRiRsRsmmbRgRsmbLgRs
bRgbLhbRibRjbRsRsmbRiRsmbLjbLjbRhbLsLcbRibRibRcRsmbRhbRibRgbLibRhbRsbL
ibLibRjbRjbRcbRgbRsbRsbRgbRjRsRsmmbLibLibRcbRibRgbRibLgbRjLsbRgRsmbRib
RsbLibLibLhbLibLibLgbLiRsbLibLibLiRsbLibRhbLgbLsbRibLibRjbLjbLjRsbRhbL
jbLibLibRibLibLibLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLcLebsbLgLsbLibLgbLsLeLibLsLibRcbRibRsLsbRgbLhbLsLgbLsLebLcbLhbLibLsL
oLibRebRgRsmbRgbLsbRgbRgbLebLhbLsbLeLsbLcbLibLeLsbLsLsLsLsmmmbLsbLeLgb
LgLsLsLsmmbLsLsmbLiLsbLsLsLsLsLsLsmmmmmbsbLsLsmbLsLsRsLgmbLsLsmbLebLgL
sbLebLsLgLsbLsbLsLcbLgLsLsmbLsLsLsmmbLeLgLgbLgbLgLgbLsLgLsbLgLsLsmbLsL
sLsmmbLiLsbLsLsmbLgLcLgbLgbLeLebLsbLgbLgLgbLgbLeLsbLgRsLsLsmbLsLsLsmmb
LobRsRebReRsmbRsbLeLcLibLsLsLsmmbRgbLsLsmbRsRebRcbRgLhRiLsRsLsbLobLsbL
gLsbLgLsbLsbLibLgbLsLgbLibLgLsbLgbLhbLsbLibLsLebRhbLsLsLimbLgbLibLsLeL
sbLsbLsbLsLsmbLgRsbLsRsLsLsLsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRgbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRcbLsRsRgRsRsRsmmmbRs
RsmbRgRsLsmbRcRsmbRcRsRsRsmmmbRcRsRsRsRsmmmmbRcbRibRibRsRcRsRsmmbRsRsm
bRsRsRsRsmmmbRcRsmbLoLsmbRcRsRsRsRsRsRsmmmmmmbRcRsRsRgmmbRjbRsRsRsRsRs
RsRsRsRsRsRsmmmmmmmmmmbRiRsmbRcbRgRiRsmbRhRsRsmmbRsbRsbRgRsmbRiRsRsRsR
sRsRsRsRsRsmmmmmmmmmbRebsbReRsRsRgRsRgmmmbRibRsRgRsLsRsRsRsRsRsRsRgRsR
sRsRsRgmmmmmmmmmmbRgbRsRsRsRsRsRsRgmmmmmbLsbLsLsmbRsRgRsmbRsRsmbRsRsmb
RjbRsRsRsRimmbRcRsmbRcRsmbRcRsmbRobRobLcLsRsmbLcbLiLsLgbLhbLhRsRsmbRib
RcbLcbRiRsmbRebRcbLibRsbRhRsRsmmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bLibLgLsbLebRjbRibLcbRobLgbLcbLsbsbLhbLcbLebLsLgbLebLebRobLebRobRgbLeb
LebLobLobLsbLcLebLiLsbRibLsbLcbLhbRjbLibRjbRhbLjLibRibRjbRgbRibLjbRibR
iRsmbRgbRibRiLsbLeLsLsmbRibRjbLjbLjbLcbLjLgbLhbLjLcLsmbLjbsbsbLhbLibRs
bRsRsmbRsbLsbLjbLhbsbLibLobLhbsbRjbRcbRsRsmbRsRgRgRsmbLjbRebRhbRibRibR
gbLjLsmbLsLsLsmmbRsbRsbsbRsbRgRsRsRsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRoRsLsmbRcbRiRsmbRhbRgbRgbRobRcbRobRiRsRsmmbLjbRibLsbRibRibLgbLobRsRj
bLebLiLgbLebLsbRgRsmbLiRsbLhbRsbRsRsmbRsbLcbLibsbsbsbsbsbsbLsbsbsbLsbR
sbRgbRebRobLebRcbLobRsLibLcbLibLobLobRcbRsbReRsmbRcRsmbRhRhRcbRhbRjbLi
LsbLebLcbLibLjbRhbRhRsmbRibRobRcbRsbLgLsLsmbLgbRjbRcbLcbRcbLcbRebLjbRs
bRsRsLsmbRsbRsbRsbRgbLsRgRsmbLcbLebLcbLgbLcbRibLiRsbRsRsmbLsbLgbRsbRsR
smbRsbRsLsbRsbRgRsRgRsmmbRiRgRsmbRhbReRsmbRiRsmbLobLcbLiRsbRsbLgbLibLe
bRibRcbRcbRobRcbLgRsbRiRgbLebLebRjbLjbLoRsRsLsmbRcbRiRsmbLsbLsbLibLibL
gbLsRsbRjbLobLobLhbLcRsbLebRjbLgbLhbRebLebRsLcbRiRsRsRhmmbLsLsLsLsmmmb
RcbRjbLsbRiRsmbLcbLcbLebLibLobReRsmbLsLsRsmbLebRiRsRsRsmmmbLcbLibLsLsL
sRsmmbRhRsRsmmbRcbLgRsRsRgRsmmbRcbRgRsRsmmbRgbRcRsmbLibRgbRsbLcbRcbRiL
sbLcbRcRgbRebRibRiRsmbRsRsRsmmbRsRsmbRsRsRsRsmmmbRsRgbRebRiRsmbRebRcRs
mbRsbLjbRcRsRsmmbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bLgLsLsLgmbLsLsLsLsLsLeLsmmmmbLsLsLgLsLgLsmbLebRsbsbsbsbRsbsbsbsbsbLsR
sbRsbLsRsbLsbLsRsbRsbRsbLsbLsbRsbLsbLibLebLsRsbLsbLsRsLsLsLsmmbLsLsmbL
sRgRsmbLsbRsLsLsmbLsLsLsLsLsLeLemmmmbLsLebLebLsLebLsLsLsLsLsLgLsLsLsLe
LsLeLsmmmmmmbLgLhbLsLsLsmmbLsLsLsmmbLsLsLsmmbRsLsLsLsmmbLsLsLgLsLsLsmm
mbLsLsLsLsLiLsmmmbLibLiLsLebRsbLsbLsbLsbsbsbsbRsbLsRsbLsRsbLsbLsbsbLsb
LsRsbLsbLsbLsbLsbRsbLsbLebRsbLsLsmbsbLsLsLimbsbLgbLgLsbRsbRcbRiLsbRibR
gRsmbRsRsLsmbRsRsmbLsLsmbLsLsLsLsmmmbLsLsmbLsbLsbLsLsLsLsLgLhmmmbLsbLs
LsLsmmbsbRsbLsLsLgLgLsLsLgLsLemmbLsRsLsLsLsLsLsLsmmmmmbLgLsLhLeLsbRcbL
ebLibLibLibLsLsLsmmbLiLsLibLcbRcbLsLeLsbLsLsLeLsLsmmbLgbLgbRsLsLsmbLsL
smbLsLsLsLemmbLsLsmbLibRsLgLgLgLgbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bLibLsbRgbLibRgbRcbRcbRgbRibRibRcbRsLsbLibLsLsmbLsLsmbRobRhbRgbRibRibR
cbRhbRibRebRebRibRoLsbRgbLobRcbRcbLjbLibRebLcLsmbLibLgbLgbLsbLgbLsbLsb
LgbLibLibLgbLgbLiLsbRsbLibRsLsbLsbLsLgLgLsLsLsLsLsmmmmbLgbLgbLsbRjbRhb
LebLebRsbReRgbRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRgLsbRgbRsbRsbRgb
RgRsRsRsRsRgRiRiRsmmmmmbRsLsRsRsRsRsRsRgLsRsRsRsRsRsRsmmmmmmmmmbRibRgb
LjbLjbLsLsLsLsLsLsLsLhmmmmmmbLsLsLsLgLimmbLgLsbLgLsLsLsLsLimmmbLsRsbLi
bLsbLebRcbLsbLsLgLsLsLembLsLeLgbLgbLsLgLgLiLeLeLgbLgLibLebLsbLsLgLsLeb
LsLibLsbRsLsLgLebLgbLsLsmbLsLsLsLsLeLeLsLgLsmmmbLsbLsLsmbLgLsLsmbLsLsL
sLsLsLsLsmmmmmmbLsLsLsLsmmmbRobLcbLibLsLebRcRsmbRiLsbRobLiLsLsLsmmbRjR
hbRgbRcLsbLjbReRsRsRsRimmmbRiLsLsmbLgbRcRsmbRibRhbRgbLgbRibRhbRhRsRgmb
RgbLsbRebRiRsLsmbRgRsmbRgbRgbRsbRgbRgLsbRsRsLsRsRsRsmmmbRcbRhRsmbRsRsm
bRgRibRgbRibRgRiRsRsRgRsmmmbRsRsRgmbRsbRsbRsbRsRiReb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRjbLsbRcbRobLibLgLsbLgbLgRgbLsbLjbLgbLebRobRobLobLobLhbLsbRebLgLsbLeb
LgbLsbLibLgLiRsbLobRiRsmbRiRsmbRcbRgbRgbRgbRgbRibRgbRgbRobRsbLhbLgbLiL
gRsLsbLgRsRsmbLibLgbLibLgLsbRcbRiRsmbRibRibRgbLgbRiRsmbRsbLgbLhbRsbsbL
sbRsbLibLgRsbLsbLoRsRsmbRebRebRiRsmbRgbRibRibLsbRiLsbRsbRiLsbRibLgbRgb
RsbRibRibLebLsbLibLibLgLsbLsbRhRgbRgbLsRsbLobLgbLibLcbRibRobRsbRcbRgbR
sRsLsmbRibLsRsbLebRjbRibRgbRiRsmbRgbRibLcLsmbLgbLgLsLsLsLsLgmmmbLibLib
LcLsmbLeLsbLsRjbLsRsbLsLsmbRjbLebLsbLeRsbRcbRobRebsbLsbsbsbsbsbsbsbsbR
sbRsLsRsbLsbsbRsbLsbLsLsmbRsLsRsRsmbLsRsbRsbLsRsbLsRsbRsbRsbsbRsbLsbLs
bsbLsbsbsbsbsbsbRsbRsbsbRsbsbsbLebLgbRsRsLsmbLsbsbLsbLsbRsbRsbLsbLsbLi
bsbRsbRsbLgbsbRsbsbsbsbsbsbLsbRsbRsRsmbLjbLsbRjbRhbLhbRcbLsRgbRebRgbRg
RsmbRsRiLsbRobRebRibRgbLsbRibRgRibLjbLhbLiRsbLibLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bLibLgbRgbLebLibLgbLhbRsbRgRsmbLsbRsbRgbRebRsRgRsmbRibRsbReLsbRibRgbRg
RsmbRgbRhRsmbRebRsbRgbRibRsbRebLsbRibLsbRgbRsbRoLcbLhbLgbLebRsbRsLebLs
bsbLebLebLebLcbRsbLgbLsbLibRsLsLhbLobRiRsLsmbLsbRgbRebRebRgLsbRsbLsbRh
bLjbRgbRebRgbRgbRgbRebRhbRiRsLsmbRibLsbLebRgbLebLgbLiLibLgLebLgLsbLebR
gbRsbRebsbRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bLobLeLsLsmbLiLsbLgLsLsmbLgbLcbLcbLibLibRsbsbLsbLsbRsbRcbLobLgbLiLsbLi
bLibLgLsbRcbRibRibsbRjLsbLsRsbLjbLcbLgLsbLgbLibLsbLsLsmbRcbRibRsRsmbRg
LsbRibRibRiRsmbRibRsbLsbRjbRebRhbRsbRsRsmbRcRsmbLgbLhLsbLhbLcLsRsmbLgb
LibLibLcbLhbLibLgbLibLibLibLeLibLjbLiRsbLgLsbLgbRiRsmbRibLcbLebRsbRcbR
iRsmbRibRiRsmbRgbsbsbLcbLgbLhbRiRsmbRiRsmbRcRsmbRibLgLsbLibLjLsmbRjbRi
RsmbLsLebLiLsbLebLibLgLgLsbLgbRjbRebRgRsmbLsbRibRgbRibRibRgbLibRsbRhbR
iLsbLcLsmbLsbLgLsbLibLibRebRhbRhRjbLgbRsbRebLoRsLsbLebLeLsbLgbLiLsbLgb
LobLhbLcbLibLgLsbLgbRcbRgbRgRsmbRgLsLsmbRgbRgbRgbRibRibRsbLsRsLsRsbRsb
LsLsLsLsmmmbRsRsRsmmbLsbRgLsbRsbRgRsRsRgRsmmmbRgbRgRsmbRsRcbRiRsmbRibR
ibRgbRcRsmbLcLsmbLhbLibRsbRebRsbsbLsbRsbRsbRsbRgRsRsmmbRgbRsRsmbRiRsmb
LsbRiLsbRgbRcbLgbLcbLcbLcbLgLsbLiLsbLsbLibLsbLsLsmbLgLsbLiLsbLsbLibLgb
LgbLhbLhLsbLibLiLsbLibLebLibLhbLgLsbLiLsbLgbLgbLgbLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bRjbLsbLsbLcbRibRjRsmbsbLsRsbLcbLgLsbRsRsLsmbRoRsmbLjbRjbLsLsLsLsLsLsL
sLsLsLsLsLsRsLsLsRsLsLsmmmmmmmmmmmmmbRjbRhbsbRibLgLsLsmbLgbLhbLiLsbLeL
sbLcbLiLsLsLsmmbRibLcbRsLoLsmbLibLebLibLibRsRgbRjbRibRibRsbRiRibRhLsbR
gbLsbLcbLgbRjbLgbRgbRcbLsbLhbLgbLebLibLgbLgbRgRsmbRebRgbRsRsmbRgRsmbRs
RsmbRjbRiRsmbLgbLhbLgbLjbLgbLebLgbLebLebLeLsLsmbLcbLcLsmbLhbRgbRjRibLc
bLsRcbLsbRibRibRiRhLsbLibRjbRibLcbLhbLibLhbLibLibLhbLiLsbLibLsbLhbRsRs
mbRcLsbRgbRgbRgbLsbRgbRgRsmbRibRgbLsbLibRiRsmbRibRgbRgbRgbRibLjbRhRsmb
sbRsbRjbLsLsmbLibRsRsLsmbLsLsmbLgLsLsRsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRjbRsbsbLsbRiLsbRiRsmbRibRibRhbLhRsbLjbRjbRiRsmbRcRsmbLhLsbRcRsRiRsmm
bRcRsmbRhbRhRsmbReRsmbRibRcbLsLibLcbLgbLgbLibLsbLibLcbRebRebRebRebRebR
ebRobsbRcRsRsRsRgRsmmmmbLgRsbRgRgRsRsRemmbRebRebReRsRimbLhbLibLhLsbLgb
RibLibLgbLgbLgbLiRsbLhbRebLcRsbLjRsbLcbRcbLibRjRsmbRjRsRsmmbLjbLibRcbL
jbRiRsRsRsmmmbLibRcRsmbRebRibRiRsmbRibRgRsmbRibRibRibLcLsmbRsbRjbLhbRj
bRsLsbLcbRibLcbRjRsmbLcbRcbLjbRcbRcRsmbLiRsbLibLobLibLsLsmbLcRsbRjRgbR
cbLjbRcbRjbLcRsbLsbLobLiLsbLsLsmbLgbLobLgRsbLibLibLiLsRsbLgLsLsLgLsmbL
ibLgLiLsLsmbLgbLcRsLsbRhbRibRcbLibLibLcbLibLsRsbLibLsbRjbLgbLgRsLsbLib
LcbLiRiRsRsmmbRcRgRsRsmmbRiRsRembRebRebRebRebRebRgbReLsbRcbRebRebRebRi
bRcLgbRsbLobRhbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bRsbsbsbsbRsbLsbsbRsbsbRsLsLsRsLsLsmmbRsLsbRsLsRsLsLsmbLsRsRsLsLsLsRsR
sLsLsRsLsRsLsLsLsLsRsRsLsRsLsRsRsRsmmmmmmmmmmmbRsRsLsmbLsRsLsbRsRsLsRs
RsRsRsmmmmbLsLsmbLsRsLsRsLsRsLsRsRsLsRsRsRsmmmbRsLsLsmbRsRsLsmbLsRsLsR
sLsRsRsLsLsmmbRsbLsRsRsmbLsRsbRsLsRsRsLsRsLsRsmbRsRsLsRsLsRsmbLsRsRsLs
RsLsRsmbRsbLsRsRsRsmmbLsbRsbsbsbLsRsLsRsLsRsLsRsLsbRsLsbRsbsbLsbsbsbsb
sbsbRsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbRsLsLsmbsbs
bsbsbsbsbsbRsbRsbsbsbRsRsmbLsbRsRsmbLsbLsbsbLsbsbRsLsbsbsbsbRsbLsbsbsb
LsRsLsRsbsbLsbsbsbLsRsbRsLsbRsLsbRsbLsRsLsbRsLsbLsbRsbsbRsbsbLsLsmbRsL
sbLsRsbRsbsbLsRsbLsbRsbRsbRsLsbLjbReRsmbLgbLcbLsbRhbLibLibLsbLebLebLeb
LgbLibLibLeRsbLibLjbRebRebReRsRsmmbRgbLsbLsbLsbLsbsbsbsbRcRsmbRibRsbLs
LsLsmmbRsRibLsbRcbRsbRcbRgbRebRibRsRsmbRgbRibRgbRgbLsbRgbLsbRgbRgRgRib
LjbLibLhLsLsmbLgLsbLiLsbRgbRobRsbLsbLobLibLibLhRsbLiLiLibLsbLcbRebRebR
eb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bLgRsRsRgmbRsRsRsmmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLcLsmbRobLobLcbRsbRjRhbLibLeLsbRcRibLcLsLsmmbLibLiLsbLcLsLsmmbLibLibL
cbLiLsbLcLsmbRcRsRsmmbRhLsLsmbLjbLeLsLsmbLiLgbLcbLcbLjbLgLsLsmbLcbLeLs
LsmbRoRsRsmmbRobLgRsbLgLsbLcbLoLsLsmmbLcbRcbRoLsbRcLsbLoLsmbRiLsbLcLsm
bRcRsRsmmbRoLsLsLsmmbLoLsmbRcRsmbReRsLsLgLsLsLsLsLsmmmmmbRebLiLsLsmbRj
bRjbRhbLcbRjRiLsbLcbRiRsmbReLsbReRsmbLiLsbLcLsLsmmbRobLobLiLsbLcbLcLsm
bLcbLibLobLhLsLsmbLcLsLsmmbLibLcLsLsmmbLiLsbLcLsmbLcLsmbLoLsmbLjbLcbLc
bLcbLiLgbRjbLcbLhLsLsmbLibLsLcLsmbLcLsmbLhbRhbLcLsmbRcLsbLebLoLsmbLcbL
iLsLsmbRhRsmbLcLgbLeLsbLhLsbLjLsmbRoRgRsRsmmbRibLhbLcbRjRcbLsRiLsbRoLs
LgLsbLiLsbLiLsLsmbLhLsbLobRobRiLsbLcbLeLsbLhLsbRcbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLibRsbRcbReReRsRsRimmbRibLhbRhRsRsLsmmbRgbRibLgbRsbLcLsmbLgLgbLgLgbLs
bLsLsmbLgbLsbLhLsLsmbLhbLsbLgLebLgbLgbLsbRibLcbRcbLeLsbLsbLgbLibLibRgb
RobLgbLibLgbLgLibLibLgbLhLsbLiLsLsmbLibLiLsbLgbLebLsbRebLjbLsLsmbRebRo
LsRsbRibLibReLsbLjbRcLsbLibLiLsbLgbLgbRebLibLibLgLgbRgbRgbRibRgbRjbRhb
LhbRhbLsbRhbsbLjbLcbLsbLcbRcbLcbsbLjbReRsRimbRgbRgbRcLsbLgbRobRcbRibLh
bLcbLgbLgbLsbLsbLcLsRsmbLiLsbLibLgLgLsbLsbLiLsbLgLsbLgbLgbLobLgbLibRib
LgbRgbLgbLcbRsbLcbLcbLibLsbRebRhbRgbRsbRoLsbRobRgbRobRibLjbLcbLhLiLsbL
sRsbLibLhbLhbLcbLibLcLsmbLibRebLsbLsbLsbsbRsbRgbLhbLcbLebLcbRsbRjbLgLi
bLobLobLibLobRsbRobRjbLobLgbLgbsbsbLgbRsLsbLgbLsbLiLsbRsLsbRsbRobRgbRo
bRsbLhbLibLobLiRsbLcbLebLgLsbLgLsLsmbLgbLiLsbsbLsRibLgbLhbReRsRsmmbLsL
cbLibRcbRiRgbRgbLsbsbRebRsbLibRobRcbRibRcbRibRcRsmbRibRibLobLsLsmbLgbL
gbRoRsmbRgbLobLibLobRgbRibRibLjbRsLsbRibRhbRibRibRsbLcbRsRcLsbLcbLobRi
bRhbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bLjbLoRsbLsbRsbLsbsbLsLsmbLiLsbLiLiRsbLebLsLibsbLebLebLebLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bLgbLiRsbLcbRobRibRebReRsmbLobLhbLiRsbLcbLcbRiRgbRebRibRibRibRibRgRsRe
mbRgbRibRibRcbRsRsmbReRiRsmbRgRebRobsbRhbRhbRhRgbRgbRebRibRibRibLcbReb
LobLibLeLsbLgbLiLsbLebLgbLgbLeLibLibLibLcbRibRibRibRibRgbReRebsbRebLgb
LhbLsbRjbRebLjbLsbRiLsbRjbRibRibRgbLcbLgbRjbLsbRgbRsRebRgbRhbRebRhbLcL
eRsbRsLsbLibRibLhbLsRsbRjbRgRgbReRsmbRgbLsRsbLjLibLebLeLsbLibLiLsbRcbL
cbLgLsbLgbLgbLsbLibRjbRibRibLsbRiRhRsRsmmbRgbRibRsbLsRsbLcbLiLsLsmbLsR
sbLibLsbsbLsbLeLsbLgbRjbLiLsLsmbLibLgLsbLiLsbLibLcbRsbRebLcbLebLebLhbL
ibLgbLebRsRsmbLhLsbLebLhbLibLibRcLsbRibRiReRsmbLsbRsbRibRcbRibRibRibRs
bReRsmbLsbLjbRcbLcbLsLeLsbLiLsRsbLebLiLsbLibLhbLsbRobRhbRgbRebReRibRgb
RibRsbRibLcbLibLhLsbLebLcRsbRgbRcbRsbRibRsbRobRibRebRebLjbLcbLhbLebRob
LsLgbRebRhLsbRjbRjRsRsmmbLibLcLsLsmmbLgbLsbLgLebLibRcRsmbRjbRibRiRsmbL
iRsbLgbLibLibLiRsbLhbRjbRhbRsbRibRgbRgbRgRsmbRgbRcbRibLibRhbRgRcbReRsm
bRebRibLgbLcbRjRsmbLibLcbLibLibRsbRhb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bRgRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRjRsmbRiLsbLcbLcbLebLcbRhbRjRsmbRcbRiRsmbLcLsmbLhLsbLcbLcbLcLsLsmmbLh
LsbLibLcLsmbLcRsbLjbLibLibRhbRcRsmbRcbRobRibRobLebLibLiLsbLsbLsRsbLcbL
cbLcLsLsLsmmmbRjbRcbRhLsbRcbLibLcbLeLsbLcbLebLiLsbLibLgRgbRhbRhbRobLcb
LhbLgLsbLgLsbLgLsbRjbLeLsbLjLibLgbRiRsmbRjRsmbLebLjLsmbLibRiLsRsbRjbRo
LsbLcbLiLsbLibRcbLcLsmbLibLibRcRsmbRcbRjRcbRhLsbRjRsmbRebLsbLcLgLsbLiL
sbLhLsbLiRsLsbRsbRjbRibLjbLcLsmbRsbRebRebRebRiRsmbRgLgbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bLibLibRcbRibRgbRhRgRsmbRcbRcbRibRhbRsbLsbRsbRsRsmbsbRcLsbLsRsbRoLsbRs
bRibRgbRebRgbLoRsLsbRiRsRgmbReLsLgLsbLcLsmbLibLcLsmbLsbLcbLcbRiLsbsbLh
bLsLsRsmbLeLiLsbLcbLcbRibLhbRhbLhbLgbRjbRobRibRibRibRcRsmbRsbRibLibRib
RibRhbRcbRibRcbRibRgbRsbRgbRhRgRsmbRibLhbRcbRiLsLsmbRsLsbLsbLhbRsRsmbR
cRsmbRoLsbRobRibRiLsbRcbRibRobRgbRoRsmbLcbLibLsbLiRsLsbRsbLgLsLsmbLibR
cbRgbRsRsmbLsLsmbRibRgLsbLjbRsbRcRsmbRsLsbLsbRibRcRsmbRibRhbRsbRgbRjRc
RsRsmmbRhbRibRcbLsbRiRsmbRibRjbLjbRiRsmbRgbRhLsbRiLsbRiRsmbRsLsbLjbLsb
sbsbsbsbRsbsbLsbRsbRsRsLsmbRsLsRsbLsRsbsbRcbLgbsbLsbsbRhRsmbLsbLsbLsRi
bRsbLcbRobsbsbRsbLsLsRsmbsbsbsbRibRiLsbRgbRgbRibLsbRsbRibRibLjLcLsLsmm
bLcbLoRgbsbLcbLsRjbRcbRcbRiRsmbRiLsbRibRibRibRebLjbRobRibRcbLgbRhbRgLs
LsmbsbLsbRgbRsRsmbRgRsmbRiLsbLsbRgbRgRsLsmbRsLsbRibRsRgbRibRibRibRgbRi
LsbRjRsmbsbsbRgbRsbRiLsbLjbRsRgbRgbRgbLhRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLsLsLsmmbLiLsLsmbLibLiLsbLgLsLgbLiLsRsbLgLsbLibLgbLgbLibLgbLsLsRsmbLi
bLibLhbLibLsLsLembLibLeLebLoRsbLebRebRibRobRsLsRsRebRhbRebLjbLjbLiLsbL
iLsbLgRsbLgLhbRsbRgbLgbLgbLgbLgbLgbLgLsbLsbLgbLgbLiRsbLibLibLgbLgbLsLs
mbLgLsbLsLsmbLgbLibLgbLgbLsLsmbLgbLibLsbLgbLhLsbLsbLibLgbRgbRiRsmbLsbL
ibLibRebRgRsRgRembRibRibRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bRjRsRsmmbRsbRgRsmbRibRsRsRsmmbRibRsbLcLsmbLibLibLgLsbLiLibLibLhbLibLg
bLibLibLhbLgbLgbLgRsbLgbLgbRgbRcRsmbRibLjbLhRsbLgbLgbLgLgbRgbLsbLibRjb
RhbRiRsRsRsmmmbRiRsmbRgbRgRsmbLjbRibRiRcbReRsmbRsReRsmbRibRibRsbLjbLhb
LcLsmbLgLibLgLoRsRsmbReReRsRsmmbRgbLsbRebLibLibLgLgLibLibLgbLiLebLeLsb
LgbLibLhbRebRibLhbLgbLjbRsbLjbRsbRibRibRgbLgbLjbLjbLgbLgbLsbLiLgbRgbRj
bRsbRibRgRsmbRgbLsbLgbLibRibLjbRgbRgbRsRsmbLjbLsLsLsLgLgLsLsLsmmmmbsbL
sbsbsbsbLsRsbsbLiRsbsbRjbRiRsmbRgbRgbRsbLjbLgbLibRjbRibRgbRgbLsbLhbLib
LhbLcbRcbRgbRcbRcbLibRgRgbRsbRiRsmbRobLsbLibRhbRibRiRsmbRsLgbRcRsmbRgR
smbRcbLiLsbLcbLgbLhbLsbLibLhbLeLsLebLgbsbsbLgLsbLgbLibLibRebRiLsbRibRi
bRgbRgbReRsmbRhRibLiLsbLhbLibRgbRcbRgbRibLhbLhLsLgbLgRsbsbLibLibLsLgLs
bLhbLhbRibRibRibLsbLibLcbReLsbLeLsLsmbLeLebRsbLeLgbLiLsLsmbLgbLgbRibLj
bLsbLibRebLibRjbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bRsRsmbRibLcbLeLibLjLibLiRsbRoRsmbRcRsRimbRcbLsLjLsLcmbLibLgLsbLoRsbLc
bLeLsbLiRsbLjLiRsRgbRsbsbRebRebRebRebRebRhbRjbLjLjLebLgbLebLgLsbLiLibL
jLiRsbLiRsbLibLcRsbLsbLoRsRiReRebLsbRsLsLsmbLcbsbsbRsbRsbsbLhbRcbLeLgb
LibLiLgLsLhRsbLiLsbLebLeLsbLgbLebLebLgbRsLsbLsbLsRjbLibRjRgRsmbRebRiRs
mbLsRibRhbRcbRgbRebLgbRoRsmbRgbRebRsbRibLeLsbLibLiLsLsmbRjbRgRsLombReL
sRjbLsbLebLjbLsLsmbRibLgRsbRjbLgbLhbLibLgbRebLibLsbRcbRibRcbRcbRjbLsbL
sbRsbRgbRibLibRcRsmbRgbRebRsRibRcbRobRhbRhbRebRibLibLjbLjLsmbLibLgLgbL
ibLibLgbLibRibRebLibLebRobLsbLhbRcbRhRsmbRiRsmbRibRgbRgbRiRgRsRhmbRsbR
ibLjLsmbLibLcLsmbLgbLibRsbRhbRibRiRsmbRibRiRebRjbReRsRsmmbRebLibLhbLcb
RsbRiRsmbLjbRiRsmbRebsbRgbRsbLjLsmbLsbLibLhbLjbLibLcbLjbLsRsbRsbRgbLcb
LebLobLiLebLsbLsRsbLgbLsbLibLgbLhbLibLibLeLsbLhbLoLsmbLgbLiLsbLibRsbRi
bRgbRoLsbRgbLcbLobLiRsbLgbLibLgLsbLjLsmbLiLsbsbRibRsRgRsmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bRgbRsbLibLsLgLsLgbRgbLiLsbRsbRebRsRebRsRsmbRsRsRsmmbRsRsRsRsRsRsRsRsR
sRemmmmmmmmbRobLobLgbLibLcbRgbRgbRebRobLcLsmbRcbRhRsmbLsbRgbRgRsRembRs
bRibRgbLcbLhbLgbLgbLsLhbLsLsmbLiLsbLgLsLsLsLsmmmbLsLsLsLgmmbLgbLsbLsLs
LsLsLsLsLgLsLsLemmmmmmbLgbLibRjbLcbLsLsmbLgLsLgLsRsbLgbLgbsbLsLsLsLgLs
mmbLsLsLsLsLsLsLsmmmmmmbLsLsLhmbLhLsbRebRsbRsRsRsmmbLgbLibRhRsmbRgRsmb
LobLgbLibLgbRsbLsLsLsLsLsLgLemmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bRjRsmbLjbLjLibRobRcRsmbRsbRsbLsLgLsLebLibRebLgRiRebRsRsLsmbRsbRcbReLs
bRiLsbRcbRibRcRsReRsRsmmmbLjbLsLhbLjLsmbLcLsmbLhbLgbLibRibRibLjbRiLsbR
ibRjbRgLsbLsbLcbLibLeLsbRsbRcbRibRcbLjLsmbLcbLibLgbLibLcLsmbLgLsbLjLsm
bLibLibLgLsbLibLibRoLsbLsbLibLibLcbLsLsmbRibRebRibRgbRcbRcbLgbRgbRhbRc
bLjLsmbLhbLsLsLsmmbLsLsLsLsLsmmmmbLsLsmbLsLsLsmmbLsbLcLsmbLcLsLsmmbRcL
sbRcbRibLeLsLsmbLiLiLsLsLhmbLsbLebLebLsLsLsLsmmmbRcbRobLjLgLsLsmbLcLsm
bLgLebLobLiLsbLcbLhbRjbLibRcbRibsbRcRsRsmmbLeLsbLcbLhLsbLhLsLsmbRcbRib
LgLsbLgLsLsLsLgmmbsbLsLsLsLsLsLsLimmmmmbRobLcLsmbLibRcbRcRsmbRgbLgLsLe
bLeRsbLebRebRcbLcbRgbLiLsbRgbLiLsbRcbRcbLcbLhbLsLgbLgbLgbRcbRcLsbRiLsb
RsbLsRibRiLsLsmbRiLsbRgLsRsbLcbLcbLibLibLgbLhbRhbRcbRebLsbLhLsbRhbRiRs
mbLjbLcbLsbLsLsLsmmbLsLsLsLsmmmbLsLsmbLsLsLsmmbLsLsLsLsLsLsLsLsLsmmmmm
mmmbRsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLsRsLsLsmbLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bLhLsLsmbRsRsRsRsRsmmmmbRibLsRsRsRgRsmmbRiRsLsmbLgLsLsLsmmbLibRcbRibRo
bLsbLcLsmbLgLgLsbLcbLgbRgbRiRsRsRsRsmmmmbRgRsRsRsRsLsRsLsmmmmbRgRgbRib
LgbLjbRjRgRsLsmbLjLsmbRgbRsbRiReRsmbRibLsbRgLsbLsLsLsLsmmmbLgLsbLeLsbL
sbLibLebLsLsmbLgbLsbLgbLgbLibRibRgbRhRsRsmmbLcLcbRiLsbRgbRgbRgbLibRoRs
mbRgLsbRibRgbRgLsbRsbRgbRebRebRiLsbRsbRcRsmbRiRsmbLebRibRgLsbRhbRgbRgb
RgbLebLiLsbLibLgbLcbLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bRgRsRsmmbRsbRobsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bRgbReReRsmbLoLebsbRibLgbRibRibLjbLobLiRsbRibRebRhbRsRgbRhbRgbRgbRebRh
bsbRjbRhbRgRebRgbRiRgbRhLsbRibLoRsRsmbLoLsmbLebLiLsbLibLsLsmbLgbLgbLob
LcLsmbLhbLibLibLibLgbLcbLgRsbLibRobRibRibRiRsmbRiRcLsbLebLgbLcbRsbLjbL
oLsmbRebLsLsmbLobLjbRsRsmbRibRebLgbRebRhRsmbRhRjbRsbRobRgbLobLibLsbRcb
RibRsRebLsbLoLsmbLiLsbLibRcRsmbRjbRobReRibRibRiRebRcbLcbRsbLebRiLsbReb
RoLsbLibRcbRebLgbLcbLgLibLobRgbRsbLsLsLsmmbLcbLjLsLsLcmmbLibLcbLgbLhbL
oRsLhbLsbRebLibRcbRibRcRsmbLcbLjLgbLjbLibLgLsbRsbRsbRibRibRgbLcbLcbLgb
LgbRhbLcRsbLobRgbRiRgbRgRcbLebLiLsbRgbRibRcbLhLgLsbLgbRebLhbLhbRiRsmbR
iLsbRgLjbLsLsmbsbLsbLibLsLsmbLsLsmbLsLsLsLsLgLsmmmbLsLsmbLsLsmbLsbLsLs
LgmbLsbRsbLgbsbRsRsRsmmbLsbLsLsLsmmbRsRsLsmbLsRobLcbRsLsbLsRebRebRiLsL
smbLsbRjLsbRhLsbsbLcbLsLsLimbRsRsmbLcbLhbRibRobLsbRgbRsbLgbLsbRsLsbLsL
smbLgLsbsbLsbLsbLsbLcbRsbsbLsbsbsbsbRgbLsbLsLsLsmmbsbLsLsLsmmbLsbRjbRs
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bRjbRcbRibLcbLjbLiLsbLgbLiLsbRibRjRsRsRsmmmbRjRsRsmmbLgbRsRjLsRsbLgbRj
RsmbLhbRhbRgbRiRsmbLhbRibRcRsmbLgRsbRhbLgbRhbReRsmbRibLibLiLsbLcLsmbLi
LsLsmbRgRsmbRibRsLhbLibRcbRcbLhbRhbRiRsRsmmbRgbLjLiLsbLcbLiRsbLsLsLsmm
bRhRsmbRiRsRsRsmmmbLgRsbRiRsmbRcbLgbRhbLgLsRsbRsRsRsRsmmmbLsRsRsRsRsmm
mbRgRsRsLsmmbLcLsLsmmbLgLsbLgbLgLsbRgRgbRjRgbRobRsLeLsbLobLebLgLsLsmbR
jRsmbRiRsmbLsbRcRsmbLiLsRsbRiRsmbRcRsmbRcbLsLhbRcbLsbLibLiLsbLibLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bRjbRsRibRobRibReRsmbReLsbRebReRsmbLoLsRhmbRsbLsbsbRgRsmbRsReRsRsLsmmb
RgReRsRgLsmbLgRsReRsmbReLsReRebRjbRiLsbLgbRibRsReRebRgbRhRsmbLiLgbRjbR
eReLsbRjRgRsmbRgRsRsRemmbRgRgbRgbRhRsmbRcRiRsmbRgbRiRsmbsbRgReRebReRsm
bLsbRiRsmbRebRiRsRembRibRhRebRgRsmbLsReLsbRgRebRiReb

>ZF Recording 2016-03-17; tW: 300s; Start: 160826; End: 161326;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bsbsbsbsbsbsbRsbsbsbLsbRsbsbLsRsbLsbRsbRsLsLsmbsbsbLsLsLsmmbRsbLobRsLs
bRsbLsbsbRsLsRsLsRsbLsbRsbRsbLsbRsRsmbLsLsmbRsRsmbLsRsbRsbLsRsbLsRsbLs
bLsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLibLcbRjRibRgbLiLsbLgbLibLiLsLibLiLsbRcbReLsbRgbRhbRgRsLsmbRgLsRsbLsb
RgbRibRibRgbRiLsbRsbRibRsRsmbRgbRjbRgbRsbsbsbRgbRsbLibLsbRgReLsbLjbLgL
gbRsbRobRhbLsbRjRebRgLsbLsbLcbLebLibRoReRibRebRibRgbLebReRsmbLjbRiRsmb
LebsbLcbRsbLebLiLsbLhbLiLsbLgbLiLebRsbRsbsbsbsbsbsbLgbRsbLjRsbLgbLgbRj
bRsbRibLsRgbRgRsRsmmbLjbLgbLgbRsLsbRsbLsbRsbRgbLjbRgbRsbRibRjbRgLsbRib
RcbRibRibRhbRsbRibRgbLgRsRsRsmmbRibLsbLjbRjbLsbRsRsmbRcbRiRgRsmbsbRjbR
gbRgbRsRgRsRsmmbRgRsmbRgLsLsmbLcbLibRsbRsLsbLsbRjRgbRebRsLsbLsbRibRgbR
ibRibLcbRgRsLembLebLebRhbLjLebLebRjbLjbLibLsbRgbRjbRsbLibLcbLibLibLibL
ibLiLsbLgbLibLibLiLibLhLsbLebLgRsRsmbLjbRcbRjbRibLgbLeLsbRibLhbRhbLsRs
bRsbRsbRsbLsbLsLjbLsbRsbLsbRsbsbRsbsbLsbLsLsRsRsLsmmbLsbRsbLgbRsbsbsbs
bRjLsLsmbRjRsmbRebRsRsRsmmbRgLsbRcbRcbLgbRgRsRsmmbRjRsRsRimmbRiRiRsmbR
cRsmbRibLibLgbLsRsbsbsbLjLsLsLsmmmbsbLsbRcbLsbsbRgbRsbsbRsbLjLsLsmmbRc
bRsbsbRcRsmbRcbLcbLiRsbLibLgbLsLebsbLsbRsLsLsmbRcbLeLsRsRsmbRgbLsLibLs
RjbLgbRobRiRsmbLsbLjbLgbLjbRcRsmbRgbLsRsbLjbRsbLsbsbLsbsbsbRgRsmbLjbRc
bRhRibRibRhbRcRsmbRhRebRcbRsLsbLjbRsbRsbRsbLjbRcRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLsbLgbLeLsbsbLibLoLsmbRgRsmbRcRsRsRgmmbRcbRsRsRsRsRsRsRsmmmmmmbLsLhbL
cLsLsmmbLcbLsbRsbLsLsmbLsLsLsmmbLiLsbRobRgLsRsRsmbRcbLgLsbRobLgbLcLsLs
LimmbLibLgLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsbLsbLsbLsRsbRcRsRsm
mbRsRsRsRsRgRsRsRsRsmmmmmmmbLsLsmbLjbLhbLsLsLsLsLsLsmmmmmbLibLjbLgbLib
LhbRgRsRsmmbRebsbLsRsRsRsRsmmmbRsRsRsmmbRoRsmbLsRsRsRsRsRsLsLsmmmmmbLs
LsmbLgbLsbLcLsLsmmbRcbRcbRcRsmbLgbRsbRsRsLsmbRsbRsbRsRsmbRsbRsbsbLsLsm
bLjbLcbRsLsbLsRsbReRsmbRsRsRsRsRgRsRgRsmmmmmbRgRsRsRsmmmbRobReRsmbRcbR
cbLibLibLsRsbLgbLsbLcLgLsbLibLcbLgbLcbLibLhbLibRobRhbRebLsLsmbLsLsmbLi
bLsLgbLsbRgbRsbRsbLsbLsbLsbLsbLsbLgbRsbLibLsbReRsmbRgbRoRsmbRiRsmbRhRs
RsRiRsmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRcmbLiRsRsRsmm
bRob

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRsbRsRiRsRsLsmmbRiRsmbRiLsbRhbRibRibLsbLcbLebLiLsbLgbLsLsmbRgbRgbLhbL
iLsRsbLsLgbRsLsLsLsLsmmmbLiLsbLgRsbRjbRcRsRsRsRsRsmmmmmbRsRsmbLjLsmbsb
LcbLhbLibLsLgLgLgbLcbLiLgLsbLibLiLibLgLsbLgbLsLgbRsbLibLsbRibLibLiLsLg
LsbRsbRjbRebRiRsRsmmbRsLsRsRsRsmmbLsLsRsmbsbsbsbLsbLsbLsbLsbLsbRsbsbLs
bLsbRsbRsbRsbsbRsbLsLsmbsbLobLhbLsbLobLiRsbLcLsmbLsLsmbLeLsbRgbLiLhbLs
bLobLsbLhLsbLibLgbLibLibLgbLebLebLibLibLibLibRjbLibLibLgbLibLhLsbLibLi
bLibLgbLgbLiLsbLsLsLsmmbLgbLsbRebLcbLhLsLgLsbLcbLgLsbLhLsbLgbLcbLiLsbL
iLsLsmbLgbLibLgbRsbRsbRsbsbRgRgbsbRsbRsbRibRebLobLibLgRgbLsLsmbLgbRibL
jbRibRjbLiRsbsbRgbRgbRsRibLgLsLsLsmmbsbsbRibLsLsRsRsRsRsRgRgmmmmbRgbsb
LsbLsbsbRgRsRsRimmbRsRsmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bLebLebLgbLsbLsbLebLgbLsbLibLgbLsbLsbLgbLgbLsbLgbRibRebRgbLgbLsLsmbRsb
LsbLsbLsbLgbRsbLsbRsbLsbLsbLsbLebLebLgRsbLsbLgbRsRsmbRsbLsbLsRsbLsbsbL
sbLsRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bRcRsmbLoLsmbRcLsLsLsmmbRjRsmbLibRobLcLsmbLeLsRsRsLsmbLsbRibLcLsmbRcbR
ebRcbLjbLcLsLsLgLsmmbLsbRsbLsbLsRsbLsLsRsLsmbsbRsLsbLsbsbRcbRcbLebLhbL
cLsLsmmbRcRsmbsbLeLsbLeLsbLibLcLibLoLsLsLsmmmbLcbRcLgbLibLcbLcLcLsLcmb
LebRgbRhbRcbLhbsbRjbRcbsbLjbRjRsRsRsmmmbRhbLebRcbRcRsmbsbRibRsLsbLjbsb
LjbRiRsmbLcbLsbLeLsLgLsbRcbRcRsRsmmbRgLsbRcRsmbRibRibRiRsmbRcbLsbLcbLe
bLsRsRsmbRcbRibsbLobLoLsmbLcbRcRhbReRsmbRgRgRsmbRibRcRsmbRiRhRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRebLibRsLsbsbLsbsbLsRsbLgbsbLsLobRebsbLoLsmbLobRoRsmbRsRsRsmmbRcRsmbR
sbRgbLsbRiRsmbRgRsRsRsRsmmmmbLobLsbLibRebLibRobLcRsbLobLcRsbLibLeLsbLg
bLcRsRsmbRhbRoLsbLobLibRsbLsbRcbRcbRibRibRjbLebLebLebRcbLebRcbLjbRebRo
LsLsmbRhbRibLcRsbRgLsbRibRgRsmbRgbRiRsmbRcbRiRsmbRiRsmbRgRibRgbRibRibR
ebRebRcbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLsRsRsRsRsRsRsLsRsLsRsLsRsRsRsRsRsRsmmmmmmmmmmbRjbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRiLsLsmbRobsbRobLjbsbsbRcbRjRsmbRcbsbRobRcbRcbLcLsmbRoRgLsbsbLcbsbsbL
sbLjbLoLsmbsbLcbLcbRobRhLsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bRgbRjbRjbRobRhbRibLjbRjbRjLsbRibLhbLcLsmbLcLsmbRebLcLsmbLcbRcbRcbRjLs
RsRsmbRhbRhbRhbRjbLcLsmbRcbLhbRebRibLibRsbRjbLjbRcRsmbLsbLcbRhbLjbRhbL
cbLcLsmbLsLsmbRjRsmbLcbLcbsbRjRsmbLiLsbRcLsbLobLhbRcbRcbRgRsmbRhbRobRg
RsmbRhbRgRsRsmmbRcRsmbLhLsbRebRobLcLsLsmmbLobLcLsmbLcbLibLsbRsRjbRsbLc
bRhRsmbLcbRhbRhRsRsmmbLcbLhbRcRsmbRcbRiRsRsmmbRibRcRsmbRcRgbRcbLhbRhRg
bRcbRiRsmbRcbLsRcLsbRcbRcbRibRhbReRsmbRcbsbLcbLgLsbLcbRcRsRsmmbRgRsmbR
ibLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRgbRsbRgbRebRgbRsbRsbLsRsbRsbLsbLibRsbLgbLgbLebLsbRsbLibLgbLibLgbLebL
sbRgRsmbRibRsbRsbLgbLgbRobLobLibRebLsbRibLsbRsbRgbRsbRsbRhRsmbRibRibRg
bRgbLsRsbRsbReRsmbRsbRsbRibRsbRgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bLsLsLsmmbLibLgLsLgLsLsmbLgLsLsmbLgLsbLgbLgLsLsmbLibLibRsLiLhbLsbLjbRi
bRsRgbRgbLsbRsbRsbLsbRsRsRsRsmmmbRsRsLsRsRsmmbRsRsRsRsmmmbRsRsRsmmbRjb
RgRsRsmmbRibRsbRsRgbRgRsmbRiRsmbsbsbsbRsbRobRibRibRsbRsbRsbRsLcbRibRiR
sRsRsmmmbRsbRibRsRsmbLgLgbLsbRibRsRgbRgRibLgbRebLobLebRcRsRsmmbLsbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLibRcbRjbRsbsbRhLsbRcbRibLibLibRcbRcRsmbRgbLsbLebLibLjbsbsbLsLsLsmmbL
sbRsRsmbLsbLsbRsbRsbRsbLsLsLsmmbRsbRcbLebLiLsbLibRsLsbLebLsbLibLibLibL
iLsbLibLsbLgbLibLgbLiLsbLsLsLsmmbLhbLiLsbLsLsmbLgLibLgbLibsbLgbLibLgLs
LsmbLibLsbLgbLgbLsLsmbLgbLiLsbLgLsbLgbLibLgbLibLibLgLsbLsbLsbLsLsLsmmb
LsbLgRsLsbLsLsLsmmbLgLsLsRsmbLiLsLsmbLgbLgLsLsmbLsRsbLsLsmbLsbLgbLsbLo
LsLsLgmmbsbRsbLsbLsRsbLibRgbLsLsmbLgLsLsLgLsmbLsLgbLgbLsRsbLsLsmbLhbLg
bLsLsLsLgmmbRjbLsbRsbRsbsbLsbsbRsLsbRjbRsbLiLsbLgLsLsLsmmbLcLsLsmmbLhL
sbLiLsbLibLsLsLsmmbLgLsbLsLsLsmmbLsbLgbLgbLibLgLsbRsLsbLeLebLebLobRhbL
cbLhbLgbLgLsbLgbRibLiLsbRjbLibLebRsLsbRsbLcLsmbLsbsbRsbLiLsbsbLiLsLsLs
mmbLgLsLsmbsbsbRjLsbsbLgLsbRgbLibRgbLiLsLsmbsbLsLsmbLsLgbLibRsLsLgbRsb
RsbLsLsLsmmbLsLsLsmmbLsbLiLsbsbRcbRobLcLsmbLgLsbLibLebRobRibLcbLhLsbLg
bLgLsbLcbRsbLiRsbLibsbLsLsLsLsmmmbRjLsbLiLsLsmbLsLsLeLsmbLibLgbLgRsbLg
LsbLsLsLsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRsRsRsmmbLjLsRsmbRcbRcLsbLjbLjbRibLibRhbLcbRcRsmbRsLjbRobRcbRiLsbRobL
jbRhbLjLsmbLjbLjbLcbRjbRibLsLsmbRcRsmbRgbLjbLjLiLsbRjbLgbRcbRibLibLcbL
ibLiLsbLibLcLsLembRsbRsbRjbRsbLsbLjbLsbLiRsRsmbRcRsRsmmbLcbRcbRgbLibLj
bLibLhRsbLsLcbLhLsbRcRiRibRhbsbLhbLjbLjLsmbRsRcbRibLsRsLsbRgbLjbLhbLiL
sLsmbLobLibLobLcRsbLcbLibLcLsmbLgLsbLcbRibRiRsRsRsRsmmmmbReRsmbRibRebR
sbLibLobLcbLibLibRcbRcRsRimbRobRibLibLibLgLsbLibRsbLjRsbLiRsbLibLibLgb
LibLgLsbLjRsbLgbLibLebRsbRobRjbLibLjRsbLsbLibRsbRiLsbLjbRibLhbLibLibLh
bLibLjRsbLjRsRsmbLgbLibLgbRjbRibLcbLhbLiLibLibLgbLibRjbRhLsbRibLgbRjbL
sbRhbLebLjbLibLiLsbRjLsbLhLsbRjbLhbRcbLcbLibLiLibLiRsbRsbRsbLsbLsbLhbR
jbRebLcbLibLgbLgLsbRibLibLiLsbLibsbLhbLcbLjRsbsbLibLcbLcRsbLibLibLibLs
bLebLhRsbLibLibLibLjLibRhbRcbRibLjbRcRgbLjbLhLsbRsbLgRsRsmbRsbRcRsmbsb
RjbRibLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLsbLgbRjbLjbRjbLcbLibLgbLgbLgbLgbRjRsmbLcbLibLgbLcbRcbRibRiRsmbRibLiL
sbLgLsbLgbRjbRcRsmbRibRiRsmbRsbRsbRcbRgRsmbRibRsRibRibRibRiRsRsmmbRiRs
mbRgbRibRibRibRibRgbRsbReLsbRgbsbRgbLsRhbRgbRibRiRsmbRibLsbLgbRgbRibsb
LjbRiRsmbLjbRibLjbLhbLgRsbLibLgbLgbLgbLgbLgbLibLiLsbsbLgbLgbLebLiRsbLe
bRsbLeRsbLebLibLibLgbRibLjbRjbRcbRibRgRsmbsbRgbRibLgbLcbLibLibLsbLgbLi
LsLibLcbLiLsbRsbRsbLibLibLgbLgbLgLsRsLsbLiLsbLibLgbLgbRcbRibRhbRiRsmbR
ibRibRiRsmbLibLibLiLsRsbLsbLcLsmbLsLhLsbRsbLgbLgbRjbRcbRgbRibRibRiRgbR
gbRibRgbLgLsbLjbLhLsbLgLsbLibLibLgLsbLgLsbRsbRjbRgRsmbRgRgRsRsmmbRgbsb
LsbRgbRiRsmbRibRgbRgbRibRgbRibRgbRjbLsbRjbRibLibLjRsLsbLebLgbLibRgbRcb
RgbRgbRgRsmbLebRibRibRgbsbsbRgbRjRsmbLibRibRgbRgbRobLgbRgbLsLjLjbLcLsm
bLgRsbRjbLjRsbLgbLjRsbRgRsmbLgbLibRhRsmbLgbLibLgbRjbLgbRjbLiLsLsmbRhbL
jbLhbLgbRebLcLsmbLgbRibRgRsmbRiRsmbLcbLeLsbLsbLgbLiLsLsmbLeLsbLhbLgbLi
LgbLgLsbLibsbsbsbLibLibLibLcLsmbLsbRibLjbLebLgbLibLhLsbLgbLgbLiLsLiLsb
LgbLobLgLsbLcLsmbLiLsbLgLgbLiRsbLibLsRsbLgLsbLgbLgbRhbRibRiRsmbLsRsRib
RgRsmbLsbLgbLjbLeLsLsmbLgbLgbsbLgbLgbRcbRibLjRsRsmbRhRsmbLsLjbLgLibLgb
LibRjbLsbRjbRibRjbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLgbLebLeLsbLsLgbLsLsLsRsRsmmmbLhbLgbLsbLsbLibLgbRsbLgbRsbLsbLsbLsbLsb
sbLsbLgbLibLgbLsbLebLebLgLgbLiLsbLiLgLsbLgLgbLiLsLgLsbLsLsLsLsmmmbLgbL
sLsLsmmbLgLgLsLsmbLgLgLgLsbLgLsLsLsmmbLiLsbLgbRsRsmbRsLsLsmbLsbLgbLsbL
ibLsbLgbLsbLsbLgbLsbLsbLgbLgbRsbLsbRsbRsbRsbLsbLgbRsRsmbLgbRiLsRsbRsLs
bLsRsLsRsbsbRsbRsLsbLsLsmbLsRsbRsbLsbRsLsbLsbLsLsmbRsbRsbRsbRsbLsbsbLs
bsbRsLsbsbLhLsbLiLsLsmbLgbRsbRoRsmbLsLsLsLsmmmbLsLgRsLsbLiLsRiLsbLibLs
LsLsLsmmmbLgLsLsmbLgLibLgLsRsbLgLsbLgLsLgbLsbRgRsmbRgbLsRsRgbRgbRsRsmb
RsbRsbRgbLsbRsbRsRsmbLsbRsbLsbRgbRsbRsbRsbRsRgbRgbRsbRebRob

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRcbRoRsRsmmbRcbRhRibRibRiRebRebLoRsbLcbLcbLhbRhRsmbLjRsbLgbRjbRhbLcbL
hbRcbLcbRcbRcbRiRsmbRcbRibLjbRcbRiLsLsRsRsmmbRhbRibReRebsbsbLobsbsbLhb
RcbRibRibRcbRsRsRsmmbRibLcbRcRsRsmmbsbRhbLcbsbRcbRjbRcRsmbsbRhbsbsbRcb
RobRcRsRsRsmmmbLeLsLsmbLsbsbRcbRcRsRsmmbRibRsRsmbRcRsRsRsmmmbLiRsbRsRs
LsRsLsmbRcbRsbLsRsRsRsRsRsRsRsRsLsLsRsRsRsRsmmmmmmmmmmmbRsLsRsRsRsRsRs
RsRsRsRsRsRsmmmmmmmmmmbRibRsRsmbRoRsmbLobRoRsmbLsLsLsLsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRsRsLsmbRgbRhbRgbLjbRjRebRgbRebRsbRgbRsbRsRsRsmmbRsRsRsmmbsbRsRgbRsRs
RsRsRsRsLsLsmmmmmmbRsRsRgRsRgmmbRibRebRibRobLibLiLsbLibLebRsbLeLsbLsbR
jbRibLjbRsRsmbRgbLjbRjbRgbRgRsmbRgbRsbLjbLibRibLsbRibRibLobLiLsbLibLib
LibLiLsbLgLsbLsbLebLgbRjbRibRiRhbRsbsbLhbLgLsLsmbLsbRsLsbRsLsbLsLsLsmm
bsbsbLgLgLgLsLebsbLsbLsLsmbRsLsbLibLhbRgbRsbLgLsLsLsLsLgLsLsmmmmbRsbRs
bsbsbLsbLsbRgbRsRebRgbLebLgbRgbRgLsbRsbRgbRibRebRhbRsLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bLsbRsbLjbRjRsRsmmbRsbRibRsRsmbLobRgRsmbRcRsRsRgmmbRhRgRsmbLcbRjRgRgRs
RsRsRsmmmmbLsRsRsRsRsRsRsRgRsRsRsmmmmmmmmbRsbRsRsRsRsmmmbRsRsmbsbLgbsb
LsbRsRsmbRibRgbRsRsmbRsbRsbRgRsmbRcRsmbLsbLebRibRsRsRsmmbRsRsmbRsRsmbR
sbLjbRsRsRsmmbLjbRsbRsRsRsmmbsbsbRsbLsbLgbRsbRoRsmbRcbRsbLoLgRsbRjbRiR
gRsRgRgRsRsRsRsRsRsRsLsmmmmmmmmbRjbRsbsbRsRcRsmbLebRsRsRsmmbRibLoLsRsm
bRhbRsbRcbLiLsbRcRsRsRsRsRsRsRsRgmmmmmmmbsbLjbLcbLsLsLiLsmbsbLsLsLsLem
mbLjLgbLgbLiLibLsbLoRsbsbRhbsbRsRhRsmbRsbRsRsmbRsRsmbRsbRhRsRsRiRsRsRs
RsRsRsRsmmmmmmmmmbRhRsmbLcLsLgmbRcbRsRsRimbRsbsbRsRsmbRgRsRsRsRsRsRgmm
mmmbRsbRibRhbRsbRgbRibRebRgbRsRgbRhbLibRiRsmbLsbLcbLhbRsLsRsbLsbRebRsb
LsRsRsRsRsRsRsmmmmmbRsRsmbRsRsmbRsLsbRsRsRsRsmmmbRsbLsRsRsRsRsmmmbRgRs
mbLoLsLimbLgbLebRsbLgbRibRcbRhRsRsmmbLibLcRsbRjRsmbRcRsmbLsbRsbLjbLeLi
LsbLgbLhbLibLsbLhbRcRsmbRibRcRsmbRgbRsbRgbRsbRebRibLcbLgbLgbRcbRgbRsRs
RsRsRsRsRsmmmmmmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRsmbRsRsmbRsbRsRsL
sRsmbRsbRsRsmbRsLsRsRsmbRiLsRsbLobLgbLsbRsRsRsmmbRsRsmbRsbRgbRgbRsbsbR
sbRgbsbsbLsbLsRsbLjbLcRsbLiRsbLhLsbLgRsbLcbRiRsRsmmbRcbRebRsbRiRsRgRsR
sRgmmmbRiRsRsmmbLjbLiLsLsLgLsRsLgLsmbLsLibLgLsbRjRsmbRgbRgRsmbsbRiRsLs
LsmmbLcLgLgbLiLsbLibRsbRsbRiRsRsRsLsLsRsLsmmmmbLcbLsbLcbLgbLiLsbLsLsmb
LsbLsbRsbLsbLsRsbRsbLgbLsbLsbRsbLsLsmbLsbRsbRsbLsbRsbLsbRsLsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsLsmbLsbLgbRsbsbLsLsmbLsLsmbRjbRsbRsLsLsLsmmbLsLsmbRsLsLsmbRsRsmb
RsLsLsmbLsLgLsLsLsmmbLsLibLsbLsLsLsmmbLsbLsLsLsLsmmmbLsbLsLsmbLsLgLsLs
mbLgbLsLsmbLsRsbRsLsLsLsmmbLsLsmbLgbLsLhbLsbLsbRsLsbLsbLsbRsbLsLsmbLsb
LsLsmbsbsbLsLsLsLsRsmmmbLsLiLsbLsbLsLsLsmmbRsLsbLsLsLgLgLembLgbRsbLsLs
mbLiLsbLsLsmbLibLgbLgbRsbLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmb
LebLsbLsbRsbLsbLsbRsbLhbRgbLsbLgLsbLgLsbLsLsLsLsLsmmmmbLgRibRsbLsLsLim
bRsbLsbLgbLsbLsbLibLiLsbRobLiLgbLgbLsLsLsmmbLgbLgLsbLsLsLsmmbLsLsLsmmb
LsbLsLsmbsbsbLeLsbLgbLgbsbRsbRsbLgbLgbLgbRsbLsbLsbLgLsLsLsLsLsLsmmmmmb
LgLsLsLsLsLsmmmmbLsLsLsmmbLsbLsbLsLsLsmmbRsbLsbLsLgLsLsLimbLibLebsbsbL
sbLsbLiLsLsLsLsLgLsLsLemmmmbLgLgLgbLsbLgLsLgbLsLsLembLsbRsbLsbLsbLgbLs
bRsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bRsRsRgmbRgRebRgRiRsmbRgbRsRhRsmbRsbLiLsLiLsLsLgLgRsLsmbLibLsLhLsbLsLs
mbLeLsbLgbLsbLsLgLgbLgLiLeRsbLsbLsbLgLgLgLsLsLgLeLgmbLiLeLsbLgbLgLsLgL
sLsLsLsmmmbLsbLsLsmbLobLsbsbLsbLgLsLsLsLsLsLsLsLsLsLsLsLsLemmmmmmmmmmm
bLsLsLsLsLeLsLsLsLsLsmmmmmmmbLsLsLembRsLibLgLsLsLsLsLgLsLsLgLgLgmmmmbL
sbLgRsLsLiLsbLebRsbLsLsLsLgLsLsLsLsLgLsLsLsLsLgLeLimmmmmmmmbLsbLsbRcLs
bRcbRcbRsbLgbLsLsLsLsLsLsLgLsLsLgLsmmmmmmbsbLiLsbRjbRjbRiRibLjbRcbRibR
iRsRsRsRsRsRsRsmmmmmmmbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bRcRsmbRgRsmbRgRsRsmmbRibRsbRebRgRsmbRoRsmbRgbRibRcbLibRgbRibLsbLobLsb
LebLgLgbRiLsRsRebRsbRebRibRebRsbRsbRebRgbRsbLebRobRcbRiLsbLcbLibRcbRib
LsbRobRsRibRgbRgbLsbRsRgRsReRembRgbRgbRibRcbRibRcRsRsmmbRsRsRsmmbRiRsm
bLcLsmbLiRsbLgLibLgbRsbRsRjbLsbRjRjbRgbRjbRsbRibRibRgLsbRsLsbRsbRibReb
LgbLiLsbLsbLhbReRibLsRsbRcRibRsRebRibRibRsLobRebRjbLjbRiLsbRcbLsRsbLjb
LsLsmbRsRibLebLebRsbRebRibRgRsmbRiRsmbRebRsbRsbRebRsRsmbRsbRgbRiRhbRsR
smbRgRsRsRsRgmmmbRiRsmbRibLsbRibRebRgbRgReRsmbsbReRibsbRibRgRsmbRgbRgb
RhbRibRcbLgbLeLsbLsbRoRsmbRibRgRsRsmmbRiRiRsmbRobLiRcbRsbLsbRsRgRsmbRs
RgReRsmbLsbLobLibRcbRhbRgRsmbRgbRebRhbRgRsmbRgbRebRibRibRgRsRsmmbLobLo
bRgRsmbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bRcbLgbRcbsbsbLgbLgbLsbLsLibLebLgLsbLgRsbLibRsbLsbRsLsLsLsLgLsmmbLsLsm
bLebLebRsbLgbRibLebLsRsbLsLsmbLsbLebLgbLgbLebLebLgbLsbLsbLsbRsbLsLsmbL
sbLsbLsbLebLibLsbsbLsRsLsRsbsbRsbsbLsbLsbLsbLibLebRsbLebRsbRgbLebLgbLg
bLibLsRsbLsbRsbLebLsbLsbLgbLgLsbRsbLgLsbLibLsLebsbRsbsbLsbLsbLsLgbRsRs
mbsbLgbRjbLibLobLgbsbLgbLebsbLsLiLsbLgbLiLsbLeLsbLebLgLsbLgbLgbLebsbLs
LgbLiLsbsbRsbLsbsbLgbLsbRgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bRibRibRsRsRsRsRsRsmmmmmbRsRgbRgRsmbRibRsbLsLsmbLsbRgbLsbsbRiRgbRgbLsb
LsbLjbLcbLsbLcbLgbLiLsbRcbRgbRsRsRsRsmmmbRsLsRsbLebLibRgRsmbRiRsmbRgRs
RsRsLsmmmbRsRsmbRiRsmbLcbLiLsbLgbLiLsbLgLsLgbRgbRiRsmbsbsbsbLsLsmbRsbR
sbRibRgbRgbsbLsbsbRgRsmbRhbsbRsbLcbLsbLibRsbRsRcbRebRgbRgbRgbLgbRobRsb
RhRsmbRibRibLsRsbLebLgbLibLibLibLgbLiLsbRgbRjbRiRsmbRgbRibRibRgbRsbRsb
sbsbRsbsbsbsbsbsbRsbRsRsRsmmbRsbLsbLgbRsRsRsmmbRsRsmbLobLgbsbRsbRjbRiR
smbRsRsmbRibLhbLeLsLsmbLhbLgbRsbLgbLsLsmbLsbLgRsbLiLsbRsLibLiRsbLibLib
LibLibLibLgbLgbLgbLgbLgbRibRebRibLsbLebLibLgbLiLsbLibLsbLsbsbLebLsbLeb
LgbLibLcRsbLeLsbRgbRcbRiRsRsmmbLsRgbRibRgbsbRhbRgbRgbRsLebRgbRgRsmbRsR
sRsRsmmmbRsbLsbRsRsmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRsbsbRsRsmbRsbRsRsmbLe
bLgbRebRsRgRsRsmmbRgRsRsmmbRsRsmbLsbLcbLiLsbLibLibRsbLgbLsbRsbLsLgbRsL
sLsmbRsLsLsLsLsmmmbLsLsmbLsbRsbLibRjbRebRsbLsbLsbRsbRsbsbsbRsRgbRgbRsR
sRsmmbRiRsRsmmbLjbLebLiLsbLsbLsbRjbLeLsbLibLsLsLsLsLsLsLsLsmmmmmmmbLsL
sLsLsmmmbLgbRgbRebsbRgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bsbRsbsbRsRsRsRsRsRsRsRsmmmmmmmbRibRhRsmbsbRsLsRsLsLsLsLsLsLgLgLgLsLsm
mmmmbLhbRibRcRsmbRgbRibRiRsmbLiLsLsRsLsRsmbsbRcbRhRsmbRgbRobRjRsmbLsLs
LsLsmmmbRcbRibRiRsmbRgRsmbRsRsmbRsbRsbRibRibLhbLcbLcRsbRsRsRsmmbRhbRhb
RibRibLgbRiRsmbRebRobRhbLgbLibLsbLgbRjbLiLsbLgbLcbLibLgbLcbLibLgLsLsmb
LgbLibLgbLibRibLcbLibLibLsbLgLsbLibLibLsbLgLcbLibLebLgbRibRibRibRibRgb
LsbLibLcbLgbLibLibLgbRibRibRgRsmbRgbsbRibRibRibRgbRibRgbRsbsbRibRgbRgR
ebRhbRibLgbLgbRsRsRsRsRsmmmmbRsbLjbRgbRiRsRsmmbRsbRibRibRibRgbRibRhRsm
bLgbLhLsbsbRjRsmbLsbLsbLsLsRsRsRsRsmmmmbLgLsbLsbRsLsbLsLsLsLsLsLsLgLsm
mmmmbRsbRibRibRsRsRsRsRsmmmmbRsRsmbRgbRgRsmbRgbLjbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRibLjbRjbRibRgbRibRibRhbRibLgbRibRiRsmbLgbLgbRjbRsbLjbRhRsLgmbRiRsmbR
jbRgbsbLjbLsRsbRhLsbLjbRhRsRsRsmmmbLcbReRsRsmmbRobRjLsbRcbLcRsbLobRcRs
mbRhbRiRsmbLcLsRsmbLcbLgbLebLgbLebRjbRibRiRsRsmmbLcbsbLhbRebLebLibLibL
ibLibLibRhbRhRsmbRibLibLcbLcbRibRcbLhbLcLsmbLcRsbLsLsmbLhbsbLiRsbLhbRg
RsmbLcbRhbLgLsbRcbLhbLgbLhbRcbLcbLcbLibRjRsRsRsmmmbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bRsbRcbRsbRcLsRsbLcbLsbsbLhbLibLeLsRsbLiLsbLsLsmbLibLibLhbRibRibRcbRgR
smbRibLsbRcbLsbRibRibRiRsmbRiRsmbRiRibRcRsRembRebReRebLoRgRibRiLsbRcLs
bLgLsbRibRcbRibRibsbRgbLibRhbRgbRcbLcbLjbLcbLcbLhbLgbLjbLgbLeLgLsbLgbR
cbLjLsmbLgLsbLibLgbLgbLgbRibRgbRibRibRibRibRcbLhbRgbRibLibRsbRhLsbRcbR
sRsmbRsbLibLgbRsLsbLgbLhbLgbLebLibLebLebLibLiLsbLgbLgLsbLgLsbRibLcbLgb
LebLcbLcbRebRsbLibsbLsLiLsbRjbLibRsbRibLgbLgRsbLiLsbLibLiLsbLsLgLsLgbR
ibRibLcLsmbLibLsLsLsmmbLibLhbLiLsbLgbLsRsRsmbRjbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bLsbsbRsbRsRsmbRsRsRsmmbsbsbLsbsbRsbRsLsbRsbLsRsbLsbLsbLsbLsbLsRsbRsbR
sLsbLsbLsbRsRsmbLsbsbLsbRsbRsbRsbLsbLsbLsRsbRsbLsbRsLsbLsbsbsbLsbRsbRs
bLsbLsbRsLsbLsLsmbRsRsRsmmbRsbLsbRsbLsbLsRsbRsbLsLsmbsbRsbLsbsbsbsbsbL
sbsbsbLsbLsbLsbRsbRsbRsbLsbRsbRsLsbsbLsbsbRsbsbRsLsbLsbRsLsbRsbRsbRsbs
bRsbRsbRsbsbLsRsbRsbRsbLsbLsbsbRsRsRsmmbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLiRsbRcLsbRcbLgLsbLcbRgbRiRsmbRibRhbLiLsLeLsbLhbLiLsbLhbLcbRgbRobRgbL
hLsbLiLsbLibLeRsbRcLsLsmbLhLsbLiLsbLhLsLsmbRcLsLsmbRcRsRsRgLsmmbRcLsLs
mbLsLsmbLsLsmbLcbLobLibLiLsbRcRsRsRsmmmbLjbLcbLibLeLsbLcbLgLsbLebLcbLi
bLiLsbLcbLiLsLsLsLsmmmbRcLsbLhbRcLsbLcLsmbLeLgbRoLsbLjbLhLsLsmbLcLsLsm
mbRcLsbsbLcLsmbsbLiLsbLjbLeLgLsLgbLcLsLsmmbLcbRcLsbLhbLcLsmbLeLsLsmbLe
bsbLhLsbLhLsLsmbLcbLsLsLsLsLsLsLhLsmmmmmbLcLsLgLsLsmmbLcLgLsbLcLsmbLhL
sbLibRcbLebRcRsmbRhbRhLsbReLsbRoRsRimbRgbRgLsbRsbRcLsbLcbLcLiLsbLcLsmb
LibLiLsbRsLcLsLsmmbLobLibRcbLcLsmbRibLhLsbLcbLiLsbLcLsmbRobRibRhbRgbLi
LsbLcbLcLsmbLcLsmbLeLiLsbLcLsmbLibLiLiLsbLgLsLsLiLsLsmmbLcLgbLsLsLsLsL
smmmmbLiLsLgLsbLeLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLhbLsbLsbLibLgbLibLgbRoRsLsmbRcbLobRibRgbLgbRibRebRibLgbRebLsLsmbRobR
ibRjbRsRiLsbLgbRcLsLsmbsbLsbRcRsmbsbRsRcLsbRhbRcbRibRsRsRsmmbRcbRcbRcb
RiRsRsmmbRhLsbRsRsRsRsmmmbRsbRgRsRsmmbRcbLoLsLsmmbRjbsbRsRsRsRsmmmbReb
LsLsLsmmbRcbLsLsLsLsLsLsmmmmmbLoRsbRcRsRsmmbRsLsbRibLgbRoLsbRsRsRsmmbR
cRsRsRsmmmbRcbLsRsbRcbRsRsLsRsRsRsRsRsLsmmmmmbLibRhbRiLsbsbLhbsbsbRsRs
mbsbRcRsmbRibLibRcbLsbRsRsRsmmbRibLsRsLsbRsbRsRsmbRsRsRsRsmmmbRcbsbLsR
sRsRsmmbLibRcRsmbLcbRjbRcRebRibLsLhbRcRsRsmmbRgRsRsRsRsmmmmbRgbRsRsmbR
ebLsRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRsRsmbLibRsbRsbRobRebRibRibRibRebsbsbsbLsRsbsbsbsbRsLsbsbsbsbRgLsLsmb
RsbLgbLgbLsbLgbRibRhbRhRibRjRsRgmbRibRhbRgbLsbRibsbRsLsRsbsbRgbRebRebR
ebRibRsbLsbLsbRebRgbLhbLgbLibRhbRibRibsbLebRobRiRgbRsbReRsmbRibLsbRibR
gbRgLsbLsRsbRhbRgLsLsmbLobLjbLsbLiRsbRsbsbLsLibLcbLibRsLsbLibRibRibRib
sbsbLsbRgbLcbLibLibLgLsbRhbRsRcLsbRgLsbsbLobLgbsbRsbRsbLebRgRsmbRiLsbR
jbLebRsbsbRjbRgbLjbLsbLsbRgbRgRsmbRiRibRgbLsRgbLobLibLebRhbRsLgbLgbRsb
RsbRsbLibsbsbLsbRsbRsbsbRsbLsbRgbRgLgbRsbRsbRsbLsbsbLsRhRsmbLcbLcbRsbs
bsbLibLgbRgbRjbLsbRibsbRibRgbLsbLgLsbLsbLsbLibLibRcbLibRiLsbLobLhbsbLi
bLgbLsLsmbLgbLebRgbLgbLhbLebRobRcbRibRiRsLsmbLsbRsLcbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRsRebLsbLjbLhbLcbLhbLibRibRjRsmbRhbRsbRibRjRsmbLjbRiRsmbLjbLjbLibLibL
jbLiRsbRiRsmbRcbLhbLibRsbLeLeLsbLsbRjbLcbLobLsbLcbLgbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bsbRsLgbRiRgLsbReLcRiRgRebLsRsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRcRsmbRcbRsRjRsmbRebRjbLebRjbRjRsmbRgbLjLgbRsRgbRjbRebsbLjbLcbRcbLsbR
cbLcLsmbLhLsLsmbRsRsmbRcRsmbRebRibLeLsbLcLsmbRsbLhLsbLgRsLsbLhLsbRsRib
RcbRgRsmbRibRhLsbRgbLeLsbLcbLibLhLsbLhbLhbLobLibLcbLsbLibLcbRgRsmbLibL
hLsLsmbLiLsLsmbLiRsbLgbLibRcRsmbRibRebRobLsLsLsLsmmmbLibLibRsRsmbRcbRj
RsmbLibRcbLoLgbLsLsmbRjbRgbRcbLcLgbRsbRsRsmbLcbRjbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRcbRibRgLsLsmbRgbRibRiLsbRiLsbRibRgbRibRibLsbsbRiLsbRiLsbRiRsmbLsRsbL
sbsbsbRibsbsbLcbLobRibRoLsbRobRebRsbRgbRiRsLsmbRsRgbRgbRibsbRsbRgbsbRg
bLsbsbLcbRcbLibRiLsLsLsLsmmmbRibLcLsmbRobRsbLcLsmbLhLiLsbLhbRjbRobRgLs
bRsbRiLsbRhLsbRhLsbLsRsbRgLsbLcLsmbRcRsmbRgbRiLsbRgbsbLsRsbRiLgbRsLsbR
sbRiLsbRiLgbRibRobLeLiLgLsLgbLgbLibLgLsLsRsmbRjbRiLsbRiLgbRibRibRibRgb
RibRgbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bsbLsbRibRhbLebRobLsbLgbRebRsbRgbRobRjbLjbLjbRsbLsbRsbLsbRsbRgbLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLcbRjbLebLibLsbLgbLgbLgLsLsLsLsmmmbLgbRsbLgbLibLgbRibLsbLgbRgbLibLibR
jbLgbLgLsRsbRsbsbLibLsbLgbLibLiLsbLibLiLsbLebLjLsmbRsLsbLjRsbLgbLcbRib
RsRibRgbLgbLibLgbLhbLsbLgbLgbLjLgbLgRsbRgbLjLsmbLibLjbLhbRiRsmbLebLibL
gbLibLgLgLgbLgbLgLsbLeLsbLgRsbLgLsLsLsRsmmbLibLibLgbLibRibRibRiRsmbRgR
gRsmbRibRibLibLsbLcbLibLiRsbLhRsRsmbLgbRibRhbLibRgRibRsbLjbRhbRgbLsbLj
bLcbRjbLiRjbLobLgLsbLsRsLsbLibRjbLhbLcbLebLjRsbRsRsmbLibLibLibLjbRjRsm
bLsRjRsmbRsbLjbLibRjbRiRgbLsLsmbRiRsRgRsmmbRgbRgbLsRsbRcbLibLibLobLhbL
gbLibLibLibRibRebLsbRhbRgRsRimbRgRsmbRsbLsbLsbLjbLhLsbLibLsbLebRebRebR
ebReRsmbRebRobLeLsbLgLsbLsLeRsbLebLebLibLhbLgbLiLsbRhbRjbRibLgbLibLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bLgbRjbLibLibLgbLsLsRsmbLgbLcLsmbLibLgbLgbLibLibLibLgbLcRsbLgbLiRsbRsb
RjbRibRibLsLsmbLibLhLsbLsbRibRibsbsbRhbRibsbLcbRibLjLsmbLhbLjLsLsmmbLs
RsbLhbLsbRiRsmbRjRsmbRibRibLiLsbLjLsmbRibRebRjRgbRhbLjLsmbLgLsbLibRsbL
ibLsLsLsmmbLgLsbLsLgbLgLsLsmbRsbLhbLhbLibLsbLsRsbLhbLibLsbLsRsbLiLsbLs
LiLsbLhbLsbLhbRsbsbRjbRibRsRsmbRhRsmbRibRibRsLgbLibRobRsRebRiRiLsbRsRs
RsRsmmmbLebRsRgRsRsmmbRsRsRsRsRsRsRsRsRsLsmmmmmmmmbRsRsRsmmbRsRsRsRsRs
RsmmmmmbRsRsmbRsbRgbRcLsbRsbLgRsbLibLgbLgRsLgLsbRsRsRsmmbLhbLibLibLiLs
LibLsLsmbLgLsbLibLiLsbLhbRsLhLsLebLobLgbLibRcbRibRgbRiRsmbRiRsRsmmbRgR
smbLebsbLgbRobLgLsbLibLibLgRsbLebLibRiRibRibRhbRibRibRgbRgbLobLibLiLsb
LgbLiLsbLgLsbLgLhbLibLibLebLibLgbLibRjbRcbRiRsmbRgbRcbRibLjbLsLsLsmmbL
hbLsbLgbLgbLsLsRsmbLgLsbRjRsmbRsbLiLsbRiRsmbRibsbRsRsRsRsRsRsmmmmmbRsR
gbRsRsLsmbLiLsbLibLibRsbLgLhbLibLibLgRsLsbLoLibLsRsLebLgbLcbLibLibsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLcbLibRsLsbLibLgRsbLobLhbRebRiRsRsRsRemmmbRebRsLsbRgbLsbRibRsRsRsRemm
bRsRibLjbLcRsbLsbLcbLsLcbRsLsLsmbLgLsLsmbLiLsLsmbLcbRcbRsRsRsmmbLjbLcb
LgbRgbLcLsmbRgRsmbLibLsbRsRsRsRsRsRsRsRgRsRsRgmmmmmmmmbLjbRsRsRsmmbRsR
sRsmmbRiRiRsmbRsbLcbLibLsbLgbLsLsLsLsLsmmmmbLebLibRgbLiLsLsLsLsLsLsLsL
smmmmmmmbLgbRgbLiLsbLgbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bRebLcbLeLsLsmbRsbLeLebRsRsLsmbRsbLgLeLsLgbRsbLsLebReRsmbLoLsmbLcLsmbR
ibRjbRhbRcbReRgbRiRsRsmmbLiLsbLcbLibRgbsbRcRsReRsRsmmmbRebLgLsRsbsbsbR
jbRcReRsRcRimbLsbRsbReLsbsbsbsbsbLsbRcbRgbRibRgbRebReRsRsmmbLjbLcLsLsm
mbLsLgLsbReLsRebReReRgbsbsbLcbLcLsLiLsmbLibRcRgbLjbLjbLjLgLsbLgbLcbLjL
sLsmmbLiLgbLgbRsbLhbLiRsRsRimbRcbRhRibRhRsmbRgbRobReRiRgRsmbRibRgRibRi
RsmbRiRsmbLjLsmbLsbLiRsbsbsbLjbLjLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLsLsLsLsLimmmbLgLsbLsLiLgLiLgLsbRsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmm
mmmmmmmbRgLsbLeLsbRcbRgbRobRcbRcRsmbLiLsbRsbRcLsbRgRsRsRsRsmmmmbLcbLib
LiLsbLcbLebLcLsmbLcLsmbLeLsbsbLibLibLsLsLgLsLsmmbLsLsLsLemmbLibLsbLibR
sbRcbRgbRibReRsLsmbRsLgbRcbRobRibsbLibLibLibRgbLcLsmbLgbRgbLcbLiLsbLib
LgbLgbLobLebLibLiLsbLibLsbLsLsLgLsRsmbLsLsLiLsLgLsmbLsLgbLhbRiLsbRhLsb
ReRsmbRsRibRgbRiLsbsbRebRiRsmbsbRhLsbRgbRhbRibRgLsbLsRsbRiLsbRobLibLhb
LibRsbLhLsbLhLsLsmbLhbRibLjbLgbLibLgLsbLebLgbLsbLiLsbRsbLibLgbLsbLibRs
bRhbRibLgbLcbLiLsbLhLsLsmbLibLhLsbRibRcbRgbRibRsLsLsLsLsmmmbLsLsmbLibL
gbRsbLibLgbsbsbLgLsLiLsLiLsLgbLgbLgbLibRebRcbRcRsmbRibRgbLeLsbLiLsLsLs
LsLsmmmmbLibLgbLsLsmbLsLsmbLsLsLsLsmmmbLsbLsLsmbLgbsbRcbLebLibLsLsLsLs
LsLgLsLsLgLsLsLsmmmmmmmbLsLgbLgLsbRsLsLsLsLgLsLsLsLgLiLsmmmmbRcbRibLjb
LiLsbLiLsLsmbLibLgLgLsLsLsLgLsLgmmbRsRjbLsbLsLsLgmbLiLsLgLsLsmbLgLsLsL
sLsLgLsmmmbLgLsbLibLsLgLsLsLgLgmbLsLgLsbLsLgbRsLsLgLgLsLgLsLsLsLgLsLiL
gLgmmbLsLsLsLsLsmmmmbsbLsbRcLsbReRsLsmbRiRsLsmbLsLsLsLgLsLsLsLsLsLsLsL
smmmmmmmmmbRsbLiLsLsLimb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRibRsbRibRgRsmbLjbRibRgbRgLsbLjbRiRsRsmmbRsLsbRsRiLsbRsbsbRgbRgbRsbRg
bRibRsLsbRebRgRsRsLsmmbRibRgbRibRibRsbRibRibRgbRiLsbRgLgbLgbLhbLebLgLs
LgbLgbLibLgbLgLsbLibRsbRobReLsbReRsLgmbRgRebRsbRcLsbRgbRiLsbRjRibLebLg
bLebLibLhbLhbLibRebRgbLcLsmbLsbRcbLebLsbLiLsbLgLsLsmbLgbLsRsbLgRsRsmbL
ibRsbLibLebRsbLiLsbLgLsLsLsmmbLsbLsbLobsbLebLcbLebLsLsmbLiLsbRsbRebLib
RibLebLsbRjbLoLsmbRgbRgbRsRjbRiLsbRgbRiLsLsmbRsbRgbRebRgbRgRsRsmmbLsRc
bRibRgbRgbLsbRgbLgbRibRibRibRsRsmbRsbLsbRsRsmbRgbsbRibRsbLsbRgLsbLsbRi
RibRsRsmbLjbRibRibRsRsmbRgbLebRcbRsbRsbRgbRgbRsRgbLsLsRsmbLhbLebLgLgbR
sLsbLibRgbLeLsLsmbRibRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bsbsbsbsbsbsbsbsbRsLsRsbRsLsbLsbLsbRsbsbLsbsbsbRsbsbsbRsbsbsbsbLsbsbsb
sbsbsbsbsbsbRsbLsRsbLsbRsRsmbsbRsLsLsRsmbsbRsbRsbsbRsLsRsLsLsmbLsbsbsb
sbsbsbsbsbRsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bRsLsRsbLsbsbsbLiLsbLsbRibRhbsbRhRsRsRsRsmmmmbRibRiRcRsRiRgmbRhbRebRib
ReRgbRoRhbRgbRibLibRoLsbRobLcbLibLebLibLibLibRibRibRcbLgLsbRebRebRebRe
bRebRiRsmbRobRibLebLjbLibRcbLiRsbRsbsbLhRsbRjbLiLsbLjLgbLhRsbRibLibLiL
sbLgLsbLcRsbLcbLhbLibLgRsbLibLgbLgLsRsbLiRsbsbLibRhRsmbRgbRoLsbRiLsbRg
bRibRgbRcbRgbLgbLibLoRsRsmbRsbLsbRgbLhbLsLsLsmmbLgbLsLsmbLgbLsbLibLiLs
LgLgbLebRsbLgbRjbLiRsbLibLsbLsbRsLsbsbLsbLsbLsbsbsbsbsbsbLsLsmbLjRsLsb
RjbRgRsRsmmbRsbRsRsmbRsRsRsmmbRsLsbLsbLhbRcbRiLsbRgbRibRcbRgbRibRgLsbR
ibRibRibRibRibRobRgbRibLsRibRibRgbRibRibLgbRibRibRibLsRsbRsbLcbLhbLibL
gbLsbLgbLsLobRibLibLgbLsLsLsLsLsLsLsLsmmmmmmmbLsbRsbLgbLeLgbLgbsbsbLcb
RsbLcbLhbLsbLsbLhbLgLsLsmbLgLsbLjLsLsmmbLhbRsRsmbRhbRibRibRgbRgbLcbLib
LgbLgbLibLsbLibsbLsbLibLcRsbRsbRgRsmbLibLhLsbLiLsLsmbLiLsbLgbRgbsbRibR
ibRgbRgbRgbRsbRcbRsbLibRjbLjbLiLsbRsbRsbLgbLsLsmbLsLgbsbLsbLsbLsLsmbLs
bLsbLsRsbLsLsLsLsmmmbsbsbLsbRgbRsRhRsmbRsLsbRibRgRibRgbRibRibRibRibRib
RgbsbRobRobLiLsbLibLgbLsLsmbLgbLibLcbRgbRiRsLsmbLcbLibLibLgbLiRsbRsbLs
RsLsbLgLsLsmbsbsbLsLsRsmbLsbRsRsmbLsbRsbLsbRsbLsLsLsLsmmmbsbsbsbRsRsmb
RsRsLsmbLsbLsLsLsLsLsLgmmmmbLsbLsLsmbRsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bRsbsbsbsbLsbsbRsbLsbRsLcLsmbLhbLgbLhbLhLiLsLsmbLeLsbLiLsbLsbLsLsLeLsL
smmbLsLsmbLcLsmbRsbLgbLgLsLsmbLcLsmbLsRsbLgbLibLeLsLsLsmmbLibLibLgbLeL
sbLgLsLsmbLiLsbLhLsLebLibLgLsbLgLsLeLibLiLsbRibRibRcbRgLsbLjbRgbLsRsbL
sbRjbLiRsbLhbLgbLeLsLiLsLeLeLsbLiLsbLsRcbRcbRibRibRjbRcbLibRibRibRhbRj
LsbRibRcLsbRcbLcLsmbLibLgbLcbLgbLsRcbRgbRgbRibRibLgbRobRibRgbRibRgbRib
RibRcbRcbRebRiLsbRsbReLsRebsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bLiLsbRjbLiLsbLsLsmbLsbLsbRcbReRsmbReRsmbRhbRebRsLebLebLcbRsbsbRjbRibR
cRsmbRsRsmbRcbLsbRcbRiRsmbRobsbRhbLsbLeLsbLibLiRsbLibLibLhbLgLsbLiLsbL
gbLibLgLsbLibLgLsLsmbLibLgLsbLgbLiRsLibLebLgLsbRebLjbLjLsmbLjLsLsmmbLi
LgbLiLgLsLsmbLebLhbLgbLibLiRsLsbLgbReRsmbLcbRebLcbRobRobLibRhRsmbRgbRc
bRcbRcRsmbLoLsLsmmbLhbRcRibRgbLcbLgbLibLgbLibLsbRcRibRcbLgbRibRgbRhbRc
bRiRhRsRgmbRibRiRsmbRcRsRimbRgbLjbLiLsbLgLsbRjRsmbRcbLgbLibLibLgbLgRsb
LibLgRsbLsbLgbLgbLgLsbLsLsmbLibLgbLgbLgbLgbLgbLsbLsRsbLgbLgbLsbLsbLiLs
bLgLsbLgbLgbLgbLgbLsbLgbLgbRcLsbLjbLjLsmbLhbRsbRsbRsbLsRjRsmbRgRsmbRgR
sRsRsmmmbRjRsRsmmbLsLsmbLsRsbLgLsbRibRibRiRgRsRsmmbsbLgRsbLsbLgbLiLsLs
mbsbsbRsbsbsbsbsbsbsbLsbsbsbsbRsbsbsbsbsbsbRsRsmbLsLgLsbsbRsbLsbLgRsRs
mbRsRsmbsbsbRsbsbLsRsbsbRsbRhRsRsRsmmmbRsLsLsRhRsRsRsmmmmbLibLsbRsRiRs
RsRsmmmbRsRsRsRsmmmbRebRebRsbLsbRibRcRsRsmmbRcbLsbRcbRebRobRcbLjLobLib
LiLsbsbLhRsLsbLsbLobLobLibReRsmbRobRebRobRcbRcbRebRobLgbLebLgbLibLibLi
bLgbLibLcbLibLgbLgbRobRobRgbRhRsmbRcbLibRiRsmbRibLgbLcbLibLjRsbLgbRibR
eRsmbRibRjRsmbRgLsbLibRcbLhbLebLgbLibLgbLhLsbLiLsRsbLgbLibLgLgLsbLgRsR
smbLgbLibLhbLibLgbLgbLgbLibLgRsbLibLgLsbLgbLibsbLgLsbLibLgLsbLgRsLsbLg
LsbLgRsbLgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bReLsbRibLsRsbRibRsbLsLsRsmbRgLsbRibRgbLebLcbRjbRhbRibRibRiRibLgbRhbsb
RhbRiRsmbRgLsbLgbsbRibRiRsmbRgRsRembRsRsmbRsLsbRsbLsbLsLgbLjbRcbRiRcRs
mbRgRebRgbsbRiLsLibLcLsmbReRhRsRcmbRsRgLsbRgbRcLsbRjbRiLsbRjbLgbLjbRhb
RibRiLsRsbRibRiRebLjbRibRgbsbLjbRgLsbRsbLsbLsbRsRsmbRsbRibRgbRjbRibRiR
sRsmmbLsLsmbRjbRibRgbLsbRsLsRsRsLsmbRsRsmbRsRsRsmmbRhbRgRsmbReRibRcRsm
bRhbRsbRiRsmbLcbLcbLiLebRobLhbRibLobLobRgbRgbRsbRibRsbRibLiLsbLoLsmbLi
LsbLibLoLsRsmbLobLgLsbLiLgbLsbLebRcbRjbLsRsbRjbRhbLcbRibLcbLsbLibRjbLc
LsLsmmbRjbRibRibRibLgbRibLibLcbLgbRebRgbRgbRgbRibRibRibRhbLsbRhbRgbRib
RgbLsRibRjRsmbRibRsbRjbRibRhbRgbRhbRsbRgbRibRibRibRibRgbRcbRgbRgLsbRjb
RjbRcbRibRibRgbsbLibRibRibLibRiRsmbsbRgbLibLibRoRsmbRibRiRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161328; End: 161828;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bRebRobLiRsbLeRsbLgRsbLiLsLsmbLiLsLebLhbLhRsRsRsRsmmmbRgRsmbRiRsmbRgbs
bRibRibRibRgRsmbRiLsbRgRsmbRgbRgRsRsmmbRibLcbLibLgbLiRsRsmbLgLhbLcbLib
LiLsbLibLibRhRsmbRhbRcbRgRsmbRgLsRsbLjbLoRsbLsbsbRsbsbLhbRjbRhRsRgmbRi
RsmbRgbRiLsbRgbRgbRcRsmbLgbRcbRibLeLsbLhbLibLebLebLobLibRoRsRsmmbRhRsm
bsbRibLhbLibLibLgLjbLhbLgbRjRsLimbLgbRjbRebLibsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRgbRsbLjbLjLgbLcRsbLobLibRcbRcRsmbRcbRebReRsmbLjbLebRebLjbLjLsmbRobRj
RsLjmbLoRsLsbLjRsRsmbRjbRibLgbLobLgRsbLjbRgbLjbLgbRcLsbRobRibRibLgbLob
LiRsbLgbLibRjbRjRjRsRsmmbRibLsRebRebReRsmbRjbLjbLebLebRiRgRsRsmmbRhRsR
smmbRsbRhRgRsmbRibRsbRjRibsbsbsbLjbRcRsmbsbsbRhbRsbRgLsbRjbReRsmbLgbLi
bRjbRjbRibLjbLcRsbLgRgbLibLjRsbRjbLibRhbLhbRsbRjbLjbRsRcbLsbRcbRcbLebR
cRsmbRsbRiRsmbRiRsmbRsRibsbsbsbsbsbRsLsbLsbRsbLsLsmbLsbRsbLsLsmbLsRjbs
bLsbsbLsLsLsmmbRsRsmbLsLsmbsbsbLsbLsbLsbsbsbRjbRcRsmbLcbLsLgbRsLsbRjbL
sLibRgbRsbsbLgbRcbRgbLjbLsbRibRiRsRsmmbRhbLsbLibLoRsbLibLcbLcLsLsLcmmb
LhbLibLjbLibLjRsbRjbsbLjLsmbRjbRsbLgbRcbLjbRiRsmbRiLsRsbLjbLgbRsbLgbRi
bLjRsRsmbRjbLiRsbRjbLjLgbRgbRibRiLsbsbsbLebRcbsbRcRsRsRsmmmbLgbRiRsmbR
obRsRsRsmmbRibLjbRsRgbRibRsbLjbLibLsbLibLgLsLebRgbLsLgbLibRgbRcLsbRgbR
eRsmbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRibsbLjbLcLsmbLgRsbLsbLsbLsLsLgLsRgmbRsLsbRsbLsbsbLsbRsbRsLsbLgLsRsbR
cbRhbLcbLibLibRsRsmbRcbRcRsmbRiRsRsLsmmbLoLsmbLiLiRsLsbRsRsRsmmbLsRsbL
sbLobRibRcbLebLcLsmbRsbRcLsbRobRhRsmbRcbLgbLjbLcbLibRobRcbRibLsRsLsLsm
bRsbLcLsmbLibLhbLhLsbLobLobLiRsLsbRgbLsbLsbLsbLgLsbsbLsbLsbsbsbLsRsbLs
bsbRsbRsbRsbRsbsbLgbLibRsbRsbLsLsmbLcbLhbsbLcbLibLcbLibLsbRibRobRcRebL
gbLsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bsbRgbRsLsbRsRsRsRsmmmbRsLsbLcbLibLsLiLgLsbLcLsLsLsmmmbLsbLcbLsLsLsLsm
mmbLibLobRiRgRsmbRebLebLgbRjbLcbLgbsbRibLiLsbLibRsbLibRsRsRgRsRsmmmbLs
bsbRibLgbRsbLjbLsLsLsLsLgLsLgLsLsLsLsLsLsLsLsmmmmmmmmmmbLibRibRsLsbLhb
LibLhLsbLibLiLgbLobRsbRsRsmbRibLgbLsRsRsmbRsbRsbRsbLsbLsbRsbLsbLsbRsbR
ebRebsbRebRebsbRsbsbsbsbLsbsbsbsbsbsbsbLsLsRsmbLsbRsbLsLsmbRsbLsbLsRsb
sbLhLcLsmbsbLsbRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRsbRsbRgbsbRsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bsbsbLibRiLsLgbRcbLcLsmbRebRibLcLsmbRsbLeLsbLhbLgLsLgLsLsmbRjbRhbLsRib
RsbLjbRcRsmbLibLsbRsbLsbLsbsbsbRsbLsLsmbsbLsbRgbRgRgRsmbRgbsbRcbLsRsLc
bLgbLsLgLsLsLsRsmmbRjbLebLebLgbLobRebLsbRebLsbReRsRsmmbReRsRsmmbLsbRhR
sRembRsbsbLibRibLcRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bsbsbsbRsbsbRgRiRsmbRgRsRsRsmmmbLsbRibLjbRsbRgRsmbRgRgRiReRsRgRsmmbRib
RiRsRsmmbRsRgRsmbRgbRiRgRebRjRiRsRsmmbLsRgbLsbRsbRcbRibLobLcbRibRebRsR
sLgmbsbRsbRsbsbRsbLsbRibRcbRibRibLsbLsLsLembLeRsLsbRgbsbsbRiRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLsbLsLgLsLsmbRjRsmbRhRgRsRsRsRsLsmmmmbRhLsbRebRgRsLsmbRjbRiLsLsmbRhbR
gRsmbRsbRsbRcLsbRibLgLsbLeLeLsbLibLibLiRsLsbRsRsmbLsbLgRsbRgbLibLsbLiL
sbLoLsmbRsRsmbLsbRsRsmbRsRsRsRsRsRhRsRsRsRsRsmmmmmmmmmbRgbLsRibLjbLeLs
LsmbLcLgbLibLsLsLgLsmbLgLsbsbsbRjbsbsbRjbRsbsbLsRsbsbRgbRsRsRsRsRsRsRs
RiRhmmmmmmbRsRsmbLgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bRcbRgbRhbLobLgLsLiLgLsbLsRsLeLsLebRoLsbRcbRibRibRebRebRebRobLoLsmbLgL
sbLiLsLsmbLgbLcLsmbRsbLobLibLiLsLgbLgbsbLiLsbRhbRoRebRibLgLsbRjbRibReb
ReRebRhbRibReLsbRiLsbRhbRgbRobLhbLibLsbLiLsbsbLcbLibLgbRjbRhbRsbRhbRsb
LsbRobLsbRsbLibLcbLgbLibRjbsbLsbsbLsbRgbRjbsbsbsbsbsbRgbLcLsmbLebLcLsm
bRebRiLsbRoLsbLgbRobLcbLibLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLcbLhbRcbRcbReRsRimbRcbLsLsmbLiLsbRcRsmbRibRhRsmbLcLsLsLsmmmbLobLsbLh
bRcRcbRcLsbRibRcbRebRcbRiRsmbRsbLjbRsbLibLgLsbLibRiRsmbRhbRcbRebRebRhL
sRsbRiReLsLsLimbLcLsLsmmbLobLobLiLsbLsbLobLcLhLsbLhbRsbRebRebRcbRiRsmb
RsbRibsbRsbRiLsbLibRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRgbRgbLgbRsbRgbRgbRcbRgbRsbRsbRgbRgLsbRgbRibRgbRgbRgbRsbRsbRsbRsbRsbR
gbRsbRsbRsbRsbRsbRsbRsbRsbRgbRgbRgbRsbRsbRsbRgbRgbRgbRsbRsbRsbLhbLebRs
bRsbRjbLgbRebLiLgLsLsmbRsbRsLsbRsbRgRsRsRsLsLsRsRsRgRsmmmmmmbLsbRsbLsb
RsbRsbLsbRgbRjbLsbLsbRsbRgbLgbRsbRsbRebRcLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRibRgRsmbsbRgRsmbRgRgRsRgmbRgRgbRgRgRsmbRgRsRgRsmmbRsRgbRibRsLsbLgbRg
bRgbRsbRibRgbRsbRgbLobRgbRsbRsbRgRsmbRsRsmbRgbRibRsRsmbRcbLobLobReRsRs
mmbRsbLgbLsbLgbLsbLgbLobLsbRgbRsbRgbRgbRhbLcbLebRibRsbLsbsbRgbRsRgbLcR
sRcRsmbRebLobRgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLgbRsLsbLgbRebRgbRibRiLsbRibRibRsRgbLsLsmbRhbLsbLcbLiLsbLibLgbLgbLgbL
iLsbLibLhRsbLgLsLsmbLgLsbLibLgbLgLsbsbRgRsLsRsmbLhbLsLsmbLiLsbLiLsLsmb
LgbLgbLgbLsbLgLeLsbLsLsLsLsLsLimmmmbLsbRsbLsLgbLiLsbLibLebsbLgbLsLsRsL
sLsmmbLibRjbLcLsmbRibRcLsRsbRibRibRgbRgLsbRibLgLgbLhbRhbRsLsLsmbRobRjb
LsbLhLsbLgbLgbLsLsLsmmbLiLsbLiLsbLsLiLsbLsLiLsbsbRsRsmbRsRsmbsbRsRsmbL
sbRsLsbLsbRsbLsbsbRsbLsLsLgLsLsLiLsmmbLeLsbLibRobLsbLsRsbRsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLsLgRsbLjbRhLsbLjRsRsmbRibRebRibLgbLiRsbRjbLcbLiRsbLiLsbRhbLsbRoRsmbL
jbRibLjbRgbLhbRibLcbLiRsbRebLjbLjbRebLjbRibsbsbRjLsbLjLsmbLjbRiRsRsmmb
RibRibLsRcbLibLsbRsRsmbRgLsbRiRsRsRsmmmbRiRsLsmbRjRsmbLibLibLgbLibLgbL
cbLiLgLsbLgbLsLsmbLgbLgRsbLibLcLsmbLiLsbsbLiRsbLiLsbLgbLgbLibRibRhbRgb
LiLsLsmbRobRhbRhRgLsbLobLgLsLsRsmbLjRsbRgbLgbLsbsbLsLsRsmbLjRsRsRsmmbL
sLibRcbLhbLiLsLsmbLcbRcbRcbLjbLcRsbLiLsLsmbLiLsLsRsmbLibLjLsmbLgLsRsLs
bLgRsbRibRiRsmbRsbLebLiLsbLibLiLsbLcLsmbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRgbLeLsLsLsmmbLgbRibLiLsbLiLsbLsbLgbRgbRjbRjRsmbLsbLjbRcbRsbRibRibLsb
RgbRiRsmbRgRsmbRgbRiLsbRsbsbRgbLjbLgbLjLsmbRsRhbRgbRiRsmbLhLibLebLibLi
bLebRjbsbLhbLgbLhbLibLgbLsbLibLhbLiLsRsbLibLgbLgbLibLibLhbLgLsbLgbRjbR
hbRgbLgbLjbRibRibRhbRiRsmbRibLjbRhbRgbRibLjbRibLgRsbRjbsbLjbRcbRiRsmbR
gbsbRibRcRsmbRgbRgbRsbLebLjbLibRsRgRsmbLsbLgbLgRsbRcRgbLsbLsbLgLsRsLsL
smbRjbRiRsmbRhbRibLjbLebsbLgbLibLjLsmbRibRjbRibLebRsRobLsbRibRiRsRsmmb
RebRiRsmbLjLjbLebLiLsbLibLibLibLiLsLiRsLsbLgLsLsmbLgRsbLibLeLsbLiLibLi
bLgbLsbLgRsRsmbLgLsbLiLsbLgbRjbRcRsmbRibRiRsmbRiRsmbLgbLgbLsbLiLsbLiLs
bLgbLibLibLgbLiLibLibLibLgbLgbLebLebRjbLgbsbsbLjbLgLsLsLsmmbLhbLgbLgbL
ebLebLcbLcbLcLsmbLibLcbLcbLoLsLimbLcbLsbLibLobRgRsmbLjbLsRsbLgbLibLgbL
gbLibLibLcLcbLiLsbRgbLgbLibLgbLiLsbLebLgLsbLgbLgRsbRhbRibLsbRibRebRibL
ibLibLibLibLgbRgbRibRgRsmbRcbRebRgLsbLcbRhbLjbLjbRjbLjbLibLhbLibLibLib
RjbLjbLibLgbLibLsbRjbRsbLiLsbLsRsbLiLsRsbLsbRjbLjbLjRsbLsbLjbRgbRjbRiR
smbLjbLibLgbLgbRsbLibRsbLcbLgRsbsbsbLgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLsLibLgbRsbLeLsbLgRebRoLsRsLsbLibLsbLsbLgLsLsLsmmbLgbLsbLiLsLgLsLsmbL
sbLebLsLgbLgLsLsmbLgbLgbLsbLeRsLsbRsbLibRjbLsLsLsmmbRebLgbsbLsLebsbRsb
LibLsbLsLgLsRsbReLsbLgbRgbRsbLgbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bReLsbRobsbRcRsmbRsbRiRsRsmmbRcRsRsmmbLsRsRsRsmmbsbRhRsmbRgRsRgRsRsRsR
sRgRgRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRcRsmbLsRsbRgRsRsRsRgRs
mmmmbRsbRsRgRsRsRgRsRsmmmmbRcRsRsmmbRsRsRsRsRsRsmmmmmbRsRsmbRebLsRsRsR
sRsmmmbLsRsRgRsmbRsRsRsRsRsmmmmbRiRsmbRiRsmbReRsmbRsRsRsRsmmmbRgRsRsRs
RsRsRsRsRsRsRsRgmmmmmmmmmmbRcRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRgRsRsRsRgRg
RgRgmmmmbRsbRhbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbL
sRibRsRsRgRsRsRsRsRsRsRsRsmmmmmmmmmbRhRsRsmmbRsRsRgRgRsRsmmmbRhRsmbRcR
sRsmmbRsRsRsmmbsbLsRsLsbsbRhRsRsRsRgRsRsRsRsRsmmmmmmmmbRcRsmbRsRsmbLsR
sRsRsRsmmmbReRsRgRsmmbRhRsmbRsRsRsRsRsRsRsRsRgRsRsRsRgRsmmmmmmmmmmmbRc
LsRsbRibRcbRsRsRsmmbRcRsRsRsRsmmmmbLsRsRgRibRhRsRsmmbLoLsmbRcbRsRsRgRs
RsRsRsRgRsRgmmmmmmbRiRsmbRiRsRsRsRgRsmmmmbLcbLsLsRsmbRcbRgRsRgRsmmbRsR
sRsRsRsRgRgRgmmmmbRgRgRsRsmmbRhbRcbRsbsbLcRsbRcRsmbRoRsRsmmbRcRiLsRsbL
ibRcbRsbLsRsRsRsRsRsRsRsRsRgRsmmmmmmmmbRgRsRsRgRsRsRgRsRsRgmmmmmmbRgRs
mbRibLcbReRsRsRsRsRsRsRgmmmmmmbRsbRhRsmbRsRsRgRsRsRsRgRsRsRgRsRsRsRsRs
RsRsRgmmmmmmmmmmmmmbRgLsRsbRsRsRsmmbRsRgbRsRsRsRsRgRsRsRsRsRgmmmmmmmbR
sLobRsRsRsRsRsRsRgRgRgLsRgRgmmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRsRsmbRgRsLsLsmmbsbsbsbRsRsLgmbLsbsbLjbLsbLcbLjbLgLsLsmbLibLhbLibRibL
obLibLhbsbsbLsbLsbLsLsmbLsbRsLsLsmbRgLsLsLsmmbLgbLeLsbLeRsbLhbLgbLsbLe
bLiLebLebLcbLeLsLsLimbRcRsRimbsbRsbLsbRsRgbRhRsRsmmbRjLsbLsbRsRsRsRsmm
mbRsRsLsmbRgbRsRsRsRsRsLsmmmmbRsRsRsRsmmmbRsRsLsRsmbRsbLsLsRsRsmmbRsLs
RsRsRsRsmmmbsbsbRsRsRsmmbRsbRsRsRsmmbRsLsbRsRsRsRsRsmmmmbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bLjbLsbLgbsbRsbRsRsRsRsmmmbRsbsbRsLsbRsRsmbRgbLsRsRsRsRsmmmbRsbsbRsRsm
bLsbLsbRebRobLsLcbRhbLhbLibLibLobLobRebRsLsRsRsmbRsRsmbRjbRgRsmbRcbReb
RsRsmbRcbRhbLcbLsbRsRibRgLsLsmbRjRhRsRsmmbRgRsRsmmbRebRsRsmbRsbRhbRsbR
iRsLsmbRsRgRsRsLsRsRsRsRsRsRsRsmmmmmmmmbRsbRjRsRsmmbRsRsRsRgRsRgRgmmmb
RhRsmbLcbLiLsRsbRsbLcRsbRcRsmbRgbRsbRsbLsRsRsRsmmbRsbRsbRsRiRsmbRsRgbR
iRsRsRgRsmmmbLjbRiRsmbRgbRsbRibRgRgRsRsRsRsRsRsmmmmmmbsbRsRsmbRsbRsRsm
bLjbLoLsmbLgbLcbRsbRhRsRsRsmmmbRsRsRsmmbRgLsRsbRiRsmbRebRhLsbRsbRibRsR
sRsRsRsRsmmmmmbLjRsbRibRcRsmbRibRjbRiRsRsRcmmbLhbLhLibRsLsbRsbLsbRsbRg
bsbRsbRsbRsRsmbRsbRsRebRcRsRsmmbLoLgRsbLibLgLsbRcbRcRsmbRgLsRsRsRsRsRs
RsRsRsRsRsRsRsRgmmmmmmmmmmmbLsLsRsRsRsRsRsRsLsmmmmmmbRsRsRsRsmmmbsbLsb
RgbsbLsRgReRsRgmbRebsbRiRsRsRgRgRsmmmbRsbRgbRgLsbLsRsRsRsRgLsmmbRsbRsb
RsbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRgbRiRsRsmmbRsRsmbRsLsRgbRibRgbRgbRgb
RebRibRiRsRsRsmmmbRebReRsmbRebLsLiLsbLibRjbRgRgRsmbRsbLsRsRgRsLsmbRhbR
sRsRgRgRsmmbLsRsRsmbRgRsRsRsRsmmmmbRsbRsRjRgRsmbRsbRsRsRsRsRsmmmmbRsbR
sRsmbRsbRsRgbRsbRsRsRembLibLsbRibRsLsRsbsbsbLcbLiRsbLsbLsbLsLsmbRsbLjb
RsRsRsRsRiRsmmmmbLsLsLsLsLsRsLsLgmmmmbRsRsRsRsmmmbsbLsbLsbRsLsbLsbLsRs
bRsbRsbRsRsmbRsbLsbsbRsbRsbsbRsbRjbRsbRgbRsbLsbLsbReRsmbLcbLibLcbLjLsm
bLcRsbRibRebLsbRsLiLsbLgRgRsmbRsbRiRsmbRsbRsbRsRsmbLsRsRsmbRsRiRsmbRsb
RgRsmbsbRsbRebRsRsRsRsmmmbRsRsmbRsbRsbRsRsRsRsRsmmmmbRsLhbRiRsmbRsRgbR
sbRiRsRsmmbRiRsmbRiRgRiRsRsRsRsRsmmmmmbRgRhRsmbRsRsRgRgmbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bLsbRsbLgLsbRsbLsbLjLsLsLsLgLsLsmmmmbLiLsLsLsLsLsmmmmbLiLsbRsLsLsLsLsm
mmbRsLsbLgLsLsmbLhLgLsbLsLsLsLgmmbRsbRsbLgbLgbLsLsmbLsLsmbRsbRsbLsbsbs
bsbLsbLsbLsbLsbLsbLgbLebLebLiLsLsmbLiLsLsLgLiLsmbLgLsbLgbLsbLsbRsbLsbL
sbLsRsbLsbLsLsLsLgLsmmbLgLsbLsbLsbLibLsbLeLsLibRsbRsbRsbRsbLhLsLsmbLsL
sLsLsLsLimmmmbLgLsLsmbsbLsLsLsLsLsmmmmbLgbRsbLsbLsRsbLsbLgbsbLsRsbLsbL
sLsmbLsbLsLsmbRsbLsbLgLsLgLsLsLsRsmmbLsbLebsbLsbLsbLsbLgbLgLsLsmbLebLe
bLgbLsbRsbLsbsbLsbLsbLsLsmbLebLiLgbLgbLgbLgbLsbLsbLibLgbLibLgbLgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bRcbRiRsRgRsRsRsRiRgRsmmmmmbRgRsRsmmbRgRsLsmbRibRsbRsRgRgbRhbRgbRgRsmb
RsbsbLsbLsLiLebLgbLgbLibLgbLsLsmbLgLsLsLgLiLgLgmbLibLiLsbLsbRsbLibLsbL
sLsLsLsmmmbLsLsmbLibLsbRcRsRsmmbRibRcRsRsRsRsRsRimmmmmbRibLsbRgRsRsRsR
gmmmbLsRgRsRsmmbRgRhRibLgbLsLsLsLsLsLsLgmmmmmbLsLgLibLgbLsLsmbLsLebLsb
LsbRibRsbRcbRsRsRsRgRgRsRimmmbRsRsRsRgRsRsRsRsRgRsRsRgRsRsmmmmmmmmmmbR
sRgRgRgRgbRsRsRsRsRiRsRgmmmmbLsbRgbRsbLgbLeRsbLsbLsLsLsLsLgLiLsLiLsmmm
bLsLsLeLgmbLsbLsLsmbLsLsLsLemmbLgbLsLeLsLsmbLsbLsbsbLsbLsLsLgmbLgLsLiL
gbLeLsLgbLgbLgLsLgbRsLsLsLsLsmmmbLsbLsbLibsbsbLcbLsbsbLgbLeLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bRsRebRsbRsbRgbRebsbsbRsRebRibRebRebRhbLsbRgbRjbRsbRhRsLsmbRsbLsRsRgbs
bRebRsRebLsbRibRebRsbsbRibsbRsbsbsbsbLsLsmbsbsbsbsbRsbRsbLsbLgRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bLsbLibLobLebLibLibLeLsbLgLhLsbLcbLebsbsbLgbRgbRibRibRsbLsbLibLgbLgbLg
bLgbLgbLsbLsbLsLsmbLgbLebLgbLsbLsbLsbsbLsbsbLsbLsbLsbsbLsbLsbLsbLsbRsb
RsbLgbLgbLsbLgbRsbLibLsbLsbRgbLsbLsbLgbLsbLsbLgbsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bLhbLgLsbLsLsmbRsbLebLebLsbLgbRsLsbLsLsmbLgbRsbRsbLgbLsbLhbLsbLgbLgLsb
LebLibLgLgLgLsLsLembLibRebRibRsbRgRsmbRibLsLsmbLsLgbLjbLeLsbRsRsRsmmbR
sbLhLsLsmbLgbRsbLsRsbLsLsmbLsLsLsmmbLsbLebLhbLgbRiRsLsRsmbRhbLsbRsbLsb
LsbLsbRsRjbRcbReRsmbLebReRsmbRibRsbLjbLebLgbLgbLibsbRibRhbRebRibRibRib
RibLibLibLcbLgbRcbRibRsRsmbRcbLjbLebLgLgbLebLeLsbLgbRibLebLibLgLsbRsLs
LsmbRjLhbRhbLsbLgLsbLibRsbLhbLsbLebLgbLsbLjbLgLsbLgbsbRjbLsbLebLsLsmbL
ibLsbRsbRsbLgLebLsbRsbLgbLebLibLsbRcbRobRcbLibLebRebLsbRsbRsbRgbRgbRsb
RgbRsbLebLgbRibRsbLibRgbLsbLsbLibLibRsbsbLibLhb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bLiRsRsRsRcmmbRiRsmbRgbRsLsbRgRsRsRsRsRsRsmmmmmmbRsRsLombLibsbRibLhbLi
bLgbLcLsmbLgbRibLobLgLsbLsbLcbLibLgLcbLhbLsLibLhbRsbRsRjbRcbRgbRgRsRsR
sRsmmmmbRsbRgbRjbLibLiLsbLgbRhbRibRibLgbsbLgLsbLgbLgbLgbLgRsbLsbRibReb
LgbRibRibRgbRgbRibLgLsbRsbRhbRsRsRsmmbRibRgbRibRibRgLsbRgRsmbLjbLeLgbL
iLsbLiLsLsLsLsLsRsRsmmmmmbRsRgRsmbRoLsbLibRiRsmbsbLsLsLsRsLsmmbRsLsRsb
RsRsRsRsmmmbRsbRsRsRsmmbRgbLhbLcLsmbLgbLgbLsLsLsmmbLsLsmbLsLsLsLsLgLsL
sLsLsLsmmmmmmmbLiLsbLhLsbLgbLhbLjbLebLibLibLcbRibLhbRebRgbLsbsbRibsbRs
bRsbRsbRsRsRsmmbRsbRsRsmbRsRsmbsbRsbRibRiRsmbRcbRgbRebRcbRgbRgRsRsmmbR
sbLsbLsbRgbRgbLsbLsbLgLsbRsLsbReLsbLgLsRsbLiLsbRsbRsbRsRsRsmmbRsbRsRsm
bRsRsRsRsRsmmmmbRsRsmbRsRsRsRsmmmbLsbLcbLibLsLsmbLgLsRsRsRsmmbRibRgbRs
bLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bsbsbLjLsmbRhbRjRibLhRgbRcbRsLjbRcbRsbRibRjbLjbLgLgbRibRcbLebRcRsRsRsm
mmbRgbRibRiRsmbRcbRjRgbReRsmbRgRsRsRsRsRsmmmmmbsbsbsbRhbsbsbRibLjLcbRe
bRjbLcbLcLsmbLoRsLsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLgbLgbLsLsmbLsLsmbLsbLsLsLgLgLembLhbLibLcLsmbLsbLiLsbLibLsbLibLibLgbR
sbRibRgbLgbLibRjbRibRsbRsLsbRcbsbLsbLsRibsbRcbLsRsbsbLgLsLgLiLebLibLhb
RcRsmbLhbLgbLgbLsbLsLsLsLsLsLsLimmmmmbLgLsLsmbLgbLsbLgbRjbRjbRiRsmbLjb
LcbLsLsmbLgLsLsRsmbLeLsbLsLsmbLebLcLsmbRcbsbsbRsbsbRsbLsbsbLsbLsRsLsbL
sLsmbLsRsRsmbLsbsbLjbsbRsbRsbRsLsbLsLsmbLsLsmbLsbRsbRsbLsbRsbRsbLiLsbR
sbsbLsbsbRsbLibLebsbLsbLsbLsbLsLsLsLemmbLeRsbLibLibLgbRcbRibRibRhbRibL
gbRibRgRsmbRiRgbRgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRsbLobRcRsmbLcbRcbLoRsbLsbLsbLobLjbLcRsbLgRsbLcbRobRcbRsbLsbRsRibRgbR
ebRsRsmbRgRsRsmmbLsRsbLjbLibLhbLcLcbLcbRsLcbLsbsbLiRsRsRsmmbsbRsbRsbRs
bsbsbLsbLsbLsbsbLjbRsRsRsRsmmmbRcbRjRsmbRiRsmbRsbLobRiRsRsRsmmmbLgbRgb
sbRiRsRsRsRsRsRsRsmmmmmmmbRsRsRsRgmmbRebRebLsRsRsmbRsbRsbLsRsRgRsRsRsm
mmbRiRsmbLjbRsbLgbLibLsbRsbRsbRsbRsRsmbRgbLobLsbLibsbLsbsbLsbsbLgbLgbL
sRsbLsbLsbLsRsbsbLsbRsbLsbsbLsbsbRsRebRgbRsbLcbRgRsmbReRsmbRgbRiRsRsmm
bLsRsRsmbRgRsRsmmbLsRsRsRsRsmmmbRhbLjbRibRsbRsRsRsmmbRsRsmbRsbRsRsmbRs
RsmbRsRsmbRsRsmbLiRsbRibRgbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLcLgLgLsLsLgLsLsmmbLeRsLsbLcLgbLhLsbLoLsLsmmbLhLsbRsbLcLsLsmmbLgLsLsL
sLgLgLgLsLeLsmmbLsLsLsLsLsLsLsLiLsmmmmmmbLhLsbRibRiRsmbRhLsbLoLsLsmmbL
cbLsLsLsmmbLiLgLhbLibLgbLibRebRsLsbRhLsbLcbRhbRobsbLcLhbLiLsLsLsLsmmmb
RsLsLsLsmmbLcLsLgLsmbLibLibLiLsbLcLsmbLsbLcLsLsmmbLcbLibLjLhLsLiLgLsbL
ebLiLsbsbsbsbLiLsbLiLgLsLsLsLsLgLsLsmmmmbLiLgLsbLebRcbLcbLeLsLsmbLobLs
LhbLeLgLsLsRgmbRebLjbLoLsmbLhbsbLcLsmbLiLsLsLgLsLsmmbLiLsbLsbLiLgLibLc
LsmbLeLsbLhLgbLobLcbsbLsLcLibLoLeLsbRcRsmbRiLsbLcLsLsmmbLsLgLgLgLgLgbL
ebLjLobLibLsbLoLsmbsbLebLeLsLsmbsbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLcLsmbRobLsbRobRsbRsRsRsmmbRcbLebLhbRcRsmbRiRsRsRsmmmbRobLgRsLsbRobRo
RibRcbLsbRsRsmbLsLsmbRgRsRsmmbLsRsLsLsmbRcbRgRsRhRsmmbLobLebLoLsmbRgbL
cLsmbLgbRjbLjLsmbLsLiLsbLsRsRsRgmbsbsbLebLibsbRobRsbRiLsbRgbRgbRiRgRsm
bRsbsbRibLibRcRsRgRimbRebRibRcbRobsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bLiLsbRoLsbReRsmbRibLcbLgRsbLsbRsbsbLsLsmbRgbRcbRsbLcbLsLsmbRsbRsbRsbL
sbsbsbsbLsbRsbRsbsbLjbRiLsbLcbRcbLcbLsbRsbRsbRiRsmbRsbRgbRibRcRsmbLcbR
gbLsbRsbLgbRsbRsbLgbRsbLiLsbLibLibsbRcRsmbRcbRcbRgbRgbLgbLiRsbRibRibRg
bRgbRgbLsbRsbRsbLsbLibsbRibRhbLibLgbLibLgbRsbLobLebsbLgLibLsbLibRjbRib
RcbRjReRsmbRsLsbRebRhbRgRsmbRebRibRibRgbRebLgbLibRibReLsbRcbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRgRibRiRibRibRgbRcbRcbsbRsLsbRsbsbsbRsbsbLsbsbLsbsbRsbRsbsbLcbLcbRobR
cRsRgmbRebRgbRibLcbLibLgRsbLhbRobRsbRebLobLgbLibLibLobLcbLibLsbRcbRibR
obRgbLebRoLsbRsbRsRhRibReRsmbRgbRibRibRibLcbLgbLobRgbLsbRgbRsbLcbLibLi
bLhLsbRcbRcRgbsbRjbLibLibRsLiLsLsRsmbLiLsbLgRsbLgbRcbsbLibLibLibRsbLiL
sbRebRiRsmbRibLebLibLhbLibLebLebLibLhbLcRsbLibLsbRebReLsbRgbRsRsRsmmbR
ebLjRsbLibRjRsmbLjbLhbLeLeLsLgbLibLibLsbLobRebRoLsbRcRsmbRgbRgbRiRgRib
RsRgbRsbRebLjbLibLgbLsRsbRsRsLsLsRsmmbRhRsRsmmbLjbLhLsbLebLiLsLsmbRjbL
hbLhbLibLibRgbsbRsbLsLsmbsbRsbsbsbRsLsbLsRsbLsbsbLsbRsbRsbRsbsbsbsbsbs
bRsbLsLsmbLcbRsbRsbLsbRsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
b

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRibLeLsbLgbRcRsmbRgbRsRgLsbLcLsmbLcbRcbRgRsRsmmbRgRsLsRsmbRiLsbLcbLcb
LoLsmbLcLsLimbsbRsRsmbRobLcRsbLcbRsRebRiRsmbRsbRsRsmbRibLoLebLibRcbRib
RhbRcbLcLsmbLibLcLsmbLobRebLibLeLsbLibLhLsbLgbLobRebLcbLhbRgbRebRibRcb
RobRcLsbRcbRebRebsbsbLebRsbRsbLibRsRsmbRsbRsbRibLcLsLsmmbLoLsmbRibLebL
cbRcbRcLsbLgbLcbLsLsLsmmbRjbRjRsmbsbRiRgRgbsbRgLsbRiRsmbRgbRhbRjRsLsmb
RibRgbRcRsmbLgbRgRsRsRsmmmbRsRsmbRibLsRsbRcbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRiLsbRgbRjbsbsbsbRcbRcRgbRhLsbLgbRhbRiRsmbRibRoRsmbRgbRcRsmbLjbRobRgb
RibLcLsmbLcLsmbsbRgbLibLsLsmbLsLebLcbLcLsmbRobRcbRibRibLgLsbRibRgbLgLg
bLsLsmbRsRsmbLsRsbLsbRsbRsbsbLsbLsLsmbRsbRsbRsbsbRibRsRcbRcbLgbLcLgbLs
bLsLsLembRebRgbsbRobRgbRobLebLcbRcbRhbRiLsbRoRsmbLsbLgbRjbRgRsmbRibLsb
sbsbRsRsLsLsLsLsmmmmbLsbRebLcLsmbLgLsLibLgLeLsbRsLsLhLsLsLiRsmbRjbsbLs
bRcbLcbRobReRsRsmmbRgbsbRsbRobLibLhbLcbLebLebLebLcbRoRhbRsbLibLgbRoLsb
LhbLcbLcbLibLcbLsbLibLcbRgbRjbRhRsmbRobLcbLoLsmbRibLoLsmbLcbLibLobRsbR
jbRsRibsbRibRibRhbRiLsLsLsmmbLgbRibRhbRhbRcbLeLsbRibRsbRhbRibRgbLsbsbR
cbsbLsLsmbLjbLsLgbRjbRcbLsbsbRiLsLsRsLsRsmbRibLobLibRsbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bRjbLebRobRgbRobLgbLgbLgbLobRebRsbRsbRsbLsbRsbRsbRsbRebRsbReRsmbRgbRsb
Rgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bRsbRibRsbRgbRgbRibRsbRibRgbRjLsbLjbLsRsbRgbLgbLjbLiRsbLjbLibRjbLiLsLs
LsLsLgmmmbLgLsbRsbLeRebRibLibLcbLjRsbRibLiRsbRgbLhbLgbRhbRgRsmbRgbRgbR
gbRgbRsbLgbLjbLibLgbLgbLibRibLjRsbLiRsbLgbLcbLibRgbLibLibRgbRgRsmbRhbR
gbReRsmbRgbRebRebReRsmbRgbLsbRibLjbRsLebRjRsmbLcbLjRsbLibRobLjbRgbRiRg
RsmbLsRsRsmbLjbRhbLsbRgbLjbLhbLgLsbLibRgbLiLgbRgbLibLibLcLsmbLgbLibLib
RsbLhbRgbLibLgbLjbRjRsmbLgLsLsmbRjbLjbRgRsmbRgbLgbRsbLsbLibRgbRibRsLcL
smbRcbRibLcRsbRsbLjbRibRibLibLsbLsLsLsLgLsLsmmmbsbsbRgbLjbRebRhbLcbLsL
smbLsLsmbRibLjbLjbRjbLjbRgbLgLhLsLsmbLsLebLgbLhbLgLsbLebLjbRjbRgbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bLebLebRsLsLsLsLsmmmbLsbLsLsmbLsbLsLsLsmmbLhLsLiLhbLsbRsLsLsmbLgLsLsLs
LemmbLsbLeLsLsmbLibsbLgbLsLcbRcbLjbLsbLebLgbLibLibRcbRibRhbRgbLjbLgbLi
bLgbLobsbLgbLsbLeLgLsbLgbLgbLgbRebLgbLsbsbLgLsbRgLsbRebRgbRiRsmbRcbRib
LibLibLgbRsbRcRsmbRgbRobLibLhbLcbLiLsbLiLgbLibLgLsbLsbRjbRcRsmbRgbRcbR
ebLcbLibLiRsbLsbLibLgbLgRsRsRsmmbLgbLsbLgbLgbRobRgbRcRsmbRibRcbRcbRiRs
mbLsbLjLcbLgRsbLsLibLjLgbRebRhbRsbLjbLsbRsLsbsbsbLeLsbLibRibLgbRsbRoRs
mbRcbRcRibRhbRgbRsRsRsmmbRgbLsRsbLeLsbRsRsmbRsbRibLsbLsbsbLjbRibRgLsRs
bRsRsRsmmbRsbLsbLebLeLsbRgRsmbRsRsmbRibRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bLsLsLsLemmbLsbLsbsbRsbLsbsbLsbRsbsbRsbLsbLibsbRcbRsRsRsRsRsRsRsmmmmmm
bRsRsRsmmbsbRsRsRsRsRiRsRsReRimmmmmbRoRsmbRsbRsRsmbRgRsRsmmbLsLjbLcbLs
LsLimbLgbLgLsbLcbLiLsbsbRgbLibLgbLsLsLsmmbLsLsmbLsbRsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bRhRsLsmbsbRcbLsRsbRsLsbRcbRgLsbRjLsbReRsRsmmbLsbLibRsbLobRjbRcbRgRsmb
RibRgbLhbRsbLjLgLsbLgLsbLjLsmbLcLsLsmmbLiRsbLhbLibRebRhbRibLgbLhbLgbLi
bLiRsLgbRjbRgbRhbLcbLeLsbLgLsbLhRsbRcRsmbRoRgbRibLeLsbLibLiRsbLsbLhLsb
LjLiLsbLibLibLgbLibLiLsRsbsbsbLsRsbLiRjbLibRjLsbRcRsmbRibRsbLgbLcLiLeb
LiRsbLgbLjbLhbLjRsbRsRgRsmbRsbRsLsRsbRsbLsbLsbLcLibRebRiRsReReRsmmbReR
ibRgRsRimbRsbLjbLgbLsbRjRsLsRsRsRsRsRemmmmbRgbsbsbsbRibLgRgRsRsRemmbRc
bReRgRsmbLcbLcLsmbLibRibRcRsmbReRsmbRiRsRsmmbLgbsbLiLsLgbLjLgbRiRsLsmb
LjLsLsLsmmmbsbLibLgLiLsLsmbLgbLcRsbLgRsbRcRsmbRibLcbLjRsbLgLsLsLsmmbLs
LgRgLsRsbLgbsbsbLjbRgRsmbLibsbsbRjbRcRsRsmmbLjbLsLebLgRsRsRgmbLibRhbRe
RsmbRibRhbRibLjbLhbRjbLjbRgbLibsbsbRsbsbLsbsbsbLgRsbRjbLibsbRcRsmbRsLs
bsbRsbsbLsbRsbsbLsbLcbLgRsbLjRsbLgRsbLibLgRsbRcbLibsbsbsbLsbLjbLsbRcbR
ebsbLjbsbLiRsRgbLibLgbLibLibRsRsRsRimmbsbLibLsLsmbLsbLgLsbRsbRgbLgbsbL
ebLibLiLsbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bRsbRcbLjLsLsmmbLsbRjbRiLsbRiLsLsmbLcbLjLgLsLsLsLsLsmmmmbLebLsLgLgLsLg
LgLgLsLsLgLsLgLsLgLsLsLimmbLgbLsLgLsLsLgLsmbLsLsRsLsLsLsLsmmmmbLsLgbRo
bRsRsRsLsLsRsmmmbLgLgLgbLsLsLsLsLsmmmmbLiLgLgLebLhRsbRsLsLsLsLsLsLsLsL
sLsmmmmmmmmbLgbLeLsbRsbLcLibLsLsmbRcRsmbRhbLsbRsLsLsLsRsRsLsmmmbRsbRsb
RsbRsbLsbsbLjbRoRsmbRcbLebRsLiLgLsbLhbRebRcLsbsbsbLebLcbLcLsmbLcbLgbLi
LsLebLsLsLsLsLsRsLsmmmmbLibRcbRiRsRsmmbRsbRsbRebRhLsLsmbLiLsbLiLiLsbLi
LsbLibLcbLibRcbRcRsmbRiLsbRjRsRsmmbLsRsRsRsRsLsRsmmmbRgRsLsmbRcbRibRhb
LibLibLibLibLibLsLsmbLiLsLgLsLiLiLeLgbLcbLgLsbLibLibLhbRibRcRsRsRsmmmb
RsRibRhbRibRiLsbRibLebLgbLgbLgbRsbsbsbLsLsmbLgLsLsmbLiLsbLgbLibRgLgLsL
sLsLsLsmmmmbLibRjbRcbLjbRibRcbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsbLsLsmbL
sLsLsLsLsLsmmmmmbLsLsLsLsLsLgLsmmmmbsbLgLsLsmbLgLsLsLsLsLgLsLsmmmmbLsb
LsLsLsLsLsmmmmbLsLsLsmmbLsLsmbLsbLsLsLsmmbLsLsLgLsLgLgLgLsLgLsLsLsLgLs
LsLiLsmmmmbLsbLgLsLsLsLsLsLsLgLsLsLsLsLsmmmmmmmmmbLsbLsLsLsLsLsLsLsLsL
sLsLgLgmmmmmmmmmbLsLsLgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRgLsbRibRgRsRsmmbLibRsbRiRsmbsbRsbsbRgbRiRsRsRsmmmbLsbRiRsRsmmbRgRsRs
mmbRgRsmbRgRsRsRsmmmbRsRsRsRsRsRsRsRsmmmmmmmbLsLsRsRgmbRebRebRgbRgRsRg
mbRgbRibRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bRobLeLibLcbLibLebLhLsbRsLsbLsbRcbRcbLcbRgLsbLsbLsbLiLsbRobRsRhLsRsLsR
sbLcLsLsmmbRsbRcRsmbRsbRcbRsRsmbRibsbRsbLsbLsLsmbLcbLgbLsbLgRsLsbLebLe
bLjbLsbLsbLsbLsbLsbLsbLsbsbLsbLsbLsbLsbLsbLsbLsbLsbRgbRcbLhbReLsbRobLc
bLsbRibRgbRhbRgbRsbsbRebRebRcbRobLcbLsLsmbLsbLgbLgbLebRcbLgLsLsmbLsbLg
bLsLsLsmmbLsbLgbLgbLcLsmbLoRsbLobLsbLibLsRsbLsbRgbRgRsmbLsbRcLsbLibLsb
LgbLgbLsbLgbRsLsbLcLsmbLcbRsbLcbLebLiLsbLiRsbsbLgbLsbLsbLhLsLsmbRsLsbR
sbLsbLcbRobRcbRsLsbLsLgLsbLsLsmbRcbRsLhbLgLgLebRcbRgRgRsmbRibRibRgbRgR
ibRebLhbLsLsLsLsmmmbLsbLgLebRsbRsbLgbLsLsLsRsLsmmbLsLsmbLgbRebRgbRsbLe
LibRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bLsLsmbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsLgmmbLsbLsLsLiLsmb
LibLsbRsbLsbLgbsbLsbLoLsmbLsbRsRsmbRcRsmbRibRgbRgLsbLibLsbLgLgbLsbLgbs
bLsLsmbLibLgbLsLibLgbLhbLgbLcbLgLsbLibRgRsmbRibRcbRgbRiLsbRibRibRgbRhb
RgbRgbRgLsLsmbRibRobRsbLobLibLcbRsRebRibLjbRoRsLsmbLsLsmbLjbRcRsmbRibR
gbRibLjLgbRsLsbLibRgLsLsLsmmbLibLiRsbLsbsbLjLsLsLimmbRsRsLsLgLsLsLsmmm
bLsLsmbLsLsLgLgLsmbLiLsbLsbRsbRsbLgbLsbRsbLeLebLeLgLhLiLgbLgbRobLsLsLg
LsLsLsLgmmmbLsLsLsLgLsLsLimmmbLibLgbLgbLebLebsbLsLsLsLgLsmmbLgbRhbRcLs
RgbLhbLsbLsbLsLsLsLsLsLsLsmmmmmmbLiRsLsbRebRgbRsbLjbRibRjbRibLjbLgLsLs
LsLsLsLgLsLgLsLsmmmmmbLsbLsRsbLsLsLsLiLgmmbLgLsLiRsbLgLgLsLsLsmmbLibLi
LebLsbLsbRoLsLsmbRiRsmbRgbReRgbRibRibLibLiRsbLgbRgbRsRsRjmbRgRsmbRibRg
LsLsLgmbLiLsbRcbRgRsmbLhbLcRsbsbsbsbLcbRgbRgLsbRibRibRibLjbLcbRjbRgbRh
bRibsbsbLjbLibLsLgLsLsmbLgLsLsLsLsmmmbRsLsLsLsLsLsLgLsLgLsLgLsLimmmmbL
sbLebLebLeLebLiLsbLiLgbLsbLsbLsbLgbLebLebLsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bsbRebReRsRsmmbRhRsmbRibLeLsbLeLsLeLsRsbLeLhbRhRsRsmmbRcbRsLsLsmbRibRg
LsRhbLcbRsRibLibLhLhLsLsmbLjRsbLgbLibLibLibLibRjbRcbLhbLcbLcbRgRsmbLcb
LcLsmbLgbLcLgLiLsbLiLsbLgbLeLsbLibLcLsLsmmbsbLibLsbLcbLibLgbRibRhbRiRi
RsmbRhbRibRibRiRgRibRiLsReLsRsLsRsRgRgRsRsLsRsmmbsbsbRsLsbRsLjbLcbLcbL
hbLcbLcbLebRsbRcRsRsRsmmmbRibRhbRhbRibRibRgbLhbRcbsbLgbLjbLhbLibRsLhLs
RsbLcLsRsmbRibLcbLgbRjbRcbRibRgbRgbRsbRsbRcbRibRgRgbRhbLibRiRsmbRjLsbL
gbRiRsmbLjLjbLcLsmbLcbRgbLibLibLsbLibLgbLhbRibLsbLjbLjLsmbLgbLgbRibLcb
LebLiLsbLgbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bsbLgbLibLibRsbRcRgRsmbRgbRgbLiLsbLcbLjLsmbLibLiLsbLibLgbRgbsbsbLgLsbL
gLgbLgLsbRsbRjRsRsmmbRsbRsRgRsRsRsmmmbRibRhbRebLsLgbRsbsbsbLsLsLsLsmmm
bsbsbRgRsRsRsRsmmmmbRebLcbRcbReRsRsmmbRcbLcLsmbLibRhRsmbLiLsbRjbRcRsRs
mmbLhbReRsRsmmbRiRsRsmmbRcRsmbLibLiLsbLibLebLebLgbLeRsLebLgbLhbLgbRebR
cbLibLcbLibLibLibLibLsLsmbRcbReRsmbLebLcbLgRsbLgbLgLsbLibLibLgLsbLgbLg
RsLsbRcbRibRiRoRsmbRjbLibLibLgbLgbRsbRjbRcbRebRgbLjbLsLibLgbLgbLsLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bLgbRsbRsRsmbLeLgbLgbLebLcbLjbLsLebLcbLsbLeLsLiLgbLebLebLebLiLibLibRsb
LobsbLiLsbRebRgRsmbRebRobRcbRebRebReRgbRebRgRebRcbRiRsmbsbRiRsmbLcbRsR
cbRebRsbRibRgbLsbRibRebRobReRsmbRebRebRebRebLjbLsRcbRcbReRsmbRgbLcbRiL
ibLibLhLcRsbLcbLobLobRsbLibLoLsmbRebRsRsmbRiRsmbRhbRibRhbRsRhbRgbRibRi
bRcLsbLhRgbRjbRgbRhbRobRoLsRebLeLeLeLsbLgLsbLgbLgbLibLebRibLcbLiRsLsLs
mbLgbLgbLgLsbLcbRibLhbRjbLcbLgLsbLibLibLcbLcbLhbLhbLsLgLsLgLsLgbLgbLgb
LebLiRsLibLgLsbLibLsbLibLibLobRcbRoLsRsbLgbLcbRgbLsbLiRsbRjbLjLibRibRi
bLgbRcbRibRobLoRsbLgLibLibLibLsbRobRhbRcbRhbRgbRebRobRebRebLiLsbLgLsbL
gRsRsmbLgbLgbLgbLgLsbRsRsmbLibLgbRsbRjbRjLsbRcbRibRhbRgbRhbRcbLsbLeRsb
LhbRsbRgbRebRibRiRsmbRibRobLhbLsbLibRjRsmbRcbRibLjbRhLsbRgbLobRcbRcbRo
bRibRobRgbRgLsbRhRsmbLhbLobLibLiLsbRibRibRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bRgbLibLibRhRsmbRhbRgbRjRsmbLibLibLiLsbLhLsbLibRhbRjbRibRibRgRsmbLibRh
bRibRgbRibRhbRgRsmbRgbRibRsbRibLibRiRsmbRibReRsmbRgbLgbRibRhbRibLcLeLs
LsmbLobLhbLibLgbLgRsbLibRcbRgbRibRhRsRsmmbRgRsmbRibRibLgbLjLsmbRgbRibR
ibRgbRibRgbRibLsbLcLsmbLcLsmbLiLsRsbLibLibLcbLgbLcbLgbLhbRsbLgbLgbLhbL
gbLgbLibLgbRibLsbLibLibLiLsbLgbLjbLibLgbRcbRiRsmbRibRibRgbRgbLibLhbLsR
sbRcbRcbRiLsbLgRsbRgRsmbRgbRibLgbLsbRgRsmbRjbRhbRgbRjRibRjbLcbRibRibRi
bRgbRgRsmbRibLjbLsbLibRiRsmbRgbLsbLsbLsRsbRibRgRsmbRgbRgbRgbRjRsmbRibR
ibRcRsmbRiRsRsLsmmbRcRsmbRhbRibLjLsLsmmbRibRsbLcLsmbRiRsmbLibRibRibRib
RibLibRiRsmbRgbsbRgbRibRgbLibLibLcbLibLgbLcbLobsbRibRibRgbRibRgbRjRsmb
RhbRhbRiRsmbRibRibRgRsmbRgLsbRgbLsbRhbRibRibRjbLgbRjRgbRibLiLsbLibRibL
hbLsbRsbLjbLgbLgbLsbRsbLcLsmbLibsbLjLsLsmmbLibLibRjbRibLcbLcbLibLhbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 161830; End: 162330;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bRebLcbLiRsbLiRsbLhbLgbLhLsbLobLcbLiLsLsmbLiRsbLobRibRiLsbRgbRibRoRsRs
mmbRgbRgRsRsmmbRibLsbLcbLcbLhbLgbRobRcbRgRgbRibRiRsmbRgbLgbRobLsRsbLcb
LoRsbRiRibRsbLobLiRsbLiRsbRebRiRsmbLsRibRgbRhRsRsmmbRsLsbLcbLsRsbLiLib
LgbLgbLgbLiRsbRcbRhbRsLsbRgRgbRgbRgbRgbRgRsmbRiRsRsmmbRibRibRgbRibRgbR
gRsmbRiRsmbRibRibRsbRibRgRsRembLsRgRsRsRsmmmbRiRsmbRibRibRgbRgbLcRsbLi
LgRsbLibsbLsbLsbLsLeLsLsmbsbLcRsbLcbLeRsbLgRsbLibLibLibRcbRgRsRsRsLsmm
mbRebRibRibLcLsLimbLgLgbLcbLsbRsRebRobRgbRjbLebLibLiRsbLiLsLsLgmbLibLg
bRibLebLibsbsbLsLsLsLsLsLsLsLsLgLsLsLsLsLsLiLsLsLsLsLsLsLsmmmmmmmmmmmm
mmmmmbLcRsbRsbRiRsmbRgbRobsbLsLsLsmmbLsLsLsmmbLsLsLsLsLsLiLsLgLsmmmmbs
bsbsbLsLsmbRsbRsRsmbRsLsRsLsbsbLsLsmbLeLsLsmbLebLiLsLsmbLhbsbRibRibRsR
ibRibRiRsRsRsmmmbRsRsRsRsRsRsReRsRsRsRgRgRsmmmmmmmmmbReRsmbRgRsRsRsmmm
bRsRiRsRsmmbRiRsRsRsmmmbLibLcLgLsRsbLiRsRsmbLsLiLsLsLsLsLsmmmmbLsLiLsb
LiRsbRibRoRsmbLsLsmbRsRsmbRgbRjbRsbRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRiRsmbsbRiRsRsRsmmmbRcbRgbLjLsmbLibLiRsRsmbLibLhRsbLjbRcRsRsLsmmbLebL
gbLgbLgbRjbLjbLjbRjbRsRibsbLjbLibRjLgRsbRibRibsbRjRsRgRsRsRsmmmmbRibsb
RibLjbLibLiRsbRjbLibRiRsRsmmbRiLsbsbLjbLibLgbLsbLgbLgRsbsbsbsbsbLgLsLs
RsmbLgbRsbsbRjbLjbRcRiRsRsRsmmmbRgbsbLsbRsRsRsmmbLsbRsbLsbLjbLjbsbRsbs
bLsbLsbsbRsRsmbsbsbRsbsbsbLsbLsbLjbsbRjbRcRsmbRhbLoRsbRgbRcRsRsmmbRcRs
mbLgbReRibRibRhRsmbRibRgRebRebLsRsbLsbLsbsbLsbLiLjbRjRsmbRhRsmbRebRcbR
cbsbRcRsmbLjbRhLsbRsLgRsbRgRgRsmbRjRsRsmmbRsRsRsmmbLibLhbRhbLsLobLhbRj
bRcRsmbRjRcbLjLsmbRgRsRsRsmmmbRgbRibLsbRiRsmbLjLsmbLjLsmbLgbLibLgRsbLg
bRjbRjbRjbLjbsbLhLsbLsRsbRjRsmbRjRsmbLjbRjRsRsRsRsRsmmmmmbRsbRiLsbLebL
ibRsRsRsmmbRjLsRsbLjbRsbRsRsmbLjbLeLsbLiLsRsbLhbLcbRsRsRsLsmmbRjLsLsmb
Rob

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLgbRgbRgbLeLsLsmbRibLcLsmbRjbRobRcRsmbRebLcbLhbLgRsbLcbLiLsbLgbLhLsLg
bRcbRebLgbReLsbRsbLcbLcbLibsbsbRcRsmbRhRibRcbLcbLcbLibsbLsbsbRcbRibRcL
sbLeRsbLeLsbLibLcRsbLhbLhbLcbRgbRibLibRibRgbLsbRsbLsbRsbRsRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRjbLebRsRsmbRsLcbRiRgbRsRsRsmmbRgRsRsRsmmmbsbRgbRcbLgRsbLjbRjbLsbLgbs
bRsLsbLsbRsbLsbLsbLsLsRsmbLsbsbsbRsbRsbLsLsmbRsbsbLsbLsbsbsbRsRsmbRsbL
sbLsbsbsbsbsbLsbLsRsbsbLsbRsbLsbsbRsLsbLsLsmbLiLsLsmbLsbRcRsmbLobLhLsL
sLsLsmmmbLsbLhbRgbRsbsbRsbRsbRsbLsbRebRebRebLsbLcbLcbLibLcbRsbLsbLgLsL
sLsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bRsbLsbLsbRsbRsbLobLsbLsbLsbRsbRsbRsbLsbRsbRsbRsbLsbRsbLsbLjbRsbLsbLob
RsbLsbLsbLsbRsbRsbRsbRsbLsbLsbLsbRsRsmbRsbRsbRsbLsbRsLsbLsbRsbRsbRsbRs
bRsbRsLsbLsbLsbLsbRjbLsbLsbRsbRcbRsbLsbRsbLebRsbLsbRsbRobLobLsbRsbLsbL
jbLobRjbRobLobLjbLjbLsbLsRsbLsbLsbRjbLsbRobLcbLsbRsbLsbLsbLobLsbLebLjb
LsbLsbLebReLsbLobRobLebRobRebRobRsbLjbRjbLibLobLsbRebLcbRobRebLsbLcbLs
bRsbRibLsbLobRibLebLcbLcbRebLebLebLjbRsbRobRobRibLebLebLobLcbRobLobReb
RcbRebLgbRebRobLobLsbRgbRebLsbRgbRibLcbRobLebRgbRebRcbLsbRebRcbRobRobL
ebLibRobRobLobLobLibLebLebRcbRsbRcbRcbRcbRobLcbRibRgbLebLobRebRhbLebLg
bLobLgbLibRibRobRsbLobLsbRcbLobRobLobLcbRebRcbRibLebRobRebLcbRcbLcbLib
LobRgbRgbRhbRebRobRgbLcbLobLebRcbRhbRcbLgbRebLobRgbLibLobRobRobRebRobR
obRibLebRebRgbLibLobRibLobLobRibRobRobLebRebLjbLgbLobLobLobRebRobRcbRg
bRebRebLobLobRcbLobLsbLjbLcbRobLobRcbLobRibLebRebRebLebLjbRebLebLgbLgb
LgbRobLobLobLebLsbLobLgbRobRobRjbRcbLsbRobLobRebRsbRibLobLsbLebLcbRobR
obRobRcbLebLibRobRgbLibRebLebRobRobRebLebRebRsbLcbRebRhbLobRebLobLcbRg
bRibLebRcbLobLebLibLobLgbLebRsbRgbRebRibRebLebRcbRebLobRobRobLobLgbLeb
RibLcbRhbRobRcbLobRebLjbLebRgbRsbLcbLobLobLcbLebRobRobLobLgbRebRcbRsbR
ibRcbLhbLobLobRibRobLobRcbLebLjbRobLebRhbRebRgbRobLobRcbLobRobLebLgbRs
bRcbRebLebLobLobRgbLobLebLibRobLobRebRsbRebRebRobLobLebRobLgbLobRobLgb
RgbRobRobLobRhbLobRobRobRcbLobLebRobLebLcbLcbLcbRgbRibLcbLebLebRcbRhbL
sbRobLebRebRebRcbLobRhbRebLobLcbLebRcbLebRcbRobLobLjbRobRibRgbRcbLcbLo
bRcbLobRobLebLobRebLobRebLobRebRibRebLobLgbRobLobLibRibRebRibRobRsbRjb
LobRebLjbLebRebRjbRobLjbRsbLjbRobLjbLebLjbLobRcbLobRsbRobRobRobLobLebL
obLjbRobLobLobRobRjbRebRobLjbLobLcbRcbRebLobLobLsbRobLobRobRobLebRobLe
bLobRjbRobRjbRebRebLjbLobLobLebRcbLebRjbRsbLjbLebLjbLjbLobLobRobLobLob
LobLsbLsbRebLcbLebLobLcbLobLobLebLcbLebLebRjbLobRcbLobRebLjbRebRebLjbR
obLobRobLebRobLobRobLcbRobRebLebRjbLjbRobRjbLjbLsbRebRebLobRobRebLobLe
bLjbRebLebRobRobRebLobLebLjbRcbRobLjbLjbRobRjbRobLobLcbRobRcbRjbLebLjb
LobRobLcbRobLebLjbRobRobLebLobRobLobRcbRebLjbLobLobRcbRobRebLobRobRobR
ebRobRebLcbRobLobRjbLobLobRsbRebLobRobLebLobRobRjbRobLcbRjbLjbRobLebRc
bRobRebLebLobRjbRobRobRobRebRobRjbLjbLebLjbLobLjbRobRobLobRjbRjbRjbRjb
RobLebLjbLjbLobRjbLjbLobLjbRobLobRebRcbLjbRjbRobLebLjbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bsbsbLsLgLsLsmbRsRgLsRsLsLsmbRcbRsbLsbLebLsbLcbLebLsRgbLobLobLcbLobLoR
sbRcRsmbsbRsbsbLebLiLsbLcbRjLsbLibLoRhRsmbLobLebRsbLebRebRsbLgbLcLsmbs
bRebLsLcbLsRsbRsRsmbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRsLsLsmbReRgbRsRgRgRhbReRsRsRsRsmmmmbRsRgRgRgbRgRsmbRgRsLsRsmbRebLsRs
RsRsRsRgmmmbRgRebRsRsRgmbLsRhReRsmbsbRsRgRgRsRsRsRemmmbRsbRsReRsRsRgRs
mmmbRiRsRsmmbsbRhbRgRebRebsbRiRsmbRsRsRembsbRsRgRiRsmbRsRgRebRsbRsRgRs
RsRgRsRsRemmmmbRhbRsbRsRgRgRsRsRsLsmmmbRsRsmbRibRsRgRsmbRgbRsbRebRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bReRgRgbRcbRiRsRsRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmmmmbRsRsRsRsReRsRgmmmm
bRjRsRsRgRiRsRgRsLsLsmmmmmbRiRsmbRsRgRgRsLsmbLsbRsRsmbRsRsmbRsRsReReRs
mmbRiLsbRsbRcbRhRsmbLsbsbsbRgRsRsLsmmbRsbRsRgbRsbRsLsbRsbRsbRgbsbRsRsR
sRsRsReRgRsRimmmmmbRgbLibRcbReRsmbRsRgRsRsRsLsRsmmmbLsRsRsmbRsRsRsRsRs
RiRsRgRgRgLsRsRsRsRsmmmmmmmmbRsRgRsRgRsRgRsRsmmmmbRiRsRsLsLsRsRsRsmmmm
mbRhbRsRsRsmmbRsRsmbRsRsRsmmbLsRgRsRsRsRsLsRsRsRsRsLsRsRsmmmmmmmmbRsRs
RsRsRsRsRsRgRgmmmmmmbRgLsRsRsRsmmbRsbRsRsmbRsRiRsRsRsRiRsmmmmbRsRgRsRs
RemmbRsRsRimbsbRsRgbRsbRsRsRsmmbRsbRsRsRsRsRsRsRsRsRgmmmmmmmbRsRiRsmbR
gRsRsRhmmbRsRiRiRsmbsbLsRsRsmbRsRsmbLsbRsbsbRgRsRsRgRsRgLsmmmbLeRsbRsR
sRsRgRsRsRgReRsmmmmmbRsRsRsLsmmbRiRsRsRsRiRsmmmmbLsbLsbRiRsRsRgRsRsRsR
gRsRsRsLsRsRsRsmmmmmmmmmmbRiRsmbRsRsLsRsRsRsLsmmmbRsbRsbRsRsmbsbRsRsRs
RsRsRsRsRsRsRiRimmmmmmmmbRiLsRsbRsRgRsRsRsRsRiRsRsRsRsRsRsRsRsRsRsmmmm
mmmmmmmmmmbRsRsRsRgRsmmmbRsRsRsmmbRsLsbRsbRgRsRsRsRsRgRgmmmmbRsbRsbRsb
RsRsRsRgmmbRgRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bLcLsLsmmbRgbLibsbRcbRobLoLsmbLhbLcbLhLsbRjbRebLcLsLsLsmmmbLeLgLsbsbLh
bRcbLibLhbRjbLobRsbLcbLgLsbLebLgLsbLcbRgbLebRobRiReRsRsmmbRibRgbRsbRiR
gbRsLsbRibLibLjLsmbLebLiLsbLsbsbReRsmbsbsbLsbsbRgbRsbRiLsLsLsLsLsLsRsm
mmmmbLiLgbLhLsLsLsLsLsLsLsLsmmmmmmmbsbLibLhLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLcbLoLsLsLsLiLsLemmmbLsbsbLebsbRebLibLhLsbLiLsLsmbRgbRiRsmbRobReRsRem
bLsRsRsLsRsmbLebLcbLcLgbLcbLcbLcLsmbLiLsbRcbRcRiRsmbLcbLcbLsLiLsbLoLsm
bLoLsmbLhbLiLsbRcbRobRobRjRsmbRsbRsRsRsmmbRhbsbLsRsbRsRsRsLsRsRsRsmmmm
bLcbRhRsmbLcLsmbRsbsbRcbRibsbsbLsRsRsLsmbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRibLjbRobLjbLsbLsbRgbLhbLgbLsbRjbLsbLsbRgLjbRsRsmbRsbLgbRibRsbRsbRobL
gb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRsbLsbRsbLjbRgbRgbRoRsmbLibRobLgbLebLgbLgbLeLsbLsbRsLgRobRobLsLsmbRgR
smbLobLsbLsbLsbLobLgbLgbLsbRsLsLsLsmmbLgbRgbLgbLsLsmbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bsbsbsbRsRsmbRsLsbsbsbsbRsLgLsLsLsLsLsLsLsLsLsmmmmmmmmbLgLsLsLsLemmbRe
bLibLhbLsLsLhmbLsLsLsLsLsLgmmmmbLibRsbLsLsLsmmbLgLsbLsLgbLebLsLgLebLiL
sLsmbLebsbRiRebRgbLjLsmbRobRibRgbRgbRsbsbLjbLsbLibLsRsLiLsbLsLgLsLsmbL
iLsbRsbLibLeLsbLiRsbsbsbLsLsmbLcLsmbRibsbLsLsLsLemmbRibLibLibLibLiLsbL
sbRsbLobRsbRjRsmbRhbRgLsRsbLeLsbLgLsbLiRsbLgbLgbLiLsbLhbLeLsbLgbLiLsbL
eLsbsbLsbsbLeLsbLiLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bLiRsbRsbLhbLhLsbLhbLjRsRsRsmmbsbRiRsmbRobRcRsmbRibRiLsLsmbLjbRjbsbLsR
sbsbLjbRcbsbRsRjRsmbLiRsRsmbLhLsbReRsmbLcbLebLiRsLsbRjbLcRsLsbRcRiRsRs
RsmmmbLgbLhbLgbLgLgbLobLcbLcbLibLobLgLsLsmbLgbLgbLibRobRhLsbRiRibRcbRg
bRcbRoLsbRiRsRcRimbRobLhbLiLibLhbLcbLhLgbLoRcbLgbRiLsbRsRjbRiRsLsmbRiR
hRsmbRcbLiLibLiLsbLgbLsbRsRsmbRsbLsbsbLsbLsLsLsRsLsLsmmmbRsbsbLiLsbLsL
smbLiLgLsbLeLsbLgbLgLiLsbLgLeLebLgRsbsbLsRsbLsbLsbsbLhbLsLibRsbLjLibLe
b

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLibLgLsLsLsmmbLgbLgbLebLgRsbLibLgbLsbRsbRebsbsbsbRibRhbsbRsbRebLsbLsb
LgbLibRiRsmbRcRcbRgbRcbRiRhRibRcbLebLgbRjbRcbLebLcLsLsmmbLiLsbLibLibLi
bLibLgbRcbRebRibLgLsbLcbLsbRcbRiRsmbRgbRgbRgbRgbLibRhbRibRgbRhbLsLsmbR
gbRgbRgbRgbRgbRgbLgbLcLibLibLsbRjbRibRibRiRsmbRibRibRjbRiLsbRgbRgRsmbL
jbRibLgbRhbRgbRsRsmbLjbReRsRsmmbLjbRcbRibRibRebReRgbsbRsbRgbLhbLibLibL
ebLsLsmbLiLsbLgLsLsLgmbLsRsbLsLsmbLsbLsRsbLgbRgbRcRobLjLhbRobRibLibLgb
LibRcbLjbLsLjbLgbRjbRgbsbLjbLiLsLgLsRsbLgbsbLibLsbsbRjbLcbLgRsbLgbLsLs
LsLsLsLgLsLiLsmmmmbLsLsLgLsLsmmbLgRsbLjbRhbRsbLibRhbRibRgbsbsbRsRsmbsb
LgRsbLsbsbLsbLgbRiLsbRsbsbLsbLsbsbRsbRgRsmbRsbLjbRobLhbRsbRcbRiRebRiLs
b

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bRsRsmbRgbLsbRgbRgbRsbLsRsbLgbLsRsbLgbLgbLsbRsbRsbRsbLgbLgbLgbLsbRsbLg
bLiRsbsbRsbLgLsbLgbLjbRsbRiLhbLsbLsbRsbRibLobRsbLsbRsbLsbLsbLsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bLsRsRsmbsbsbRsRsRsRsRgmmmbRsbRsRgbRgbRcbRsRsRsRsmmmbRsRsmbRiRhbRsRgRs
RsRsRsRsmmmmmbRgRsRgRsRsRgRsLsmmmmbRsRsRsmmbRiRsRsRsmmmbRsRgRsRsRsmmmb
LsRsRsRsRsmmmbRsRsRsRgRsRsRsRsRemmmmmmbRgRsmbRgRgRgbRgRsRsRsRsRsmmmmmb
sbRiRsRsmmbRsRsRsRsRsRgRsRgRsmmmmmmbRsbLsRsRsRsRsRsRsRsRsmmmmmmmbRgRsR
gmbRcbsbLebsbsbRcbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRgRsRgRsRsRsRgRsmmmmmmm
mmmmbRsRsRsRsRsRgRgRgRgRgRsmmmmmbRiRsmbRcbRsRsRgmbRcRsRsRsmmmbLsLsmbRs
RsRsRsRsRsmmmmmbRsbRiRsmbRobLgbRsbLsLsRsLsRsLsRsmbRsRgRsRsRsRsRgRsRgRi
LsmmmmmbRgRsmbLgRgRgbRibsbLcbRebRibLcbLcbRcbRsRgRibRgRsRgmbRsRsRsRsRsm
mmmbRcRsmbLsRcbsbRsRsRsRsRsRsRsLsmmmmmmbRgRsRsRgRsRsRsRsmmmmmmbRsRsRsR
sRsRsRsRiRgRsRsRsRgRsmmmmmmmmmmbRiRsLsmbRsRsRsRsRsRsRgRgRimmmmmbRgRsRs
RsRsmmmmbRgbRibRsRsmbRsRsRsRsRsRsRsRsRsRsRgRsRsRgRsRgRsmmmmmmmmmmmmmbR
sbRsRgRiRsRsmmbRgRiRsmbRgbRsRgRiRsRsRgmmbRsRgRgRsRsRgRsmmmbRsbRgRgLsbR
sRgRgbRibRibRgRgRsmbRcbRsRsRsmmbRiRgRsmbRgRgRhLsbRgRsmbRgRgRsLsRsRgmbs
bsbRiRsmbRgRgRgRsRgRgRsRsmmmbRsRsmbRiLsbRsbRgbRgRsRsRgmmbRjRsRgmbRgRsR
iRsmmbRsRsRsmmbRgRsRsRsRsRsRsRsRsRgRsRsRgRsRgmmmmmmmmmmmbRgRgRsRsRsRsR
immmmbLsRiRsmbLobRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRgbLsLsmbRgRsmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsbRsRsRsRsLsRsRsmmmmbRsRsm
bRsbLsLsLsRsmmbRsRgbRsRsmbsbRsbLsLsLsmmbsbRsRsmbRsRsmbsbRsRsmbRsRsRsRs
RsRsmmmmmbRsbsbRsRsRsRsRsRsmmmmmbsbRsRibRsRiRsmbRgbLsLsmbLsbRsRgRhRibR
ibRsRsRsRhmmbRsbRsRsRsRemmbRcbRsbLsbRsbRsbRsbRebRsRsRsRiRsmmmbRsRiRhbR
ibLsbLjbLobLebLobRhRsmbRjLsLsmbRibRgbRibLgLsbRhbRsbRiLsbRsbRgbRibReRsm
bRsRgbLsbRsbRsbsbsbRebsbRsbRsbRgbRgbRiRsmbRgbRibLibRhRiRhbRgbRsRiRsmbL
sbRsbsbRsRgbRsLsLsmbRsRsRsmmbsbLsLsmbRsLsbRsLsbLsRsRsmbLsbLsLsmbLsbLsb
RsLsbLsbRsbRsLsRsbsbsbsbsbRsbRsbLsbsbRsbRsbRsbRibLsRsRsmbsbRsLsbRsbRsR
sRsRgmmbRebRibRibLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRsRgRsRsRsmmmbsbLsbRsbRgbRsbRsRsmbRsRsRsRsmmmbRsbRsbRsbRgbRgbRsbRsbRs
bRgbRgbRsRsRsRsRsRsRsLsmmmmmmbRgbRsRsmbRsbRsRsRsmmbRsbRsbRgbsbRsbRhRsm
bRsbRebLgbRcbRibRebRsbLjbsbLsLsmbRsRsRsmmbRsRsmbRsbRsLsbRsbRsRsRsmmbRs
LsbRsRsRsRsRsmmmmbRsRsmbLsRsbRsbRsbRgbRgbRsRhbRsRsRsRgRgRiRsmmmbRsRsRs
RsRsRsRsmmmmmmbLsRsbRsRsmbLsRsRsRsRsRsRgmmmmbRebRibLsLsmbsbRsRebRgLsbR
gbRgbRsRsRsmmbLsbRsbRsbRsbRsRsRsmmbRsRsmbLsRsRsmbRsbRgbRsLsbRsRsRsmmbR
sbRgbRsRsmbRsRsRiRsRgmmbRsRsmbRsbRsbLsbRsbRsbLsbLsbRsbRsbRsRiRsmbRsbRs
bRsRsmbLsRsbRsbRsbRsbRsbRsRsmbLsbRsRsRsmmbRjRsLsRsLsmbRgbRibLsbRiRsmbR
sbLsbRsbRsbRsbRsbRsbRsbRsbRsbLsRsbRsbRgbRsbRgbRsLsRsbRgbRsRsRsRsRsmmmm
bLsbRsbRsbRsbRsRsRsmmbRsRsRsmmbsbRsbRsbLsRsRsmbRsbRsbRsbRsRsmbRsbRsbRs
bRgRsmbRsbRsbRgRsRsRsmmmbRsbRsbRsbRsbRsRgbsbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsbLsbRsbLebLgbRsbLsbLgbLgbLjbRsbLsbLsbLsbsbsbRsbLsbLsbLsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bLgLsbLcLsmbRebLcLiLsbLibRsLgbRibLjbLiLsbLebLgbLgbRcbRiLsbRcbRhbRgbRgb
RibRebRibRsbRobRobLgbLgbLgbRibRsbRgRsRgmbLobsbLeLsbLgbRibRgbsbsbsbsbLs
bRebLgbsbRsRgRsmbLsRsRgRsRsRsRsmmmmbRgbRebLeLsLsLsLimmbLsLsmbLgLsLsmbL
ebLsLgbRsLsLsmbLebLgLsbLebLsLsLsLsmmmbLsLsmbLebLgbLgLsbRsbLsbLsbRsbLgL
gLsLsLhmbLgbRjbRebLjbLjbLebLcbLsLsLgLembLgbLibLoLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bsbLsbReRsmbRhbLeLsLsmbLiLsLiRsbRibRebRibRiRsmbLgbRgRsmbRsRsmbRcbLeLsb
LgbRcbReRsmbRibLebRsLjbRobLsbsbLsLsLsmmbLcbLsbLsLsLsmmbRsbRsbRsbRebRhb
LobLib

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bLibsbLgbLgbLsbLsbRsbLgbRsbLsbLgbLgbRsRsmbLsbLsbLsbLsbRsbRsbLgbRsbLsbL
sbRebRsbLjbRgbLsbLsbLsbLsbLsbLibLsbLsbLsbLsbLsbLsbLjbLibLibsbLgbLsbLsb
RsbRsbRjbRsbLsbLsbRsbRsbRsbLjbRsLsbLjbRsbLebLsbLjbRsbRgbRgbRsbRsbRsbRs
bLobRebsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bLsbRsRsmbsbRsRsmbsbRsbsbRsLsbLibLgLsLsmbLsLsRsmbLsLsmbLsLsmbLsLsmbLsL
sLsmmbsbsbLsLibRsbRsLsbRsbRsbLsbLsbLiLgbRsLsbLsbsbsbRsLsRsbLsbRsLsbsbR
sbLebLibLcbRgbRsbRsbLgbRsRsmbRsbRsRsmbRsbsbRsRsRsmmbRibLibLebLebsbLgbL
ebLhbRibRsRsmbRgbRgbRsRsmbRsRsmbRgRgbRgLsbRsbLeLibLsbLsbRcbRsRsRsRsmmm
bReb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bRiRsRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmmmbRgbRsbRiRsmbLebLibLibRjbLcbLgLs
bLhLsbRhRsmbsbLiLsbRsLsRsRsRgRgRsRemmbRsbRsRsRsRsmmmbRsRsmbRsRiRsmbRiR
sRsmmbRsRsmbRsbRibRibRgbRsbLibRebRcbRiRsRgLsmbRsbLibRjbRcbReRsmbRgbLgb
LcbLeLsbRsbLsRsbRsRsmbRobLsLsmbLcbLebLibRsRsmbRsbLhLibLgbLsbLcbLhLsbLc
bLsLgbLobLsbRibRcbsbLibRibRibLsRsRsRsRsRsRgRgmmmmbRsRsmbRgbRgbLgbRibRi
bRgRsRsRsRsRgRsRsRsRsmmmmmmmmbRsbRgbRibLcbsbLgLsLsLsRsmmbRsbLgbLgbRsbR
gbLiLsbLgbLsbLgbLgbLgLsLsmbLgLsLsRsRsRsmmmbRsbRsbLhbLsLsLsmmbLsbLsbLsR
sbRsbRgRsRsRsRsRgmmmmbRsRsRsRsRsmmmmbRsbRsRsRsRsmmmbRsbRgbRiRsmbRsRgRs
LgmbLjbLgLsbLibLsbRsbRgbLebRgRsmbRsRgRsRgRgmbRibLibLgbLsbRhbRiRsmbRsRs
RsmmbRsRsmbRsbLsbRebRsbRebRjbRsbLsbLebLebLcbLebRsLsRsLsRsLsRsbRsbRsbRs
b

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bRibLsbRsRhRsmbsbsbRhLsbRiLsRsbRobRcbRibRcbLsbLjbReRiRsmbRgLsbsbRiRgRe
bsbRobRcbLcbLcbRibRcbRcbLcbLibLiLoRibLibLibLhbLcbRgbRibLcbsbLibLgRsbLc
bLsbLcLsmbLibLiRsbRjRsmbLgRsbRgbRsRebRsRsmbRgbRgRsmbsbRcRsmbsbsbRgRsRs
RsmmmbRjRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLebLgbLgbLibLiLiLiLsLsLsmmbLsbLeLsbLsbRsRsLsLsmmbRjbRcbLsbRhRsRsRsRsR
smmmmmbRiRsRsmmbRsRsRsmmbRhRsRsLsmmbLobLibRjbLhbLibLibLsbLsRsbLsLibLeb
LeLsbLgbLgbLibRgbRsbLiLsbRsbLgbLsbRjbRebRgbRgbRgbRsRgbLsbRgbLgbRcbRhbR
cbLgbRcRsmbRiRsmbLsbRgRsRsmmbRsbRgRsmbRsLsRsbRsbRgbLsbRgbsbReLsbRgbRgR
sLsmbLiLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRsbLsbRsRsmbRsbRgbRsbRsbRsbRgbRsbRgRsRsmmbRsRsRsRsmmmbReRsmbRsRsmbRsR
sLsmbRsbRsbRsbRsbReRsRsmmbLsRgbLeLgRsbRsbRsbRiRsmbRgbRsRsmbLsRsRsmbLsR
sRsRsmmbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsbRsbRibRgbRsRsRgRsmmbRgbRsb
RsbRsbRsRgRsmbRgRsRsmmbRsRsmbRgbRsbRiRsRsRsmmmbRsRsmbRsRsmbRiRsmbRgRsR
smmbRsRsRcmbRhRsmbRsRsRsmmbLsRcbRgbRebLibRgbRibsbRgRsmbRiRsRsRgmmbLjbL
oRsRsmbLibLibLsbLiLsbLgbLsbLsLsmbsbsbsbRsbsbLsbLsbRsbRsbsbRsbRsbRsbsbL
sbRsbRsbsbRsbLsbRsbRsLsbRsbRsRsmbLsLsmbLsRsRsmbsbRsbRsbsbRsbRgRsmbRsRs
RsRsmmmbLgbsbsbsbRsbRsbRsbLsbRsbLsbRsbRsbRsbRsRsmbLsbLsbsbsbRsbLsbRsbR
sbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsRsmbRsbRsbLsbRsbLsbLsbRsLsRsbsbsbRsb
RsbLsbRgbReRsRsmmbRsRebRgRsRsRsmmmbRsRsRsmmbRsRsRsmmbRgRsmbRgRsmbReRsm
bRiRsRsmmbRgbReRsmbRgRsRsRsRsmmmmbRiRsRsmmbRcRsmbReRsRsmmbRcRsRsmmbRsR
ibRiRsmbRsRsmbRsbRsLsbLsbRsbRgbRsRsmbRgbLsbRsbLsbRsbLsbRsbRsbRsbRsbRsb
LsRsbRsbRsbRsbRiRsmbReRsmbRobRsRsRsmmbRsbRsRsmbRsRgRsmbRsRsRsRsmmmbRsb
RgRsRsRsmmmbsbRsRsRsmmbLcRsbLjbRsbRcRsmbRibRgbLgbRsRsmbRgbLsbRsbRgbRsR
sRsmmbLsbRsbsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLiLibLgLsbLcLsmbRsbLoLsLsmmbLcLsLsLsLsLsLsLgLsLsLsLsLsLhmmmmmmmmmmbLi
LgLgLsLsmbLcLsmbLgLsbLcLsLsLsLiLsmmmbRcbLcbLibLhLsLsmbLeLsbLjbsbLgRsRs
LsLsmmbRgbRsLsbLeLiLsbLsLsLsmmbLibLcLsmbLhLsRsRsRsmmbLcLsLsmmbLiRibLcb
LiLsLsLsLsmmmbLoLgLsbLcLsLsmmbLeLsLsLsLsLgLsLsmmmmbLeLsbLcLsLsmmbLcLsL
smmbLsLsLsLsLsLsRgmmmmmbRcbLebLcLsmbLobRibLgbLjLsLsmmbLiLsLsLsRsmmbRsR
cRsRsmmbLjbLcLsLsLsLsLsLsLsLsLsmmmmmmmmmbLhbLiLsLsLsLsmmmbLiLsLsLsLsLs
LsLsmmmmmmbLiLsbLcLsLsLsmmmbLsLgLsLsLsLsLsLiLgLsmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bRsbLsbLcbLoLsmbsbLcLsmbLsLsLsLemmbLgbRoLsbsbRcbRgbLcbLsLsLsmmbLsLsmbL
sLsLsLsLsmmmmbLiLsLsmbRjbRcbRsRsRsmmbLsRsbRsRgRsRsRsRgRgmmmbRsRsRsmmbR
sRsRsLsmmbRsRsmbRsRsRsLsmmbRsRsRgmbLsRsbRsbLsbRsbRsbRgbRsbLsbRsbRgbRsb
RsbRgbRebLibRsRsRgRembRibRsbRgRsmbLjbRcbRsRibRsLsbLsbRsRsReRsmmbRsbRib
LgbLgLsLsLsLgLemmbLsLibLgLsbsbLiLsbLibLsLsRsLgmbLsLsLembsbRsLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRobsbLjbsbRsbRsbLsbRiLsbRiLsRsbLibRibRiRsmbLsbRhbRiRhbRhbRgbRiRsmbRsL
sbsbRhbRgbRsRsmbRgbRsbRsbRsbRibLgbLcbRsRsmbRcbRiLsbRibRgLjbLibLgbLgbsb
sbLiRsLsbLibsbRhbLsbLsbRsbRibLsbRhbRobLjbLjbRsbRsbsbsbsbRsbRgbRgbRsRsm
bRgRsmbRiRibRsbRgbRibRgbRgbRiRsmbRgbLsLcbsbReRsRsmmbRgbRsbRibRgRsmbRgb
ReRsmbLsbRiRsmbRsbRhRsRsmmbRgRsmbRsRgbsbsbRebRgbRgbsbsbRsbRsbLsbsbsbLs
LsRsmbRsLsbLsbsbsbsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRcbLiRcbLebRcRsmbRiRgbRibRhbLsbLoLsmbLcbRhbRibRgbLibRjbRibLhbLcLsmbLj
bLhbLibRcbRsbRibsbRibRgbRibRsbLjbRsLsRsbsbsbsbLiLsbLsLgLsLsLsmmbLsLgLs
bLsLsmbLsbLgLsbLibRsbRsRsmbRsbRgLjLsRhmbLiRcbRobsbRobLibRobsbRobRobRcR
smbLcbLcLsmbLcbsbRjbRcbsbsbLibRsbRsRsmbRsRsRsRimmbRsRsRsRsmmmbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bReLsbReRsRimbRebRiRebRsRsmbLgbLgLsbRcbRsRgbLebLebLebRsbRobRebLgbRcLgR
sLsbRoRgbRiRsmbRebRiRsRsmmbRibRhRibsbRcLgbLcbLcbLiLsbLgRsbLiRsbLibLhbL
gbLeLgbRsbRsbLcLsmbRgLgRjbRsbRibRgbRibRsbRsRjbRhbRgbLsRgRsmbRobLsbLgLi
bRjbLsbRoRsmbRhbRibRgbRobLibRcbRsbRsbsbRsbRsbLsbRsbLsbsbsbRjbLjbLjbRsR
smbRcbRgbRsbRobRgbRgbRibRcRgbRobLibLiLsbLiLgLeLsbRjbRcbRibLibsbLcLsmbL
ibLsbsbRjRsmbLcbRsRcbRgRsmbRiRsmbRhRsmbLsLsRsmbRebLiLsbLibLibLgbRgbRob

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRjRsmbRcbLoLsmbRgbRsbRsLsLsmbLsLsmbRjbsbRgRsRsmmbRibRcbsbRebRsRsRsmmb
RsbRcRsmbRobsbRjbReRsmbRibLcLcbRsRibRjbRibRgRsmbRcRsRsmmbRiRsmbRjbLsbR
gRsRsRsRsLsRsmmmmbsbRcbLsbRiRsmbRibRsLsLsmbLsLsLsmmbLhbLeLsLsmbRebRgbR
sbRebRibRgRsRsRsRsRsmmmmmbRgLsbRgRsRsRgRsRsmmmmbLsbRibRsbRcLsbsbRhbReR
smbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bLgbLcbRcbRgbRsRsRsmmbRgRsRsmmbRsbRsRsmbLsLsmbRsbLsLsmbsbsbRsbsbRibRiL
sbRibRcRsmbRobRsbRsbsbRhRsRsLsmmbRcLgbLibsbLibRobRgbLcbRhbLsbLgLsbRcRs
mbLoLsmbLcbLiLsbLobLcRsLsbLibLoLsmbRcRcRsmbRiRsmbRibRobLebLeRsbLebsbLs
RcbLsbLcLsmbRsLsbLoRsbLibRjbRibRebLobLobLhbLhbLgLsLsmbsbLgRsbLgbLebLeL
sLhbLobLebLsLsLgRgmbRcbRjRsRsmmbLjbLibLsbLjbRcbReRsRsmmbRsbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bRjbLjbLgbRsbLsbRibRsbRgbRgbRsbRcbLebLsLobsbsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLibLibLebReRsmbLibLcbLibLgbRsRsRsmmbRcbRibRoRsLsmbLibRsbRgbLsbLjbRibR
gbLjbRgbRgbLjbReRsmbRibRibRgLsbRcRsmbLibLcbLgbLiRsbLhbLcbLgbLibLebLibL
sbLhbLibLibLiRsbRgbLgbLgbLgbLibLeLsbLhRsbRibLjbRsLsLsmbLjRsbLgbLhbRsbL
iRsbRgbRibLjbLsbRobRcbLsbRsbsbLibLibRgbLjbLgbRsbLsLsLsmmbLiLsLsmbLgbLs
LsmbLiLsbLgbRcbLeLsLsLsmmbLgLsLsLgLsLsLsmmmbLsRsRsRsRsmmmbRsRibLjbLibL
iRsRsmbRibLibLgbLsbLgbLibRsRsmbLsbLgbLibLjbRsRsRsRsRsRsmmmmmbRsbRhRsmb
LcbsbLcLsmbRibLgLsbLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bRsRibRsRebLcLsmbLibLebLgLsbLsRsLsLsRsmbRiRsmbRiRsRsRsRsmmmmbRsbRhbRib
LjbLobLgbRoRsmbRsbRgbRhbRsbRhbRgbRiRgbRgbLibLcLsmbsbsbLsbLsLsmbLsLsLsL
sLsLeLsmmmmbLiLsLsmbLsbLsLsLsLsmmmbLsLsLsLsLsLsLemmmmmbLgLsbLgLsbReRsm
bRsRsmbRsRsRsRsRsRsmmmmmbRsLsbLgLsbLgbRsbRsbRsLsbsbsbLgbLsLsLgLsLgLhLs
LsRsmmbLsbsbLsLsLsLgLgLsRsmmbLsbLibLsbLsLsmbLiLsLsLsmmbLiLsLsLembLsLsL
sLsmmmbLsbRsbRsRsLsmbLsLsRsmbLsbLsbLsLsLsLemmbLcbLsLsLgmbLhRsbsbLgLsbL
eLebRsbLsbRsbLsbLsLgLsbLiLiLibLibLsLgLsbLobRgLjbRhRsmbsbRgbRebRsRsRsmm
bRsRsmbRebRsbRebRsbRsbLgbLcbLibLibRcRsmbRibLsbRsReLsbRiRsRsmmbRsRsRsRs
RsRsRsRsRgRsmmmmmmmmbRsRsmbRsRsmbRsbRsRsRgRgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bsbRsRsRsmmbLsbRsRsRsRsRsRsRsmmmmmmbRibLsRsRsmbRsbLsbLsLsLsmmbLgbLsRsb
LobLeLsbLsLsmbsbLjbRcbRgbRobRsbRsbRhbRsbRgbRsRsRsmmbLsbsbRsbLsbLgbLsLg
RsbLsbLsLsLsmmbRsbLgbLsbLsbsbsbLsRsbRebLcbsbsbRgbRsRsRsRgmmbRsbLcbRebR
eRsmbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bLibLsbLjLgbLgbRsbLjbRjbRibReRsRsmmbRibRhLsLsmbRcRsReRsmmbLobLgbLibLgR
sbRsbReRsRsReRsmmmbLsbRiRsmbRcRgbRgRsmbLoRsbLibLhLsbLiRsbLibLjRsRgbReR
sRsRsRsmmmmbRibRiRsmbRgRgRsmbRhbRiRsmbLjbLibLibLcLsLsLgmmbsbLhLsbLsLsR
smbRsbLjbLjRebLgLsbLjbLgRsRsmbLibLgLsbLiRsbLjLebLsRsbLebLhbLsbLjLsLsRs
mmbLiLsRsbRsRsmbRjRsmbsbLibLibLjbRsRgRsmbsbsbRjbRsLjLsLsLsLgLsmmmbsbLj
bLjRsRsmbLhbLgbLobLibLhLsbLibLgbLjRsbLhRsRsmbLebLjRsLsbRebRhbRiRsmbReb
RiRsmbRiRsRhmbRibRiRsRsRsmmmbRhRsRsmmbLgLsbRcRsmbRebRcRsRhRsmmbRcbRiRs
RembRiRsRsRsRemmmbRiRgbReRsmbLcbRebRgRsmbLcbRcbRibRiRsmbRgbRibRibReRsR
smmbLjbLgLsbLgLsbRgRsmbLjRsRsmbLjLsRsRsmmbRsbRjbLiRsbLjRsRsRsRsmmmbRhR
sRsRsRgmmmbRebLcLsLsmmbLiRsbLiRsLhLsLibLgbLsLsRsmbsbsbsbLsLsLsmmbsbRsb
sbRsbLsLsmbsbsbRsLsbRsbLsLsmbsbLgRcRsRembsbRebRebRebRibLhbLjRsRsmbRcbR
eRsReRsmmbRiRsmbRcRsRsmmbRibLibLhbLiLsbLibLgLsbLgbLibLsRsRsRsRimmbRjRs
RsmmbsbsbLjbRgbRsbRsRsmbRebRobRgRsmbLhbLgbReRsRsRsRsmmmmbLgbReRsmbsbRh
bRgRebReRsRgRsRimmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLsLsLsLsRsmmmbLsLsmbLsLsLgLsLhmbLsbLsLgbLgLsLiLgLiLsLsLsmmbLgLsLsLsLs
LsmmmmbLsLsLgLsLsLsLsmmmmbLsLsLsLsLsmmmmbLiLsbLsLgLsLgLsLgLsLgLsLgLsbL
sbLsLsLsLgLsLsLsmmmmbLsLsLsLsLsLgmmmmbLsbLsbLgbLiLsbLiLsLsLgLsLimbLhLs
bRsRsRsmmbRcbRibRoLsbLcbRsLsbLibLiLsLsmbRsRsmbRgbLiLsbLgbLibRebLiLsbLc
bLsLsLsLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLcbRebRhbLsLgbLcRsbRcbRobLeLc
bRsbLebLibLsbLiLsLgLebLsLsLsLsLsLsLsLsmmmmmmmbRsLsRsbLsLsLsmmbLsbsbsbs
bsbLsbsbsbLsbLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRsbRgRhRebRebRgbsbRgbsbRsRsRsLsmmbLsLsLsmmbLsLsLsLsLsmmmmbLsLgLsLsLsL
smmmbsbLsbLsLsLsmmbRsLsLeLsbLcbRobRjbLeLsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bRgbLebLgbLebRebRhbRsbRiRsmbLsRsRsRsmmbRsbRsLsbRsbRsRgbLibRsbRgRgbRhbR
sRebRgbRsbRsbRsbRsbRsLsbRhbLsLsmbRsLsLsmbLsLsmbLsbLsbLcbRebRibRsbRsRgb
LsRsbRebLibRcLsbRgRsmbRsbRsbRsbRsbRsbLjbLhbRsbRebRsRsmbRsRsmbRsbRsRsmb
LsRsbRibRsbRsRgbLcbLhbRgbRsRsRsRimmbRsbRebLebRsbReRsmbLsbRsbRgbRibRgRg
bRgRgbLcLsLsmmbLgbLibLhbLeLsbLsbLsbLgbRsbLgbLsbLsLsLsmmbLsbLebRsbLsbRs
LsbLsLsmbLibRgbLibLsbLsbLsbLsRsbLsRsbLsLsmbRsbRobLsbLsbLgLgbRsLsbLibLs
bLsLsmbLsbRsbRsLsbLsbsbLsbLsbLibLsLhbRsLgbLgbLsbLsLsmbRsbLgLebLsLsmbLg
bLsLsLsLgRsmmbRsbLsbRsLsbLgbRsbLgbLgLsbLibLsbLsbLsbLsbLsbLgbLgbLsbLgbL
sbLsbLsbLgbLsbLibLsbLgbLsbLgbLsbLsbsbLsbLsbLgLsbLsbLgbLsbsbsbLsLsmbLgb
LgRsbLsbLsbLgLsbLgbLsbLsbLsbLsbLsbLsbLgbLsbLib

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bLgbLgbRsbRsbLebLeLebLgbLhbRjRsRsmmbRjRsmbRoRsmbRgbRibRiRsmbRibRgbRibR
jRgRsmbRibRibRcbRjbRcbRibRoRsmbRibLjbLibLhLsbLibLhLsLsmbLcbLibLcbLcbRj
RsmbRgRsmbRibRjbRibRgbRibRibRiLsbRibsbLgbLgLsbLibLjbLhbRsLsLsLsLsLsLsL
sLsLsmmmmmmmmbLsbLsLsmbLsbLsbLsLsLgLimbLsbLeLsLsmbLsbLebLibLgbLeLsbLsb
LgRsbLsLsLsLsLsLgLsLgLgmmmmbLibLsLsLeLsmbLiRsbRsLsbLgbLgLiLhbLeLgLgbLs
LsLsmmbLsbLsLsmbLsLsmbLsRsLsLsLsLsLsmmmmbLsbRsRsmbRsbRsLibRsRsmbRiRsRs
RsmmmbRhRsmbRgbRgbRgbRiLsbLjLgLsbRibRgbRgbRgbRgbsbRgbRgbLsLsLsmmbRgRsm
bLsLsRgRsRimmbRibLgbsbRsLsLsLembLibLeLsLibsbRsLsLsLsLsLsLsLsLgmmmmmmbL
sbLjbLsbRsbRsbLsbLgLgbLiLeLibLsbRcRsmbLeLgbRoLsbLobLgbLgbLcbRiRsmbRgbR
jbRibRcbRgbRgbRjbLjLsmbLsRgRhbRsLsRgRiRsRembRgRsmbLsbLsbRsbLsLsmbLsbLj
bRsbRsRsmbLsbRsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bLhbRgRsRsmmbLcLsmbRgLsbRjbRhbRibRibLgbRibLjbLcbLibLibLgbLibRibLgbRjbs
bRjbRcbRhbLibLibsbLsbLeLsbLcbRibLhbLibLsLsRsmbLcbLcbLgbLsbRgbRjbLsRsbR
sRsRsmmbRsbLsbLcbLgbLeLebLgLsbRebRcbRibRgbLjbLcbRsbLcbRiLsbLibLgbLibLh
bRhbRgbRibLgbLebLibLcbRgbRsbLibRsRsmbRgbLsbLcbRsbLcbLcbRibLcbLibRibLcL
smbLibLibLsLgLsLsLgLsLsmmbLgbRjbLcbLgbRsLiLsbLgbLhLsbRjbLgLsLgLsLsLsLh
mmbLgbRjbLcbRjbRsbRcRsmbRcRsRsmmbRgbLsbRsbsbRgbLjbLsbRsbLsbRjbRsbLsbLs
bRsbLsbRibRebRibRcbRgbRibRibRibRibRcRsRsmmbRibRibRgbRiLsbRhbRgRhLsbRgb
LjbLgLgbLibLiLiLsbRjRcbRiLsbRibRibRiLsbRgRsmbRibRibRiLsbRibRibRiRsRsmm
bRiLsbRsbLcLebLobLcbLgLgbLobLibLcLsmbLibLgbLcbLsbRgbLobLsbLgbLiLiLsbLe
b

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bsbRjbLebRjbRjbRgRebReRsmbRibLebLcbLibRibRcbRcbRcbRcbRsbRgbLebLeRsLsbR
cRsmbRebLgbLobLibLobLsbLcbLcLsmbLebLhLsbLgbLibRibRjRsRsmmbsbRhbLebsbLs
RcbRiRsmbRgbRgbRhbLibLibRiRsmbRibRhRsRsmmbRgbRsbRibRsRsmbsbRgbRsbsbRgR
smbRgRsRsRsRsmmmmbRhRgbRsbLsbRsbRsbRsRsmbRiRsRsRsmmmbRsRsRsRsRsRsRsRsR
smmmmmmmmbRsRibRhbLcbRiRsmbRebRsRsRsRsRsRsRgRiRsmmmmmmbRibRgbLibRhRsRg
RsmmbRgbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsRsRsRsRsRsRgmmmmmmmmbReRcbReRs
mbRiRibsbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsRsRsRgRsRimmmmbReRsRsmmb
RsRsRsRsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bRgbRcbRibLibRibRcRgbRhbRibRhbLibLeLcLsmbLibLibLcbLhbLhRsbLcbRsLebLhbL
hLibLhbLcbLibLibLibLgbLhLibLibLibLhbRsbLibRjbLhbRcbRiLsbRsRebLibRhbRib
RcbLcbLibRhbRhbRibsbRjLsbLibRhbLjbRoLsbLebLjLsmbLsLgbLibLebRibLgbLibLi
bRsbLhbLibRiRsmbLebLibRjRgbLiLsbLgbRgbLiRsbLgLsbRibRcbRgbLibLhbRcbRibR
jbRiRsRsmmbRibRjbLibLeLsbRhbLhbsbRiRsmbRebLibRibRcbRibLibRibLobLibLhbR
gbLibLcbLebLibLibLibLhbLibLibLibLgbLibLibLgbLobLibLibLibLibRsbLcbLibLj
LgLsbLgbLcRsbLjbLsbLgbLgbLibLibLgRsbLgLsLsmbLgbLgLsLsmbLhbRhbRcbRebReR
smbRobLiLsLsmbLibLjbRobRsbLsLgbRibRebLeLsbLibRjRebsbLjbLobRoRgRsmbLibL
cbLcbLsLgbLgbLgLsRsbLiLsbLcbLsbLhLsbLiLsLsmbRsbRsRibLsLebLibLibLgbLibL
ibLsLsLimbLgbRgbRhbRcbRjbLobLobLjbLhbRjbLgbLhbLibLibLgLsbRgbLibRjRsmbL
jLsmbRjbLiLsbLibRjbRhbLeLsbLibsbLjLsmbLjbLjbLsbLcbLhbLgbLibLiLgbLsbReb
LgLsbLjLsmbLibRcbRjRibLiLhbLcbLibLibLibLcbLsbLibLhLsLgbLgbLhLsbLcbLcLs
LsmmbLiLsbLibLjbRgbRcbRgbRcbLsbLsbRjbLobLebLgbLobLgbRsbLibRhbRebLcbLib
LobLjbRibLcbLebLebLibLiLibLiLsbLhbLibLhbRibRebRcbRibLgbLhbLgbRsbLibLgb
LibLgbLcbLgbLibLgLibLgbLibLgRsbLiLsbLibLibLsLsmbLhbLgbLeLsbLibLgbLibLg
bLgbRsLsbLibLibLibLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bRibLiLsbLibLebLcbLgbLobLgbLibLibLibLgbRibRcbRibRibReRsmbRsLsbRsReLcbR
hbRgRsmbRgbRjbLjLsmbLjbLibRgbLcbRgbRcbRgbRgbRsRibLjbRgbsbLhLsbLcbRibRi
bRgbRibRcbRgRsmbRgbRgbRgRibLgbRibRsbRhbRibRibRibRgbRibRgbLobLibRjbRcbR
jbRibLjLsmbLhbLibLgLsbLibLcbRjbLibLsbLibRjRsRsmmbLhbRgbLsbRgbLjLibRsRh
bRjLsbLhbLibRibRibRgbRibRgbRsRsmbRibRebRibLcbRgRsmbRsbRibRibRibRibRibR
gbRiRsRsmmbReRsmbRiRsRsmmbRobRgbLcbLobLgbLcbLibLiLgLeLsLebsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162333; End: 162833;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bRsRsmbRsRebsbsbRsbRsRsReRsmmbRiRgRiRsRsRsRsRsRsRgmmmmmmbRibLgbLobLiRs
LsbLibLiLibLcbLibLeLsbLibLiRsbRjbRcbRcbLgbLgbLobLgLgbLhRsRgbRcRsmbRibR
ibRgbRibRibRsbsbRibRgbRsbRibLhLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLibLgLebLe
RsbLgbLcRsRsmbRgbLebLgLsLiRsbRcbRiRsmbRgRsRsRsRsRgRsRsRsRsRsRsRsRsRsRs
RsmmmmmmmmmmmmmmmbRsRsmbRobRiRsmbsbRsbRsbRgbRsbRsRgRsRsmmbRibLjbRgbLiL
sbLgRsbLobLsbRcbRgbRsbRgbRibRgbRhbRgbLoLsLcmbLgbLhRsbLgbLgbLgLsLsmbLhb
LsRsbRcbRgbRibRgbRsRsRsmmbRsRsRsRsRsRgRsRsmmmmmmbRsbRsbRsRsRsRsRsRsReR
sRgmmmmmmbRgbRgRsmbLjbLiRsbsbsbsbRgReRsmbRgRgRebRebLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bRjRgbRhbRgRgRsRgReRsmmbRibLebLcLibRibLjbsbRjbRjbLjbLjLsLsmmbRjbRibRjb
LjbLjLsmbRsbRjbRjRsRsRsmmmbRibsbsbRgLsbRgRsRsRsmmmbLgbsbRcRsRsmmbLsbLi
RgbLjbLiRsRsmbRjbLjbRgbRjRibLebLsbRhRsRsmmbRibLgbLsbsbsbRebRiRsmbLibRo
LebLgbRsbLgbRsbRjbRhbLsbLsbsbsbsbsbsbsbsbsbRgRsmbLsRhRsRsmmbRcRsRsmmbs
bLeLsbLcbLgbLibLhRsRsmbLgbLgbLcRsbRibLsbLsbRsbLsbLjbLibRhbRcRsmbRsbReb
RsbsbRsbsbsbsbRgRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bLsLsmbLjbRiRsmbRcbRcbRcbRcRsmbRibLcbLhLsbLgLsbLsRsbLsLgbRsLiLsbLsRsbL
cLsmbLcbLcbLgbRjbRcRsmbRcRsmbRhLsbReRsmbRobRgRsmbRibLjbLiLsbLsbsbLebLg
RsbsbLsLsmbLsLsLgmbLgbLhLsbLgbLiRsLsbLsLsmbLsbLibsbLsbsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bRsLsbLgLsbLsLsmbLsLsLsLsLsLgmmmmbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bsbLsbRsbRibsbLiLsLsRsRgmbRibLgbRsbRibLebLebLsLsLsLsmmmbLebLoRsbLoLsmb
LoRsbLebsbsbsbsbsbReLsLsLsmmbLhbLebLiRsbsbLsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bsbRsbLsbsbLsbLgLsbLebLsbLebLebLsLhbLebLebLebRcbRgbRsbsbsbLebLsLsLsLem
mbLiLsRsbLgbsbLgLiLsbRsbLebRsRsRsmmbLeLsbLeLsbLgbLsLsRsLembRsRsLembRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bRgRsLsRsRsReLsmmbRgRsRsRsRsRgRsRsRgRsRsRsRsmmmmmmmmmmbRiRsmbRsRgRsRsR
sLsRsRsRsRsRsRsRsRgRsRsRsRsRsRsRsRsRsRsRsRgRsRgRsRsRsmmmmmmmmmmmmmmmmm
mmmmmmmbRsbRsbLsbLiLsLsLsLsLiRsmmmbLsbLsbLsbLgLgLsLgLgLsLebLsbLsbLgbLg
RsbsbLsbsbRsbLsLsLsLsLgLsLgmmmbLgbLsLsLgLiLiLsLiLsLimbLsLsLsLsLgLsLemm
mbLsbLsbLgbLgbRsbLsLsLgmbRsbLsbLsbRsbLgLsLsLsLsLeLsLsLsmmmmmbLsLsLsLsL
sLsLsLgLsmmmmmmbLsLsmbLsbLsbLsLgLsLgLsLsLsLsLsmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bLcLsLgmbLcbRobRobRcLsbLiLgLsbLsLsmbLgLsbRcLsLsmbLgLsLsLsLsLsLsLsLcLsm
mmmmmmbLibRhbRsbsbsbLsbLsRsbLeLsLsmbLsLsLsLsLsLsLsLsLsLsLsLsLiLsLsLsLs
mmmmmmmmmmmmmmbLsbRoRsmbRiRsmbLsbRcLsbsbsbLgbRcRsmbLcLsLsmmbLcLsmbRcbL
sbLsbRcLsLsmbLhLgLsLgLsbLibRobRebRsbLjbLsLsLsLsLsLsLgLsLsmmmmmmbLoLsmb
LsbLcLsLsLsLsLsLsLgLemmmmmmbLiLsbRsbLcbRibRobRebsbRgbRsbLjLsmbRcbRhLsR
sbRgbLeLsLsmbRobLsbLsbLsLsLsLsLsLsLsmmmmmmbLcbLsLsmbRsbLhLsbRcbLcLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLcbLcLsRsmbLcLsLsmmbLeLsbsbRcRsmbRsbRsRsRsRsmmmbLebLhLsbsbRsbLcbLcbLg
bLcLsmbLcbRsbRcbsbRcbRcbRcbLcLsmbLebLcLsmbRsbLsLsLsmmbLsbLcLsmbLsLsLsR
sLsLsLsLsLsLsLsLcLsmmmmmmmmmbLsLsmbLsbLcbLsLsLgLsLsLsRsRsLsLsmmmmmbLcL
smbLobLoLsmbLhLsLsmbLeLsRsbLgbLcbLgbRebRsbLeLsbLoLsmbLobLcbLsbLeLsLsLs
mmbLhLsLsLsLsLgLgmmmbLcLsmbRsbsbLjbRhbRsbRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bLsbRjbRibRsRsmbLsbLsRsRsmbRsbLebRsbRobsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bLgLebLeLsLsmbRsLhbRsbLgLsbLgbLsLsLsLsLemmmbLibLsLsmbsbLsbLsLiLsbLsLsL
eLsmbLibRsbsbRsbLsbLgLsLibsbLsbLebRsLsLgLebLiLsbLiLsbLiLsbLeLsbRsbLsLs
LiLsLsLsmmmbLebLibLsRsLebLiLsbLibLhbRsbRsLibLsLebLsLsmbLibLhbRsLsLsLsL
sLsLsLsLemmmmmmbLibLeLsbLibLsbLibLiLsbLiLsbRsLebsbsbLsLiLsbLsLgbLebLeL
sbRsLgLsLgbsbRsbLsbLsLebLobRsbLibLcbRibRhbRgRsmbRiLsbLjbLhbLebsbRsLsLs
LsmmbLsbLsLsLsmmbLsLsLsLimmbLgLsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRsbLibLsRsRsmbRgbLobLibLcbLiLsbLsbRsRsRsmmbLibLibLibLibLibLiLsbLjRsLs
bsbLsLibLsLibsbsbRsRsLsmbLsLsLsLsmmmbLjRsLsLsmbLsLsLgmbLsbRsbLsbLgbRgb
RebLsRsbRcbLsbLjRcLcRobLcbLiLhbLibRiLgbLjbLibRjbLobRsbLiRsbLiLsbRgbLcb
LhbLibLibLhbLgbLibLibLibRgbLcbLebLsbLgLsLsmbLhbLgLsbLgLsLsmbsbLsRsbRsL
sLsLsLgLsLgLiLsLemmbRibRhbLhbLjbLsbsbRsLsLsLsLsLsLsmmmmmbLsbRsbRgbLibL
sbRsbRebLibLcbRcbRhLsbLobLibLibLgbLcLsLjmbLobRsbLsbLcbLhbLeRebReRsmbRg
bRjbRobLibLhbLgbLibLibLgbLiRsbLobLgbLjRsbRibRibLhbRibRsbLsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bLjbLgRsbLebsbLsLsLimbLebRobRgRsmbRcbLibLgbRobLcbLibLibRjbLgbRibRibLjb
RhbLgbLjLibLgbLgbLgRsbLibLcbLgRsRsmbRgbLibLjbRjbLiLsbLgbLebLgbLgLsbLib
LsLsLgmbsbLjbLebRsbLebLsbRsbRsbsbLsbRsbRsbLgbRgRgbLsbLgLsbRcbRgbRsRhRs
mbsbRsbRsRobRgbRhbLjbLjbLgLsRsbLhbLgRsbLsbLiRsLgbRsLsbLgbLibLsRsbLibLs
bLebLcbRsbLcbLgLsbRjbLsLsmbLibLgbLcbRsbLcbRibRibRjbLibLcLsmbLgbLgbLibR
sbLgbLcbRibRobRjRsmbLsbRebRibRgbLsbRsRsmbRiRsmbRgbLsbLgbLibLcbRsbRibLj
bLjbLiLsbLgRsbLsbLgRsbRjbLjbLiLsRsbRcRsRgmbLsbReRsmbRgRsRsmmbRsbRsbRsR
gRebRiRsmbLsRgRsRsmmbsbLjbLibLjbLsbRibRsbsbRsbLsRsbRsLsbRsbLsRsbsbsbsb
LsbLsbLsbLsRsRsmbLsbsbsbsbLsLsmbsbsbsbLsLsmbRsLsLsmbLgRsbLeRsbLhLsbRgb
RebRebRebRsRgbRgRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bRsbLobLobLebLsbsbLsbLsbRsbLsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRobRiRsmbRsRgRsRgRsRsRsRsRsmmmmmmbRgbRsRsRsmmbRgRsRsRsRsRsRsRsRsRsRsR
gRsRiRsmmmmmmmmmmmmbRiRgRgRgRgbRsLobRcbRsbRsRgRsRgRimbRsRsRsRsRsRsRimm
mmmbRgRiRgRgRsmbRsRsLsmbRsRsRsRsRsRsRgRsRsRimmmmmmmbRsRgbRhRgRsRgmbRhR
sRgRsRgRgmmbRgLsRsRsRgRsRsmmmbRebRiRsRgLsmbRsRsRsRsRsRsRsRsRsmmmmmmmmb
RibRsRsRsRsRimmmbRibsbRcbRgbRhLsRsbRsRsRsRsRsRsRgRgmmmmmbRgRsRsRimmbRs
RsRsRgmmbRsRgbRgbRcbRcbRgbRjRgRsRsRiRsRgmmmbRsbRsRsRgRsmmbRgbRgbRibLsR
sbRsLsbsbRgRsRgmbRgbRsLsbRsRsRsRsRsRsRsRsRgRgRimmmmmmmbRgbRhbRsRiRsRim
bRsRgbRsRsRsRiRsRimmmbRgRibRsbsbRgRsRgRsRsRsRgmmmmbRiRsmbRgRsRiRgRsRsR
iRsmmmmbRcbLobRebRebRibReRgbRsRsRsRgRsmmmbRsRsRgRsRgRsRgmmmbRibRsbRsRs
RsRsRsRsRsRsRimmmmmmmbRgRsRsRsRiRsRgRgmmmmbRsRsRsRsRgmmmbRcbRiRgbRsbRi
RgbRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbRobLsRsRsRsLsmmbsbLsLcbRg
RgRgRsRgRgRimbRsRsRsRsRsRsRsRemmmmmmbsbsbRsRsRsRsRgRsRgmmmmbRgbRgRsReR
gmbRiRgRsRsRgRsmmmbRgbRgRsRimbRgRgRsRsRimmbRgbLsRsRsRgRsRsRsRsRsRgRgmm
mmmmbRsRgRiRiRsRgmbRgRiRsRsRsRgRgmmmbRibLsRsReReRgRsmbRiRsmbRsbRsRsRsR
sRiRiRimmmbRgbRhLgbRgbRgRgRgLsbRsRsmbRsRsmbRibRiRsmbRibRiRsRsRsmmmbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bsbRsbRsRsRgmbRsRsRgRsRsmmmbRsbRsRsRsRsRsRsmmmmmbRsLsLsRsmbRsRsRsRsRsR
sRsRsRsRsRgmmmmmmmmmbRgRsLsmbRgRsRgRsRsmmmbRsRibRsRsLsRsRiLsmbRsRibsbR
sRsRsmmbRgRsmbRsRebLebLcbLebRhbLoLsmbLcbLgbLebLgbLebRgbLebLgbLcbRcbLhb
LsbsbsbLsbLgLsbLsbLiLsbRsbLsLsLgLsLsLsmmmbLsRsLeLsbLgbLebLsLsLsLsmmmbL
gbLsLiLsbLsLsLgLsLsLsLsLsLemmmmmbsbRsbRsbRgRgRsRsmmbRsbRsRsRsLsRsRsmmm
bRsbsbsbsbRsbRsbRsRsRsRsRsRsLsmmmmmbRsRsmbRsRgRsRsmmbRsRsRsmmbRsLsRsRs
RsmmbRsRgRsRsmmbsbRsLsRsbRiRsRsRsRiRsmmmmbRsRsRsRsRsmmmmbRsRsmbsbRsbRs
LsRsRsRsRsRsRsRsmmmmmmbsbRsRsRsRgRsRgRsRgmmmmbRgRsmbRsRgRgRsRsRsRemmmb
RsRsmbRsRgbRsRsmbRgLsbRgbRsbRgRsRsRgRemmbRgbRsRgRsmbsbRgRsRsRsmmmbRsRg
RgbRgRsmbRsRsRgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRsbRsbLsbRsRiRsmbRsbRsbRsRsRsmmbRsbRsbsbRsbRsbsbsbRsbRsRsmbRsbRsRibRs
LsbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbLsbRsbRgbRgRsRimbsbRebLebRsbRsbLsb
RsbRsbRsbLsRsRsRsmmbRsbRsbsbRsRsmbRsbLsRsLsbRsbRsRsRsRsRsmmmmbRsRsRgRs
RsmmmbRsRgRsRsRsRsRsmmmmmbRsRsRgmbsbRgRgLsbRsRsmbLsRsbLsLsmbLsRibRsRsR
sRsmmmbRsRgbRsRgRgRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsbRsbRsbRsbRsbRsbRsbRsR
smbRsbRsLsRsbRsRsRsRgmmbRsbRsRsRsmmbsbRsRsRsmmbRsbRsbRsRsmbsbRsRsRsRsR
smmmmbRsbRsLsRsRsRsRsmmmbRebRgbRgRsmbRebRcbRgbRsRsmbRsRsmbRsbRsRsRsRsm
mmbRsbRsbRgbRsbRsRgRsRsmmbRgbRsbRgRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsRsR
sRsmmmmmmmmmbRsRsRsRsRsmmmmbRsRsmbRsRsmbRsbRsRsRsmmbRsbRsRsRsRgmmbRsRs
RsmmbRsbRsRsRsmmbRsRsRsRsRgRsRsmmmmmbRsRsmbRsRsRsRsRsmmmmbRsbRgRibRgbR
gRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsbLsbsbsbsbLsbLjbRsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bsbLsLeLibLgbLcbRjbLsLiLiLibLgbLebRebRsRsRsRsmmmbRgbRsbRhbsbRgRsmbRebL
obLhbLsLsLsLsLgLimmmbRsLsLsLgLembsbRsRsmbRsbLsLsLsLeLsmmbLhLgLeRsbLgbL
ebLgbLebRsbLsbLebLibLebLgbLsbsbRsbRjbLsbRebRibsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bLgbLobLibRibRcbRcbLiRsbRiRgbRsLsbRebRsbsbLsbLcLgbLhbRibRebRibReRsmbRe
bRebRiRsmbLsbRsbRsRsRsmmbLsbRebRsbReRsLsmbRgbRsbRsbRebLgbRibRgRsRembLs
bRgRsmbLsbsbLsRebRiRsmbRibRgbRgbRsbLsRsbRcbRibRibRibRebLsbLsbRiLsbLsbs
bLibLsLgbRsbsbRsbRsbsbsbLsbReRsRsmmbReRsLsLiLsLsmmbLgbLgbLsbRgbRcLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bRsbsbRsbsbsbsbLsbsbsbsbsbRsLsbsbsbsbsbLsbsbsbLsbsbLsbsbsbsbsbsbRsbLsb
RsbsbsbsbsbRsbRsbLsLsmbsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bRgLsbRobRgbLjbLcbLibLsbLebsbRgbLibLsbLgbLgbLsbLgbLgLsLsmbLibLiLsbRsbL
ibLgbLgbLibLgbLiLsbLibReLsbLjbRsbsbRsbRsbRsbRibLgbRjbRgbRcbLgbLsbLgbRo
bLsbLsbLgbLjbRcbLgbRhbRsbLsbLsbLibLsbsbLgbLiLsbLhbLgbLsbRsbRibRgbLsbLe
LsbLsRsbRsRsmbLebLibLgRsbLibLgbLsbsbLgbRsbLibReRsmbRobRibRgbRsbLjbRsbL
sbLjbLcb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bRgRsRgRsmmbRebsbRgbRsbRsRsmbRsRsmbRsbRsbLsbRebRibRebsbLeLsbLsbLibLibL
ebRebLsbRsbRsbRiRebLsbLibLcbRcbLiRsRgRsRgmbRgbRgLsbRebRgbLebLjbRjbRsbL
sbLsbRebRobRsbRsbLsbLiLsbLsbRsRsLsmbRebRjbRhbRebLhbLhRsbLsLsmbLcbRsbRs
bLgbLsbRhbLgbRsbRsbRsbRhbRcbLibLgbRsbLsRsbLsLsLsLsmmmbsbLcbRibLsbLsbLs
bRsbsbLcbRgbRsbRsbRgbLgbRsRsRgmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bsbsbReRsRsmmbLobsbRgRibRiRsmbRiRsmbsbRsbRebRcbRcRgbsbsbsbRsRsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bLobLebLibLobRsbLebRgbRsbRsbRobLebRgbRjbLobLcbRhbLjbRobLebLjbLebRgbLeb
LobRobRjbLcbRcbRebLobLobRsbRobRsbRobLcbLibLobLebRjbRobLcbRcbRibLcbRebR
ebRebLobRgbRobLjbRobRgbLebLibLibLobLcbLsbRobRcbRobRgbLebLebLobRobLsbRs
bLsbRjbLobRhbRebLebRebLebRcbRgbRobRibLcbLobLobLibRobLibLebLsbLebRcbRob
RebRebLebRobRjbLibLibLobLebLobLobLebLcbLebRobLobRobRibRebRebRobRobLobR
obLebLobRebRgbLobLgbRobLobRobLsbRibRobRobRibLobLebRsbRcbRjbRsbRgbRcbLo
bLebLobRgbLsbRobLebRobLobLebRgbLjbLobRcbLobLobRgbRobLobRobRibRcbRsbLob
LobRebRibRcbLobRobLhbLobRobRjbLobLobRobRobRobRobLcbLsbLebRobLebRobRobR
ebRcbLobLebLcbLebLebRobLsbRobLcbRgbLhbLebRibRsbRgbRobLsbLgbRobRcbLibLc
bLobLobRcbRobLsbRcbLcbLebLcbRobLsbLgbLobLebRebLobRobRobLhbRobLsbRebRcb
RobLobLobRebRebRobLsbRebRebLobRibRobLebLebLebRcbRebRcbRobRobRobRebRebL
ebLebLjbRobRobRibLobRcbLgbLobRobLebLobLibRcbLebRsbLobLebRobLcbLobLobLc
bLobRobRebLebLobRibRgbRobRobLgbLebRobRebLebLobLobLobLobRebLobRsbLcbReb
LebLobRobLobLebLobLgbRobLobRgbRobLcbLobLebRgbLebRobLsbRibLebLibLcbRebR
obRcbLebLobLcbRebLobLsbLgbRcbLobRobLsbLobRebLobRobLobRcbLibRibRobRobLe
bLjbRsbLebRcbLebLebRcbRobLebRebRobRobRobLcbRgbRebLebLebRebRobRobLebLib
RcbLobRobLobLobLobLobRobLsbLcbRcbLebRobLobLobLobRebRgbRebLobLibLebLcbR
cbRcbRebLgbRobLebLibRobLobLobRibRobLcbLobRibRobLebLobRcbLcbRcbRobLobRi
bRibLobRcbLobLobLobLobLcbLobRobLsbRobLobRobLgbLibLobRobLcbRobRcbLobLeb
RobRebRcbLobRebRobRgbRebLebRebRebRibLobLobLobLebRebLebLsbRgbRgbRgbLobL
obLobLgbRsbRebRebRgbRebRebRebLibLcbLsbRibLcbLobRsbRobRobLobLobLobLobRo
bLebLobRobRebLgbRibRjbLebRjbLibLcbRobLcbRobRobRcbLobLcbLobLobRobLobLcb
LibRcbLobRebRcbRebRibLobLsbRsbRgbLibLobRobRebRebRebRebRobLobLebLebRcbL
obLobLcbLcbLcbRobLibRibLobLibLcbRcbRsbLobRobLgbLebLsbRgbRcbRgbLobRhbLe
bLobLcbRobRebRcbLebLebRebLobLibLobLobLebLcbLobLjbRcbRebRobRgbLobRobLob
RebRobLcbLobLcbLcbRobLibRobRobLibLcbRobRsbRgbLebRebRobRobRobLebRebRebL
ebRibRibLobLobLsbLcbLebRobRsbLcbRebRcbLibLgbLibLebRebLobRobLibLobRobRo
bLibRobRcbRebLibLobLobRebRibLcbRebLibLcbLhbLobLjbRjbLebRsbLsbLobRobRib
RsbLobLobLebRebRebLcbLebRobRhbRgbLebLebLebLebLibRebLebRjbRgbLcbRobLsbL
ebRobRobRcbRobRgbLobLcbRsbLobRebRobLebRibRibRibRhbRobRcbLobRibRibRebRo
bRobRobLsbLebRsbLsbLobLebLjbLsbRsbLobRobLgbLibLobRibRcbLcbRebRibRobReb
RcbLobLebRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRsbLsbLsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRgRsmbRgRsRsmmbRsRsmbRcRsRsmmbRgR
smbRiRgbRgbLeRsbRgRsmbRsRgbRsbRgbRgRsmbRgRsmbLsRsbLcbLhbLsbsbRsbRsbRsb
RiRsRsRsmmmbReRsmbRsRsRsmmbRsbRsRsmbRiRsRsmmbRsRsRsmmbRsRsRsmmbRsbRsRs
mbRsRsmbReRsRsmmbRgRsRsRsmmmbsbRgRsRsmmbRsRsmbRiRsmbRgRsRsmmbRsRsRsRsR
smmmmbRsRsmbRsRsmbReRsRsRsLsmmmbRgRsRsmmbRsRsmbRgRgbRgRsRsmmbLsbRsbsbR
sbRsbsbRsbsbRsbLsRsbRsbRsbRsRsRsmmbRsbRsRsmbRsbRsbRsbLsRsbLsbLsbLsbRsb
RsRsmbRsbLsLsRsRsRsmmmbRsbRsbsbRsRsmbRsbRgbRsRsRsRsmmmbRsbRsbLsbLsbRsb
RsbRsRsmbRsRsmbLsbRsbLsbRsbRsbRsRsmbRsRsmbRsbLsbRhbLsLsRsmbLsbLobLibLg
bLsbLgbLebLibLgRsbLgRsLsbRsbLgbRsbLgbLgbsbLgbLsRsbLjbRsbLsLsmbLiRsbRsR
sRsmmbReRsRsmmbLsRsRsmbRsRsmbLsRsbLibRiRsmbRsbsbRsbRsbRsbRsbLsbLsbRsbR
sbLsbRsbLgRsbRsbRsbRgbRgLgRsRsmbRgRsRsmmbRgbRsRsmbRsbsbLsbRsRsmbRsRsLs
mbRgbLsbRsbRsbRsRgbLsRsbsbRgbRsbRjbRsRsmbRsRsmbRebRcRgbRjbRsLsbRoRsmbR
sRsRsmmbRgRsRsRsRsmmmmbRsRsRsmmbRgbRebLsbRgbRsbRgbLsRgRsmbRgRsmbRiRsmb
ReRsmbRcbRsRsmbRibRsbLsbRsbRsbRsRsRsmmbRgbRibRsbRiRsmbRsbLiRsRsLsRsmbL
jbLiRsbLsbRjbRgbRsLsbsbsbLsbRgbRsbLsRsbRsbRsbsbRgbRsRsmbLsRsbRsbLibRsb
RsbRsRsmbRibRiRsmbRsRsRsRsRsRsmmmmmbLsRsRsmbRsRsRsmmbRsLsbRiRsRsRgmmbL
sbLsbRibLibRsbRsRsmbLsbRsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bRsbLsLsRsmbLsbRcbRiRsRsRgLsmmbRsbsbRsRsRsLsmmbLeLsLsLsLsLsLsLsLsLsLsL
sLsLsmmmmmmmmmmmmbLiRsbsbLhLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLhLsLsLsLsRsm
mmbRjRebLcLsmbLobLobLiLsLsLsLsLsmmmmbLeLsbLcbLibLjLgLsLsLsLsLsLsmmmmmb
LibLgbRhbLiLsbLiRsLsLgbLcLgbLcLsmbLgLsbRcbRiRsmbRibRsbRiLsbRgbRiLsbRiL
sbRhbLcbLcLsLeLsmbLcLsmbLeRgLsbLebLebLeLsLsLsLemmbLsLiLiLsbLiLsLiLsbLe
bRsLebLgbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLebsbLsbRsbLeLsLiLsbLibRsLsLsLsLgLgmmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLiLs
LeLsmmbLsLgbsbsbLsLeLebLsLsmbLsRsbLebsbRsbLeLsRsbLsLgLsLsmbLsLhLiLibLe
bLgbLiLsbLsbLsbLebLsbLsRsRsmbLsLeLgbLsLsLhmbLiLsLsmbLsLhbRsLsbsbLebLeb
LsbLsLsmbLgbRsbLhLsbLibsbLsLibLgbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bLjbRebRgbRjbRgbRsbRsRgbRsRsmbLsbRgbRsRsmbRsRsmbRsbRsbRsbsbsbRgbLebLsb
RsRsmbRsRsRsLsmmbRsbLsbLsbRsbsbRsRsRsRsmmmbRsbRsbRsbRsbRsRsmbRibRgbRsR
smbRgbRsbRgbRgbRgbRgbRgbLcLsmbLsLsLsmmbRhRsmbRhRsLsmbLjbLsbRsbLsbLsbLs
bRgbRsbsbsbLsbsbLsbsbRsbRsbLsbLsLsmbLsbLsbRsbsbsbsbsbsbsbsbsbRsbLsLsRs
mbRsbsbLsRsLsbLsbLgLsbLsbRsbsbRsbsbsbsbsbLsLsmbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bsbsbRsbRsbLsbRsbRsbLsbRsRsmbRsbRsbsbRsbsbLsbRsbRsbRsbsbRsbsbLsbRsbLsL
smb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bLebLibLgbRgLsbRebRcbLhLsbLgLsbRsbRsRebRibLjbLibLcbLgRsbLibLgbLgLsbRjb
RoRsmbRibLsbRgLsbLsbLibRjbLebLebLeLsbRsbLgbLebLebLgLsbLibLebLhLebLebLe
bLebLgbLsbLcbLebLsLsLgmbLebLsbLibLgbRgbLsbRjbLibRsbLsbLsbRcbRebRgRgbRg
bRiLsLsRimbRebRebRebRebReRebRsRsmbRsbLsbRgbRebRibRebRiRgbRsReRebRhRsRi
mbRsbRibReRsmbRsRsmbRibLsReRsmbReRsmbLsbRsbRebRgbRgRebRebRsRgRgbRsRsRs
mmbReb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bsbRcLsbRgRsmbRsRsRsRsRsmmmmbLsbRibLoLsmbLgLebRsbRsbLsbRsbRsRsmbLcbLob
RsbLobLgbLibRibLcbLiLsbRibLjbRsRsRsmmbRgRebRgbRsbRsRsRsRsmmmbRsRsRsmmb
LcLsmbLsLsmbRsbRcbLsLsmbRhRsRsmmbRjRsmbRsRsRsmmbRibLgLsLsmbRsbRcbRsRsR
sRsmmmbRsbLsbRgbLcbsbsbRgRsmbLsLsmbLsLsLsLsLsRsmmmmbRjbRiLsLibLcbRgbRs
RsRsmmbsbRsbRsRsRsRsmmmbLiLsbLsbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bLcbsbsbLjbRhbRsbRjbLhbLsLsmbLiLsbLebRgbLeLsRhbLibRcRsmbsbRcbLoLsLsmmb
LsbLsbRibRebLcRgbLebRgbLsbsbsbLeLebLsbRibLhRsbLsRsbRjbRobLobLibRjbRhbL
ebRjbRcRsmbRsbRobRhbRgbRcbLsbLcbRsbRhbLsRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bLcbRgbRsLobLibLhbLsbRsbRibRsbLgbLibLcbLsLhbLeLsbLcbLoLebLebLibLsbLsbR
obRebLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bLsbRsbLsbLsbLebLebLiLsbLeLeLibsbLiLgLsbLgbLcbLibLibReRsmbRgbsbLeLsbLc
bLcbRsbRsLhbLcLsmbLebLebLeLeRsbRebRhbRebsbRebRiRgRsRsLsmmbLsRiLsbLiRsb
RebLjbLcbLibRjbRcbRebLibLjbLhbLgbLjbRjRsmbRibRebRgbRiRsmbRgbLsbLcbLobL
gbLebLcLiLsbRsbLhbRsLsbLibLibLcbRibRibRibLgLsbRhLsbLibLibLhbLcbLibLgbL
jbLsbLgLsLiLsbLgbRsbLeLibLebLebLjbRgbLjbLibsbsbLebLgbLebLebLhbsbLeLsLs
mbLgbLibLsLhbLgbLcbRcbRsbRsbRebsbsbsbLsbsbsbsbsbsbsbsbLsbRsLsbLsbsbsbR
sbRsbRsbRsLsbsbLsbRsbRsbRsbLsRsbRsRsLsmbRsbsbsbsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bRsbRsbRsRsmbRsbsbsbRsLsRsLsRsRsRgRgRsRimmbRsRsRsmmbRsRsRgRsRemmbRsRsm
bsbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbsbRsRsmbRgRgRsmbRsRsRembRsbRgbsbRg
bRiRsmbRsbLjbLiLsbRebRsLsbRebRsbLsRsbRsRgRsRgmbRsRsRsRsmmmbRsRibRiRgbR
obsbLsLsmbLsLsmbLsbsbLsbsbLsRsLsRsLsbLsLsmbRsLsbLsbLsLsLsmmbLsLgbLsLsL
sLsLsLsLsLsLgLsLsLsLsLgLsLsmmmmmmmmmmmbLsbRsbLiRsbLiLgbLsbLsbsbLsLsRsm
bLsLsmbLsLsmbLsLsmbLgLsbLsLsLsRsRsLsLsmmmmbLsLsLsLsLsRsLsLgLsLeLemmmmb
sbLgLsLsmbRsLgLsLeLeRsbLiLsbLgLgLsbLsbLeRsLsbLiLsRsbLsRsbRjbRsbLcbRcbL
sbRsLsLsLsLsmmmbLsLsLgLgmbLsLsmbLsbsbRsbRsbRsbLsbLsbLsbLsbLsLsmbLiLsbL
sbRsLsbLgbLhLsbRjbLhLebLsRsRsRsmmbsbLibLsbLsLsLsLsLsLsLsRsmmmmmmbLsLsL
sLsLemmmbLgbLgLgbRsRsmbLsLsLsLemmbLebLhbLsLsLsmmbLsRsbLsbLsLsLsLsLsLsm
mmmmbLsLsLsLsLsLeLsmmmmbLeLsLsRsmbLsbLgbLibRsLsLsLeLsLsRsmmbLsbsbLsLgL
gLebLgbLsLsmbLsbLiLsbLiLsbLebRoRsmbRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bRsRebRsRgbRgRsLsmbRsRsRsRsRsmmmmbRsRgRsmbRiRgbRsRsLsmbRsRebReRsmbRsRs
mbRibRsRsReRsRgRsmmmbRebRgbRsRsRimbRsRsRsRsRsRsmmmmmbReRsmbRsRsRsRsRsm
mmmbRgRsmbRsbRsRsRsRsRimmmbRsRsRimbRsRsRgLsmbRsRsRsRsRsRsRgmmmmmbRiRsm
bRsRsRsRsmmmbRgbRsRsRsRimmbRsRsRembRgRhRsRsRsRgRsRsmmmmmbRsRsmbRibRsRs
RsRsRsRgmmmmbRsRgbLsRsRsRgRsmmbRsbLsbRebRsRibRsRsRgLsRsmbRsbRsbRgbRsRs
RsRiRsmmmbRsRsRsRsRsRsRemmmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bLsLsmbRsRgRgRibRgbRiRgRiRsReRimbsbsbsbsbsbsbsbsbsbLjbLjbsbRiRebsbsbsb
LsbRsbRiRsRsRemmbRebLjbsbLsbsbRsbLjRsbReRsmbLsReRsmbRiLsRsbLgbLcbLhLgb
LgbLcbLcbRebRiLsbRsRsRsmmbRgbRcRsmbLgbRjbLsbsbsbRsbLsLsLsmmbsbsbsbRjbR
ebRebReRsmbLsbRebRebRhRsLsmbRcbRebRibRebsbRcRsmbLsbLhbLibLjRsRsLgmbRcR
gbRibRibRgRsmbLgbLjbLjbLgbLgRsRsmbLgbLgLsLsmbLhbRjbRhbLjbLiLsbLjLsmbRs
RsRsRsmmmbRibRcbRsRsRsLsLsRsmmmbLsLsmbLjRsLsLsLsmmbLgbLjbLcbLibLgLgbRg
bLgRsRsLsRsmbRibLgLgbLgLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLsLsLsLgLsLiLsLemmbLsLiLsLsmbLgbLgbLsbLsbRsbLsLsLgLgLsLsLgmmbLsbLsLsL
smmbLsLgLgLgbLsbLsbLsbRsLibRibLiLsLsmbLgbLiLsbRgbRhbRsbLiLsLgLsLsLsLsL
gLiLimmmbRsLgbRsLgLsLibRsbLgLibLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmbLsLs
mbLibLsLsLiLsmbLsLsLsLsLgmmmbsbLsLgLhLsLsmbsbLsLsLsLsmmmbLgbLsLgLgRsbL
sLgbLgbLsLsmbLsLsmbLsbLsLsmbLsLsmbLebLsLsmbRsbLsLsmbLsbLsLsLsLgLsmmbLs
LsLsmmbLsbLgbLcbLsLsLsLsLsLsLgLgmmmmmbLibLgbLsbLsbLibLgLsLsmbLcbLsLsmb
LgbLsbLsLsLsLsLsLsLgLsLsLsLsLsRsmmmmmmmmmbLsbsbRcbRsRsmbRsRsRiRgmbRsbR
sLsbRgbRjLsbRebLsLsLsLsLsLsLsLsLemmmmmmmbLsLsLsLsLsLsmmmmmbLsLsmbLgLgL
sLsLsLsLsmmmmbLsbLibRsbLsbLsLsmbLibRcbLgbLibLibLgLsbLgbLgbLiLsLsLgLsLs
LsmmmbLsLsmbLsbLsLsmbRsLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRgLsLsmbRsLgLsbLsbRcbsbsbRsRsmbRibRgbRibRgbRgbRgRsRsmmbsbsbsbsbRsLsbR
hbRsRsRsRsmmmbLsRsRsRsmmbRgbRgRsRgmbRsRsRsRsRsmmmmbRsbRsRsRsRsRsmmmmbR
sRsRsRsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bLsLsmbLsbLsbLsbLsbLgbLsbLsbLgbRsbLsbLsbRsLsbsbsbLsbLgbLsLgbLgbLsbLsbL
sbLsbLsbLsbLsLsmbLsLsmbLgbLsbLsbLsbLsbLsLsmbLsbLsbLsbRsLgbLsbLgbLsbLgb
LsbLgLsbLsLsmbLsbLsbLgbLsLsmbLgLsbRobLsLsmbLsbRsbRsbLsbsbLiLgbLsbLsbRs
bLsbLsbRsbLobRsbRobLgbRsbLsbRsbLgbLgbRjbRsbRcbRsbLgLeLsbLsbRoLsbRobLgb
LsbRsbRsbLsbRsLsbRsRsmbRsbLsbRsbRsbLsbRsbLsbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bLhbLsbLgbLebsbRsRsmbsbsbsbsbLsbLsbLsbLebLiLgbRcbRibRcbRobRhbsbLjbLcbR
eRsRimbRebRsbLsbRsbsbLsbRsLsbLsLsmbLsRsbRsbRsbRsbLsbLsRsRsmbRsbRsbRsbR
sbLsbRsbRgLsbRsRsmbsbRcbRjbRibRgRiRibRebLsbRgRebRibRsReRgRsmbRsbRsbReb
RebRebRebRebRgbLjbLsbLcbLcbRoRsLsmbRjbRobLibLsLgbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bLebLobRcbRibLcbLhLgbLcLsmbLsbRsbLibLiLsbRgbLgbRjbRiRgRgbLhbLcbLsbLhLs
bLgbLhbLiLsbRjRsmbLgbLsbLiLsbRjbLgbLgbLhbLcbLiRsbRsbRsRsmbsbsbRsbsbRsL
sRsbLsbRsbLsbLsbLsLsLsmmbLebLebLsLiLsLeLsbsbsbRsLsbLsRsbsbRsbRsbLsLsmb
sbRsbRsbsbRsbsbsbsbsbsbsbRsbsbRsbsbsbsbRsbsbLsbRsbsbsbLebRhbsbRcbRcbLj
LiLeLcbLibLebLibLibsbRsLebLgLsbLcLsmbRgbLebLsbLebLeLsbLsbsbLsbRsLsbLsb
LeLsbLebRgLibLibLebLgLeLsbsbLebLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bRsRsmbsbRsRsmbsbRsbsbRsRsmbsbRsLsbLsbRsbRsbLsbRsbsbLsbsbRsbsbLsbRsbLs
bRsbsbRsbLsbRsbRsbRjbRsbRsbLsRsbRsbRjbRgbLsbRsRsmbsbLsRsbRsbRsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bsbRibRibRibRhLsbRibRgbRibLgbRcbRibRibRebRibRibRiLsbLibLsLgLsbRoLsbRhb
RsRsRsmmbRiRsmbRhRsmbRcRsmbRcbRibsbLibRjRsmbLibLibLhbLibLhbLjbRhbLjLsm
bRsRibRibLjLsLsLgmmbLsLsLsmmbRsbRgbRhbRibsbRsRsmbRgRgRsRsLsRsmmbRsRsmb
RgbRjbRgRsmbRgRsmbRgRsRsmmbRsRsmbRsbLsRsRsmbRsRsRsRsRsRsRsmmmmmmbRgbLs
LsRsmbRjbRsbRgRsmbsbsbRsRsRsmmbLiLsbRjbRcRsRsmmbsbRibRcRsmbRgLsLsmbRjR
sRsmmbLcbLcLsLsmmbLhbLeLsbLcLsmbLcbLhbLiLgbLgbLibLgbLobLcbLcbLsbRcbLgb
LcbLhLsLcbLebLibLoRsbRibRcbLcbLcbLcLsmbLebLgbLgbLibLgbLgbLgbLcLsLsLimm
bRibLjbLhLsLibRsbLibLgLsbLibRsLsbLgbLgbRjbRcbRibRsbRiRsRsmmbRibRibRebR
sLsLsmbRibLjLsLsmmbRgbLcbRcbRebLsRsbRsRsLsmbLsbLgbRcbReRgReRiRgRsRsRsR
smmmmbReRsRemb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bsbsbRhbLjbLcbLhbRibRibRjRgbRhbLcbLcbLibLgLsbRsbLcLsmbLgbLcbLiLsLsmbRg
bRcRsRsmmbRibRibLcbLiLsbLhbLibLiLsbLcbRgbRcbRcbRibRiRsRsmmbRiRsmbRibLs
bsbLjbLibLcbLcbLibLsbRhbRsRibRiRsRsmmbRibLcbLcbLibLjRsbRgbRjbRcbRjbRgb
RibRsbRibLgbRsLsLsmbsbRibRsbRsRsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 162835; End: 163336;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bLsRsbRsbLsRsbRsRsRsRsRsRsRgRemmmmmbRiRsRsmmbRibRobLgbLiRsbLibLiLsRsbL
ibLibLibLgbLcbLibLsLgbRebRcbLsbsbRsbRgbRgReRgRsRimbRcbRsLsRsRsmbRcRsmb
RiRhbLobsbRsRsRsmmbRsbRsbRsbRsRgRgRsRgReRsmmbRsRsRembLhLsbLsRobRebRhRs
mbLibLcbLibLgRsbLibLiRsbLiRsbLgRsbRsbRcbRcbRgbRebRgbsbLsbRsbRgReRsmbRg
bRgRsRsmmbLobLibLobLgbLibLibLgLibsbLsbRsRgRsRsRsRgRsRsRsmmmmmmbLcbRhbR
ebRsRebRsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 1; Drug: NDMC 10 然 Apo 50 然
bLgbLibLjbRcRsmbRiRsmbRiRsLsmbLgbsbRibReRsRgRsLimmbLsLsLsmmbsbRsRsmbRs
LsLsRsmbLsLsLimbLeLeRsbRsbsbsbLibRibLibLeLsbRhbLjbRsbLibRsbRsbRgRsmbLj
bLebLcbLhRsbLsRsbLibRjbRiRsmbLgbLhbRsbLsbLsbRsbsbsbLsbsbsbsbsbRjbsbsbL
sRgbLhbRgbLibReRsRsmmbLsLsRsRgRsLimmbLgbLsbLsbLsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 2; Drug: NDMC 10 然 Apo 50 然
bRcbRjbLobRobRjbRgbLjRsbRgRsRsRsmmmbRcbLebLiLsbLobLsbRcLsbRgbRibRsbRib
RhRgRsmbRgRebRob

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 3; Drug: NDMC 10 然 Apo 50 然
bLgbLsLsRsLsLsmmbLsLsLsLsmmmbLsLsmbLsLsmbLsLgbLsLsLsLsLsmmmmbLsRsLsbLs
LsmbLgbLsLsLsmmbLsbLsLibLcbRsLsbLsbLsbLsbLsbLsbLibRsRsmbLsbRebRsRsRgRs
RiRsmmmbRebRibRsbRsbLsRgbLebLcbLgbLibLgbRsbRgbRsRsmbRsbRsbRsRgbRibRsRg
bRsRsmbRsbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 4; Drug: NDMC 10 然 Apo 50 然
bLjbRjbLjbRebLjbLobLobLebRebRebRjbRjbRebLobLjbLobLebLobRebRcbLobRcbRcb
RgbLcbLebLibLibRobLobRobLobLobLobRobLsbRgbLebRcbRebRcbRsbLcbRebRobRobL
obRobRobLobRobRibLcbRsbRgbLobRobRebRcbLobRhbRobRibRobRobLcbLebRgbRibLj
bRibRgbLobRhbRebLobRobRebRebRgbLobLobRobLebLsbLobLcbRebLibRobRebLcbRgb
LibLibRsbRgbRebRhbRebLobLjbRcbRgbRgbRhbLobLibLcbRobLgbLgbLebRcbLobRibR
cbRibRobRobRibLcbRobRobLobRcbRibRobRebLhbLebRgbRibRebRebLebLobRebRobLs
bLebRcbLcbRibRebRcbRibLebRsbLgbRebRcbLsbRobRebLibLobLibLobLgbLobRobLob
LibRcbRgbLobRobLobLobRibLebRobLobLibLebLebRgbRobRcbRebLebLgbLgbRebLobL
gbLebRcbRibLobRobRcbLobRebLsbRobLhbRobLibRebLobRobLobLhbRobRebLobRebLo
bRebLhbRcbLobLebLebRobLibLobRsbLcbLobRcbRibLobLobLgbLcbRobRobLgbLibLeb
LcbRobRcbLobRobRgbLebLebRibLebRibLobRibLobRgbLcbLebRobRobLobLjbRcbLobL
hbRcbLobLgbRhbRgbRebRebLobRebRcbLobRibLgbRobLobLobLebLcbLibLobRebRcbRo
bLebLobRcbLsbLebLjbRcbRgbLibRobLibRebRobRcbLsbRobLcbLcbLebLobLcbRebRgb
LobLgbRobLobRcbLebLcbRcbRgbLobLgbLgbRobRobRebLebRobLobLobRebLcbRobRcbR
cbLibRibLcbLgbRebRobRcbRcbLcbRobLibRsbRibRobRibRobRebLobLcbLebLcbLobLo
bRebRgbLobRgbLgbRgbRebRobLgbRcbRcbRjbRobLebRibRobRhbLsbRobLobLobLgbRgb
LcbRgbLsbLobLobRobRobRjbLcbLobRebLebLebRebLcbRobLcbRibLobRobRibLibLibL
obRebLebLobRobLgbRebRobLsbRobRgbLebLobLobRobLebLcbRobRebLobRobRobLhbLe
bLobRibRobRobRibRgbLcbRobRobLebLobLobRebLibRobLobLebLebLebLebLibLebRgb
RebLobLobLgbLjbRsbRcbLgbRcbLibLgbRobLcbLcbRobLibRobLebLebRebLobRobRcbL
ebLebLcbLebLibLjbRjbRibLebRsbRobLobLcbLcbLobLebRibLcbLobRobRsbLebRobLo
bRobRcbRgbRobRobLebRjbRcbRebRjbLebRcbLsbRsbLobLobLcbLsbRhbLobRobRobLob
LjbRebRcbRobRebLobRebRebRcbLcbRobLobLebRebLebRcbRebRebLobLobRcbRgbRebL
cbRsbLgbRobLobRgbLibRobRibRcbRebLobLcbRebRobLcbLobRobRobRobLobLebRobRo
bLcbRebLobLcbRebRobLjbRcbRobLebLebRcbLebRobRibLebRjbRebRebLhbLcbLjbReb
RobRobLebLobRobRcbLcbRgbLobRibLibRobLobLobLebRobLsbRobRobLobLebLsbRibL
obRebLebRcbRobLcbRebLobRebRibRobLjbRobRebLobLebLjbLcbRsbRcbRobRsbRobRe
bLsbRobRjbRibRjbRsbRjbRebLobRebLobRobRjbRobRobRebRebRobLjbRjbLjbLjbRsb
RjbRsbLobLobLebLsbLobLsbLsbRebRobLsbLobLebRsbLjbRebRjbRjLsbRjbLebRsbLj
bLsRgbLjbLjbLsbLsbLsbLsbRsbRjbRjbRsbLsbLsbLsbLjbLsbLsbRsbLsbLsbRsbRsbR
jbLsbRebLsbLsbLsLsmbRsbLsbRsbRsbRsbRsbLsRhbLjLsmbLsbLsbRsbLsbRsbRsbRsb
LsbRsbLsRsbRsbRjbRsbRjbLsbRobRsbRsbRsbLsLjbLsRsbLsbLsbRsbLsbLjbLsbLsbL
sbLsbRsbLsbLsbRsbRsbRsbLsbRsRsmbRsbLebRsbRsbLsbLjbLsbRsbRsbLsbLsbRsbLs
bLsbRsbRsbLsbRsbLsbRsbRsbsbLsbRsRsmbLsbRjbLsbLsbLsbRjbLsbLsbLsbLsbLsLs
mbRsbLsbRsbRsbLjbRsbLsbLsbLsbLsbLsbRsbRsbRsbLsbRsbRsbLsLsmbLsbRsbRsbRs
bRsbLsbRsbRsbLoLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 5; Drug: NDMC 10 然 Apo 50 然
bLibLibLhbRobLobLobLsRsLsbLcbLebLgbsbRjbRibLeLsLsmbLhbLibLcLgbLcRsbRhR
sRcRsmmbRobRobLeLsbLcbRgLsbRcRsmbLebLiLsLsmbRcbLobLoRsbLibRoRsRsmmbReR
smbRiRsRiRsmmbLibReRsmbsbsbRsRsRsReLsLsmmmbLsbRibLibRsbRsbsbsbLsbsbRiR
sRsRemmbLibLeLsLsLsRgmmbRebLsbsbRsLsRsRsmbRsRsRsmmbLebLebsbsbsbsbsbsbs
bsbsbsbsbRsbLsRsRsmbsbLsbsbLsbsbsbsbsbRsLsbsbRsbLsbRsbsbsbsbsbsbLsbLgb
RsbLsbLsbLsbRsbRsbLsbsbsbsbsbsbLsbLsbRsbRsbRjbLhRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 6; Drug: NDMC 10 然 Apo 50 然
bRsbLsbRsbRsbRsbLsbRsLsbLsRsbRsbRsbsbLsbRsbsbLsbRsbsbLsbRsbRsRsLsmbLsL
sLsLsmmmbLsbLsbLsLsLsLsmmmbRsbRsbRsbLsbLsbLebLgLebLeLsbLebRsRjbLsLsmbL
gbLebLebLebsbLebLgbLhbLiLsbLgLsLsLsLsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 7; Drug: NDMC 3 然 Apo 50 然
bLebLebsbsbsbsbsbRsbLebLsLiLsRsbLgLiLhbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 8; Drug: NDMC 3 然 Apo 50 然
bLsLgLgLsLebRcbsbsbsbsbRiLsLgbLiLhbRjbRcbsbRgRsRsRsRsRgRgRsRsmmmmmmbRs
bsbLsLgLsLgLsLsLsLsLsmmmmbLgbLhbRcbRoLsbLeLsLsmbLeLsLsmbRcRsmbLcLsLsLg
mmbLgbLsLibLiLsLsLsmmbLiLsLiLsLsLimbReRsmbLcbLibLibLgLsbLgLsbRsbLgbLgb
RcbsbRebRibRhLsLsmbLsbRiLsbRgRsmbLoLsLimbLiLsLsmbLhbReRsRsmmbRcLsbsbLs
bsbLsbLsLgLsLsLsLsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 9; Drug: NDMC 3 然 Apo 50 然
bLeLsbLsLcLsmbLsLsmbsbLcLsmbRsRsmbLcLsmbRsbLsRsRsRsmmbRsRcRsmbRcbLgLsL
sLhmbLoRhRsmbRcLebRsbRhbLiRgbLsbRsRsRsRsRsmmmmbRsbRsRsRsRsmmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 10; Drug: NDMC 3 然 Apo 50 然
bRsbLsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 11; Drug: NDMC 3 然 Apo 50 然
bRsbRsbsbsbsbRsbRsbLsbLsLjbsbsbsbLsbRsLsRsbLsbsbLjbsbRjbLsbLsbLsbsbLsL
smbLsLgbLsRsbLsbLsbRsLsbRsbRsbRsbRsbRsbLoLsLimbLsRsbRebRsbReLsbLebLsbR
jbRebLobLsbLobLsbRebRebLobRibRcbLobLsbRebLcbRobRobRobRgbLgbRobRgbRobRg
bLcbRcbRobRsbRgbRgbRebLobLebLsbRobRobLobLgbRibLcbLebLobLgbLobLobLobLob
RebRebLobLobRibLebRcbLgbLcbLobLobRobRebLebRobLibRjbLobRhbLobLobRobLobR
obRobRebLcbLsbRobRobLibRibLcbLsbRcbRobRobRcbLibRobRebRobRobLcbLobLcbLo
bLjbRjbRebLebRebRebRebLgbRhbLgbRebRobLobLobRgbLjbLcbRhbLjbLsbLgbLebLcb
RgbRobRgbRcbLobLobRobRobLcbRobRobLebRibRebRebRobRgbLgbLobLobRobLebLobL
ebRobRobRobLebRcbLobRjbRcbRgbRcbLobLebRobLobLobRcbRobRebLsbLobLsbRobRe
bRobRcbLebRobLebLcbRibRobRebRgbLcbRebRebRcbRobRebLjbLibRobRcbLcbRobRib
RobLobRobLobLobRobRobLebLobLibRcbRebLebLebRebLebLobRibRobLebRcbLebLobL
obRebRcbRobLebRjbLobLgbLobRebLobRgbRjbLobLgbLobRebRibRobRobLsbLobLobLo
bRobRcbLibLobRobRibLobRcbLobLsbRcbRsbLsbLibLebRobRibRebLobLgbRcbLebLob
RebRebLcbRobLibRibLgbRibRsbRobRibLcbRobRebRobLobRibRobRsbRobRobRsbRcbR
cbLebLebRsbLibRcbRobRcbLebRobRcbLobRsbLebLobLobRobRcbLebRobLgbRgbLsbRo
bRjbRcbRobRobLobRgbRobRgbRsbLebRobLebRobLgbLobRcbRibRcbLobLobRsbRobLob
LcbRobRibRebLobRcbLebRebLobLcbLebLhbLcbLsbRobLobLobRobRibRjbLgbLobRobR
cbLobRobLebRcbRobLobRobLobRibRobLobRebRobRobLobRobRebLebRcbLebRobRobRe
bLebRjbRobRebRcbRhbRebLsbRobLobLjbLobLebRebLcbRcbLebLebRobRcbLobLhbReb
RcbLcbRobRsbLgbLebLgbLebLebLobLobRgbRcbRebRebRebLibRobRcbLebRcbRobRsbL
obLobLgbLobLebLobRobRibRebRebRibRobLibLobRobLsbLcbRcbRcbRibLobRobLsbLo
bLobRobRcbLobRobRobLobRcbRsbLibRjbLobRcbRcbRebLgbLobRcbRsbRobLobRcbRgb
RobLcbRibRsbLsbRsbRebRcbRcbLgbRobRobRcbLebRgbLobRobLcbRcbLhbRibLibLhbL
cbLobRcbRebLsbLebLobLcbRebLcbLobLobLsbLobLsbRebLibLobLobLcbLsbLhbRgbLo
bRcbLcbLebLibRgbLobLobRibRhbRibLobLobLibRobRibLgbRhbLibLobRobLobLgbRcb
LobRcbLgbRsbLobRibLobRobLcbLebRobRobRebRobLgbLobLobRobRcbRebRebLobLobL
obLobLcbRhbLobLibLobRobRcbRcbRobRebRhbLhbRsbRobRgbLobLcbLebLibRebRibLg
bRgbRebLobLcbLibRobRcbLebLobLebLebLhbRobLebLobLobLobRibLobLsbLobLobLob
RcbLobLobLobRibLebRhbRcbLobLobRobLcbLebLobRobLobLobLebRebLhbLobLobLcbL
ebRobLobRibRcbRobLgbRibLobRobRcbLebLcbRcbRobRobLibLebRcbLobRebLobLibLi
bRebRobRobLibRcbRhbRibRsbRgbRobLobRgbRgbLebRobLobRobLobRcbRobLgbRcbReb
RcbRebRebLobRobRibRhbLsbLobLebLcbLobLcbLcbLebLobLobLsbRobLebRobLgbLcbL
jbRebRsbRebLebRobLcbLobRobRcbLebLcbLcbRebLcbLcbRcbRobLebLebRhbLobRcbRo
bRobLebRobRibRhbLebLgbLobLobLobLibRobLsbLebLcbRebLcbRobLobLobLibLgbRib
LibRebLebLobRcbLobRcbRobRgbRcbRcbLcbRebRobRcbLobRibRebRobRobLobRobLsbL
obRibRobRebLgbLibRobRobRobRgbLobLcbRobRcbLobLcbRsbLcbLebRhbLsbLebLcbRe
bRebRebLobLobRgbLhbRobRobRcbLobLobLobRobLebRjbRobLebLcbLobLobRobRobLob
RobLobLebRobRobLobLobLebLobRcbLibRibLebRcbRsbLibLcbLcbRobRobLobRobRobL
obRibLobLgbLcbLebLibRobRebRobRobRobRebLebRebRobRebLebLobRobRobLobLebRe
bRhbRibRobLobLobRcbLobLgbLobLhbLobRgbLobRebRibRebRobLibRobLobLobLibRob
RgbRobRobRgbLsbLjbRebRibLgbRebLebLhbLebLebLgbRobLobLibLebLobRcbLobRebL
obLcbRobRcbLobRebLcbLobLobLcbLobRebRobLgbRebRcbRobLobLebLebLibLjbLebLo
bRobLobLgbRjb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 12; Drug: NDMC 3 然 Apo 50 然
bRsLsLsmbsbLsbLsLsLgLsmbRsRsLsLsLimmbsbLsbRsLsLsLsLsmmmbLsLsLimbLeLsbL
iLsbLhLsLsmbLiLsbLsLsLsLgLsmmbLgLsbRsLeLsbLibLgLsLsLsLemmbRsRsLsRsLsLs
LsLsLsmmmmmbLsRsLsbsbsbsbsbsbsbLsbLsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 13; Drug: NDMC 1 然 Apo 50 然
bRsRsRsRsRsRsmmmmmbLsLgLsLsRsLsLsLsLsLsLsLsLsLeLsmmmmmmmmbLgbRgbRcbRhb
RebRgLsbRobRibLcRsRibLsLsLsLsLsLgLgLsLsLsLeLimmmmmmbLgbRsRsRsRsLgLgLsL
sLsLsLsLgLsLgLsLeLsmmmmmmmbLibRibLcbLjbLjbRsbRsbRgbRgbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 14; Drug: NDMC 1 然 Apo 50 然
bRgbLcbLcbRgbRcbRhbLcbLcLsmbLibLibLibLibRibRibRiRsmbLjbRgbLibRcbRiLsbL
jbLgbLiRsbsbsbLsLsRgmbRsRgRgRsRsmmbRsRsRsmmbsbsbRsRsRsRsRsRsRsRgLsRsRs
mmmmmmmbRsbRgbRsRsRsRsmmmbRsRsmbRsbRsbRcRsRsmmbRcbLcbLobLcbRebLcbLoRsb
RibRebLebLebLcLsmbLeRsbLiLsbLcRsbLebLibLgRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 15; Drug: NDMC 1 然 Apo 50 然
bLcbLobLebLcbRobLcbRobRobLobLcbRsbRebRcbRebRebRebRobLgbLobRebRebRobLsb
RsbRebRcbRobRebRobLebRobRibLobRcbRebLcbLibRebLobRobLobRobRobLgbLcbLobL
cbRebLobLobRcbLibLobLebRobRobRcbLcbRobLebRebLobRgbLebRhbLebLobLobLebRe
bRobLobRobRgbRobRebRibLjbLcbRsbRcbRgbLcbRgbRgbLibRobLhbRebRobRebLibLgb
LobLobRebLobLjbLebRobLebRgbRobLcbLebRobRsbRebRcbLobLjbLhbLobLebRibRibL
obRobRobRebRobRcbLcbRobLobRcbLjbLcbLobLsbLobLgbLobLobRebLcbRcbLibRobLo
bRebRcbRobLobLobRobLebRobRobLebLgbRobRcbLobLgbRebLibLcbLobRibLcbRebRib
LobLebRcbLobRobRhbLobLobRobRobRcbLobRebRibRcbLobRibLobLebLobRgbRebRebR
obLcbLobLcbLebRibRcbRcbRebLcbRobLobLebRobRgbLcbLobRobRgbLcbRobRcbRjbRi
bLebRcbRsbRobRibLcbRibLgbLobLsbRcbRhbRebRebRebLobRsbLcbLobRobLobLibLcb
RebLibLebLobLebRibRobRibRobLjbLibRobLebRobRobLcbRobRebRcbRebRebLebLobL
cbRcbRebRobRsbLgbLibRsbLibLebLobLobRebRsbRobRebLibRobLebLhbRsbRobLgbRg
bLibLobRobLcbLobRobRcbRibRobRobRebLebLebLobLobLcbLobLebRebRobRibRebRcb
LobLobLebRgbRebRobRobRgbRcbRobRibLibLcbLjbRgbRebLibRhbRobLebLcbLobLebL
ebRobLgbRcbLebRcbLobLhbLobLobRobLobLgbRobRibLobRcbLebLcbRcbLibRobRebRs
bLobRobRobLebLebLcbRcbRobLcbRsbLobLebRobLgbLobRebRcbLibRibLcbLebLibLeb
RebLcbLebLcbLebLcbRibLcbRcbLobLobLobRhbLgbLebLibLibLcbLobRobLebLcbLgbR
ebRobLibLhbLcbRobLhbLcbLobLsbLobLebRebRcbLibLobLobRebLebLobRsbLcbLcbLs
bLgbRobRobRsbRcbRibLgbRibLebRobLebRebLsbLcbRcbRgbLibRgbRcbRsbRsbLobLob
LebRebLcbRgbLobRgbLebRebRobLcbRobRhbRcbLgbLsbLebLobRcbRsbLsbRobRobLebL
ebRebLebRcbRobRcbRhbRebLobRobLebLobLibLobRsbRebLgbRobLcbLcbLobRobRebLi
bLcbRibLhbRobRcbRibLgbLobRobLhbRgbRibLebRebLebRobRobRcbLcbRcbRobLobReb
LebLobRobLobLobLobRobRcbLibLcbLebLibLobLobRobLebRgbLobRobLobLobRobRobL
cbLebLibRobLibLibLobLsbRobRobRcbRobLobLcbRobLebLgbRebRcbLcbRcbRobRebLi
bRobLcbRcbLibRobLobRcbRebRgbRebLobLcbLebRcbRgbLobRobLobRcbRgbRibLobLob
RebRobRcbRobRebLcbRebRobLcbRgbRobRibLobLibRsbLcbRobLcbRebLebLcbLcbLobR
ebRobLobLibLcbLgbLebRobRcbLcbRgbLcbRobLjbRsbLebRhbRobRcbRobRebLobLcbLg
bLobRsbLobLibLibRobRobLhbLcbRebLebLebLobRobLebRgbRobLobLcbRcbRebRebLeb
LobLobLjbLobRsbRibLebRebLcbLobRobLebLobLgbLobRcbRobRsbRobRgbLobLcbLebR
ebRobRibRcbLgbLebLebRobLobLgbRibLebRcbRobLebRebRcbLsbLcbLsbLibRcbRibRe
bLcbRobRgbLobLobRobLgbLebRebLobRgbRcbLebLebLobRibRgbRobLgbLobRebLobRcb
LobRibRcbRhbLebLobLobRobRhbRebLebLebRobRcbLebRcbRcbRcbLobLobRobRobLobR
sbLebLebRgbRobRobLgbLsbRgbRobLobRobLobRobRcbRobLobRobLcbRibLgbRobRobLo
bLobRgbRcbRebRibLcbLobLebLobLcbRobLebLobRebRobLibLobRgbRobRebRobRcbRjb
LcbLebLibLhbRobRsbLcbRobLobLobLibLebLobRcbRsbRebLgbRsbLcbRobRgbRcbRebR
obRebRebLobRobLcbRsbRebLgbLebRobRcbRobRobLobRobLjbLebLobRgbRobRebRobRg
bLobLobLgbRibLebRobRcbRobLjbRebRjbRebLobRibLsbRebLobRcbRebRjbRebLobLob
LgbRibLcbLebLcbRobRcbRobRjbLibLebRebRebRibLsbRobRobLobRibLebLobLebLobL
obRobRobRcbLobRobLsbLcbRobLobRjbRcbLebRcbRhbRobRobRobRjbLobRibRobRgbRo
bRebLgLobRobLgbLjbRgbRobLibRebLjbRebRobLebLebLcbLobRebLsbLjbLebLebLobR
obLcbLjbRobRhbLobRebLsbLebRobLsbRebLobLobLebRhbRobLcbLobLcbLcbLobRobRo
bRsbLcbLobLibRibRsbLebLobLebLjbRebLobRobLjbLobLobLobRobLobRobRobRobRcb
LjbLobRcbLcbLebLobLebRobRjbRebLobRobLjbLjbLjbLjbLjbLebLebLobLebLobRjbL
ebRebLjbRebLobLobLobRebLjbRibLobLsbLjbRcbLebRobLsbLibRobRjbLjbLebLobLo
bRobRcbRebLebRebRobLcbRebLgbLebRjbRjbRjbLebRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 16; Drug: NDMC 1 然 Apo 50 然
bRgbRsRsRsReRsRimmmbRgLsRsRsRsRgRsRgmmmbRcRgbRgbRibRgbRsbRgbLsRsbRsRgR
sRgmbRcRsmbLgLsbRsRsRsRiRsRsRgmmmmbRgbRsRsRsmmbRsRsRimbRibLsRsRsRsmmbR
sRsRsLsRgmmbRgbRsRsRgRgmbRgbRsRsRsRsmmmbRsbRgbRsRsRgRsmmbRsRsLimbRsbRs
RgRsRsRsRgRemmmbRsRsRgmbRsRgRsRsRsRgLsmmmbRsbRgbRibLjbRsRsmbRgRebRsRsR
sRgRsRsRgRgRsRgRgReRsRgRsmmmmmmmbRcRgbsbRsbRsRsRgRsRsmmmbRiLsbRsRiRsRs
mmbRiLibRiRsRgRgRgRsRgmmbRsRsRgmbRgbRgbRiLsbRiRsRsRsRiRsLsmmmmbRsRsRsR
sRgRsmmmmbLsRibRibRgRgRsRgRgmbLsbRsRsRsRsRsRgRsRgmmmmmbRsRgbRsRsRgmbRg
LsbRgbRiRsmbRgRsmbRibsbRcbLgbRcbRiReRsmbRsRgRsmbLsbRebLsRsRsRsmmbsbRsb
RsRsmbRibRcbRsRsLsmbRgRgRsmbRgRsRsmmbRgRsRsRgmmbLsRgbRsRsmbRgbRgRsRimb
RsRgRibRsbRiRgRgLsbRgRsRsRgRgLsmmbRsRsRsRsRgRiRgmmmbRsRsRsRgmmbLsRsRsR
sRgmmbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsRsRsRgRsRsmmmmbRiRsRsRsRgRsRgRsRgmm
mmmbRsRsmbRsRsRsRsRsRsRsRsRsRsRemmmmmmmmmbRsRgbRiRsRsRsRsRgRsRsmmmmmmb
RsRsRsRsRsRsRgRsRsRiLsRgmmmmmmmbRgbRsRsmbRsLsRsRsRgRsRsRgmmmbRgRgRsmbL
sbRgRsRsRgmmbRsRsRsRgmmbsbRgLibRsRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 17; Drug: NDMC 1 然 Apo 50 然
bRibLsRsRsRsRgRsRsRsRsReRsmmmmmmmbReRsRsRsmmmbRsRsRgmbRebRgbRsRebRsRsR
sRsRsRsmmmmmbReRsRsRsRsRgmmmmbRsRsRsRsmmmbRgRsRsmmbRsRsRsRsRimmmbRgbRs
RgRsRsmmbRsRgbRsRsRgmbReRsRhmbRsRiRsRsmmbRsRgbRsRgRsmbRsRsRsRsRsRiRsRs
RemmmmmmbRcbRobLsbLgbLsbLibRsRsmbLsLsmbRsbLiLsbLsLiLsbLsbLsLsmbLeLsbsb
sbRsLibLeLsbLgLsbLsLsmbLgLsbRebLsbLsbRsbsbRsbLsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 18; Drug: NDMC 1 然 Apo 50 然
bRsRgbRsRsRiRsRsRsRgmmmmbRhLsbRsbRsbsbRsRsmbRsRsmbLsRsRsmbRsbRsbRsbRgR
smbRgLsbRsLsbRsbRsbRsbRsbRsbsbRsbRsRsmbRsLsbRgRsRhRsmmbRgReRsmbRsRsRsR
sRsRsRsRsRsmmmmmmmmbRsRsRgRgRsRgRsRsmmmmbRsRsmbRsbsbLsRhbRsbLsbRsRsRgm
bRsbRsbRsbRsbRsbRsbRsbRsbLsRsbRsbRsbRsRsmbLsRsbRebLoLsmbsbRsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bRebRebLjb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bLgLsbLsbsbsbRsRsLimbLebRcLsbRsbLsLsmbsbLgLsbRcbLebLgbLgbRsbLsbLibLgbL
eLsbLeLsbsbReLsbRibRcbRebRiLsbRiLsbRcbRebRsbLsbRsRsmbLsbLibLibLsLcbsbL
sbRsLsbLjbLobLgLsLsmbLgLsLsmbLebLgbLibLsbLgbLsbsbsbsbLsbRsLsbRjbLibLcL
smbLgLeLsbLgLeLsbLgLeLgbLsbLsLsmbRgbLsbLsbLebLgbLeLsbsbsbLebRsbLhLeLsb
LoLsmbsbsbLsLsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bRcbsbLsRsRsmbRebLsbRebRgRsRsmmbRgRsmbsbReRsmbRoRsmbRibRsLsbRsbsbsbRsb
sbLsbLsbRsbLjbRsbRebRibRobRobRgbLsbRebRhbsbRgRsRgLsmbRebRiRsmbLibLsbRi
bReRsmbRiLgbLoRibRhLebLebRsLsbLibsbLsbLgbLgbLgbLiRsbRebLsRgbRhbRibRobL
gLsbRgbRsbRgbRebRgbRgbRgbRgbRgbRib

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bRibRebLsbRgbLsbsbLsbRsRsRhmbRgbRobRgbRsLsbLsbRgbRsbRsbRsbRobRsbRebReb
sbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bLsbLsbLsbRsbLsbsbRobLhbLcbRobLsbReRgRsRimbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bRsRsmbRsbRsbLsRsbRsbRobRjbRobLgbLcbRsRibRebLsRsbRgRsmbLsbRibLcbRsbLsL
sLsmmbLsbRsbLsbLhbLgbRsbsbLsbLsbLsbRsbRsRsRsmmbRsbRsbRsbLebLibRsbsbRib
LgbRsbRsbRebRebRsbRibRsbRebsbLsRsRsmbRgbLibsbLibLhbRiRsmbLibLsbLjbRobR
cRsmbLibLibLibsbLsbLsbLgbRsbLgbLsbLsbLsLgLsLsmbLsbLsLsmbLsbLsbLsbLsbLg
bRjbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 25; Drug: NDMC 10 然 Apo 50 然
bLsbRsbRebRebRiLsbRsRgRsmbRsbRgRsmbLcbRcbRebRiRsmbsbRsbRsReRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 26; Drug: NDMC 10 然 Apo 50 然
bRsbLsbRobLsbRhbRgbRgbsbRsbRsbLsbRsbLsbRsbRsbRsbRsbRsbLsbLsbLsbRsRsRsR
smmmbLsRsLsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 27; Drug: NDMC 10 然 Apo 50 然
bRsbLsbRsbRiRsmbRsRsmbRsRsmbRsbRsbRsbsbsbRiRsmbRsRsmbRsRsRsmmbLgRsbRsR
smbRsRsRsmmbRsbLjbLhbLiLsbLsbLsRsbRjbRcbRibRsbRsbRhRsRsmmbRsbRsRsRsRsm
mmbRsRsRsmmbRgRsRsmmbLsRsRsmbRgRsRsRsmmmbRsbRsbRsRsRsmmbRsbRgRsRsmmbRs
RsRsRsmmmbRgbRhbRgRgbRgbRsRsRsmmbRsbRsRsmbRcRsmbRsRsRsRsmmmbLsRsRgbRgb
RibRgbRhRsmbRgbRgbRiRsmbLgbRsRsmbRsRsmbRibRsRsmbRsbLsbRiRsRsmmbRebRibR
gbRcbRcRsmbRebRobLiRsbLgbLibLobsbLhbLibLhbLibRebRsbLebLibLibLgLsbLsbRs
bLgbLgbLsRsRsmbLgbLgbLsbLgbsbLgbLsbLsbLsbLgbLsbLgbLibLgbRcbLjbLibLibLs
LgbLgbLibRcRsmbRsbRsbsbRgbRgbRsbRsbLjbRgbRgbRsbRsbRgLsbLcbRgbRebLgbRgb
RsbRiRgbRibLiRsbRgbLjbRgRgbRgbRgbRgbRsRgbLibRsRsmbLgbRgLsbLsRsbLoRsbRi
bLibRjbLjbRcbRibsbRsbLsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 28; Drug: NDMC 10 然 Apo 50 然
bLiLsRhbLibsbLeLsbLiRsRibsbRsRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 29; Drug: NDMC 10 然 Apo 50 然
bLiLibRsbsbLsbLsbLsLsLsLsmmmbLhLeLibLibLsbLsLsLsLsLsmmmmbLgLsLgLgLebLg
bRgRsmbLsbLsbLsLebLhbLsLsLsLemmbLsLgbLsbRsbsbLsbRsbRsbRsbLsbLsbLiLsLeb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 30; Drug: NDMC 10 然 Apo 50 然
bRibRsbsbsbRgbRsRsRsmmbRsbRsbRsbRsbLsbRsbLsbLsbLgbRsbLsbRgbRgbLebsbsbs
bsbsbRsbRibsbRsbRgbRsRsmbLoRsbRcbLoRobLobLsbsbLgLsLsmbLsRsRsmbRsbRsbRs
bRsbRsbRgbRebRgbRsbRsbRgbRsbRibRgRsmbsbsbRsRsmbRsbRsbRgbLsbRhbRgbRgbRi
bRibRebRsRsRsRsmmmbRibRgbRsbRsbRgbRgRsmbRsbRhRsRsmmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 31; Drug: NDMC 3 然 Apo 50 然
bRebLebRobLgbRobLgbRebLobRobLobRcbRgbRobLobLobLobRcbRobLobLcbLobRcbLob
LebLobRobLsbRsbLgbLebLcbLebRhbRcbLobLebRcbRcbLobRhbLobLobLebLcbLobRobL
ibLobRebLcbRsbRebRsbLebRibRobLobRsbLhbLobLebRobLibRobRgbRebLobRcbRgbRs
bRcbRebLobRsbRebLobRebLebRobRobRobRobLobRobLibLobLgbLobRebLhbLobRcbLgb
LebLcbRobRobLobRebLgbRcbLobLcbRebLcbLobRebLobRcbLebRobRobRcbLebRobLobL
ebRsbRibLobLcbLgbRobLobLebRcbRcbRibLobRobRobRobLebLobLebRcbRgbRebRobLo
bRcbRcbLcbRebLgbLsbLcbRcbRobLgbRhbRobLobRobRibRcbRcbRhbLebRebLcbRobLob
RebRobLobLebLebLcbLcbRcbRsbLebLobLobLgbRobRobRsbLobLgbRobRebRobRsbRhbL
gbLobLgbLibRibLobRebLcbRgbRsbLgbLobLsbRibLcbRgbLgbLcbRebRsbLebRjbLibLi
bLebLobLebRebRobRobRgbRibRobLobLobLobLebLebRobLcbRobLibRebLebRcbRobRgb
LhbRibRebRsbRobRcbLebLobRcbLobRsbRebLgbLibLgbRgbRibLobLibLcbRobRobLobR
ebLibRobRobRobLibRgbLibLobLibRgbLobRcbRsbLcbRobLebRcbRobRcbRebLgbLobRo
bRebLobRebLebLobLobRobRibLgbRobLgbRcbRibLibRibLobLebLhbLobLebRebRobLgb
RobLgbRgbRcbLebLobRobRsbLcbLebLobLhbLebLobRebLibLibLcbRobRobLebRebRobR
obRibLebLgbRcbRcbRebLcbRhbRgbLgbRebRebLcbRibRebLobRibLebRobRsbLobLobRc
bRibRobRobRebRcbLibLcbRcbRcbRebLobLgbLobRobLebRobLcbRobRobLcbRobLobReb
RcbRebRsbRebLobRibLibRobRobLibRgbLobRobLobRebLobRobLsbLibRebLobRhbLebL
cbRebLebLibRobRgbRobLsbLobLsbRsbLobRebLgbLebLobRibLcbRobRebRsbRcbRebRe
bRibRebLobRibRobRcbLhbLobLibRobRebLobRibLcbRobLobRibLobLobRobRcbLgbLeb
RibRibRgbRhbRobLebLobLobLcbRobLebLobLgbLgbLcbRobRcbLibRobLobLebRcbRobL
ebLobRebRcbRcbLgbRcbRibRebLebRobRobRebRobLcbRebLebLobLebLobLebRhbRobRs
bLobRebLcbRjbLcbLobLebLobRibRebLebLobLcbLebRobLobRhbRobRebRibRobLobReb
RgbRsbLibRebRobLobRhbLcbRobLobRcbLobRebRobLsbLjbLcbLebRibLgbLobRobRobR
ibRobLobRgbLobLebLebLebRebLebLgbLcbLobLgbLcbLhbRcbRcbRobLhbLgbLcbRibLo
bRobRibLebRebLgbLcbLobRobLebRobLcbLobLsbLebRcbLobRobLcbLobLobLcbLebRcb
LebLcbRebLebRebRcbRobLibLebRobLsbRobRibRebLcbLobRobLobLibRibRsbRsbLobL
ebLebRebLobRobRcbRobLcbLobRobLobLobRebLgbRobRcbLibRobRebRhbLobRhbLcbRc
bRsbRobLcbLibLobLebLobRobRcbLcbLcbRgbLobRobLcbRhbRobRebRobLobRobLcbLsb
RcbRobRcbLebLobRobLcbRobRcbLcbRgbRebLobRobLobLobRibRgbRcbLobRobRebLebR
ebLibRobRobRebRibLobRobLgbRobLobRsbRibLobRebRobLobLibLcbLcbLcbRebRobRc
bRebLobLsbLhbLebLgbRobRgbLebLgbLobRobLobRobRcbRcbLibLsbLcbRobRsbLgbLob
LobLebLjbLibLobLobRebRobRcbRebRibLibRgbRebRobRobRebRcbRgbRebRcbLebLibL
ebRobRobRebRebRebRibRobLebRebRobRebLobLcbRgbRgbRobRibLobLobRjbRobLebLo
bRibRcbLobLobLcbLibLcbRobRobRebLobLibRcbLebLebRibLebLobLebLobLgbRcbRob
LobLobRobRsbRebRcbRebRobRjbRobLobLcbLibRcbRgbRebRhbRobLcbLobRobRibLgbR
ebLgbRobLibRobLcbLsbRobRobLobRebLsbLobRobRobLobRobLgbRgbRibRebRsbLibRo
bRobRgbLsbRcbLobRobLcbRibRobRebLobRebRebLebLcbRjbLgbRebLobRebLibRcbLob
RcbRebLobRebRebRcbRcbRcbLebRcbLibRebRobRobLobLhbRjbLebLobRobRebRsbRebL
obLsbRebLcbRgbRobLhbRobLibLebRobLob

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 32; Drug: NDMC 3 然 Apo 50 然
bRsRsReRsmmbReLgLsRcbRgRsRembRsbLsRiRsmbRibRebReRgbRsRebReRsmbRgbsbRsL
sLsmbRsRebRgbReRsmbRebRebRsbRgbReRibRibRsRsmbRhbLgbRibRebRgRebRgRsmbRg
bRgLsLibRsbLsbLsbLeLebLgLeRsbLsLiLsbLsLsmbLsbLgbLgLsLsmbLsLsLgLimbLeLs
bLiLsLsLeLeLsLembLgLebLsbLsLsmbLsLsLsLsRsmmmbLeRebRebsbLsLiLgbLsbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 33; Drug: NDMC 3 然 Apo 50 然
bRobRsRsmbRsRsmbRsRsRsRsmmmbsbRibRgLsLsmbRsLsbRibLsLsmbRhRsmbRsbLobLsL
sLsLsmmmbLcLsmbLgbRgbRcRsmbRiRsmbRsLsLsLsLsmmmbRhRsLsmbLsRsLsbLsLgLgbR
cRsmbLgbLiLsLsmbLgLsbLsbLsbLhLsbLsbLgbLiLsLsmbLsRsRsLsmbLsLsLsmmbLsbLi
bRebRcbRsRsRsRemmbRcbLsLgLgbLsbLsLsLsmmbLsLsmbRebLsbRiRgbRgbLgb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 34; Drug: NDMC 3 然 Apo 50 然
bRcbRibRgbsbRcbLeLsbLcbLgbsbLgLsRsRsmbRoRsmbLcbLcbLcLsmbLiRsRsLsmbsbRs
bsbRcbLsbRcbsbLcbLibLsLsmbRsbLiLsLsLsmmbLcLsmbRcbRgbRgbRibRgbRibLsLcbL
cbRcbRibRgLsbLgbRgbLhLsbLgLgLgLsLsmbLsRsbRhbLibRjbRsRsRsRsmmmbRiLsbLhb
RjbRjbLsLsLsLsmmmbRjbsbRhLsbLsbRjbRcbRsRsmbRjbRiRsmbRibLibLhLsLsmbLcbL
ibLcLsmbLiLsLebLgbLsbLebLebRcb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 35; Drug: NDMC 3 然 Apo 50 然
bRjbRhbRgbRebRibRgbLsRgbRsbRgbRsbRsbRgbRgRsmbRsbRsbLsbLsbRsbRebLsbLsbL
obRsbLsbLcbRobRebLsRsbRsbRcbRcbLcbRcbLob

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 36; Drug: NDMC 3 然 Apo 50 然
bRsReRsLcmbRsLhLeRsbLsLsmbLgbRoRsmbRebLeLsbsbsbsbsbsbsbsbsbsbLcbRebLoL
smbLsLebLibRibLgbRjbRebReRsmbReRobLebRgbLsLcbRibLgbLjLsmbLcbLeLebLgbRs
bLgLsbLsbLebLeRcbLebLgbLibLgLeLsbLgbLibsbLeLibLjbLibLibLgbLsLibLibLebL
sb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 37; Drug: NDMC 1 然 Apo 50 然
bsbLsbRsbRsRsRsmmbRsRsRsRsRsRsRsRgRsmmmmmmmbRsRgRsmbRgRsmbRgbRsRsRsRsR
smmmmbRgbRgRsmbRgbLsRsRsmbsbLsbLcLsmbLsbLeLsbsbRsLsRgbRgRsRsmmbRsRsRsR
sRsRsRsRemmmmmmbRsRiRsmbRsRsLsmbRgbRebLcbRobRobLibLgbLibLobLsLgLsbLsLg
LsLgbLsLgLgLsbLgbLsLeLsbLsLsLgmbLgbLgbsbLsbLsRsLsLsmbLiLsbLsLsmbLsLsLs
LsLsLgLgLsLsLimmmmmbLsbLgbsbRsbLsbLibLgLsbLgLsLsLsLemmbLgLsbRcRsmbRcbL
iLsbLsbRobRcbRsRiRgbRgbRhRebRsbRsLsbRgRsRsmmbRsLsRsRsRsmmbRgbRsbRsRsmb
RgRsmbRsRsRgmbRgb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 38; Drug: NDMC 1 然 Apo 50 然
bRsRsRgmbRsRsRsmmbRsRgbRsRgbRsRsRsRsRsRsRgmmmmmbRsRsRsRsRgmmmbRsRsmbRs
bLsLsRsmbRhbRsRsRgmbRcRsmbLibRsRsRsRgRsmmmbRsRsRsRsRgRimmmbsbRsRsmbRiR
smbRsRsRsRsmmmbRsbRsRsRsmmbRsRebRsRsmbRsRsRgRsmmbRsRsRsRsRsmmmmbRsRsmb
LsRsbRsRsRsRgmmbsbRsRgbRsbRhRsmbRsLsRsLgbsbRibsbRsRsRsRsRsRimmmmbRsRsm
bRsRsRsmmbRsRsmbRhbReRebRgbsbRsRsRembLibsbRsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 39; Drug: NDMC 1 然 Apo 50 然
bLgbLsLsLsRsmmbRsbRsbLsbRibRgRsRsmmbRcbLsRsRgRsRsmmbLobRsbRsRsmbReRsRs
RsReRemmmbLjbLsLsmbLsLsmbRibLsLsmbRsbRibsbRjbRiRsRgRembRibReRgReRiRsRs
mmbRiRsRsRiRsmmmbLgbLcRsbLibLobLhbLibLibsbsbsbsbsbsbsbsbsbRsbsbsbsbRsb
LsbRgbRgbsbLibLibLgbLibLgLebRjbLgbLgbRhRgRebLhbReRsmbLobLsbLsbRibRebRe
bLibLobLiLsLiLsRsbLgLsRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 40; Drug: NDMC 1 然 Apo 50 然
bLsbLsLsmbLcbRgbLgbRgLsbRsLebLsbLsLsmbRsLgbLsbLsbLsLsmbLibLcbLsLibRibL
sbLgbLsbLgbLsbLsbLgbLibLgLsLsLsmmbLgbLgLsbLgbRsbRebLibLgbLsLsLsLsmmmbL
gLsLgLsbLsLsLsRsmmbLebLsLgbLsLsmbLsbLsLsLsLsmmmbLiLsbRgLsbLsbLsbLebLsb
LsbLgLgbLsbLibRebRcbRcbLsLsmbLsbLsbLeLsbLsLsLgLsLsLiLgmmbLibLgbLeLsbLo
bRsbLsLsLsLsLsLsLsLgmmmmmmbLsbLibLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLs
LsLimmbRcbRsbLsRsLsRsRsmbRsbsbLsbLsLsLsLsmmmbLibLgLsbLsLsLsmmbLsbLiLsL
smbLsbLsbsbLsLsLsLsLsLsLgmmmmmbRcLsLsmbRsLsbLsbLsLsLsmmbLsbLgbLsbRjbLe
bLcLsmbLgLsLgLsLsmbLgbLgLsLsLsLsmmmbRsbRgbRcbLsbLsbLsLsmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 41; Drug: NDMC 1 然 Apo 50 然
bRsbsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 42; Drug: NDMC 1 然 Apo 50 然
bLebRsLsbRsbRcbRobsbsbsbsbsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bRsRsReLsmbRebsbRsRgbRsbRgbLobRibLjbRcbsbRsLsLsmbLsbRsbLsbRgbRsbRgRsRs
RgRiRsmmmbRsbsbLsLsmbRebRiRsmb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bLgLsLsLsmmbLeLsbsbLsRsLsbsbsbRsbRsbsbsbLsbsbsbsbsbLsbsbsbsbsbRsbRsbLs
bRsbRsbLsLgLeLsbLgbRcbLobRsbRsbRsbsbRsbRsbRgbRsbsbsbsbLsRsLsbRsbsbLsbs
bsbsbRgbRsbsbRgLsbLsbsbRsbsbRsbRsbRsbLsbsbLobLibRsRibRcbLiLsbRobRoLsbs
bsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bRjRsRsRsRsRsRgRsRsLsmmmmmmmbLsLebRsLsbLgbLgRsRsmbRjbLsbReRsmbRsLsLsRs
mbRsbRsbRsbLsLsmbRebRebLcbRcbRcbLeLiLgLsbRebRibRobLobLibLiLsbRebRcbRib
RsRcRsmbLibRjbRcbRgRsRsmmbRsbRcRsmbRobRebRhbLibLgbLeRsbLgbLeLsbLibLhRs
bRsbLibLcbLiLsRsbLibLibLgbLibLhbLibRsRsmbLjLiLsbRebRiRsRsRsmmmbRsbsbLi
bLgLgLsLgbsbLgLsLsLsLsLsLsLsmmmmmmbLsbLsbRjbReRsmbRsRobLsRcbLibRcbRcbs
bRcbLcbLibLgbLgbLsLsLsLhmmbLgbLiRsLsbLibLgLsbLjLcbLgRsbLebLiLsbRebRiRs
mbLcbLibLeLsbLgLsbLsLsLsLsmmmbLsbLsLsmbRjbReRsmbRebReRsmbLgbRsLsbLgbLg
bLgLhbLobReLsbLeLsbLgbLcLsmbLibRebRcbRhbLibLibLgbLgbRebRebLsbLcbLcbLgR
sbRibLhbRsbsbLcbsbRhbRcbRsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
bRsRsRsmmbRsRsmbsbsbRsbRsRsRsLsRsmmbRsbLsbLsLsLsmmbLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bRsLsbsbRgRsRsRsmmmbsbRcRsmbRibLcbRhLsbRcbRebRgbsbRibRibRcbRsRsRsRsmmm
bRsRsRsRsRsRsRsRgRsRsRsRsRsRsRsmmmmmmmmmmmmmbRhbRiRsRsRsRsRsRsRsRsmmmm
mmmmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsmbRsRsRsRgRsmmmbRsRsRsRsRsRsRsRsRsRsR
sRsRsRsRgmmmmmmmmmmmmmbRsRsRsRsRsRsRsRsRgmmmmmmmbLobRcbRebRsbLcbLjbLcL
smbLobLhbLhLsb

>ZF Recording 2016-03-17; tW: 300s; Start: 163337; End: 163837;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bRsRsRsmmbReRgbRgbLhRsbLgRsbLiRsLsLsmbRhbRibRgRibLsReRgRsRgRsRgRsRsRsm
mmmmbRsRsRsRsRsRsRgRgRemmmmmbRsRgRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsRsRsRsm
mmmmmmmmbRsRsRsRsRsmmmmbLsRsRsRsRsRsReRsmmmmmbRsRsRsRiReRsRemmmbRgRgLs
RsRsRsRsRsRsRsRsRsRgRsRsRsmmmmmmmmmmmbRsReRgRsRgmbRgRsRgmbRsRsmbRsRsmb
LsRsRsRsRsmmmbRsReRsmbsbsbsbRsRsReRgRsRsRsReRimmmmbRsRsRsRgRsRsReReRsR
smmmmmmbsbLsbRsRsReRiRsRsReRsmmmmbRiRibLsRgRsRsRgRsmmmbRsbRsRsReRsmmbR
gRsmbRsRhbReRiRsRsmmbLobLeRsRsmb

